CAROL A. DERBY

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$6,296,132

FY 2026

Project Title

Einstein Aging Study

Grant Number:

5P01AG003949-41

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/29/1982

End Date:

3/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

ABSTRACT The etiology of Alzheimer’s disease and related dementias (ADRD) is multifactorial and given the current lack of disease-modifying treatments, there is a growing need to better understand the roles of modifiable risk factors. The overarching goal of this Einstein Aging Study Program Project...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Panagiotis Konstantinopoulos

DANA-FARBER CANCER INST, BOSTON, MA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,955,232

FY 2026

Project Title

Targeting Replication Stress and DNA Damage Response in Uterine Cancer

Grant Number:

5P01CA269021-03

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2024

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY Uterine cancer (UC) incidence and death rates are both significantly increasing in the United States. Most UCs are endometrial cancers which arise from the inner lining of the uterus and are defined by several different histologic subtypes, the most common of which is endometrioid. A...

Research Terms

<1-Phosphatidylinositol 3-Kinase><ARID1A><ARID1A gene><AT- rich interactive domain-containing protein 1A><AT-rich interactive domain 1A gene><Address><Advocate><Animals><Antioncogene Protein p53><Applications Grants><Assay><Basic Research><Basic Science><Bioassay><Biologic Models><Biological Assay><Biological Markers><Biological Models><Biometrics><Biometry><Biopsy><Biostatistics><Boston><CRISPR editing screen><CRISPR screen><CRISPR-based screen><CRISPR/Cas9 screen><Cancer cell line><Cancers><Carcinoma><Cell Communication and Signaling><Cell Signaling><Cellular Tumor Antigen P53><Checkpoint inhibitor><Clinical><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Collection><Communication><Communities><Computational Biology><Computer software><DF/HCC><DNA><DNA Alteration><DNA Damage><DNA Damage Repair><DNA Injury><DNA Repair><DNA Replication><DNA Sequence Alteration><DNA Synthesis><DNA analysis><DNA biosynthesis><DNA damage check point><DNA damage check point response><DNA damage checkpoint><DNA damage checkpoint response><DNA replication fork><Dana-Farber Cancer Institute><Data><Data Analyses><Data Analysis><Data Bases><Data Collection><Databases><Death Rate><Deoxyribonucleic Acid><Disease><Disorder><Dose><Endometrial Cancer><Endometrial Carcinoma><Endometrium><Endometrium Cancer><Endometrium Carcinoma><Epithelial cancer><Experimental Designs><Experimental Models><FLJ11330><Female Reproductive Cancer><GEM model><GEMM model><Genetic Alteration><Genetically Engineered Mouse><Genome Instability><Genomic Instability><Goals><Grant><Grant Proposals><Gynecologic Cancer><Gynecologic Pathology><Gynecological Cancer><Histologic><Histologically><Hospitals><Human><IFN-regulatory factor 3><IRF-3 protein><IRF3><IRF3 gene><Immune><Immune checkpoint inhibitor><Immune mediated therapy><Immunes><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologically Directed Therapy><Immunologics><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunotherapy><In Vitro><Incidence><Interferon Regulatory Factor 3><International><Intracellular Communication and Signaling><Investigators><Kinases><Laboratories><Lead><Leadership><Malignant Cell><Malignant Epithelial Neoplasms><Malignant Epithelial Tumors><Malignant Female Reproductive System Neoplasm><Malignant Gynecologic Neoplasm><Malignant Gynecologic Tumor><Malignant Neoplasm of the Uterus><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Female Reproductive System><Malignant Tumor of the Uterus><Malignant Uterine Neoplasm><Malignant Uterine Tumor><Measures><Mediating><Methodology><Methods><Mismatch Repair><Model System><Modeling><Modern Man><Monitor><Mutate><NF-Kb-Activating Kinase Gene><Oncoprotein p53><Organoids><Outcome><P53><PDX model><PI-3 Kinase><PI3-Kinase><PI3CG><PI3KGamma><PI3k><PIK3><PIK3CG><PIK3CG gene><Pathology><Pathway interactions><Patient derived xenograft><Patients><Pb element><Phase><Phosphatidylinositol 3-Kinase><Phosphatidylinositol-3-OH Kinase><Phosphoinositide 3-Hydroxykinase><Phosphoprotein P53><Phosphoprotein pp53><Phosphotransferase Gene><Phosphotransferases><Post-Replication Mismatch Repair><Pre-Clinical Model><Preclinical Models><Protein TP53><Protocol><Protocols documentation><PtdIns 3-Kinase><Recurrence><Recurrent><Relapse><Reporting><Research><Research Personnel><Researchers><Salvage Therapy><Salvage-Tx><Sampling><Sequence Alteration><Serous><Signal Transduction><Signal Transduction Systems><Signaling><Software><T2K><TBK1><TBK1 gene><TP53><TP53 gene><TRP53><Translating><Translational Research><Translational Science><Transphosphorylases><Treatment Efficacy><Tumor Immunity><Tumor Protein p53><Tumor Protein p53 Gene><Type I Phosphatidylinositol Kinase><Type III Phosphoinositide 3-Kinase><United States><Unscheduled DNA Synthesis><Uterine Cancer><Uterine Neoplasms><Uterine Tumor><Uterine lining><Uterus><Uterus Cancer><Uterus Neoplasms><Uterus Tumor><Woman><Work><analyze DNA><anti-cancer research><anti-tumor immunity><antitumor immunity><bio-markers><biologic marker><biological adaptation to stress><biological signal transduction><biomarker><black female><black women><cancer cell><cancer immunity><cancer research><check point inhibition><checkpoint inhibition><clustered regularly interspaced short palindromic repeats screen><computer biology><data base><data interpretation><design><designing><drug development><epithelial carcinoma><experiment><experimental research><experimental study><experiments><female outcomes><genetically engineered mouse model><genetically engineered murine model><genomic alteration><gynecologic malignancy><gynecological malignancy><heavy metal Pb><heavy metal lead><immune check point inhibition><immune check point inhibitor><immune checkpoint inhibition><immune suppression><immune suppressive activity><immune suppressive function><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><improved outcome><in vitro Model><in vivo><inhibitor><intervention efficacy><kinase inhibitor><malignancy><member><mortality rate><multidisciplinary><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><outcomes among females><outcomes among women><outcomes in females><outcomes in women><p53 Antigen><p53 Genes><p53 Tumor Suppressor><pathway><patient derived xenograft model><programs><protein p53><quality assurance><reactioncrisis><replication fork><replication stress><response><statistics><stress response><stressreaction><survival outcome><synergism><targeted agent><therapeutic efficacy><therapeutic outcome><therapy efficacy><therapy outcome><translation research><translational investigation><translational progress><translational progression><tumor><womb><women's outcomes>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joyce Liu

DANA-FARBER CANCER INST, BOSTON, MA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,955,232

FY 2026

Project Title

Targeting Replication Stress and DNA Damage Response in Uterine Cancer

Grant Number:

5P01CA269021-03

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2024

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY Uterine cancer (UC) incidence and death rates are both significantly increasing in the United States. Most UCs are endometrial cancers which arise from the inner lining of the uterus and are defined by several different histologic subtypes, the most common of which is endometrioid. A...

Research Terms

<1-Phosphatidylinositol 3-Kinase><ARID1A><ARID1A gene><AT- rich interactive domain-containing protein 1A><AT-rich interactive domain 1A gene><Address><Advocate><Animals><Antioncogene Protein p53><Applications Grants><Assay><Basic Research><Basic Science><Bioassay><Biologic Models><Biological Assay><Biological Markers><Biological Models><Biometrics><Biometry><Biopsy><Biostatistics><Boston><CRISPR editing screen><CRISPR screen><CRISPR-based screen><CRISPR/Cas9 screen><Cancer cell line><Cancers><Carcinoma><Cell Communication and Signaling><Cell Signaling><Cellular Tumor Antigen P53><Checkpoint inhibitor><Clinical><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Collection><Communication><Communities><Computational Biology><Computer software><DF/HCC><DNA><DNA Alteration><DNA Damage><DNA Damage Repair><DNA Injury><DNA Repair><DNA Replication><DNA Sequence Alteration><DNA Synthesis><DNA analysis><DNA biosynthesis><DNA damage check point><DNA damage check point response><DNA damage checkpoint><DNA damage checkpoint response><DNA replication fork><Dana-Farber Cancer Institute><Data><Data Analyses><Data Analysis><Data Bases><Data Collection><Databases><Death Rate><Deoxyribonucleic Acid><Disease><Disorder><Dose><Endometrial Cancer><Endometrial Carcinoma><Endometrium><Endometrium Cancer><Endometrium Carcinoma><Epithelial cancer><Experimental Designs><Experimental Models><FLJ11330><Female Reproductive Cancer><GEM model><GEMM model><Genetic Alteration><Genetically Engineered Mouse><Genome Instability><Genomic Instability><Goals><Grant><Grant Proposals><Gynecologic Cancer><Gynecologic Pathology><Gynecological Cancer><Histologic><Histologically><Hospitals><Human><IFN-regulatory factor 3><IRF-3 protein><IRF3><IRF3 gene><Immune><Immune checkpoint inhibitor><Immune mediated therapy><Immunes><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologically Directed Therapy><Immunologics><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunotherapy><In Vitro><Incidence><Interferon Regulatory Factor 3><International><Intracellular Communication and Signaling><Investigators><Kinases><Laboratories><Lead><Leadership><Malignant Cell><Malignant Epithelial Neoplasms><Malignant Epithelial Tumors><Malignant Female Reproductive System Neoplasm><Malignant Gynecologic Neoplasm><Malignant Gynecologic Tumor><Malignant Neoplasm of the Uterus><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Female Reproductive System><Malignant Tumor of the Uterus><Malignant Uterine Neoplasm><Malignant Uterine Tumor><Measures><Mediating><Methodology><Methods><Mismatch Repair><Model System><Modeling><Modern Man><Monitor><Mutate><NF-Kb-Activating Kinase Gene><Oncoprotein p53><Organoids><Outcome><P53><PDX model><PI-3 Kinase><PI3-Kinase><PI3CG><PI3KGamma><PI3k><PIK3><PIK3CG><PIK3CG gene><Pathology><Pathway interactions><Patient derived xenograft><Patients><Pb element><Phase><Phosphatidylinositol 3-Kinase><Phosphatidylinositol-3-OH Kinase><Phosphoinositide 3-Hydroxykinase><Phosphoprotein P53><Phosphoprotein pp53><Phosphotransferase Gene><Phosphotransferases><Post-Replication Mismatch Repair><Pre-Clinical Model><Preclinical Models><Protein TP53><Protocol><Protocols documentation><PtdIns 3-Kinase><Recurrence><Recurrent><Relapse><Reporting><Research><Research Personnel><Researchers><Salvage Therapy><Salvage-Tx><Sampling><Sequence Alteration><Serous><Signal Transduction><Signal Transduction Systems><Signaling><Software><T2K><TBK1><TBK1 gene><TP53><TP53 gene><TRP53><Translating><Translational Research><Translational Science><Transphosphorylases><Treatment Efficacy><Tumor Immunity><Tumor Protein p53><Tumor Protein p53 Gene><Type I Phosphatidylinositol Kinase><Type III Phosphoinositide 3-Kinase><United States><Unscheduled DNA Synthesis><Uterine Cancer><Uterine Neoplasms><Uterine Tumor><Uterine lining><Uterus><Uterus Cancer><Uterus Neoplasms><Uterus Tumor><Woman><Work><analyze DNA><anti-cancer research><anti-tumor immunity><antitumor immunity><bio-markers><biologic marker><biological adaptation to stress><biological signal transduction><biomarker><black female><black women><cancer cell><cancer immunity><cancer research><check point inhibition><checkpoint inhibition><clustered regularly interspaced short palindromic repeats screen><computer biology><data base><data interpretation><design><designing><drug development><epithelial carcinoma><experiment><experimental research><experimental study><experiments><female outcomes><genetically engineered mouse model><genetically engineered murine model><genomic alteration><gynecologic malignancy><gynecological malignancy><heavy metal Pb><heavy metal lead><immune check point inhibition><immune check point inhibitor><immune checkpoint inhibition><immune suppression><immune suppressive activity><immune suppressive function><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><improved outcome><in vitro Model><in vivo><inhibitor><intervention efficacy><kinase inhibitor><malignancy><member><mortality rate><multidisciplinary><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><outcomes among females><outcomes among women><outcomes in females><outcomes in women><p53 Antigen><p53 Genes><p53 Tumor Suppressor><pathway><patient derived xenograft model><programs><protein p53><quality assurance><reactioncrisis><replication fork><replication stress><response><statistics><stress response><stressreaction><survival outcome><synergism><targeted agent><therapeutic efficacy><therapeutic outcome><therapy efficacy><therapy outcome><translation research><translational investigation><translational progress><translational progression><tumor><womb><women's outcomes>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

URSULA Anne MATULONIS

DANA-FARBER CANCER INST, BOSTON, MA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,955,232

FY 2026

Project Title

Targeting Replication Stress and DNA Damage Response in Uterine Cancer

Grant Number:

5P01CA269021-03

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2024

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY Uterine cancer (UC) incidence and death rates are both significantly increasing in the United States. Most UCs are endometrial cancers which arise from the inner lining of the uterus and are defined by several different histologic subtypes, the most common of which is endometrioid. A...

Research Terms

<1-Phosphatidylinositol 3-Kinase><ARID1A><ARID1A gene><AT- rich interactive domain-containing protein 1A><AT-rich interactive domain 1A gene><Address><Advocate><Animals><Antioncogene Protein p53><Applications Grants><Assay><Basic Research><Basic Science><Bioassay><Biologic Models><Biological Assay><Biological Markers><Biological Models><Biometrics><Biometry><Biopsy><Biostatistics><Boston><CRISPR editing screen><CRISPR screen><CRISPR-based screen><CRISPR/Cas9 screen><Cancer cell line><Cancers><Carcinoma><Cell Communication and Signaling><Cell Signaling><Cellular Tumor Antigen P53><Checkpoint inhibitor><Clinical><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Collection><Communication><Communities><Computational Biology><Computer software><DF/HCC><DNA><DNA Alteration><DNA Damage><DNA Damage Repair><DNA Injury><DNA Repair><DNA Replication><DNA Sequence Alteration><DNA Synthesis><DNA analysis><DNA biosynthesis><DNA damage check point><DNA damage check point response><DNA damage checkpoint><DNA damage checkpoint response><DNA replication fork><Dana-Farber Cancer Institute><Data><Data Analyses><Data Analysis><Data Bases><Data Collection><Databases><Death Rate><Deoxyribonucleic Acid><Disease><Disorder><Dose><Endometrial Cancer><Endometrial Carcinoma><Endometrium><Endometrium Cancer><Endometrium Carcinoma><Epithelial cancer><Experimental Designs><Experimental Models><FLJ11330><Female Reproductive Cancer><GEM model><GEMM model><Genetic Alteration><Genetically Engineered Mouse><Genome Instability><Genomic Instability><Goals><Grant><Grant Proposals><Gynecologic Cancer><Gynecologic Pathology><Gynecological Cancer><Histologic><Histologically><Hospitals><Human><IFN-regulatory factor 3><IRF-3 protein><IRF3><IRF3 gene><Immune><Immune checkpoint inhibitor><Immune mediated therapy><Immunes><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologically Directed Therapy><Immunologics><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunotherapy><In Vitro><Incidence><Interferon Regulatory Factor 3><International><Intracellular Communication and Signaling><Investigators><Kinases><Laboratories><Lead><Leadership><Malignant Cell><Malignant Epithelial Neoplasms><Malignant Epithelial Tumors><Malignant Female Reproductive System Neoplasm><Malignant Gynecologic Neoplasm><Malignant Gynecologic Tumor><Malignant Neoplasm of the Uterus><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Female Reproductive System><Malignant Tumor of the Uterus><Malignant Uterine Neoplasm><Malignant Uterine Tumor><Measures><Mediating><Methodology><Methods><Mismatch Repair><Model System><Modeling><Modern Man><Monitor><Mutate><NF-Kb-Activating Kinase Gene><Oncoprotein p53><Organoids><Outcome><P53><PDX model><PI-3 Kinase><PI3-Kinase><PI3CG><PI3KGamma><PI3k><PIK3><PIK3CG><PIK3CG gene><Pathology><Pathway interactions><Patient derived xenograft><Patients><Pb element><Phase><Phosphatidylinositol 3-Kinase><Phosphatidylinositol-3-OH Kinase><Phosphoinositide 3-Hydroxykinase><Phosphoprotein P53><Phosphoprotein pp53><Phosphotransferase Gene><Phosphotransferases><Post-Replication Mismatch Repair><Pre-Clinical Model><Preclinical Models><Protein TP53><Protocol><Protocols documentation><PtdIns 3-Kinase><Recurrence><Recurrent><Relapse><Reporting><Research><Research Personnel><Researchers><Salvage Therapy><Salvage-Tx><Sampling><Sequence Alteration><Serous><Signal Transduction><Signal Transduction Systems><Signaling><Software><T2K><TBK1><TBK1 gene><TP53><TP53 gene><TRP53><Translating><Translational Research><Translational Science><Transphosphorylases><Treatment Efficacy><Tumor Immunity><Tumor Protein p53><Tumor Protein p53 Gene><Type I Phosphatidylinositol Kinase><Type III Phosphoinositide 3-Kinase><United States><Unscheduled DNA Synthesis><Uterine Cancer><Uterine Neoplasms><Uterine Tumor><Uterine lining><Uterus><Uterus Cancer><Uterus Neoplasms><Uterus Tumor><Woman><Work><analyze DNA><anti-cancer research><anti-tumor immunity><antitumor immunity><bio-markers><biologic marker><biological adaptation to stress><biological signal transduction><biomarker><black female><black women><cancer cell><cancer immunity><cancer research><check point inhibition><checkpoint inhibition><clustered regularly interspaced short palindromic repeats screen><computer biology><data base><data interpretation><design><designing><drug development><epithelial carcinoma><experiment><experimental research><experimental study><experiments><female outcomes><genetically engineered mouse model><genetically engineered murine model><genomic alteration><gynecologic malignancy><gynecological malignancy><heavy metal Pb><heavy metal lead><immune check point inhibition><immune check point inhibitor><immune checkpoint inhibition><immune suppression><immune suppressive activity><immune suppressive function><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><improved outcome><in vitro Model><in vivo><inhibitor><intervention efficacy><kinase inhibitor><malignancy><member><mortality rate><multidisciplinary><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><outcomes among females><outcomes among women><outcomes in females><outcomes in women><p53 Antigen><p53 Genes><p53 Tumor Suppressor><pathway><patient derived xenograft model><programs><protein p53><quality assurance><reactioncrisis><replication fork><replication stress><response><statistics><stress response><stressreaction><survival outcome><synergism><targeted agent><therapeutic efficacy><therapeutic outcome><therapy efficacy><therapy outcome><translation research><translational investigation><translational progress><translational progression><tumor><womb><women's outcomes>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Dario C Altieri

WISTAR INSTITUTE, PHILADELPHIA, PA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,855,437

FY 2026

Project Title

Consolidated Basic Cancer Research Program

Grant Number:

2P30CA010815-57

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/1997

End Date:

2/28/2031

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY – OVERALL Rated Exceptional at both the 2013 (impact score, 19) and 2018 (impact score, 14) renewals of the Cancer Center Support Grant (CCSG), and receiving a two-year MERIT extension from the National Cancer Institute (NCI) in 2022, the Wistar Cancer Center continues an exponential...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JILL M DANIEL

TULANE UNIVERSITY OF LOUISIANA, NEW ORLEANS, LA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,799,973

FY 2026

Project Title

Estrogens, Cardiometabolic Health, and Female Cognitive Aging

Grant Number:

5P01AG071746-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/1/2022

End Date:

2/28/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Overall Summary Loss of ovarian function at menopause is hypothesized to be a risk factor for Alzheimer’s disease and related dementias. Research in preclinical models indicates that estrogens are neuroprotective and can positively impact the cognitive aging trajectory. However, clinical data have b...

Research Terms

<20S Catalytic Proteasome><20S Core Proteasome><20S Proteasome><20S Proteosome><AD and related dementia><AD dementia><AD related dementia><AD risk><AD risk factor><ADRD><APF-1><ATP-Dependent Proteolysis Factor 1><Adult-Onset Diabetes Mellitus><Affect><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer risk factor><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimer's disease risk><Alzheimers Dementia><Ammon Horn><Aquadiol><Arteriosclerotic Dementia><Autoregulation><Behavior><Blood Vessels><Brain><Brain Nervous System><CTX><CYCLO-cell><Cardiometabolic Disease><Cardiometabolic Disorder><Cardiovascular><Cardiovascular Body System><Cardiovascular Diseases><Cardiovascular Organ System><Cardiovascular system><Carloxan><Ciclofosfamida><Ciclofosfamide><Cicloxal><Clafen><Claphene><Clinical Data><Cognition><Cognition Disorders><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive aging><Cognitive decline><Cognitive function abnormal><Cornu Ammonis><Cycloblastin><Cycloblastine><Cyclophospham><Cyclophosphamide><Cyclophosphamidum><Cyclophosphan><Cyclophosphane><Cyclophosphanum><Cyclostin><Cyclostine><Cytophosphan><Cytophosphane><Cytoxan><Development><Diet><Dimenformon><Diogyn><Diogynets><Disease><Disorder><Disturbance in cognition><Dysfunction><ENOS><ERalpha><ERα><ESR1><ESR1 gene><Encephalon><Endocrine Gland Secretion><Endocrine Therapy><Endothelial Nitric Oxide Synthase><Endoxan><Endoxana><Enduxan><Ensure><Estrace><Estradiol><Estradiol Receptor alpha><Estradiol Receptor α><Estradiol-17 beta><Estradiol-17beta><Estraldine><Estrogen Receptor 1><Estrogen Receptor alpha><Estrogen Receptor α><Estrogen Receptors><Estrogen Therapy><Estrogens><Female><Fosfaseron><Functional disorder><Genoxal><Genuxal><Goals><HMG-20><Health><Health Status><Heart Vascular><High Fat Diet><High Mobility Protein 20><Hippocampus><Homeostasis><Hormonal Therapy><Hormones><Hypertension><Impaired cognition><Impairment><Incidence><Insulin Resistance><Investigation><Ketosis-Resistant Diabetes Mellitus><Leadership><Ledoxina><Level of Health><Long-Term Potentiation><Macropain><Macroxyproteinase><Maturity-Onset Diabetes Mellitus><Measurement><Memory><Menopause><Metabolic><Metabolic syndrome><Mitoxan><Modeling><Molecular><Multicatalytic Proteinase><NIDDM><NOS3><NOS3 gene><NR3A1><Neosar><Nerve Degeneration><Neuron Degeneration><Nitric Oxide Synthase 3><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Ovarian><Ovocyclin><Ovocylin><P01 Mechanism><P01 Program><Personalized medical approach><Physiologic><Physiological><Physiological Homeostasis><Physiopathology><Pre-Clinical Model><Preclinical Models><Primary Senile Degenerative Dementia><Procedures><Process><Procytox><Program Project Grant><Program Research Project Grants><Progynon><Prosome><Proteasome><Proteasome Endopeptidase Complex><Proteosome><Recommendation><Regulation><Reproducibility of Findings><Reproducibility of Results><Research><Research Program Projects><Risk Factors><Rodent Model><Sendoxan><Signal Pathway><Slow-Onset Diabetes Mellitus><Stable Diabetes Mellitus><Syklofosfamid><Synaptic plasticity><System><T2 DM><T2D><T2DM><Testing><Therapeutic Estradiol><Therapeutic Estrogen><Therapeutic Hormone><Type 2 Diabetes Mellitus><Type 2 diabetes><Type II Diabetes Mellitus><Type II diabetes><Type III nitric oxide synthase><Ubiquitin><Variant><Variation><Vascular Dementia><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Weight Gain><Weight Increase><Woman><Zytoxan><adult onset diabetes><aged brain><aging brain><aging delay><alzheimer risk><attenuate aging><blood glucose regulation><body weight gain><body weight increase><cardiometabolic><cardiometabolism><cardiovascular disorder><cerebrovascular contributions to dementia><circulatory system><cognitive change><cognitive disease><cognitive disorder><cognitive dysfunction><cognitive function><cognitive loss><cognitive syndrome><decelerate aging><delay age related><design><designing><developmental><diets><estrogen hormone therapy><estrogen treatment><experiment><experimental research><experimental study><experiments><glucose control><glucose homeostasis><glucose regulation><health level><high blood pressure><hippocampal><hormone therapy><hyperpiesia><hyperpiesis><hypertensive disease><hypertensive disorder><individualized approach><insulin resistant><insulin tolerance><ketosis resistant diabetes><maturity onset diabetes><menopausal hormone therapy><menopausal hormone treatment><mid life><mid-life><middle age><middle aged><midlife><midlife estradiol><multicatalytic endopeptidase complex><neural degeneration><neuro-vascular coupling><neurodegeneration><neurodegenerative><neurological degeneration><neuronal degeneration><neuroprotection><neuroprotective><neurovascular coupling><pathophysiology><pause aging><personalized approach><postpone age related><precision approach><preservation><primary degenerative dementia><programs><response><retards aging><risk factor for developing Alzheimer's><risk factor in Alzheimer's><risk of developing Alzheimer's><senile dementia of the Alzheimer type><slow aging><slow down aging><slow the rate of aging><tailored approach><treated with estrogen><treatment with estrogen><type 2 DM><type II DM><type two diabetes><vascular><vascular contributions in dementia><vascular contributions to dementia><vascular related dementia><wt gain><♀>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Darrell N. Kotton

BOSTON UNIVERSITY MEDICAL CAMPUS, BOSTON, MA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,784,712

FY 2026

Project Title

Developing Pluripotent Stem Cells to Model and Treat Lung Disease

Grant Number:

5P01HL170952-03

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/1/2024

End Date:

2/28/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

SUMMARY: OVERALL PROGRAM The goal of this Program Project Grant (PPG) is advancing the latest discoveries in stem cell biology, human organoid models, and gene editing to understand and treat genetic lung diseases. After a century of basic sciences advances, culminating in recent Nobel Prize-winning...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John Sai Keong Kauwe

WASHINGTON STATE UNIVERSITY, PULLMAN, WA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,765,989

FY 2026

Project Title

Natives Engaged in Alzheimer's Research

Grant Number:

5P01AG066584-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2021

End Date:

1/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

OVERALL: ABSTRACT American Indians/Alaska Natives (AI/ANs) and Native Hawaiians and Pacific Islanders (NHPIs) are increasingly concerned about Alzheimer’s disease and related dementias, as these conditions will soon have a major impact on their communities. Although AI/ANs and NHPIs share a high pre...

Research Terms

<65 and older><65 or older><65 years of age and older><65 years of age or more><65 years of age or older><65+ years><65+ years old><> 65 years><AD and related dementia><AD dementia><AD patients><AD related dementia><AD risk><AD risk factor><AD therapy><AD treatment><ADRD><Address><Adherence><Adult-Onset Diabetes Mellitus><Aged 65 and Over><Alaska Indian><Alaska Native><Alaska Native group><Alaska Native individual><Alaska Native people><Alaska Native population><Alaska Natives><Alaskan American><Alaskan Indian><Alaskan Native><Alaskan Native American><Alaskan Natives><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer disease treatment><Alzheimer risk factor><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer treatment><Alzheimer's><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease patient><Alzheimer's disease related dementia><Alzheimer's disease risk><Alzheimer's disease therapy><Alzheimer's patient><Alzheimer's therapy><Alzheimers Dementia><Amentia><American Indian><American Indian Population><American Indian group><American Indian individual><American Indian people><American Indian reservation><American Indians><Area><Articulation><Awareness><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Sciences><Behavioral Therapy><Behavioral Treatment><Blood Sample><Blood specimen><Cataloging><Catalogs><Cholesterol><Clinic><Clinical><Clinical Sciences><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive function abnormal><Collection><Communities><Community Health Care><Conditioning Therapy><DNA><Data><Decrease disparity><Dementia><Deoxyribonucleic Acid><Detection><Disparities><Disparity><Disturbance in cognition><Economic Burden><Economics><Elderly><Ensure><Family><Frequencies><Friends><Genetic Markers><Genetic Research><Genetic predisposing factor><Genotype><Goals><Hawaii><Hawaiian><Health><Health Benefit><Health Care Systems><High Prevalence><Hypertension><Impaired cognition><Indian reservation><Indigenous Population><Intervention><Investigators><Island><Ketosis-Resistant Diabetes Mellitus><Knowledge><Leadership><Life Expectancy><Lower disparity><Maturity-Onset Diabetes Mellitus><Minnesota><NIDDM><National Institute of Aging><National Institute on Aging><Native Hawaiian><Native Hawaiian and Other Pacific Islander><Native Hawaiian and Pacific Islander><Native Hawaiian or Other Pacific Islander><Native Hawaiian or Pacific Islander><Native People><Native-Born><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Obesity><Observational Study><Obstructive Sleep Apnea><Persons><Physical activity><Population><Primary Senile Degenerative Dementia><Provider><Public Health><QOL improvement><R-Series Research Projects><R01 Mechanism><R01 Program><Randomization trial><Randomized, Controlled Trials><Research><Research Grants><Research Methodology><Research Methods><Research Personnel><Research Priority><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Saliva><Sampling><Satellite Centers><Sleep Apnea><Sleep Apnea Syndromes><Sleep Hypopnea><Sleep-Disordered Breathing><Slow-Onset Diabetes Mellitus><Smoking><Social Sciences><Special Population><Stable Diabetes Mellitus><Syndrome, Sleep Apnea, Obstructive><T2 DM><T2D><T2DM><Testing><Training><Translating><Type 2 Diabetes Mellitus><Type 2 diabetes><Type II Diabetes Mellitus><Type II diabetes><Underrepresented Ethnic Minority><Underrepresented Minority><Universities><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Washington><Work><above age 65><adiposity><adult onset diabetes><advanced age><after age 65><age 65 and greater><age 65 and older><age 65 or older><age > 65><age of 65 years onward><aged 65 and greater><aged 65+><aged ≥65><alzheimer risk><behavior intervention><behavioral intervention><catalog><cognitive dysfunction><cognitive function><cognitive loss><cohort><community care><community partners><community partnership><community-based partners><corpulence><culturally adapted intervention><culturally appropriate intervention><culturally centered intervention><culturally focused intervention><culturally informed intervention><culturally responsive intervention><culturally tailored intervention><dementia risk><demographics><depository><disparity elimination><disparity in health><disparity reduction><economic><effective intervention><effectiveness testing><eliminate disparities><eliminating disparities><experience><gene biomarker><gene expression biomarker><gene marker><gene signature biomarker><genetic biomarker><genetic risk factor><geriatric><health disparity><high blood pressure><high risk><human old age (65+)><hyperpiesia><hyperpiesis><hypertensive disease><hypertensive disorder><improved><improvements in QOL><improvements in quality of life><inherited factor><innovate><innovation><innovative><interest><ketosis resistant diabetes><low SES><low socio-economic position><low socio-economic status><low socioeconomic position><low socioeconomic status><maturity onset diabetes><mild cognitive decline><mild cognitive disorder><mild cognitive dysfunction><mild cognitive impairment><mild cognitive loss><mild neurocognitive impairment><mitigate disparity><nation reservation><native elder><natives><observational research study><observational survey><older adult><older adulthood><over 65 years><patient living with Alzheimer's disease><patient suffering from Alzheimer's disease><patient with Alzheimer's><patient with Alzheimer's disease><patients with AD><polygenetic risk scores><polygenic risk score><preservation><prevent><preventing><primary degenerative dementia><programs><public health research><quality of life improvement><randomized control trial><randomized trial><recruit><reduce disparity><reduction in disparity><repository><research and methods><reservation community><risk factor for dementia><risk factor for developing Alzheimer's><risk factor in Alzheimer's><risk for dementia><risk of developing Alzheimer's><rural clinic><rural health clinic><saliva sample><salivary sample><senile dementia of the Alzheimer type><senior citizen><sleep-related breathing disorder><social><tribal community><tribal reservation><type 2 DM><type II DM><type two diabetes><under-representation of minorities><under-represented minority><underrepresentation of minorities><≥65 years>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Sterling M McPherson

WASHINGTON STATE UNIVERSITY, PULLMAN, WA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,765,989

FY 2026

Project Title

Natives Engaged in Alzheimer's Research

Grant Number:

5P01AG066584-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2021

End Date:

1/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

OVERALL: ABSTRACT American Indians/Alaska Natives (AI/ANs) and Native Hawaiians and Pacific Islanders (NHPIs) are increasingly concerned about Alzheimer’s disease and related dementias, as these conditions will soon have a major impact on their communities. Although AI/ANs and NHPIs share a high pre...

Research Terms

<65 and older><65 or older><65 years of age and older><65 years of age or more><65 years of age or older><65+ years><65+ years old><> 65 years><AD and related dementia><AD dementia><AD patients><AD related dementia><AD risk><AD risk factor><AD therapy><AD treatment><ADRD><Address><Adherence><Adult-Onset Diabetes Mellitus><Aged 65 and Over><Alaska Indian><Alaska Native><Alaska Native group><Alaska Native individual><Alaska Native people><Alaska Native population><Alaska Natives><Alaskan American><Alaskan Indian><Alaskan Native><Alaskan Native American><Alaskan Natives><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer disease treatment><Alzheimer risk factor><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer treatment><Alzheimer's><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease patient><Alzheimer's disease related dementia><Alzheimer's disease risk><Alzheimer's disease therapy><Alzheimer's patient><Alzheimer's therapy><Alzheimers Dementia><Amentia><American Indian><American Indian Population><American Indian group><American Indian individual><American Indian people><American Indian reservation><American Indians><Area><Articulation><Awareness><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Sciences><Behavioral Therapy><Behavioral Treatment><Blood Sample><Blood specimen><Cataloging><Catalogs><Cholesterol><Clinic><Clinical><Clinical Sciences><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive function abnormal><Collection><Communities><Community Health Care><Conditioning Therapy><DNA><Data><Decrease disparity><Dementia><Deoxyribonucleic Acid><Detection><Disparities><Disparity><Disturbance in cognition><Economic Burden><Economics><Elderly><Ensure><Family><Frequencies><Friends><Genetic Markers><Genetic Research><Genetic predisposing factor><Genotype><Goals><Hawaii><Hawaiian><Health><Health Benefit><Health Care Systems><High Prevalence><Hypertension><Impaired cognition><Indian reservation><Indigenous Population><Intervention><Investigators><Island><Ketosis-Resistant Diabetes Mellitus><Knowledge><Leadership><Life Expectancy><Lower disparity><Maturity-Onset Diabetes Mellitus><Minnesota><NIDDM><National Institute of Aging><National Institute on Aging><Native Hawaiian><Native Hawaiian and Other Pacific Islander><Native Hawaiian and Pacific Islander><Native Hawaiian or Other Pacific Islander><Native Hawaiian or Pacific Islander><Native People><Native-Born><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Obesity><Observational Study><Obstructive Sleep Apnea><Persons><Physical activity><Population><Primary Senile Degenerative Dementia><Provider><Public Health><QOL improvement><R-Series Research Projects><R01 Mechanism><R01 Program><Randomization trial><Randomized, Controlled Trials><Research><Research Grants><Research Methodology><Research Methods><Research Personnel><Research Priority><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Saliva><Sampling><Satellite Centers><Sleep Apnea><Sleep Apnea Syndromes><Sleep Hypopnea><Sleep-Disordered Breathing><Slow-Onset Diabetes Mellitus><Smoking><Social Sciences><Special Population><Stable Diabetes Mellitus><Syndrome, Sleep Apnea, Obstructive><T2 DM><T2D><T2DM><Testing><Training><Translating><Type 2 Diabetes Mellitus><Type 2 diabetes><Type II Diabetes Mellitus><Type II diabetes><Underrepresented Ethnic Minority><Underrepresented Minority><Universities><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Washington><Work><above age 65><adiposity><adult onset diabetes><advanced age><after age 65><age 65 and greater><age 65 and older><age 65 or older><age > 65><age of 65 years onward><aged 65 and greater><aged 65+><aged ≥65><alzheimer risk><behavior intervention><behavioral intervention><catalog><cognitive dysfunction><cognitive function><cognitive loss><cohort><community care><community partners><community partnership><community-based partners><corpulence><culturally adapted intervention><culturally appropriate intervention><culturally centered intervention><culturally focused intervention><culturally informed intervention><culturally responsive intervention><culturally tailored intervention><dementia risk><demographics><depository><disparity elimination><disparity in health><disparity reduction><economic><effective intervention><effectiveness testing><eliminate disparities><eliminating disparities><experience><gene biomarker><gene expression biomarker><gene marker><gene signature biomarker><genetic biomarker><genetic risk factor><geriatric><health disparity><high blood pressure><high risk><human old age (65+)><hyperpiesia><hyperpiesis><hypertensive disease><hypertensive disorder><improved><improvements in QOL><improvements in quality of life><inherited factor><innovate><innovation><innovative><interest><ketosis resistant diabetes><low SES><low socio-economic position><low socio-economic status><low socioeconomic position><low socioeconomic status><maturity onset diabetes><mild cognitive decline><mild cognitive disorder><mild cognitive dysfunction><mild cognitive impairment><mild cognitive loss><mild neurocognitive impairment><mitigate disparity><nation reservation><native elder><natives><observational research study><observational survey><older adult><older adulthood><over 65 years><patient living with Alzheimer's disease><patient suffering from Alzheimer's disease><patient with Alzheimer's><patient with Alzheimer's disease><patients with AD><polygenetic risk scores><polygenic risk score><preservation><prevent><preventing><primary degenerative dementia><programs><public health research><quality of life improvement><randomized control trial><randomized trial><recruit><reduce disparity><reduction in disparity><repository><research and methods><reservation community><risk factor for dementia><risk factor for developing Alzheimer's><risk factor in Alzheimer's><risk for dementia><risk of developing Alzheimer's><rural clinic><rural health clinic><saliva sample><salivary sample><senile dementia of the Alzheimer type><senior citizen><sleep-related breathing disorder><social><tribal community><tribal reservation><type 2 DM><type II DM><type two diabetes><under-representation of minorities><under-represented minority><underrepresentation of minorities><≥65 years>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Zahi A. Fayad

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,685,855

FY 2026

Project Title

Targeting trained immunity in transplantation

Grant Number:

5P01AI168258-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2023

End Date:

3/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

SUMMARY – OVERVIEW Transplantation has revolutionized the lives of patients suffering from organ failure. The design of modern immunosuppression has employed a time-honored focus on controlling T cell-mediated responses. However, current immunosuppressive therapies have suboptimal success rates and ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joren C Madsen

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,685,855

FY 2026

Project Title

Targeting trained immunity in transplantation

Grant Number:

5P01AI168258-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2023

End Date:

3/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

SUMMARY – OVERVIEW Transplantation has revolutionized the lives of patients suffering from organ failure. The design of modern immunosuppression has employed a time-honored focus on controlling T cell-mediated responses. However, current immunosuppressive therapies have suboptimal success rates and ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bruce E. Landon

HARVARD MEDICAL SCHOOL, BOSTON, MA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,664,320

FY 2026

Project Title

Medicare at a Crossroads

Grant Number:

5P01AG032952-17

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/15/2009

End Date:

4/30/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

The Methods & Theory Core aims to develop and apply innovative statistical methods, economic theory, and distributional analysis tools to enhance research on Medicare policies and their impact on the health and health care of older adults. Through its position as an intellectual hub within the P...

Research Terms

<21+ years old><Acceleration><Address><Adult><Adult Human><Age><Amentia><Attention><Behavioral><Caring><Case-Mix Adjustments><Code><Coding System><Collaborations><Communities><Contracting Opportunities><Contracts><Data><Dementia><Disabling condition><Disabling health condition><Drug Prescribing><Drug Prescriptions><Economics><Eligibility><Eligibility Determination><Enrollment><Event><Face><Flounder><Fostering><Friction><Future><Generalized Growth><Goals><Growth><Health><Health Care><Health Care Systems><Health Insurance for Aged and Disabled, Title 18><Health Insurance for Disabled Title 18><Incentives><Insurance Carriers><Insurers><Intention><Investigators><Learning><Long-Term Care><Marketing><Medicare><Methodology><Methods><Mission><Modeling><Modernization><Modification><Motivation><National Institute of Aging><National Institute on Aging><Outcome><P01 Mechanism><P01 Program><Performance><Physicians><Policies><Policy Maker><Population><Position><Positioning Attribute><Privatization><Program Project Grant><Program Research Project Grants><Protocol Screening><Public Policy><QOC><Quality of Care><R-Series Research Projects><R01 Mechanism><R01 Program><Randomized, Controlled Trials><Regulation><Research><Research Grants><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Researchers><Risk><Role><Scientific Advances and Accomplishments><Scientist><Self-Help Groups><Shapes><Social Insurance><Social Sciences><Social Security><Statistical Methods><Stream><Support Groups><System><Talents><Techniques><Thinking><Tissue Growth><Title 18><Training><Travel><Update><Work><access to health care><accessibility of health care><accessibility to health care><adulthood><aged group><aged groups><aged individual><aged individuals><aged people><aged person><aged persons><aged population><aged populations><ages><aging population><analytical tool><beneficiary><care delivery><data infrastructure><data resource><design><designing><differences in health><disability><economic><economic security><economic self-sufficiency><economic stability><economic well-being><enroll><evidence base><experience><extended care><faces><facial><financial security><financial stability><financial well-being><flexibility><flexible><health care access><health care availability><health care service access><health care service availability><health difference><health insurance for disabled><improved><innovate><innovation><innovative><insight><interest><knowledge base><medication prescription><method development><next generation><older adult><older adulthood><ontogeny><payment><population aging><population health><prescribed medication><programs><prospective><public health insurance><public insurance><randomized control trial><scientific accomplishments><scientific advances><self help organization><social role><statistic methods><stem><success><theories><thoughts><tool><welfare>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John Michael McWilliams

HARVARD MEDICAL SCHOOL, BOSTON, MA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,664,320

FY 2026

Project Title

Medicare at a Crossroads

Grant Number:

5P01AG032952-17

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/15/2009

End Date:

4/30/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

The Methods & Theory Core aims to develop and apply innovative statistical methods, economic theory, and distributional analysis tools to enhance research on Medicare policies and their impact on the health and health care of older adults. Through its position as an intellectual hub within the P...

Research Terms

<21+ years old><Acceleration><Address><Adult><Adult Human><Age><Amentia><Attention><Behavioral><Caring><Case-Mix Adjustments><Code><Coding System><Collaborations><Communities><Contracting Opportunities><Contracts><Data><Dementia><Disabling condition><Disabling health condition><Drug Prescribing><Drug Prescriptions><Economics><Eligibility><Eligibility Determination><Enrollment><Event><Face><Flounder><Fostering><Friction><Future><Generalized Growth><Goals><Growth><Health><Health Care><Health Care Systems><Health Insurance for Aged and Disabled, Title 18><Health Insurance for Disabled Title 18><Incentives><Insurance Carriers><Insurers><Intention><Investigators><Learning><Long-Term Care><Marketing><Medicare><Methodology><Methods><Mission><Modeling><Modernization><Modification><Motivation><National Institute of Aging><National Institute on Aging><Outcome><P01 Mechanism><P01 Program><Performance><Physicians><Policies><Policy Maker><Population><Position><Positioning Attribute><Privatization><Program Project Grant><Program Research Project Grants><Protocol Screening><Public Policy><QOC><Quality of Care><R-Series Research Projects><R01 Mechanism><R01 Program><Randomized, Controlled Trials><Regulation><Research><Research Grants><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Researchers><Risk><Role><Scientific Advances and Accomplishments><Scientist><Self-Help Groups><Shapes><Social Insurance><Social Sciences><Social Security><Statistical Methods><Stream><Support Groups><System><Talents><Techniques><Thinking><Tissue Growth><Title 18><Training><Travel><Update><Work><access to health care><accessibility of health care><accessibility to health care><adulthood><aged group><aged groups><aged individual><aged individuals><aged people><aged person><aged persons><aged population><aged populations><ages><aging population><analytical tool><beneficiary><care delivery><data infrastructure><data resource><design><designing><differences in health><disability><economic><economic security><economic self-sufficiency><economic stability><economic well-being><enroll><evidence base><experience><extended care><faces><facial><financial security><financial stability><financial well-being><flexibility><flexible><health care access><health care availability><health care service access><health care service availability><health difference><health insurance for disabled><improved><innovate><innovation><innovative><insight><interest><knowledge base><medication prescription><method development><next generation><older adult><older adulthood><ontogeny><payment><population aging><population health><prescribed medication><programs><prospective><public health insurance><public insurance><randomized control trial><scientific accomplishments><scientific advances><self help organization><social role><statistic methods><stem><success><theories><thoughts><tool><welfare>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alexander Drilon

SLOAN-KETTERING INST CAN RESEARCH, NEW YORK, NY

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,442,880

FY 2026

Project Title

Targets for Therapy for Carcinomas of the Lung

Grant Number:

2P01CA129243-16A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2007

End Date:

4/30/2031

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY/ABSTRACT Lung cancer remains the leading cause of cancer related deaths in the US. In 2021, 134,592 people died from lung cancer, comprising 22% of all cancer-related deaths. The morbidity of lung cancer surpasses that of breast, prostate, and colorectal cancers combined, underscorin...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Piro Lito

SLOAN-KETTERING INST CAN RESEARCH, NEW YORK, NY

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,442,880

FY 2026

Project Title

Targets for Therapy for Carcinomas of the Lung

Grant Number:

2P01CA129243-16A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2007

End Date:

4/30/2031

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY/ABSTRACT Lung cancer remains the leading cause of cancer related deaths in the US. In 2021, 134,592 people died from lung cancer, comprising 22% of all cancer-related deaths. The morbidity of lung cancer surpasses that of breast, prostate, and colorectal cancers combined, underscorin...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PAUL M. LIEBERMAN

WISTAR INSTITUTE, PHILADELPHIA, PA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,411,466

FY 2026

Project Title

Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers

Grant Number:

5P01CA269043-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/11/2023

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

OVERALL – PROJECT SUMMARY The overall aim of this new Program Project (P01) proposal is to generate highly collaborative and integrated basic and translational research on the urgent, unmet medical need of epithelial cancers caused by Epstein-Barr Virus (EBV). EBV latent infection is causally linked...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

James A. DeCaprio

DANA-FARBER CANCER INST, BOSTON, MA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,380,970

FY 2026

Project Title

Convergent Epigenetic Control of Neuroendocrine Cancers

Grant Number:

5P01CA295524-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/1/2025

End Date:

3/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Summary (Overall) The overall goal of the Program “Convergent Epigenetic Control of Diverse Neuroendocrine Cancers” is to interrogate epigenetic and transcriptional states that are required for the development of neuroendocrine (NE) cancers. We propose to study NE cancers in four tissue types to te...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ELLIS L REINHERZ

DANA-FARBER CANCER INST, BOSTON, MA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,253,088

FY 2026

Project Title

RNA-based HIV-1 chimera vaccines encoding a trimerizing host self-protein protomer linked to a viral MPER-TM segment

Grant Number:

5P01AI181597-03

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/1/2024

End Date:

3/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

SUMMARY – OVERALL While there is an urgent need for vaccines eliciting broadly neutralizing antibodies (bnAbs) against the highly mutable HIV-1 retrovirus to stem its global spread, this goal remains elusive. Antibodies produced against trimeric gp160 sites of vulnerability during natural infection...

Research Terms

<7S Gamma Globulin><AIDS><AIDS Virus><Ab response><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Advanced HIV><Affinity><Antibodies><Antibody Formation><Antibody Production><Antibody Response><Antigen-Presenting Cells><Antigenic Determinants><Antigens><Assay><B-Cells><B-Lymphocytes><B-cell><Binding><Binding Determinants><Binding Sites><Bioassay><Biocompatible Materials><Bioinformatics><Biological Assay><Biomaterials><Blood Plasma Cell><Bone Marrow><Bone Marrow Reticuloendothelial System><Charge><Chimera><Chimera organism><Clinical><Clinical Treatment Moab><Cloning><Combining Site><Complex><Cryo-electron Microscopy><Cryoelectron Microscopy><DNA mutation><Data><Development><Electron Cryomicroscopy><Encapsulated><Envelope Protein><Epitopes><Face><Formulation><Fostering><Frequencies><Future><Generations><Genes><Genetic Change><Genetic defect><Genetic mutation><Germ Lines><Glycans><Goals><Grain><HIV><HIV Envelope Glycoprotein gp120><HIV Envelope Protein gp120><HIV env Protein gp120><HIV-1><HIV-I><HIV1><HTLV-III gp120><Health><Human><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Virus-1><Human Immunodeficiency Viruses><Human immunodeficiency virus 1><Hydrophobicity><Ig Genes><Ig Somatic Hypermutation><IgG><IgG1><IgG3><Immune system><Immunization><Immunoglobulin G><Immunoglobulin Genes><Immunoglobulin Somatic Hypermutation><In Vitro><Individual><Infection><KI mice><Knock-in Mouse><LAV-HTLV-III><Length><Licensing><Link><Lipid Binding><Lipids><Liposomal><Liposomes><Lymphadenopathy-Associated Virus><Mediating><Membrane><Messenger RNA><Methods><Mice><Mice Mammals><Modern Man><Modification><Molecular Dynamics Simulation><Molecular Interaction><Monoclonal Antibodies><Motion><Murine><Mus><Mutation><NIH><National Institutes of Health><Non-Polyadenylated RNA><Patients><Plasma Cells><Plasmacytes><Polymers><Polysaccharides><Preventative vaccine><Preventive vaccine><Principal Investigator><Prophylactic vaccine><Proteins><Proteome><Protomer><RNA><RNA Gene Products><RNA vaccine><RNA-based vaccine><Reactive Site><Recombinants><Retroviridae><Retroviruses><Ribonucleic Acid><Sampling><Serology><Severe HIV Disease><Single Crystal Diffraction><Site><Structure><Technology><Texas><Uncertainty><United States National Institutes of Health><Vaccines><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Virus-Retrovirus><Writing><X Ray Crystallographies><X-Ray Crystallography><X-Ray Diffraction Crystallography><X-Ray/Neutron Crystallography><Xray Crystallography><accessory cell><antibody biosynthesis><arm><autoimmune reactivity><autoreactivity><base><bases><biobank><biological material><biorepository><chimeras><cryo-EM><cryoEM><cryogenic electron microscopy><design><design and construct><design and construction><designing><developmental><doubt><env Antigens><env Gene Products><env Glycoproteins><env Polyproteins><env Protein><faces><facial><genome mutation><global health><gp120><gp120 ENV Glycoprotein><gp120(HIV)><gp160><immunization strategy><immunogen><immunogenicity><immunoglobulin biosynthesis><immunoreactivity><in vivo><knock-in animal><knockin animal><knockin mice><lipid based nanoparticle><lipid bound><lipid nanoparticle><mAbs><mRNA><mRNA vaccine><mRNA-based vaccine><membrane structure><molecular dynamics><monoclonal Abs><monoclonal antibody production><nanodisk><neutralizing antibody><particle><plasmocyte><polymer><polymeric><prevent><preventing><somatic hypermutation><stem><technology platform><technology system><tool><vaccination strategy><vaccination study><vaccination trial><vaccine formulation><vaccine study><vaccine trial><viral infection><virus infection><virus-induced disease>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jennifer S Pollock

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$2,193,510

FY 2026

Project Title

Early Life Stress Induced Mechanisms of Cardiovascular Disease Risk and Resilience

Grant Number:

5P01HL158500-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/15/2023

End Date:

1/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

OVERALL SUMMARY Early life stress (ELS) is defined as stressful and traumatic events, such as household dysfunction, neglect, sexual or physical abuse, economic hardship, and exposure to violence, experienced up to 18 years. ELS was identified as a cardiovascular disease (CVD) risk factor over 20 ye...

Research Terms

<0-11 years old><12-20 years old><21+ years old><Address><Adolescence><Adolescent><Adolescent Youth><Adult><Adult Human><Animal Model><Animal Models and Related Studies><BP control><BP management><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Blood Pressure><Blood Vessels><Blood monocyte><CNS Nervous System><Cardiac Chronotropism><Cardiovascular><Cardiovascular Body System><Cardiovascular Diseases><Cardiovascular Organ System><Cardiovascular system><Central Nervous System><Child><Child Rearing><Child Youth><Children (0-21)><Clinic><Clinical><Collaborations><Data><Diastolic Pressure><Diastolic blood pressure><Diet><Dysfunction><Endothelium><Ensure><Europe><Exposure to><Financial Hardship><Functional disorder><Future><GI microbiome><Goals><Grant><Health><Heart Rate><Heart Vascular><History><Household><Human><Hypertension><Immune Cell Activation><Individual><Inflammation><Inflammation Mediators><Inflammatory><Intervention Strategies><Life><Life Stress><Macrophage><Manuscripts><Marrow monocyte><Measurement><Mediating><Mentors><Mission><Modern Man><Molecular><Mφ><NHLBI><National Heart, Lung, and Blood Institute><Neuraxis><North America><P01 Mechanism><P01 Program><PBMC><Parenting><Parenting behavior><Peripheral><Peripheral Blood Mononuclear Cell><Persons><Phenotype><Physical activity><Physiologic pulse><Physiopathology><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Program Project Grant><Program Research Project Grants><Psychologic Stress><Psychological Stress><Publications><Pulse><Recording of previous events><Reproducibility><Research Program Projects><Research Specimen><Risk><Risk Factors><Rodent><Rodent Model><Rodentia><Rodents Mammals><Sampling><Scientific Publication><Sexual abuse><Specimen><Stressful Event><Structure><System><Techniques><Technology><Telemetries><Telemetry><Temperature><Translating><Translations><Vascular Diseases><Vascular Disorder><Vascular Endothelium><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Vascular resistance><Work><abuse neglect><adolescence (12-20)><adulthood><blood pressure control><blood pressure management><blood vessel disorder><cardiovascular disease risk><cardiovascular disorder><cardiovascular disorder risk><childrearing><circadian><circulatory system><clinical relevance><clinically relevant><cost><data analysis core><data analysis research core><data analytics core><data analytics research core><data management><diets><digestive tract microbiome><disease risk><disorder risk><early adulthood><early life stress><economic hardship><economic strain><effective therapy><effective treatment><emerging adult><enteric microbiome><epigenome><experience><exposure to violence><financial adversity><financial burden><financial distress><financial insecurity><financial instability><financial strain><financial stress><financial worry><gastrointestinal microbiome><global gene expression><global transcription profile><gut microbiome><gut-associated microbiome><health care burden><high blood pressure><histories><hyperpiesia><hyperpiesis><hypertensive disease><hypertensive disorder><immune activation><inflammatory mediator><insight><intestinal biome><intestinal microbiome><juvenile><juvenile human><kids><later in life><later life><life-style factor><lifestyle factors><metabolome><metabonome><model of animal><monocyte><multiomics><multiple omics><neglect and abuse><neural network><novel><panomics><pathophysiology><physical abuse><physical maltreatment><programs><prospective><protective factors><resilience><resilient><sex abuse><sexually abused><stressful experience><stressful life event><stressful life experience><stressor><synergism><telemetric><transcriptome><translation><translational opportunities><translational potential><translational study><traumatic event><vascular><vascular dysfunction><vasculopathy><violence exposure><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Roger A Greenberg

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$1,725,282

FY 2026

Project Title

Genome Instability Induced Anti-Tumor Immune Responses

Grant Number:

5P01CA265794-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/8/2023

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Summary The overarching objective of this Program Project Grant is to understand fundamental mechanisms underlying communication between cancer cell genomic instability and the immune system. Foundational work from the investigators on this P01 demonstrates multivariate ways in which genomic damage ...

Research Terms

<3-D><3-Dimensional><3D><Acute><Address><Affect><Agreement><Aneuploid><Aneuploidy><Architecture><Artificial Mammalian Chromosomes><BRCA2><BRCA2 gene><Basic Research><Basic Science><Biology><Body Tissues><Breast Cancer 2 Gene><Breast Cancer Type 2 Susceptibility Gene><Cancer Control><Cancer Control Science><Cancers><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Chemicals><Chromosomal Instability><Chromosome Instability><Chromosome Segregation><Collaborations><Communication><Complex><Cytoplasm><DNA><DNA Damage><DNA Injury><Deoxyribonucleic Acid><Detection><Double-Stranded RNA><Early Onset Gene Breast Cancer 2><Engineering / Architecture><Environment><Event><FANCD1><Gatekeeping><Gene Expression><Genome Instability><Genomic Instability><Genomics><Goals><Hereditary Breast Cancer 2><IFN><Immune><Immune Cell Activation><Immune mediated therapy><Immune response><Immune system><Immunes><Immunologically Directed Therapy><Immunotherapy><Inflammasome><Inflammatory><Innate Immune Response><Innate Immune System><Interferon Type I><Interferons><Intracellular Communication and Signaling><Investigators><Ligands><M Phase><Macrophage><Malignant Cell><Malignant Neoplasms><Malignant Ovarian Neoplasm><Malignant Ovarian Tumor><Malignant Tumor><Malignant Tumor of the Ovary><Malignant neoplasm of ovary><Mechanical Stress><Mechanics><Mitosis><Mitosis Stage><Mitotic><Modality><Molecular><Mφ><Non-Polyadenylated RNA><Nuclear Envelope><Nuclear Membrane><Nucleic Acids><Ovary Cancer><P01 Mechanism><P01 Program><Pathway interactions><Patients><Pattern Recognition><Pattern recognition receptor><Phagocytes><Phagocytic Cell><Pre-Clinical Model><Preclinical Models><Process><Program Project Grant><Program Research Project Grants><Publishing><RNA><RNA Gene Products><Reporting><Research><Research Personnel><Research Program Projects><Researchers><Ribonucleic Acid><Signal Transduction><Signal Transduction Systems><Signaling><Solid Neoplasm><Solid Tumor><Testing><Tissues><Treatment outcome><Tumor Cell><Viral><Work><adaptive immune response><amebocyte><anti-cancer immunotherapy><anti-tumor immune response><anticancer immunotherapy><arm><biological signal transduction><brca 2 gene><cancer cell><cancer immunotherapy><cancer microenvironment><check point blockade><check point inhibition><checkpoint blockade><checkpoint inhibition><chromosomal missegregation><chromosome division><chromosome missegregation><dsRNA><gatekeeper><host response><immune activation><immune check point blockade><immune check point inhibition><immune checkpoint blockade><immune checkpoint inhibition><immune microenvironment><immune system response><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immuno therapy><immunogenic><immunoresponse><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><immunotherapy for cancer><immunotherapy of cancer><improved><in vivo><malignancy><mechanic><mechanical><mechanical force><micronucleus><multidisciplinary><mutant><neoplasm/cancer><neoplastic cell><ovarian cancer><pathway><prevent><preventing><rational design><response><response to therapy><response to treatment><sensor><therapeutic response><therapy response><three dimensional><treatment response><treatment responsiveness><tumor><tumor growth><tumor immune microenvironment><tumor microenvironment><tumor-immune system interactions>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lucia R. Languino

THOMAS JEFFERSON UNIVERSITY, PHILADELPHIA, PA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$1,656,379

FY 2026

Project Title

Neuroendocrine Prostate Cancer Progression and Novel Therapeutic Vulnerabilities

Grant Number:

1P01CA298993-01A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/6/2026

End Date:

2/28/2031

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Neuroendocrine prostate cancer (NEPC) has long been considered a rare and largely unrepresentative variant of prostate cancer (PrCa), lacking canonical disease traits, such as androgen dependence. This perspective, however, has now evolved. First, NEPC is not as rare as previously thought. This cond...

Research Terms

<3-D><3-Dimensional><3D><Achievement><Achievement Attainment><Acute><Affect><Androgen Suppression><Androgenic Agents><Androgenic Compounds><Androgens><Anti-Cancer Agents><Anti-Oncogenes><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Antioncogenes><Beta Proprotein Interleukin 1><Binding><Biochemical Pathway><Bioinformatics><Biometrics><Biometry><Biostatistics><Bone Metastasis><Bone cancer metastatic><Bony metastasis><Budgets><Cancer Center><Cancer Drug><Cancer Patient><Cancer Suppressor Genes><Cell Communication and Signaling><Cell Locomotion><Cell Migration><Cell Movement><Cell Signaling><Cell membrane><Cell to Cell Communication and Signaling><Cell-Cell Signaling><Cellular Migration><Cellular Motility><Chemotactic Cytokines><Chronic><Clinic><Clinical><Collaborations><Community Outreach><Credentialing><Cytoplasmic Membrane><Data Science><Data Science Core><Data Science Resource Core><Dependence><Diagnosis><Disease><Disease Progression><Disease Resistance><Disorder><Dysfunction><ER stress><Emerogenes><Enhancers><Ensure><Environment><Event><Functional disorder><GEM model><GEMM model><Gene Transcription><Genetic Transcription><Genetically Engineered Mouse><Goals><History><Homologous Chemotactic Cytokines><Hormonal><IL-1 beta><IL-1 β><IL-1-b><IL-1β><IL1-Beta><IL1-β><IL1B Protein><IL1F2><IL1β><Immune><Immunes><Incidence><Inflammation><Inflammatory><Institution><Integrins><Integrins Extracellular Matrix><Intercrines><Interleukin 1beta><Interleukin-1 beta><Interleukin-1β><Intracellular Communication and Signaling><Investigators><JAK-2><JAK2><JAK2 gene><JAK2 protein><Janus kinase 2><Kinases><Knowledge><Life Expectancy><MGF protein><MGSNF protein><Malignant neoplasm of prostate><Malignant prostatic tumor><Maps><Mediating><Medical><Metabolic><Metabolic Networks><Metastasis><Metastasis to bone><Metastasize><Metastatic Cancer to the Bone><Metastatic Lesion><Metastatic Mass><Metastatic Neoplasm><Metastatic Neoplasm to the Bone><Metastatic Tumor><Metastatic Tumor to the Bone><Metastatic malignant neoplasm to bone><Mitochondria><Modality><Molecular><Molecular Interaction><Molecular Tumor Suppression><Motility><Neoplasm Metastasis><Neoplastic Disease Chemotherapeutic Agents><Neuroendocrine Prostate Cancer><Onco-Suppressor Genes><Oncogenes-Tumor Suppressors><Organ><Organoids><Osseous metastasis><Outcome><P01 Mechanism><P01 Program><PDX model><Palliative Care><Palliative Therapy><Palliative Treatment><Patient derived xenograft><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Peer Review><Phosphotransferase Gene><Phosphotransferases><Physiopathology><Plasma Membrane><Preinterleukin 1 Beta><Production><Program Project Grant><Program Research Project Grants><Prostate CA><Prostate CA therapy><Prostate Cancer><Prostate Cancer therapy><Prostate malignancy><Publishing><RB1><RB1 gene><RNA Expression><Recessive Oncogenes><Recording of previous events><Recurrence><Recurrent><Research><Research Personnel><Research Program Projects><Researchers><Role><SIS cytokines><STAT5><STAT5A><STAT5A gene><STAT5a Transcription Factor><Secondary Neoplasm><Secondary Tumor><Secondary cancer of bone><Secondary malignancy of bone><Secondary malignant neoplasm of bone><Shapes><Signal Transducer and Activator of Transcription 5A><Signal Transduction><Signal Transduction Systems><Signaling><Skeletal metastasis><Specific qualifier value><Specified><Stat5 protein><Stat5a protein><Stat5alpha protein><Stress><Structure><Testing><Therapeutic><Therapeutic Androgen><Transcription><Transphosphorylases><Tumor Cell><Tumor Suppressing Genes><Tumor Suppression><Tumor Suppressor Genes><Tumor Suppressor Proteins><Tumor-Specific Treatment Agents><Tyrosine-Protein Kinase JAK2><Variant><Variation><Visceral><Work><androgen ablation therapy><androgen blockade therapy><androgen deprivation therapy><androgen deprivation treatment><anti-cancer drug><anti-cancer research><biological signal transduction><bone neoplasm secondary><cancer addiction><cancer drug resistance><cancer metastasis><cancer research><cell motility><chemoattractant cytokine><chemokine><comfort care><cytokine><design><designing><disease model><disorder model><disparities in race><disparity due to race><endoplasmic reticulum stress><experience><extracellular vesicles><first in man><first-in-human><genetically engineered mouse model><genetically engineered murine model><histories><improved><improved outcome><inequality due to race><inequity due to race><intercellular communication><mammary gland factor><mammary gland-specific nuclear factor><mitochondrial><mitochondrial dysfunction><neoplastic cell><new anti-cancer agent><new anticancer agent><new anticancer drug><new antineoplastic><new cancer drug><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic target><new therapeutics><new therapy><new therapy target><next generation therapeutics><novel><novel anti-cancer agent><novel anti-cancer drug><novel anticancer agent><novel anticancer drug><novel antineoplastic><novel cancer drug><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel therapeutic target><novel therapeutics><novel therapy><novel therapy target><oncosuppressor gene><palliative intervention><pathophysiology><patient derived xenograft model><patient oriented outcomes><plasmalemma><pre-clinical><preclinical><pressure><programs><prostate cancer metastasis><prostate cancer progression><prostate cancer treatment><protein homeostasis><proteostasis><race based disparity><race based inequality><race based inequity><race disparity><race related disparity><race related inequality><race related inequity><racial disparity><racial inequality><racial inequity><racially unequal><resistance to cancer drugs><resistance to disease><resistant disease><resistant to cancer drugs><resistant to disease><retinoblastoma-1><rho G-Proteins><rho GTP-Binding Proteins><rho GTPases><rho Protein P21><rho Small GTP-Binding Proteins><signal tranducer and activator of transcription 5><social role><therapeutic target><three dimensional><trait><tumor cell metastasis><tumor growth><tumor suppressor><tumorigenic><vesicle release><vesicular release>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

James Eisenach

WAKE FOREST UNIVERSITY HEALTH SCIENCES, WINSTON-SALEM, NC

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$1,639,004

FY 2026

Project Title

Oxytocin: a pain disease-modifying agent in the nervous system after injury

Grant Number:

5P01NS119159-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

This P01 will address fundamental gaps in knowledge that currently impede translation of findings in the preclinical literature to improved clinical practice regarding the utility of oxytocin as a pain therapeutic and potential disease-modifying agent to prevent the transition from acute to chronic ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

THOMAS JEFFREY MARTIN

WAKE FOREST UNIVERSITY HEALTH SCIENCES, WINSTON-SALEM, NC

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$1,639,004

FY 2026

Project Title

Oxytocin: a pain disease-modifying agent in the nervous system after injury

Grant Number:

5P01NS119159-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

This P01 will address fundamental gaps in knowledge that currently impede translation of findings in the preclinical literature to improved clinical practice regarding the utility of oxytocin as a pain therapeutic and potential disease-modifying agent to prevent the transition from acute to chronic ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Dan H. Barouch

BETH ISRAEL DEACONESS MEDICAL CENTER, BOSTON, MA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$1,500,997

FY 2026

Project Title

Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination

Grant Number:

5P01AI177687-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/11/2023

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

SUMMARY The goal of this P01 program is to define mechanisms of efficacy of broadly neutralizing antibodies (bNAbs) and therapeutic vaccines for HIV-1 in a highly collaborative and multifaceted research program. Our overall hypothesis is that immunologic strategies for HIV-1 cure delay viral rebound...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Anthony B. Firulli

INDIANA UNIVERSITY INDIANAPOLIS, INDIANAPOLIS, IN

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$2,741,575

FY 2026

Project Title

Morphogenesis and growth of the ventricular wall in development and disease

Grant Number:

5P01HL134599-09

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/15/2017

End Date:

1/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT Congenital heart defects (CHDs) are the most commonly encountered birth defect. Despite its prevalence, the underlying molecular etiology of most CHDs is not yet known. The central theme of this Program Project Grant application is to elucidate mechanisms that regulate growth and morphogene...

Research Terms

<0-11 years old><21+ years old><Address><Adult><Adult Human><Animal Model><Animal Models and Related Studies><Applications Grants><Area><BHLH Protein><Basal Transcription Factor><Basal transcription factor genes><Basic HLH Protein><Basic Helix-Loop-Helix Protein><Basic Helix-Loop-Helix Transcription Factors><Birth Defects><Brachydanio rerio><Cardiac><Cardiac Muscle Cells><Cardiac Myocytes><Cardiac conduction system><Cardiac development><Cardiocyte><Causality><Cell Communication and Signaling><Cell Signaling><Child><Child Youth><Children (0-21)><Chromatin><Coiled-Coil Containing Protein Kinase 1 Rho-Associated><Complex><Congenital Abnormality><Congenital Anatomical Abnormality><Congenital Cardiac Defects><Congenital Defects><Congenital Deformity><Congenital Heart Defects><Congenital Malformation><Cues><DNA><DNA Binding><DNA Binding Interaction><DNA bound><Danio rerio><Data><Defect><Deoxyribonucleic Acid><Development><Disease><Disorder><EC 2.1.1><ES cell><Embryo><Embryonic><Enhancers><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Etiology><Event><Family member><Fingers><Gene Modified><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Generalized Growth><Genes><Genetic><Genetic Transcription><Genome><Gestation><Grant Proposals><Growth><Hand1 protein><Health><Heart><Heart Conduction System><Heart Muscle Cells><Heart myocyte><Human><Image><Intervention><Interventricular Septum><Intracellular Communication and Signaling><Investigators><Knock-out><Knockout><L-Lysine><Laboratories><Left><Left Ventricles><Left ventricular structure><Life><Link><Lysine><Mediating><Mesoderm><Methylation><Methyltransferase><Mice><Mice Mammals><Mission><Modeling><Modern Man><Molecular><Morphogenesis><Morphology><Murine><Mus><Mutate><N-Cadherin><NHLBI><NIH><National Heart, Lung, and Blood Institute><National Institutes of Health><P01 Mechanism><P01 Program><P160ROCK><Pathogenesis><Pathway interactions><Patients><Pattern><Phenocopy><Physiology><Population><Pregnancy><Prevalence><Prevention><Primitive Streaks><Progenitor Cells><Program Project Grant><Program Research Project Grants><Proliferating><Proteins><Public Health><Publishing><RNA Expression><ROCK1><ROCK1 gene><Regulation><Research><Research Personnel><Research Program Projects><Research Proposals><Researchers><Role><Sarcomeres><Side><Signal Pathway><Signal Transduction><Signal Transduction Systems><Signaling><Situs Inversus><Specific qualifier value><Specified><Stem cell in the heart><System><Testing><Tissue Growth><Transcription><Transcription Factor Proto-Oncogene><Transcription factor genes><United States><United States National Institutes of Health><Variant><Variation><Ventricular><Ventricular septum><Work><Zebra Danio><Zebra Fish><Zebrafish><adulthood><biological signal transduction><cardiac progenitor><cardiac stem cell><cardiogenesis><cardiomyocyte><causation><developmental><disease causation><eHAND gene product><eHAND helix-loop-helix protein><eHAND protein><embryo derived stem cell><embryonal stem cells><embryonic progenitor><embryonic stem cell><epigenetic regulation><epigenetically><gastrulation><gene modification><gene regulatory network><genetically modified><heart development><heart formation><heart progenitor><heart stem cell><heterotaxia syndrome><heterotaxy><hiPSC><histone H3 methyltransferase><histone methylase><histone methyltransferase><histone modification><human disease><human iPS><human iPSC><human induced pluripotent cell><human induced pluripotent stem cells><human inducible pluripotent stem cells><human inducible stem cells><imaging><induced human pluripotent stem cells><insight><inversion of viscera><kids><laterality sequence><methylase><migration><model of animal><morphogenetic process><mutant><novel><ontogeny><p160-ROCK><papillary muscle><pathway><planar cell polarity><progenitor Cell growth><progenitor cell differentiation><progenitor cell fate><progenitor differentiation><progenitor fate><progenitor growth><programs><situs abnormality><situs inversus viscerum><social role><stem and progenitor cell fate><stem and progenitor differentiation><stem cell differentiation><stem cell fate><stem cell growth><stem cell of embryonic origin><stem cells><transcription factor><transcriptomics><transmethylase><transposition of viscera><visceral heterotaxy><visceral transposition><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KENNETH E. COVINSKY

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$2,704,542

FY 2026

Project Title

Deploying High Value Longitudinal Population-Based data in Dementia Research (DEVELOP AD Research)

Grant Number:

2P01AG066605-06A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/30/2020

End Date:

2/28/2031

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Alzheimer Disease and related dementias (ADRD) are chronic multi-year neurodegenerative diseases that start slowly and gradually worsen over time. All with ADRD will die with or from ADRD. People with dementia (PWD) typically face years of progressive physical and cognitive dependency accompanied by...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

R. Sean Morrison

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$2,704,542

FY 2026

Project Title

Deploying High Value Longitudinal Population-Based data in Dementia Research (DEVELOP AD Research)

Grant Number:

2P01AG066605-06A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/30/2020

End Date:

2/28/2031

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Alzheimer Disease and related dementias (ADRD) are chronic multi-year neurodegenerative diseases that start slowly and gradually worsen over time. All with ADRD will die with or from ADRD. People with dementia (PWD) typically face years of progressive physical and cognitive dependency accompanied by...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JAY D. HORTON

UT SOUTHWESTERN MEDICAL CENTER, DALLAS, TX

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$2,484,600

FY 2026

Project Title

New Approaches to Reduce Residual Cardiovascular Risk

Grant Number:

5P01HL160487-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

1/1/2022

End Date:

12/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PPG Title: New Approaches to Reduce Residual Cardiovascular Risk SUMMARY/ABSTRACT In the last 40 years, significant progress has been made in reducing cardiovascular events by lowering plasma LDL-cholesterol (LDL-C). While statins and PCSK9 inhibitors effectively decrease LDL-C levels, significant r...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Paul F. Lambert

UNIVERSITY OF WISCONSIN-MADISON, MADISON, WI

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$2,069,205

FY 2026

Project Title

Molecular Biology and Genetics of Human Tumor Viruses

Grant Number:

5P01CA022443-48

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/1997

End Date:

2/28/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – PROJECT SUMMARY/ABSTRACT Molecular Biology and Genetics of Human Tumor Viruses Paul F. Lambert, PI Viruses cause approximately 15% of human cancers. A viral etiology to a human cancer can have substantive consequences on its treatment and prevention. For example, many virally-caused human ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

RICHARD M. PEEK

VANDERBILT UNIVERSITY MEDICAL CENTER, NASHVILLE, TN

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$1,694,664

FY 2026

Project Title

H. pylori-induced Inflammation and Gastric Cancer

Grant Number:

5P01CA116087-19

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

1/1/2009

End Date:

2/28/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROGRAM PROJECT GRANT OVERALL SUMMARY Helicobacter pylori is the strongest risk factor for gastric adenocarcinoma, the fourth leading cause of cancer- related death. One H. pylori determinant that increases gastric cancer risk is the cag type IV secretion system (T4SS) which exports a bacterial onco...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Seth Michael Rubin

STANFORD UNIVERSITY, STANFORD, CA

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$1,413,001

FY 2026

Project Title

Determining and targeting mechanisms controlling cancer cell division

Grant Number:

5P01CA254867-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/25/2022

End Date:

2/28/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL SUMMARY The Cyclin D-Cdk4/6-Rb-E2F pathway integrates external and internal signals to control cell cycle progression at the G1/S transition of the cell cycle. Alterations in the Cyclin D-Cdk4/6-Rb-E2F pathway are found in the vast majority of human cancers. These alterations are thought to ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jan M Skotheim

STANFORD UNIVERSITY, STANFORD, CA

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$1,413,001

FY 2026

Project Title

Determining and targeting mechanisms controlling cancer cell division

Grant Number:

5P01CA254867-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/25/2022

End Date:

2/28/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL SUMMARY The Cyclin D-Cdk4/6-Rb-E2F pathway integrates external and internal signals to control cell cycle progression at the G1/S transition of the cell cycle. Alterations in the Cyclin D-Cdk4/6-Rb-E2F pathway are found in the vast majority of human cancers. These alterations are thought to ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Tayyaba Hasan

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$1,206,614

FY 2026

Project Title

Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response

Grant Number:

5P01CA084203-20

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

12/1/1999

End Date:

2/29/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROGRAM SUMMARY For optimal cancer therapy, combination approaches that are mechanistically complementary and directed at non-overlapping molecular targets are needed. Strategically, combinations should be selected such that the first treatment primes the tumor for the second treatment. Buil...

Research Terms

<5-FU><5-Fluracil><5FU><Abscission><Acceleration><Animals><Automobile Driving><BPD verteporfin><BPD-MA><Behavior><Benzoporphyrin Derivative Monoacid Ring A><Biological Markers><Budgets><CAT scan><CT X Ray><CT Xray><CT imaging><CT scan><Cancer Treatment><Cancers><Categories><Checkpoint inhibitor><Clinical><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Combined Modality Therapy><Computed Tomography><Development><Diagnostic><Disease><Disorder><Dose><Economic Burden><Eligibility><Eligibility Determination><Endoscopic Ultrasonography><Endoscopy><Environment><Excision><Exocrine Pancreas Carcinoma><Extirpation><Fibroblasts><Fluoro Uracil><Fluorouracil><Fluoruracil><Fluouracil><Future><General Radiology><Human><Image><Imaging Device><Imaging Instrument><Imaging Tool><Immune><Immune Monitoring><Immune checkpoint inhibitor><Immune infiltrates><Immune mediated therapy><Immune response><Immunes><Immunochemical Immunologic><Immunocompetent><Immunologic><Immunologic Monitoring><Immunological><Immunological Monitoring><Immunologically><Immunologically Directed Therapy><Immunologics><Immunomodulation><Immunomonitoring><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunotherapy><Incidence><Industry><Infiltration><Keratinocyte carcinoma><Keytruda><Knowledge><Learning><Lesion><Literature><Lymph Node Reticuloendothelial System><Lymph node proper><Lymphatic nodes><Lymphocyte Subpopulations><Lymphocyte Subset><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Skin Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Mediating><Mice><Mice Mammals><Microsatellite Instability><Modeling><Modern Man><Molecular><Molecular Target><Monitor><Morbidity><Multimodal Therapy><Multimodal Treatment><Murine><Mus><Non-Melanoma Skin Cancer><Optics><Organoids><Outcome><P01 Mechanism><P01 Program><PD 1><PD-1><PD-1 antibody><PD-1/PD-L1><PD-1/PDL1><PD1><PD1 antibody><PD1-PD-L1><PD1/PD-L1><PD1/PDL1><PUVA><PUVA Photochemotherapy><Pancreas Adenocarcinoma><Pancreas Cancer><Pancreas Ductal Adenocarcinoma><Pancreatic Adenocarcinoma><Pancreatic Cancer><Pancreatic Ductal Adenocarcinoma><Pancreatic carcinoma><Pathway interactions><Patients><Pattern><Peer Review><Permeability><Photochemotherapy><Photodynamic Therapy><Pre-Clinical Model><Preclinical Models><Preclinical data><Process><Prognosis><Program Project Grant><Program Research Project Grants><Proteins><Protocol Screening><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Radiology><Radiology Specialty><Regimen><Removal><Research><Research Grants><Research Program Projects><Research Project Grants><Research Projects><Scientific Publication><Skin Cancer><Skin Carcinoma><Surgical Removal><T-Cell Activation><T-Cell Subsets><T-Lymphocyte Subsets><Techniques><Therapeutic><Time><Tomodensitometry><Toxic effect><Toxicities><Tumor Escape><Tumor Immune Escape><Tumor-Infiltrating Lymphocytes><United States><VIT D><Verteporfin><Visible Light><Visible Light Radiation><Visible Radiation><Visudyne><Vitamin D><Work><X-Ray CAT Scan><X-Ray Computed Tomography><X-Ray Computerized Tomography><Xray CAT scan><Xray Computed Tomography><Xray computerized tomography><aPD-1><aPD1><activate T cells><anti programmed cell death 1><anti-PD-1><anti-PD-1 Ab><anti-PD-1 antibodies><anti-PD-1 monoclonal antibodies><anti-PD1><anti-PD1 Ab><anti-PD1 antibodies><anti-PD1 monoclonal antibodies><anti-cancer therapy><anti-programmed cell death protein 1><anti-programmed cell death protein 1 antibodies><anti-programmed death-1 antibody><antiPD-1><benzoporphyrin D><bio-markers><biologic marker><biomarker><cancer evasion><cancer immune escape><cancer immune evasion><cancer microenvironment><cancer therapy><cancer type><cancer-directed therapy><catscan><check point inhibition><checkpoint inhibition><chemotherapy><clinical translation><clinically translatable><cohort><combination therapy><combined modality treatment><combined treatment><computed axial tomography><computer tomography><computerized axial tomography><computerized tomography><conference><confocal imaging><convention><conventional therapy><conventional treatment><cost><cytotoxic><design><designing><developmental><dosimetry><driving><endoscopic imaging><endoscopic ultrasound><high resolution imaging><host response><image guidance><image guided><imaging><immune cell infiltrate><immune check point><immune check point inhibition><immune check point inhibitor><immune checkpoint><immune checkpoint inhibition><immune competent><immune modulation><immune regulation><immune suppression><immune suppressive activity><immune suppressive function><immune system response><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immunecheckpoint><immuno therapy><immunogenic apoptosis><immunogenic cell death><immunologic reactivity control><immunomodulatory><immunoregulation><immunoregulatory><immunoresponse><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><innovate><innovation><innovative><lymph gland><lymph nodes><lymphnodes><malignancy><malignant skin tumor><mortality><mouse model><multi-modal therapy><multi-modal treatment><murine model><neoplasm/cancer><neoplasm/cancer photoradiation therapy><non-contrast CT><noncontrast CT><noncontrast computed tomography><nonmelanoma skin cancer><novel><optic imaging><optical><optical imaging><pancreas carcinoma><pancreatic cancer model><pancreatic cancer patients><pancreatic malignancy><pancreatic tumor model><pathway><patient subclass><patient subcluster><patient subgroups><patient subpopulations><patient subsets><patient subtypes><patients with pancreatic cancer><pembrolizumab><pharmacologic><pre-clinical><pre-clinical study><preclinical><preclinical findings><preclinical information><preclinical study><programmed cell death 1><programmed cell death protein 1><programmed death 1><programs><radiomics><recruit><resection><response><response to therapy><response to treatment><side effect><sle2><success><summit><symposia><symposium><systemic lupus erythematosus susceptibility 2><therapeutic response><therapy response><tool><treatment response><treatment responsiveness><treatment strategy><tumor><tumor evasion><tumor immune evasion><tumor microenvironment><ultrasound><verteporphin><αPD-1><αPD1>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Edward V Maytin

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$1,206,614

FY 2026

Project Title

Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response

Grant Number:

5P01CA084203-20

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

12/1/1999

End Date:

2/29/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROGRAM SUMMARY For optimal cancer therapy, combination approaches that are mechanistically complementary and directed at non-overlapping molecular targets are needed. Strategically, combinations should be selected such that the first treatment primes the tumor for the second treatment. Buil...

Research Terms

<5-FU><5-Fluracil><5FU><Abscission><Acceleration><Animals><Automobile Driving><BPD verteporfin><BPD-MA><Behavior><Benzoporphyrin Derivative Monoacid Ring A><Biological Markers><Budgets><CAT scan><CT X Ray><CT Xray><CT imaging><CT scan><Cancer Treatment><Cancers><Categories><Checkpoint inhibitor><Clinical><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Combined Modality Therapy><Computed Tomography><Development><Diagnostic><Disease><Disorder><Dose><Economic Burden><Eligibility><Eligibility Determination><Endoscopic Ultrasonography><Endoscopy><Environment><Excision><Exocrine Pancreas Carcinoma><Extirpation><Fibroblasts><Fluoro Uracil><Fluorouracil><Fluoruracil><Fluouracil><Future><General Radiology><Human><Image><Imaging Device><Imaging Instrument><Imaging Tool><Immune><Immune Monitoring><Immune checkpoint inhibitor><Immune infiltrates><Immune mediated therapy><Immune response><Immunes><Immunochemical Immunologic><Immunocompetent><Immunologic><Immunologic Monitoring><Immunological><Immunological Monitoring><Immunologically><Immunologically Directed Therapy><Immunologics><Immunomodulation><Immunomonitoring><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunotherapy><Incidence><Industry><Infiltration><Keratinocyte carcinoma><Keytruda><Knowledge><Learning><Lesion><Literature><Lymph Node Reticuloendothelial System><Lymph node proper><Lymphatic nodes><Lymphocyte Subpopulations><Lymphocyte Subset><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Skin Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Mediating><Mice><Mice Mammals><Microsatellite Instability><Modeling><Modern Man><Molecular><Molecular Target><Monitor><Morbidity><Multimodal Therapy><Multimodal Treatment><Murine><Mus><Non-Melanoma Skin Cancer><Optics><Organoids><Outcome><P01 Mechanism><P01 Program><PD 1><PD-1><PD-1 antibody><PD-1/PD-L1><PD-1/PDL1><PD1><PD1 antibody><PD1-PD-L1><PD1/PD-L1><PD1/PDL1><PUVA><PUVA Photochemotherapy><Pancreas Adenocarcinoma><Pancreas Cancer><Pancreas Ductal Adenocarcinoma><Pancreatic Adenocarcinoma><Pancreatic Cancer><Pancreatic Ductal Adenocarcinoma><Pancreatic carcinoma><Pathway interactions><Patients><Pattern><Peer Review><Permeability><Photochemotherapy><Photodynamic Therapy><Pre-Clinical Model><Preclinical Models><Preclinical data><Process><Prognosis><Program Project Grant><Program Research Project Grants><Proteins><Protocol Screening><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Radiology><Radiology Specialty><Regimen><Removal><Research><Research Grants><Research Program Projects><Research Project Grants><Research Projects><Scientific Publication><Skin Cancer><Skin Carcinoma><Surgical Removal><T-Cell Activation><T-Cell Subsets><T-Lymphocyte Subsets><Techniques><Therapeutic><Time><Tomodensitometry><Toxic effect><Toxicities><Tumor Escape><Tumor Immune Escape><Tumor-Infiltrating Lymphocytes><United States><VIT D><Verteporfin><Visible Light><Visible Light Radiation><Visible Radiation><Visudyne><Vitamin D><Work><X-Ray CAT Scan><X-Ray Computed Tomography><X-Ray Computerized Tomography><Xray CAT scan><Xray Computed Tomography><Xray computerized tomography><aPD-1><aPD1><activate T cells><anti programmed cell death 1><anti-PD-1><anti-PD-1 Ab><anti-PD-1 antibodies><anti-PD-1 monoclonal antibodies><anti-PD1><anti-PD1 Ab><anti-PD1 antibodies><anti-PD1 monoclonal antibodies><anti-cancer therapy><anti-programmed cell death protein 1><anti-programmed cell death protein 1 antibodies><anti-programmed death-1 antibody><antiPD-1><benzoporphyrin D><bio-markers><biologic marker><biomarker><cancer evasion><cancer immune escape><cancer immune evasion><cancer microenvironment><cancer therapy><cancer type><cancer-directed therapy><catscan><check point inhibition><checkpoint inhibition><chemotherapy><clinical translation><clinically translatable><cohort><combination therapy><combined modality treatment><combined treatment><computed axial tomography><computer tomography><computerized axial tomography><computerized tomography><conference><confocal imaging><convention><conventional therapy><conventional treatment><cost><cytotoxic><design><designing><developmental><dosimetry><driving><endoscopic imaging><endoscopic ultrasound><high resolution imaging><host response><image guidance><image guided><imaging><immune cell infiltrate><immune check point><immune check point inhibition><immune check point inhibitor><immune checkpoint><immune checkpoint inhibition><immune competent><immune modulation><immune regulation><immune suppression><immune suppressive activity><immune suppressive function><immune system response><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immunecheckpoint><immuno therapy><immunogenic apoptosis><immunogenic cell death><immunologic reactivity control><immunomodulatory><immunoregulation><immunoregulatory><immunoresponse><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><innovate><innovation><innovative><lymph gland><lymph nodes><lymphnodes><malignancy><malignant skin tumor><mortality><mouse model><multi-modal therapy><multi-modal treatment><murine model><neoplasm/cancer><neoplasm/cancer photoradiation therapy><non-contrast CT><noncontrast CT><noncontrast computed tomography><nonmelanoma skin cancer><novel><optic imaging><optical><optical imaging><pancreas carcinoma><pancreatic cancer model><pancreatic cancer patients><pancreatic malignancy><pancreatic tumor model><pathway><patient subclass><patient subcluster><patient subgroups><patient subpopulations><patient subsets><patient subtypes><patients with pancreatic cancer><pembrolizumab><pharmacologic><pre-clinical><pre-clinical study><preclinical><preclinical findings><preclinical information><preclinical study><programmed cell death 1><programmed cell death protein 1><programmed death 1><programs><radiomics><recruit><resection><response><response to therapy><response to treatment><side effect><sle2><success><summit><symposia><symposium><systemic lupus erythematosus susceptibility 2><therapeutic response><therapy response><tool><treatment response><treatment responsiveness><treatment strategy><tumor><tumor evasion><tumor immune evasion><tumor microenvironment><ultrasound><verteporphin><αPD-1><αPD1>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Matthew S. Gentry

UNIVERSITY OF FLORIDA, GAINESVILLE, FL

High-opportunity lead · 80/100

Likely hiring

Large award

Very recent

Active award

$1,055,382

FY 2026

Project Title

Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential

Grant Number:

5R35NS116824-07

Activity Code:

R35

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/15/2020

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Brain metabolism is a fundamental aspect of biology and human disease. The brain critically depends on glucose, consuming large quantities as the biochemical fuel for cognition, memory, and behavior. Fundamental aspects of brain metabolism have been extensively studied, but recent evidence regarding...

Research Terms

<12-20 years old><AD dementia><Abscission><Adolescence><Affect><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimers Dementia><Ataxia><Ataxy><Autoregulation><Behavior><Biochemical><Biology><Body Tissues><Brain><Brain Nervous System><Carbohydrates><Cell Communication and Signaling><Cell Function><Cell Physiology><Cell Process><Cell Signaling><Cellular Function><Cellular Metabolic Process><Cellular Physiology><Cellular Process><Cessation of life><Cognition><Complex><Comprehension><Consumption><Coordination Impairment><D-Glucan><D-Glucose><DNA mutation><Data><Death><Development><Dextrose><Diagnosis><Disease><Disease Progression><Disorder><Dyssynergia><Encephalon><Epilepsy, Progressive Myoclonic, Lafora><Event><Excision><Extirpation><Freedom><Funding><Genetic Change><Genetic defect><Genetic mutation><Glucose><Glycogen><Glycogen Storage Disease><Glycogenosis><Homeostasis><Intermediary Metabolism><Intracellular Communication and Signaling><Intractable Epilepsy><Knowledge><Lafora Body Disease><Lafora Disease><Lafora Type Progressive Myoclonic Epilepsy><Liberty><Memory><Metabolic><Metabolic Processes><Metabolism><Modality><Modeling><Molecular><Mutation><NINDS><National Institute of Neurological Diseases and Stroke><National Institute of Neurological Disorders and Stroke><Nerve Degeneration><Nervous System Diseases><Nervous System Disorder><Neurologic Disorders><Neurological Disorders><Neuron Degeneration><Patients><Physiological Homeostasis><Play><Primary Senile Degenerative Dementia><Refractory epilepsy><Removal><Research><Role><Seminal><Signal Transduction><Signal Transduction Systems><Signaling><Subcellular Process><Surgical Removal><Symptoms><Therapeutic><Tissues><Translating><Vegetative States><Work><adolescence (12-20)><autosome><biological signal transduction><biomarker development><brain metabolism><cell metabolism><cellular metabaolism><develop therapy><developmental><driving force><drug-resistant epilepsy><flexibility><flexible><genome mutation><glucose metabolism><glycogen metabolism><human disease><insight><intervention development><mouse model><murine model><neural degeneration><neurodegeneration><neurodegenerative><neurological degeneration><neurological disease><neuronal degeneration><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><polyglucosan><pre-clinical><preclinical><primary degenerative dementia><resection><senile dementia of the Alzheimer type><sex><social role><therapy development><tool><treatment development>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Sundeep Khosla

MAYO CLINIC ROCHESTER, ROCHESTER, MN

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$3,509,878

FY 2026

Project Title

Targeting Cellular Senescence to Extend Healthspan

Grant Number:

5P01AG062413-08

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2019

End Date:

1/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL: Targeting Cellular Senescence to Extend Healthspan – SUMMARY This proposal is for the renewal of P01 AG62413, Targeting Cellular Senescence to Extend Healthspan. In the initial funding cycle, we made major conceptual and technical advances in the understanding of cellular senescence, its m...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Nathan K LeBrasseur

MAYO CLINIC ROCHESTER, ROCHESTER, MN

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$3,509,878

FY 2026

Project Title

Targeting Cellular Senescence to Extend Healthspan

Grant Number:

5P01AG062413-08

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2019

End Date:

1/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL: Targeting Cellular Senescence to Extend Healthspan – SUMMARY This proposal is for the renewal of P01 AG62413, Targeting Cellular Senescence to Extend Healthspan. In the initial funding cycle, we made major conceptual and technical advances in the understanding of cellular senescence, its m...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Megan Sykes

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$3,278,603

FY 2026

Project Title

A Tolerance Approach to Xenotransplantation

Grant Number:

5P01AI045897-25

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2000

End Date:

12/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

This proposal represents the renewal of a highly integrated PPG aimed at induction of tolerance to porcine organs transplanted into primates. We propose to combine two unique tolerance induction platforms, one based on mixed hematopoietic chimerism and the other on vascularized thymus transplantatio...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

David John Irwin

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$3,215,718

FY 2026

Project Title

From Molecules To Complex Syndromes: Using Networks to Understand Heterogeneity in FTD-TDP and Aging

Grant Number:

2P01AG066597-06A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

12/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Frontotemporal degeneration (FTD) is a complex neurodegenerative disorder characterized by variable neuropathological, genetic, and clinical features. Clinically, FTD can present as a behavioral/executive disorder (bvFTD) or language disorder (primary progressive aphasia; PPA) and both syndromes oft...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Corey T McMillan

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$3,215,718

FY 2026

Project Title

From Molecules To Complex Syndromes: Using Networks to Understand Heterogeneity in FTD-TDP and Aging

Grant Number:

2P01AG066597-06A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

12/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Frontotemporal degeneration (FTD) is a complex neurodegenerative disorder characterized by variable neuropathological, genetic, and clinical features. Clinically, FTD can present as a behavioral/executive disorder (bvFTD) or language disorder (primary progressive aphasia; PPA) and both syndromes oft...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stephanie W Watts

MICHIGAN STATE UNIVERSITY, EAST LANSING, MI

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$2,579,357

FY 2026

Project Title

Perivascular Adipose Tissue (PVAT) as a Central Integrator of Vascular Health

Grant Number:

5P01HL152951-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

12/22/2021

End Date:

11/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Summary - Overall Vascular health is essential to the normal regulation of cardiovascular function. That dysfunctions of blood pressure regulation, such as hypertension, remain difficult to treat suggests that the scientific community does not fully understand the mechanisms by which normal and pat...

Research Terms

<21+ years old><Adipocyte precursor><Adipocytes><Adipose Cell><Adipose tissue><Adult><Adult Human><Adventitia><Affect><Animals><Applications Grants><Arteries><Autoregulation><BP homeostasis><BP regulation><Bioinformatics><Blood Pressure><Blood Vessels><Blood capillaries><Body Tissues><Cardiovascular Diseases><Cardiovascular Physiology><Cell Body><Cell Function><Cell Physiology><Cell Process><Cells><Cellular Function><Cellular Mechanotransduction><Cellular Physiology><Cellular Process><Collaborations><Common Rat Strains><Communication><Communities><Complement><Complement Proteins><Dahl Rats><Development><Disease><Disorder><Dysfunction><Elements><Excess Mortality><Fat Cells><Fat progenitor cell><Fat stem cell><Fats><Fatty Tissue><Fatty acid glycerol esters><Fibroblasts><Functional disorder><Genes><Goals><Grant><Grant Proposals><Health><High Fat Diet><Home><Homeostasis><Human><Human Figure><Human body><Hypertension><Immune><Immunes><Immunomodulation><Inbred Dahl Rats><Individual><Informatics><Investigators><Investments><Knowledge><Laboratory Animals><Learning><Lineage Tracing><Lipocytes><Literature><Mature Lipocyte><Mature fat cell><Mechanical Signal Transduction><Mechanics><Mechanosensory Transduction><Mesenchymal><Mice><Mice Mammals><Microscopic><Microscopy><Modeling><Modern Man><Murine><Mus><Nature><Nerve><Nerve Cells><Nerve Unit><Neural Cell><Neurocyte><Neurons><Obesity><P01 Mechanism><P01 Program><Pathologic><Physiologic><Physiological><Physiological Homeostasis><Physiology><Physiopathology><Preadipocytes><Precursor to adipocyte><Progenitor Cells><Program Project Grant><Program Research Project Grants><Publishing><RNA Seq><RNA sequencing><RNAseq><Rat><Rats Mammals><Rattus><Regulation><Research><Research Personnel><Research Program Projects><Researchers><Scientist><Stem Cell like><Stretching><Subcellular Process><Systems Integration><Testing><Therapeutic><Therapeutic Intervention><Thoracic aorta><Time><Tissues><Tunica Adventitia><Vascular Diseases><Vascular Disorder><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Work><adipocyte progenitors><adipocyte stem cell><adipocyte-derived stem cell><adipose><adipose derived stem cell><adipose progenitor><adipose stem cell><adipose tissue derived stem cell><adipose tissue stem cells><adiposity><adulthood><blood pressure homeostasis><blood pressure regulation><blood vessel disorder><capillary><cardiovascular disorder><cardiovascular function><cell lineage analysis><cell lineage mapping><cell lineage tracing><cell lineage tracking><cell type><cellular lineage mapping><cellular lineage tracking><complementation><corpulence><data sharing><developmental><experiment><experimental research><experimental study><experiments><fat cell precursor><fat derived stem cell><fighting><genetic approach><genetic strategy><high blood pressure><homes><hyperpiesia><hyperpiesis><hypertensive disease><hypertensive disorder><immune modulation><immune regulation><immunologic reactivity control><immunomodulatory><immunoregulation><immunoregulatory><improved><innervation><integrated system><intervention therapy><mechanic><mechanical><mechanical force><mechanosensing><mechanotransduction><model organism><nerve supply><neuronal><new approaches><novel><novel approaches><novel strategies><novel strategy><optogenetics><pathophysiology><peripheral blood vessel><pressure><progenitor capacity><progenitor cell like><progenitor-like><progenitor-like cell><regulate BP><regulate blood pressure><response><stem cell characteristics><stem cells><stem-like><stem-like cell><stemness><synergism><system integration><transcriptome sequencing><transcriptomic sequencing><translational opportunities><translational potential><vasa vasorum><vascular><vascular dysfunction><vasculopathy><white adipose tissue><yellow adipose tissue>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mansun Law

SCRIPPS RESEARCH INSTITUTE, THE, LA JOLLA, CA

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$2,111,046

FY 2026

Project Title

Broadly Effective HCV Vaccine

Grant Number:

5P01AI168251-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2022

End Date:

1/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Program Summary The overarching goal of this P01 proposal is to develop novel hepatitis C virus (HCV) vaccine candidates that can elicit potent broadly neutralizing antibody responses in immunization. Despite highly effective antiviral drugs against HCV now being available, the continuous increase i...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Erol Fikrig

UNIV OF MARYLAND, COLLEGE PARK, COLLEGE PARK, MD

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$1,898,910

FY 2026

Project Title

Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne Pathogens

Grant Number:

5P01AI138949-07

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/13/2018

End Date:

1/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – Abstract The proposed renewal Program Project (P01), entitled “Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne Pathogens”, aims to understand the molecular mechanisms by which a set of newly recognized I. scapularis conserv...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

UTPAL PAL

UNIV OF MARYLAND, COLLEGE PARK, COLLEGE PARK, MD

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$1,898,910

FY 2026

Project Title

Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne Pathogens

Grant Number:

5P01AI138949-07

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/13/2018

End Date:

1/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – Abstract The proposed renewal Program Project (P01), entitled “Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne Pathogens”, aims to understand the molecular mechanisms by which a set of newly recognized I. scapularis conserv...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joao Pedra

UNIV OF MARYLAND, COLLEGE PARK, COLLEGE PARK, MD

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$1,898,910

FY 2026

Project Title

Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne Pathogens

Grant Number:

5P01AI138949-07

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/13/2018

End Date:

1/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – Abstract The proposed renewal Program Project (P01), entitled “Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne Pathogens”, aims to understand the molecular mechanisms by which a set of newly recognized I. scapularis conserv...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mark S Anderson

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

High-opportunity lead · 74/100

Likely hiring

Large award

Active award

Team-scale grant

$1,764,521

FY 2026

Project Title

STAT3 variants as a rheostat of immune tolerance

Grant Number:

5P01AI155393-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/17/2022

End Date:

1/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary/Abstract (Overall) Dysregulation of the immune system can have severe consequences on health and wellbeing. Although this is often a complex process, recent progress in human genetics has allowed for the identification of single gene variants that are strongly associated with immune ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LEONIDAS C. PLATANIAS

NORTHWESTERN UNIVERSITY AT CHICAGO, CHICAGO, IL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$6,423,784

FY 2025

Project Title

The Robert H. Lurie Comprehensive Cancer Center

Grant Number:

2P30CA060553-31

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/1997

End Date:

7/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University (NU) is an NCI-designated, comprehensive matrix cancer center conducting a broad range of multidisciplinary clinical, basic, translational and population science research. The Lurie Cancer Center (LCC) integrates the expertis...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Geoffrey Roger HILL

FRED HUTCHINSON CANCER CENTER, SEATTLE, WA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$4,395,431

FY 2025

Project Title

Adult Leukemia Research Center

Grant Number:

5P01CA018029-49

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/28/1997

End Date:

7/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary/Abstract Overall Acute Myeloid Leukemia (AML) and multiple myeloma (MM) are diseases of the elderly, with median incidence of disease beyond 60 years of age. The mainstay of curative therapy for adult acute leukemia over the last two decades in younger patients has been allogeneic st...

Research Terms

<21+ years old><AML - Acute Myeloid Leukemia><Acute GVHD><Acute Graft Versus Host Disease><Acute Lymphoblastic Leukemia><Acute Lymphocytic Leukemia><Acute Lymphoid Leukemia><Acute Myeloblastic Leukemia><Acute Myelocytic Leukemia><Acute Myelogenous Leukemia><Acute leukemia><Adoptive Cell Transfers><Adult><Adult Human><Affinity><Age Years><Allogenic><Anti-Rejection Therapy><Antigens><Autologous><Autologous Stem Cell Transplantation><Biometrics><Biometry><Biostatistics><Bone Marrow><Bone Marrow Grafting><Bone Marrow Reticuloendothelial System><Bone Marrow Transplant><Bone Marrow Transplantation><CAR T cell therapy><CAR T cells><CAR T therapy><CAR modified T cells><CAR-T><CAR-Ts><CD19><CD19 gene><CD8 Cell><CD8 T cells><CD8 lymphocyte><CD8+ T cell><CD8+ T-Lymphocyte><CD8-Positive Lymphocytes><CD8-Positive T-Lymphocytes><CTX><CYCLO-cell><Cancers><Carloxan><Categories><Cell Body><Cell Communication and Signaling><Cell Function><Cell Physiology><Cell Process><Cell Signaling><Cell Therapy><Cells><Cellular Function><Cellular Physiology><Cellular Process><Cellular immunotherapy><Chronic GVHD><Ciclofosfamida><Ciclofosfamide><Cicloxal><Clafen><Claphene><Clinical><Clinical Research><Clinical Study><Cycloblastin><Cycloblastine><Cyclophospham><Cyclophosphamide><Cyclophosphamidum><Cyclophosphan><Cyclophosphane><Cyclophosphanum><Cyclostin><Cyclostine><Cytophosphan><Cytophosphane><Cytotoxic cell><Cytoxan><Disease><Disorder><Effectiveness><Elderly><Endoxan><Endoxana><Enduxan><Engineering><Failure><Fosfaseron><GVL><Generations><Genoxal><Genuxal><Germinoblastic Sarcoma><Germinoblastoma><Goals><Grant><GvHD><HSC transplantation><Hematologic Cancer><Hematologic Malignancies><Hematologic Neoplasms><Hematological Malignancies><Hematological Neoplasms><Hematological Tumor><Hematopoietic Cancer><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hemophagocytic Lymphohistiocytoses><Homologous Wasting Disease><Immune><Immunes><Immunity><Immunochemical Immunologic><Immunologic><Immunologic Factors><Immunological><Immunological Factors><Immunologically><Immunologics><Immunosuppressive Therapy><Incidence><Individual><Induction Therapy><Infection><Infection prevention><Infusion><Infusion procedures><Intracellular Communication and Signaling><K lymphocyte><Learning><Ledoxina><Lentiviral Vector><Lentivirus Vector><Long-term Follow-up><Lymphoma><MHC Receptor><Major Histocompatibility Complex Receptor><Malignant Hematologic Neoplasm><Malignant Lymphoma><Malignant Neoplasms><Malignant Tumor><Marrow Transplantation><Memory><Minor Histocompatibility Antigens><Minor Histocompatibility Peptides><Mitoxan><Modeling><Modernization><Morbidity><Morbidity - disease rate><Multiple Myeloma><NEOADJ><NK Cells><Natural Killer Cells><Neoadjuvant><Neoadjuvant Therapy><Neoadjuvant Treatment><Neosar><Nervous System Poisoning><Neurotoxic Disorders><Neurotoxicity Syndromes><Neurotoxin Diseases><Neurotoxin Disorders><Opportunistic Infections><Outcome><P01 Mechanism><P01 Program><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Phase><Phase 1/2 trial><Phase I/II Trial><Phenotype><Plasma-Cell Myeloma><Precursor Cell Lymphoblastic Leukemia><Precursor Lymphoblastic Leukemia><Prevent infection><Prevention><Probability><Procytox><Progenitor Cells><Program Project Grant><Program Research Project Grants><Progression-Free Survivals><Proteins><QOL><Quality of life><Receptor Protein><Recurrent disease><Refractory><Relapse><Relapsed Disease><Research><Research Program Projects><Research Resources><Resources><Reticulolymphosarcoma><Runt Disease><Safety><Sampling><Sendoxan><Sensitivity and Specificity><Signal Transduction><Signal Transduction Systems><Signaling><Stem Cell like><Subcellular Process><Syklofosfamid><System><T cell based immune therapy><T cell based therapeutics><T cell based therapy><T cell differentiation><T cell directed therapies><T cell immune therapy><T cell immunotherapy><T cell targeted therapeutics><T cell therapy><T cell treatment><T cell-based immunotherapy><T cell-based treatment><T cells for CAR><T cellular immunotherapy><T cellular therapy><T lymphocyte based immunotherapy><T lymphocyte based therapy><T lymphocyte therapeutic><T lymphocyte treatment><T memory cell><T-Cell Antigen Receptors><T-Cell Receptor><T-Cells><T-Lymphocyte><T-cell therapeutics><T-cell transfer therapy><T8 Cells><T8 Lymphocytes><Testing><Therapeutic immunosuppression><Toxic effect><Toxicities><Transplantation><Treatment Failure><Tumor Antigens><Tumor-Associated Antigen><WAGR><WT1><WT1 Gene Product><WT1 Protein><WT1 gene><WT33><Wilms Tumor 1><Wilms tumor suppressor WT1><Work><Zytoxan><acute graft vs host disease><acute graft vs. host disease><acute granulocytic leukemia><acute granulocytic leukemia cell><acute lymphatic leukemia><acute lymphogenous leukemia><acute lymphomatic leukemia><acute myeloblastic leukemia cell><acute myelocytic leukemia cell><acute myelogenous leukemia cell><acute myeloid leukemia><acute myeloid leukemia cell><acute nonlymphocytic leukemia cell><adoptive T cell transfer><adoptive T lymphocyte transfer><adoptive T-cell therapy><adoptive cell therapy><adoptive cellular therapy><adult leukemia><adulthood><advanced age><artificial immunosuppression><biological signal transduction><blood stem cell transplantation><cancer antigens><cell based intervention><cell mediated intervention><cell mediated therapies><cell-based immunotherapy><cell-based therapeutic><cell-based therapy><cellular therapeutic><cellular therapy><chimeric antigen T cell receptor><chimeric antigen receptor><chimeric antigen receptor (CAR) T cell therapy><chimeric antigen receptor (CAR) T cells><chimeric antigen receptor T><chimeric antigen receptor T cell therapy><chimeric antigen receptor T cells><chimeric antigen receptor T therapy><chimeric antigen receptor fusion protein T-cells><chimeric antigen receptor modified T cells><chronic graft versus host disease><chronic graft vs host disease><chronic graft vs. host disease><curative intervention><curative therapeutic><curative therapy><curative treatments><cytokine><cytokine release syndrome><cytokine storm><data management><design><designing><dimensional analysis><disease prevention><disorder prevention><engineered T cells><genetically engineered T-cells><genetically engineered cells><genetically modified cells><geriatric><graft failure><graft versus host disease><graft versus leukemia><graft vs host disease><graft vs leukemia><graft vs leukemia effect><graft vs leukemia response><graft vs. host disease><graft vs. leukemia><graft vs. leukemia effect><graft vs. leukemia response><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high dimensionality><high risk><immune cell therapy><immunogen><immunologic substance><immunological substance><immunosuppression therapy><improved><improved outcome><induction therapies><infusions><innovate><innovation><innovative><leukemia><leukemia relapse><leukemia treatment><leukemic therapy><long-term followup><malignancy><memory T lymphocyte><mortality><myeloma><myelomatosis><neoplasm/cancer><new approaches><next generation><novel><novel approaches><novel strategies><novel strategy><pathogen><patient oriented outcomes><post-transplant><post-transplantation><posttransplant><posttransplantation><pre-clinical><pre-clinical study><preclinical><preclinical study><prevent><prevent relapse><preventing><progenitor capacity><progenitor cell like><progenitor-like><programs><rational design><receptor><receptor function><recurrent leukemia><relapse prevention><response><safety assessment><senior citizen><stem cell characteristics><stem cells><stem-like><stemness><success><therapeutic T-cell platform><therapy failure><thymus derived lymphocyte><transgenic T- cells><transplant><transplant survivor><tumor><tumor-specific antigen>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Sallie R. Permar

WEILL MEDICAL COLL OF CORNELL UNIV, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$4,302,307

FY 2025

Project Title

Immunologic strategies to prevent congenital cytomegalovirus transmission and disease in rhesus monkeys

Grant Number:

5P01AI129859-08

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/24/2019

End Date:

5/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT - OVERALL Congenital cytomegalovirus (cCMV) is a prevalent in utero infection, affecting approximately 1 in 200 newborns and leading to severe neurological impairment in 1 in 5 infected infants. Maternal CMV-specific adaptive immunity is partially protective against cCMV infection, with red...

Research Terms

<0-4 weeks old><4q Chemokine><Acquired brain injury><Acute><Address><Affect><Animal Model><Animal Models and Related Studies><Antibodies><Antibody Response><Antigen Targeting><Bioinformatics><Biologic Models><Biological Models><Birth Defects><Brain Injuries><C-X-C Chemokines><CD8 Cell><CD8 T cells><CD8 lymphocyte><CD8+ T cell><CD8+ T-Lymphocyte><CD8-Positive Lymphocytes><CD8-Positive T-Lymphocytes><CMV><CMV infection><CMV vaccine><CXC Chemokines><Cell Body><Cell Mediated Immunology><Cell-Mediated Immunity><Cells><Cells Placenta-Tissue><Cellular Immunity><Chemotactic Cytokines><Chronic><Clinical Trials><Complex><Congenital Abnormality><Congenital Anatomical Abnormality><Congenital Defects><Congenital Deformity><Congenital Malformation><Containment><Cytomegalic Inclusion Disease><Cytomegalovirus><Cytomegalovirus Infections><Cytomegalovirus Vaccines><Data Science Core><Data Science Resource Core><Development><Disease><Disorder><Engineering><Epidemiology><Epithelial Cells><Evaluation><Fc Receptor><Fetal Diseases><Fetomaternal Transmission><Fetus><GeneHomolog><Gestation><Glycoproteins><Goals><Grant><HCMV><Hearing Loss><Homolog><Homologous Chemotactic Cytokines><Homologous Gene><Homologue><Human><Hypoacuses><Hypoacusis><Immune><Immune Evasion><Immune Targeting><Immune response><Immunes><Immunity><Immunochemical Immunologic><Immunocompetent><Immunologic><Immunologic Factors><Immunological><Immunological Factors><Immunologically><Immunologics><Impairment><Inclusion Disease><Infant><Infection><Intercrines><M mulatta><M. mulatta><Macaca mulatta><Macaca rhesus><Maternal-Fetal Exchange><Maternal-Fetal Transmission><Math Models><Mediating><Model System><Modeling><Modern Man><NHP models><Neurologic><Neurologic Deficit><Neurological><Newborn Infant><Newborns><Normal Placentoma><Organoids><P01 Mechanism><P01 Program><Placenta><Placenta Embryonic Tissue><Placentome><Pregnancy><Primary Infection><Program Project Grant><Program Research Project Grants><Proteins><Research><Research Program Projects><Rhesus Macaque><Rhesus Monkey><Risk><Role><SEQ-AN><SIS cytokines><Salivary Gland Virus Disease><Salivary Gland Viruses><Sequence Analyses><Sequence Analysis><T cell response><T-Cells><T-Lymphocyte><T8 Cells><T8 Lymphocytes><Testing><Transmission><Transplacental Exposure><Vaccination><Vaccination acquired immunity><Vaccination induced immunity><Vaccine Antigen><Vaccines><Viral><Viral Activity><Viral Burden><Viral Function><Viral Load><Viral Load result><Viral Pathogenesis><Viral Physiology><Virus><adaptive immunity><alpha-Chemokines><antibody receptor><brain damage><brain-injured><chemoattractant cytokine><chemokine><communicable disease transmission><congenital CMV><congenital cytomegalovirus><congenital cytomegalovirus infection><cost><cytomegalovirus group><design><designing><develop a vaccine><develop vaccines><development of a vaccine><developmental><disease transmission><dysfunctional hearing><efficacy study><efficacy trial><embryo/fetus disorder><epidemiologic><epidemiological><female infections><fetal disorders><fetus disorder><hearing challenged><hearing defect><hearing deficient><hearing deficit><hearing difficulty><hearing dysfunction><hearing impairment><host response><immune competent><immune evasive><immune system response><immunization strategy><immunologic substance><immunological substance><immunoresponse><improved><in utero><in utero transmission><infant infection><infected females><infected infant><infected women><infections among women><infections in females><infections in women><infectious disease transmission><maternal to fetal transmission><maternal-fetal interface><mathematic model><mathematical model><mathematical modeling><model of animal><neutralizing antibody><new approaches><new vaccines><newborn child><newborn children><next generation><next generation vaccines><non-human primate><nonhuman primate><nonhuman primate models><novel><novel approaches><novel strategies><novel strategy><novel vaccines><phase 3 trial><phase III trial><prevent><preventing><programs><social role><thymus derived lymphocyte><trafficking><translational study><transmission during pregnancy><transmission process><vaccination strategy><vaccine acquired immunity><vaccine associated immunity><vaccine candidate><vaccine development><vaccine-induced immunity><vaccine-induced protection><viral transmission><virology><virus pathogenesis><virus transmission><women experiencing infections><women infections><women with infections>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Christopher Mark Norris

UNIVERSITY OF KENTUCKY, LEXINGTON, KY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,958,139

FY 2025

Project Title

Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias

Grant Number:

5P01AG078116-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2022

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – ABSTRACT SUMMARY This P01— Strategies for Targeting Astrocyte Reactivity in AD and ADRD (STAR-ADRD) addresses the (patho)physiologic roles of reactive astrocytes in Alzheimer’s disease (AD) and related dementias (ADRD). Though highly significant to many disease phenotypes, astrocyte functi...

Research Terms

<2-photon microscopy><ABCC9><ABCC9 gene><AD dementia><AD model><AD pathology><AD related dementia><ADRD><Address><Aging><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Amyloid beta-Protein><Alzheimer's Disease><Alzheimer's amyloid><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease model><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease pathology><Alzheimer's disease related dementia><Alzheimer's pathology><Alzheimers Dementia><Amentia><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid beta-Protein><Amyloid β><Amyloid β-Peptide><Amyloid β-Protein><Animals><Area><Astrocytes><Astrocytus><Astroglia><Attention><Autopsy><Awareness><Aβ><Back><Biochemical Pathway><Biological Markers><Biology><Biometrics><Biometry><Biostatistics><Blood Vessels><Body Tissues><Brain><Brain Nervous System><Brain Pathology><Brain Vascular><Brain Vascular Disorders><CLG4B><CRSP130><CRSP133><CRSP3><CRSP3 gene><Categories><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Cerebral small vessel disease><Cerebrovascular Disease><Cerebrovascular Disorders><Cofactor Required for Sp1 Transcriptional Activation Subunit 3><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive function abnormal><Communities><Complex><Consultations><DRIP130><Data Analyses><Data Analysis><Dementia><Disease><Disorder><Disturbance in cognition><Dorsum><Dysfunction><EEG><Electroencephalogram><Electroencephalography><Electrophysiology><Electrophysiology (science)><Encephalon><Functional disorder><Future><GELB><Gene Expression Monitoring><Gene Expression Pattern Analysis><Gene Expression Profiling><Glutamate Translocase><Glutamate Transport Glycoprotein><Glutamate Transporter><Glutamates><Goals><Grant><History><Hortega cell><Human><Imaging Procedures><Imaging Technics><Imaging Techniques><Impaired cognition><Impairment><Insulin Receptor><Insulin Receptor Protein-Tyrosine Kinase><Insulin-Dependent Tyrosine Protein Kinase><Intervention><Intracellular Communication and Signaling><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Kentucky><L-Glutamate><Leadership><Liquid substance><MMP9><MMP9 gene><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Measures><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Metabolic><Metabolic Networks><Mice><Mice Mammals><Microelectrodes><Microglia><Miniaturized Electrodes><Modeling><Modern Man><Murine><Mus><NIH><NMR Imaging><NMR Tomography><National Institutes of Health><Nerve Cells><Nerve Unit><Neural Cell><Neurocyte><Neurons><Neurophysiology / Electrophysiology><Nuclear Magnetic Resonance Imaging><Pathologic><Pathology><Phenotype><Physiologic><Physiological><Physiopathology><Primary Senile Degenerative Dementia><Property><Receptor Signaling><Recording of previous events><Renaissance><Research><Research Resources><Resources><Risk-associated variant><Role><SUR2><Signal Transduction><Signal Transduction Systems><Signaling><Statistical Data Analyses><Statistical Data Analysis><Statistical Data Interpretation><Structure><Techniques><Technology><Testing><Therapeutic><Time><Tissues><Transcript Expression Analyses><Transcript Expression Analysis><United States National Institutes of Health><Universities><Zeugmatography><a beta peptide><abeta><alzheimer model><amyloid beta><amyloid-b protein><analyze gene expression><astrocytic glia><beta amyloid fibril><bio-markers><biologic marker><biological signal transduction><biomarker><biomarker validation><brain vascular disease><brain vascular dysfunction><cardiac disease induced cognitive impairment><cerebral small vessel disorder><cerebral vascular><cerebral vascular disease><cerebral vascular dysfunction><cerebro-vascular><cerebrovascular><cerebrovascular contribution to cognitive impairment and dementia><cerebrovascular dysfunction><cognitive dysfunction><cognitive loss><consultation><data integration><data interpretation><data management><data pipeline><design><designing><disease phenotype><electrophysiological><fluid><gene expression analysis><gene expression assay><gitter cell><glutamatergic><hippocampal sclerosis><histories><human data><human subject><in vivo><insulin signaling><intra-vital imaging><intracranial vascular dysfunction><intravital imaging><knock-down><knockdown><limbic-predominant age-related TDP-43 encephalopathy><limbic-predominant age-related TDP43 encephalopathy><liquid><marker validation><mesoglia><microglial cell><microgliocyte><mouse model><murine model><necropsy><neural inflammation><neural network><neurochemical><neurochemistry><neuroinflammation><neuroinflammatory><neuronal><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><overexpress><overexpression><pathophysiology><perivascular glial cell><postmortem><pre-clinical><pre-clinical research><preclinical><preclinical research><primary degenerative dementia><risk allele><risk gene><risk genotype><risk loci><risk locus><risk variant><senile dementia of the Alzheimer type><social role><soluble amyloid precursor protein><statistical analysis><transcriptional profiling><two photon excitation microscopy><two photon microscopy><vascular><vascular cognitive impairment and dementia><vascular contribution to impairment or dementia><vascular contributions to cognition/dementia><vascular contributions to cognitive decline and dementia><vascular contributions to cognitive impairment and dementia>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MARK P DOESCHER

UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OKLAHOMA CITY, OK

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,458,490

FY 2025

Project Title

Improving Cancer Outcomes In Native American Communities (ICON)

Grant Number:

5U19MD020537-02

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/17/2024

End Date:

6/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL COMPONENT: PROJECT SUMMARY American Indian and Alaska Native (AI/AN) communities experience cancer incidence and mortality rates that are strikingly worse than those of the overall US population. In Oklahoma, which has the second highest population of AI/AN persons in the US and is the home ...

Research Terms

<2nd World War><Abscission><Address><Alaska Indian><Alaska Native><Alaska Native group><Alaska Native individual><Alaska Native people><Alaska Native population><Alaska Natives><Alaskan American><Alaskan Indian><Alaskan Native><Alaskan Native American><Alaskan Natives><American Indian><American Indian Population><American Indian group><American Indian individual><American Indian people><American Indians><Area><Arsenic><Attention><Cancer Center><Cancer Patient><Cancer health equity><Cancers><Cherokee Nation><Choctaw Nation><Choctaw Nation of Oklahoma><Chronic><Clinical Trials><Collaborations><Communication Programs><Communities><Community Health><Consultations><Curriculum><Death Rate><EXTMR><Economics><Education><Educational Curriculum><Educational aspects><Elements><Ensure><Environment><Equity><Evaluation><Excision><Exhibits><Exposure to><Extirpation><Extramural><Extramural Activities><Fostering><Foundations><Funding><General Population><General Public><Grant><Health><Health Care Team><Health Status><Health system><Home><Household><Hydrogen Oxide><Incidence><Indian Health Service><Indigenous><Infrastructure><Intervention><Investigators><Leadership><Level of Health><Location><Malignant Neoplasms><Malignant Tumor><Medical Care Team><Mentorship><Monitor><Native American><Native American community><Needs Assessment><Oklahoma><Oncology><Oncology Cancer><Outcome><Outcomes Research><P01 Mechanism><P01 Program><Patients><Perception><Performance><Persons><Population><Prevention><Prevention Research><Program Project Grant><Program Research Project Grants><R-Series Research Projects><R01 Mechanism><R01 Program><Removal><Research><Research Grants><Research Personnel><Research Priority><Research Program Projects><Research Project Grants><Research Projects><Researchers><Reservations><Rights><Rural><Second World War><Structural Racism><Surgical Removal><System><Testing><Translating><Tribal Participatory Research><Tribally Based Participatory Research><Tribally-driven participatory research><Tribes><Trust><United States><United States Indian Health Service><Uranium><Water><Work><World War II><access to health care><accessibility of health care><accessibility to health care><anti-cancer research><arsenics><cancer care><cancer prevention><cancer research><care coordination><career><collaborative care><community engagement><community partners><community-based health><community-based partners><consultation><coordinating care><design><designing><develop therapy><drinking water><economic><engagement with communities><experience><federal policy><health care access><health care availability><health care service access><health care service availability><health level><homes><improved><intervention development><lesson plans><lung cancer early detection><lung cancer screening><malignancy><member><mortality><mortality rate><mortality ratio><neoplasm/cancer><novel><programs><recruit><research study><resection><resilience><resilient><rural area><rural location><rural region><screening><screening program><screenings><telehealth><therapy development><treatment development><tribal Nation><tribal agency><tribal board><tribal community><tribal entity><tribal governance><tribal government><tribal health><tribal organization><tribal self-governance><tribally engaged research><tribally led research><tribally-driven research><urban American Indian><urban Indian><urban Native American><urban area><urban location><urban region>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Dorothy Alison Rhoades

UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OKLAHOMA CITY, OK

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,458,490

FY 2025

Project Title

Improving Cancer Outcomes In Native American Communities (ICON)

Grant Number:

5U19MD020537-02

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/17/2024

End Date:

6/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL COMPONENT: PROJECT SUMMARY American Indian and Alaska Native (AI/AN) communities experience cancer incidence and mortality rates that are strikingly worse than those of the overall US population. In Oklahoma, which has the second highest population of AI/AN persons in the US and is the home ...

Research Terms

<2nd World War><Abscission><Address><Alaska Indian><Alaska Native><Alaska Native group><Alaska Native individual><Alaska Native people><Alaska Native population><Alaska Natives><Alaskan American><Alaskan Indian><Alaskan Native><Alaskan Native American><Alaskan Natives><American Indian><American Indian Population><American Indian group><American Indian individual><American Indian people><American Indians><Area><Arsenic><Attention><Cancer Center><Cancer Patient><Cancer health equity><Cancers><Cherokee Nation><Choctaw Nation><Choctaw Nation of Oklahoma><Chronic><Clinical Trials><Collaborations><Communication Programs><Communities><Community Health><Consultations><Curriculum><Death Rate><EXTMR><Economics><Education><Educational Curriculum><Educational aspects><Elements><Ensure><Environment><Equity><Evaluation><Excision><Exhibits><Exposure to><Extirpation><Extramural><Extramural Activities><Fostering><Foundations><Funding><General Population><General Public><Grant><Health><Health Care Team><Health Status><Health system><Home><Household><Hydrogen Oxide><Incidence><Indian Health Service><Indigenous><Infrastructure><Intervention><Investigators><Leadership><Level of Health><Location><Malignant Neoplasms><Malignant Tumor><Medical Care Team><Mentorship><Monitor><Native American><Native American community><Needs Assessment><Oklahoma><Oncology><Oncology Cancer><Outcome><Outcomes Research><P01 Mechanism><P01 Program><Patients><Perception><Performance><Persons><Population><Prevention><Prevention Research><Program Project Grant><Program Research Project Grants><R-Series Research Projects><R01 Mechanism><R01 Program><Removal><Research><Research Grants><Research Personnel><Research Priority><Research Program Projects><Research Project Grants><Research Projects><Researchers><Reservations><Rights><Rural><Second World War><Structural Racism><Surgical Removal><System><Testing><Translating><Tribal Participatory Research><Tribally Based Participatory Research><Tribally-driven participatory research><Tribes><Trust><United States><United States Indian Health Service><Uranium><Water><Work><World War II><access to health care><accessibility of health care><accessibility to health care><anti-cancer research><arsenics><cancer care><cancer prevention><cancer research><care coordination><career><collaborative care><community engagement><community partners><community-based health><community-based partners><consultation><coordinating care><design><designing><develop therapy><drinking water><economic><engagement with communities><experience><federal policy><health care access><health care availability><health care service access><health care service availability><health level><homes><improved><intervention development><lesson plans><lung cancer early detection><lung cancer screening><malignancy><member><mortality><mortality rate><mortality ratio><neoplasm/cancer><novel><programs><recruit><research study><resection><resilience><resilient><rural area><rural location><rural region><screening><screening program><screenings><telehealth><therapy development><treatment development><tribal Nation><tribal agency><tribal board><tribal community><tribal entity><tribal governance><tribal government><tribal health><tribal organization><tribal self-governance><tribally engaged research><tribally led research><tribally-driven research><urban American Indian><urban Indian><urban Native American><urban area><urban location><urban region>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PAUL G SPICER

UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OKLAHOMA CITY, OK

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,458,490

FY 2025

Project Title

Improving Cancer Outcomes In Native American Communities (ICON)

Grant Number:

5U19MD020537-02

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/17/2024

End Date:

6/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL COMPONENT: PROJECT SUMMARY American Indian and Alaska Native (AI/AN) communities experience cancer incidence and mortality rates that are strikingly worse than those of the overall US population. In Oklahoma, which has the second highest population of AI/AN persons in the US and is the home ...

Research Terms

<2nd World War><Abscission><Address><Alaska Indian><Alaska Native><Alaska Native group><Alaska Native individual><Alaska Native people><Alaska Native population><Alaska Natives><Alaskan American><Alaskan Indian><Alaskan Native><Alaskan Native American><Alaskan Natives><American Indian><American Indian Population><American Indian group><American Indian individual><American Indian people><American Indians><Area><Arsenic><Attention><Cancer Center><Cancer Patient><Cancer health equity><Cancers><Cherokee Nation><Choctaw Nation><Choctaw Nation of Oklahoma><Chronic><Clinical Trials><Collaborations><Communication Programs><Communities><Community Health><Consultations><Curriculum><Death Rate><EXTMR><Economics><Education><Educational Curriculum><Educational aspects><Elements><Ensure><Environment><Equity><Evaluation><Excision><Exhibits><Exposure to><Extirpation><Extramural><Extramural Activities><Fostering><Foundations><Funding><General Population><General Public><Grant><Health><Health Care Team><Health Status><Health system><Home><Household><Hydrogen Oxide><Incidence><Indian Health Service><Indigenous><Infrastructure><Intervention><Investigators><Leadership><Level of Health><Location><Malignant Neoplasms><Malignant Tumor><Medical Care Team><Mentorship><Monitor><Native American><Native American community><Needs Assessment><Oklahoma><Oncology><Oncology Cancer><Outcome><Outcomes Research><P01 Mechanism><P01 Program><Patients><Perception><Performance><Persons><Population><Prevention><Prevention Research><Program Project Grant><Program Research Project Grants><R-Series Research Projects><R01 Mechanism><R01 Program><Removal><Research><Research Grants><Research Personnel><Research Priority><Research Program Projects><Research Project Grants><Research Projects><Researchers><Reservations><Rights><Rural><Second World War><Structural Racism><Surgical Removal><System><Testing><Translating><Tribal Participatory Research><Tribally Based Participatory Research><Tribally-driven participatory research><Tribes><Trust><United States><United States Indian Health Service><Uranium><Water><Work><World War II><access to health care><accessibility of health care><accessibility to health care><anti-cancer research><arsenics><cancer care><cancer prevention><cancer research><care coordination><career><collaborative care><community engagement><community partners><community-based health><community-based partners><consultation><coordinating care><design><designing><develop therapy><drinking water><economic><engagement with communities><experience><federal policy><health care access><health care availability><health care service access><health care service availability><health level><homes><improved><intervention development><lesson plans><lung cancer early detection><lung cancer screening><malignancy><member><mortality><mortality rate><mortality ratio><neoplasm/cancer><novel><programs><recruit><research study><resection><resilience><resilient><rural area><rural location><rural region><screening><screening program><screenings><telehealth><therapy development><treatment development><tribal Nation><tribal agency><tribal board><tribal community><tribal entity><tribal governance><tribal government><tribal health><tribal organization><tribal self-governance><tribally engaged research><tribally led research><tribally-driven research><urban American Indian><urban Indian><urban Native American><urban area><urban location><urban region>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Susan S. Huang

UNIVERSITY OF CALIFORNIA-IRVINE, IRVINE, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,252,905

FY 2025

Project Title

MDRO Carriage, Transmission, Sequelae, and Prevention in Nursing Homes

Grant Number:

5U19AI172725-03

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/11/2023

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Abstract Overview: MDRO Carriage, Transmission, Sequelae, and Prevention in Nursing Homes This P01 Program proposal will address critically important questions surrounding the expanding problem of multidrug-resistant organisms (MDROs) in nursing homes (NH). Of the 1.4 million residents residing ann...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

AMBER E BARNATO

DARTMOUTH COLLEGE, HANOVER, NH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,149,542

FY 2025

Project Title

Causes and Consequences of Healthcare Inefficiency in Alzheimer’s Disease and Related Dementias

Grant Number:

5P01AG019783-23

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2001

End Date:

7/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Motivated by soaring spending and stagnating life expectancy, the first 20 years of this Program Project Grant (PPG) has focused on the causes and consequences of healthcare efficiency in the U.S. This work has advanced fundamental scientific knowledge regarding sources of inefficiency and has motiv...

Research Terms

<21+ years old><AD related dementia><ADRD><Acute Disease><Adult><Adult Human><Affect><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease patient><Alzheimer's disease related dementia><Alzheimer's patient><American><Area><Behavior><Caring><Communities><Data><Detection><Development><Diagnosis><Diagnostic tests><Eligibility><Eligibility Determination><Excess Mortality><Face><Health><Health Care><Health Care Systems><Health Care Utilization><Health Policy><Health system><Heterogeneity><Home><Hospitals><Housing><Individual><Institution><Integrated Delivery Systems><Knowledge><Life Expectancy><Low income><Measures><Medicaid><Medical><Methodology><Modeling><Nursing Homes><Outcome><Ownership><P01 Mechanism><P01 Program><Patient Care><Patient Care Delivery><Patients><Pattern><Perception><Persons><Physicians><Policies><Primary Care><Process><Program Project Grant><Program Research Project Grants><Protocol Screening><Provider><Research><Research Program Projects><Research Resources><Resources><Running><Services><Shapes><Source><Structure><System><Testing><Work><acute care><acute disease/disorder><acute disorder><adulthood><before conception><care coordination><care delivery><care for patients><care of patients><care outcomes><caring for patients><clinical decision-making><community based service><coordinating care><developmental><disease diagnosis><end of life care><faces><facial><federal policy><health care organization><health care outcomes><health care policy><health care service><health care service organization><health care service use><health care service utilization><home based service><homes><improved outcome><malleable risk><modifiable risk><novel><nursing home><older adult><older adulthood><optimal therapies><optimal treatments><patient living with Alzheimer's disease><patient subclass><patient subcluster><patient subgroups><patient subpopulations><patient subsets><patient subtypes><patient suffering from Alzheimer's disease><patient with Alzheimer's><patient with Alzheimer's disease><payment><point of care><practice factors><practice-level factors><preconception><preference><primary care practice><prior to conception><referral services><social><synergism><trend>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Eva Harris

UNIVERSITY OF CALIFORNIA BERKELEY, BERKELEY, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,121,080

FY 2025

Project Title

Protective immunity following dengue virus natural infections and vaccination

Grant Number:

2P01AI106695-11

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/29/2015

End Date:

7/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

SUMMARY (OVERALL) The four dengue virus serotypes (DENV1-4) cause the most important mosquito-borne viral disease of humans. Yet, no treatment is available, and the only registered vaccines are problematic. A major challenge is the dual potential of the immune response to protect against or enhance ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Suresh S. Ramalingam

EMORY UNIVERSITY, ATLANTA, GA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,106,678

FY 2025

Project Title

Winship Cancer Institute Cancer Center Support Grant

Grant Number:

5P30CA138292-16

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/7/2009

End Date:

3/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT OVERALL The mission of Winship Cancer Institute of Emory University (Winship) is to discover cures for cancer and inspire hope. Winship is the only NCI-designated comprehensive cancer center in Georgia, the eighth most populous state in the United States, with the second hig...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PAUL NGHIEM

UNIVERSITY OF WASHINGTON, SEATTLE, WA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,994,993

FY 2025

Project Title

Immunobiology and Immune Therapy for Merkel Cell Carcinoma

Grant Number:

2P01CA225517-06A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/4/2019

End Date:

7/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Summary - Overall: Immunobiology and Immune Therapy for Merkel Cell Carcinoma Our Seattle-based P01 team, with collaborators around the world, has played a leading role in characterizing the immune response against Merkel cell carcinoma (MCC), an often-lethal, polyomavirus-driven, skin cancer. We l...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CARL H. JUNE

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,863,199

FY 2025

Project Title

Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19

Grant Number:

5P01CA214278-08

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/15/2017

End Date:

8/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY / ABSTRACT The long-term goals of this renewal P01 are to develop next generation immunotherapy with chimeric antigen receptor (CAR) T cells and to translate this research into new therapies with curative potential for patients with blood cancer. The CAR developed at our cent...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mina Kay Chung

CLEVELAND CLINIC LERNER COM-CWRU, CLEVELAND, OH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,841,649

FY 2025

Project Title

Atrial Fibrillation Post-GWAS: Mechanisms to Treatment

Grant Number:

5P01HL158502-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2022

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL COMPONENT PROJECT/SUMMARY ABSTRACT Atrial fibrillation (AF), the most common cardiac arrhythmia, afflicts the U.S. and world with increasing prevalence. AF incidence, progression to persistent AF, and AF complications, including stroke, are fed by increasing obesity and age. Current therapie...

Research Terms

<21+ years old><4q25><AI based><Ablation><Address><Adult><Adult Human><Age><Amines><Animal Model><Animal Models and Related Studies><Apoplexy><Arrhythmia><Atrial><Atrial Fibrillation><Auricular Fibrillation><Back><Basic Research><Basic Science><Body Tissues><Brain Vascular Accident><Cardiac><Cardiac Arrhythmia><Cardiac Atrium><Cardiac Muscle Cells><Cardiac Myocytes><Cardiocyte><Cell Body><Cell Nucleus><Cell model><Cells><Cellular model><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Cheese><Choline><Clinical><Collaborations><Data><Dietary Intervention><Dorsum><Drug Targeting><Drug Therapy><Drugs><Dysfunction><Electrophysiology><Electrophysiology (science)><Engineering><Environment><Fibrosis><Functional disorder><GI microbiome><GI microbiota><GWA study><GWAS><Gastrointestinal microbiota><Gene Action Regulation><Gene Expression><Gene Expression Regulation><Gene Regulation><Gene Regulation Process><Gene Targeting><Genes><Genetic><Genetic Risk><Genomics><Goals><Heart Arrhythmias><Heart Atrium><Heart Muscle Cells><Heart myocyte><History><Human><In Vitro><Incidence><Individual><Inflammasome><Inflammatory><Intermediary Metabolism><Intervention><Investigators><Knowledge><LKB1><LKB1/STK11 Gene><Leanness><Left><Link><Meat><Medication><Metabolic><Metabolic Processes><Metabolism><Methods><Mice><Mice Mammals><Mitochondria><Modern Man><Molecular><Murine><Mus><Muscle Cells><Myocytes><Neurophysiology / Electrophysiology><Nucleus><Nutrition><Nutrition Interventions><Nutritional Interventions><Obesity><Oxides><Pathway interactions><Patients><Pharmaceutical Preparations><Pharmacological Treatment><Pharmacotherapy><Phenotype><Physiology><Physiopathology><Prevalence><Prevention><Preventive><Proteomics><Pulmonary veins><RNA Seq><RNA Sequences><RNA sequencing><RNAseq><Recording of previous events><Research><Research Personnel><Researchers><Risk><Risk Factors><Risk-associated variant><Role><STK11><STK11 gene><Single-Nucleus Sequencing><Stroke><Study models><Systems Biology><Testing><Therapeutic><Thinness><Tissue Model><Tissues><Transgenic Mice><Translating><Translations><Variant><Variation><adiposity><adulthood><ages><amine><artificial intelligence based><atrium><biobank><biorepository><brain attack><candidate identification><cardiac tissue engineering><cardiomyocyte><causal allele><causal gene><causal mutation><causal variant><causative mutation><causative variant><cerebral vascular accident><cerebrovascular accident><clinical applicability><clinical application><clinically actionable><co-morbid><co-morbidity><comorbidity><corpulence><diet intervention><dietary><digestive tract microbiome><drug detection><drug discovery><drug intervention><drug repositioning><drug repurposing><drug testing><drug treatment><drug/agent><egg><electrophysiological><engineered heart tissue><enteric microbial community><enteric microbiome><enteric microbiota><gastrointestinal microbial flora><gastrointestinal microbiome><gene interaction><gene locus><genetic locus><genome resource><genome wide association><genome wide association scan><genome wide association study><genomewide association scan><genomewide association study><genomic data><genomic data resource><genomic dataset><genomic location><genomic locus><genomic resource><genomic sequencing resource><gut community><gut flora><gut microbe community><gut microbial community><gut microbial composition><gut microbial consortia><gut microbiome><gut microbiota><gut microbiotic><gut microflora><gut-associated microbiome><histories><iPS><iPSC><iPSCs><in vivo><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><inhibitor><insight><intestinal biome><intestinal flora><intestinal microbiome><intestinal microbiota><intestinal microflora><intestinal tract microflora><knowledge database><liver kinase B1><metabolism measurement><metabolomics><metabonomics><mitochondrial><mitochondrial dysfunction><model of animal><mouse model><multidisciplinary><murine model><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapeutic target><new therapeutics><new therapy><new therapy approaches><new therapy target><new treatment approach><new treatment strategy><next generation therapeutics><novel><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapeutic target><novel therapeutics><novel therapy><novel therapy approach><novel therapy target><pathophysiology><pathway><pharmaceutical intervention><pharmacologic><pharmacological intervention><pharmacological therapy><pharmacology intervention><pharmacology treatment><pharmacotherapeutics><prevent><preventing><programs><repurposing agent><repurposing medication><risk allele><risk gene><risk genotype><risk loci><risk locus><risk variant><sNuc-Seq><single nucleus RNA-sequencing><single nucleus seq><single-nucleus RNA-seq><snRNA sequencing><snRNA-seq><social role><stressor><stroked><strokes><synergism><therapeutic evaluation><therapeutic testing><transcriptome sequencing><transcriptomic sequencing><translation><whole genome association analysis><whole genome association study>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Theodore S Hong

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,749,617

FY 2025

Project Title

Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.

Grant Number:

5P01CA261669-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/21/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL - SUMMARY This is a joint application for a program project grant by Massachusetts General Hospital and MD Anderson Cancer Center. The progress we made in our most recent program projects (a P01 and a U19) has been criti- cal to the clinical, physical, and biological aspects of proton therap...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

RADHE MOHAN

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,749,617

FY 2025

Project Title

Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.

Grant Number:

5P01CA261669-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/21/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL - SUMMARY This is a joint application for a program project grant by Massachusetts General Hospital and MD Anderson Cancer Center. The progress we made in our most recent program projects (a P01 and a U19) has been criti- cal to the clinical, physical, and biological aspects of proton therap...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

HARALD PAGANETTI

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,749,617

FY 2025

Project Title

Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.

Grant Number:

5P01CA261669-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/21/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL - SUMMARY This is a joint application for a program project grant by Massachusetts General Hospital and MD Anderson Cancer Center. The progress we made in our most recent program projects (a P01 and a U19) has been criti- cal to the clinical, physical, and biological aspects of proton therap...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DAVID E FISHER

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,734,241

FY 2025

Project Title

Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment

Grant Number:

5P01CA163222-12

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/12/2013

End Date:

6/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall Summary Tumor-microenvironment interactions underlie fundamental features of both tumorigenesis and therapeutics. Surviving a hostile environment represents profound selective pressure to which aggressive malignancies like melanoma evolve, in part because the cutaneous melanoma genome is typ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Michael S Diamond

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,716,452

FY 2025

Project Title

The Development and Evaluation of Pan-Coronavirus Vaccines

Grant Number:

4P01AI168347-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/2/2022

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall Summary Given the historical outbreaks of coronaviruses, coupled with the recent emergence of SARS- CoV-2 and the destabilizing consequence of COVID-19 on global health and economy, there is an urgent and critical need to develop new vaccines capable of broad protection against existing and ...

Research Terms

<2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Ad vector><Address><Adenoviral Vector><Adenovirus Vector><Amino Acids><Animal Model><Animal Models and Related Studies><Animals><Antibodies><Antigens><Assay><Attenuated><B-Cells><B-Lymphocytes><B-cell><Bats><Bioassay><Biological Assay><Biology><Blood><Blood Reticuloendothelial System><Blood Serum><Body Tissues><CD8 Cell><CD8 T cells><CD8 lymphocyte><CD8+ T cell><CD8+ T-Lymphocyte><CD8-Positive Lymphocytes><CD8-Positive T-Lymphocytes><COVID-19><COVID-19 affected><COVID-19 consequence><COVID-19 effect><COVID-19 impact><COVID-19 impacted><COVID-19 virus><COVID19 virus><CV-19><Catalogs><Chimp><Chimpanzee><Chiroptera><Cloning><CoV emergence><CoV-2><CoV2><Collaborations><Communication><Computer Analysis><Coronaviridae><Coronaviridae Infections><Coronavirus><Coronavirus Infections><Coronavirus Infectious Disease 2019><Coupled><Cricetinae><DNA Recombination><Data><Decision Making><Development><Diamond><Disease><Disease Outbreaks><Disorder><Distant><Elements><Evaluation><Feedback><Future><Generations><Genetic Recombination><Goals><Hamsters><Hamsters Mammals><Human><Immune><Immune response><Immunes><Immunity><Immunization><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologics><Immunologist><Infection><Intramuscular><Laboratories><Machine Learning><Merbecovirus><Messenger RNA><Meta-Analysis><Mice><Mice Mammals><Modern Man><Molecular><Mucosa><Mucosal Tissue><Mucous Membrane><Murine><Mus><ORFs><Open Reading Frames><Orthocoronavirinae><Outbreaks><P01 Mechanism><P01 Program><Pre-Clinical Model><Preclinical Models><Preparedness><Program Project Grant><Program Research Project Grants><Protein Coding Region><Protein Region><Proteins><Quality Control><R-Series Research Projects><R01 Mechanism><R01 Program><RNA vaccine><RNA-based vaccine><Readiness><Recombination><Recommendation><Records><Research Grants><Research Program Projects><Research Project Grants><Research Projects><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sarbecovirus><Serum><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Site><Source><Speed><Structural Biologist><Structure><T cell response><T-Cell Epitopes><T-Cells><T-Lymphocyte><T-Lymphocyte Epitopes><T8 Cells><T8 Lymphocytes><Testing><Tissues><VSV><Vaccination><Vaccine Design><Vaccines><Vesicular Stomatitis Virus><Vesicular stomatitis Indiana virus><Viral Pathogenesis><Viral Vaccines><Viral Vector><Virus><Work><Wuhan coronavirus><Zoonoses><Zoonotic><Zoonotic Infection><adeno vector><adenovector><aminoacid><attenuate><attenuates><beta CoV><beta coronavirus><betaCoV><betacoronavirus><catalog><computational analyses><computational analysis><computer analyses><corona virus><corona virus emergence><coronavirus disease 2019><coronavirus disease 2019 consequence><coronavirus disease 2019 effect><coronavirus disease 2019 impact><coronavirus disease 2019 virus><coronavirus disease-19><coronavirus disease-19 impact><coronavirus disease-19 virus><coronavirus emergence><coronavirus infectious disease-19><coronavirus vaccine><cross immunity><cross protection><cross reactivity><data management><data sharing><design><designing><develop a vaccine><develop vaccines><development of a vaccine><developmental><efficacy study><emergent CoV><emergent corona virus><emergent coronavirus><emerging CoV><emerging corona virus><emerging coronavirus><experiment><experimental research><experimental study><experiments><future pandemic><global health><hCoV19><host response><immune system response><immunogen><immunogenicity><immunoresponse><innovate><innovation><innovative><interest><mRNA><mRNA vaccine><mRNA-based vaccine><machine based learning><member><model of animal><nCoV><nCoV2><nano particle><nano-sized particle><nanoparticle><nanosized particle><neutralizing antibody><new CoV><new corona virus><new coronavirus><new vaccines><next generation vaccines><next pandemic><novel CoV><novel corona virus><novel coronavirus><novel vaccines><pan CoV vaccine><pan coronavirus vaccine><panCoV vaccine><pancoronavirus vaccine><pandemic concern><pandemic potential><pandemic risk><pandemic threat><plasmid vaccine><product development><programs><response><scaffold><scaffolding><structural biology><thymus derived lymphocyte><universal CoV vaccine><universal coronavirus vaccine><vaccine against coronavirus><vaccine candidate><vaccine candidate against coronavirus><vaccine development><vaccine platform><vector><vector vaccine><virtual><virus pathogenesis><β CoV><β coronavirus><βCoV>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Sean PJ Whelan

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,716,452

FY 2025

Project Title

The Development and Evaluation of Pan-Coronavirus Vaccines

Grant Number:

4P01AI168347-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/2/2022

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall Summary Given the historical outbreaks of coronaviruses, coupled with the recent emergence of SARS- CoV-2 and the destabilizing consequence of COVID-19 on global health and economy, there is an urgent and critical need to develop new vaccines capable of broad protection against existing and ...

Research Terms

<2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Ad vector><Address><Adenoviral Vector><Adenovirus Vector><Amino Acids><Animal Model><Animal Models and Related Studies><Animals><Antibodies><Antigens><Assay><Attenuated><B-Cells><B-Lymphocytes><B-cell><Bats><Bioassay><Biological Assay><Biology><Blood><Blood Reticuloendothelial System><Blood Serum><Body Tissues><CD8 Cell><CD8 T cells><CD8 lymphocyte><CD8+ T cell><CD8+ T-Lymphocyte><CD8-Positive Lymphocytes><CD8-Positive T-Lymphocytes><COVID-19><COVID-19 affected><COVID-19 consequence><COVID-19 effect><COVID-19 impact><COVID-19 impacted><COVID-19 virus><COVID19 virus><CV-19><Catalogs><Chimp><Chimpanzee><Chiroptera><Cloning><CoV emergence><CoV-2><CoV2><Collaborations><Communication><Computer Analysis><Coronaviridae><Coronaviridae Infections><Coronavirus><Coronavirus Infections><Coronavirus Infectious Disease 2019><Coupled><Cricetinae><DNA Recombination><Data><Decision Making><Development><Diamond><Disease><Disease Outbreaks><Disorder><Distant><Elements><Evaluation><Feedback><Future><Generations><Genetic Recombination><Goals><Hamsters><Hamsters Mammals><Human><Immune><Immune response><Immunes><Immunity><Immunization><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologics><Immunologist><Infection><Intramuscular><Laboratories><Machine Learning><Merbecovirus><Messenger RNA><Meta-Analysis><Mice><Mice Mammals><Modern Man><Molecular><Mucosa><Mucosal Tissue><Mucous Membrane><Murine><Mus><ORFs><Open Reading Frames><Orthocoronavirinae><Outbreaks><P01 Mechanism><P01 Program><Pre-Clinical Model><Preclinical Models><Preparedness><Program Project Grant><Program Research Project Grants><Protein Coding Region><Protein Region><Proteins><Quality Control><R-Series Research Projects><R01 Mechanism><R01 Program><RNA vaccine><RNA-based vaccine><Readiness><Recombination><Recommendation><Records><Research Grants><Research Program Projects><Research Project Grants><Research Projects><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sarbecovirus><Serum><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Site><Source><Speed><Structural Biologist><Structure><T cell response><T-Cell Epitopes><T-Cells><T-Lymphocyte><T-Lymphocyte Epitopes><T8 Cells><T8 Lymphocytes><Testing><Tissues><VSV><Vaccination><Vaccine Design><Vaccines><Vesicular Stomatitis Virus><Vesicular stomatitis Indiana virus><Viral Pathogenesis><Viral Vaccines><Viral Vector><Virus><Work><Wuhan coronavirus><Zoonoses><Zoonotic><Zoonotic Infection><adeno vector><adenovector><aminoacid><attenuate><attenuates><beta CoV><beta coronavirus><betaCoV><betacoronavirus><catalog><computational analyses><computational analysis><computer analyses><corona virus><corona virus emergence><coronavirus disease 2019><coronavirus disease 2019 consequence><coronavirus disease 2019 effect><coronavirus disease 2019 impact><coronavirus disease 2019 virus><coronavirus disease-19><coronavirus disease-19 impact><coronavirus disease-19 virus><coronavirus emergence><coronavirus infectious disease-19><coronavirus vaccine><cross immunity><cross protection><cross reactivity><data management><data sharing><design><designing><develop a vaccine><develop vaccines><development of a vaccine><developmental><efficacy study><emergent CoV><emergent corona virus><emergent coronavirus><emerging CoV><emerging corona virus><emerging coronavirus><experiment><experimental research><experimental study><experiments><future pandemic><global health><hCoV19><host response><immune system response><immunogen><immunogenicity><immunoresponse><innovate><innovation><innovative><interest><mRNA><mRNA vaccine><mRNA-based vaccine><machine based learning><member><model of animal><nCoV><nCoV2><nano particle><nano-sized particle><nanoparticle><nanosized particle><neutralizing antibody><new CoV><new corona virus><new coronavirus><new vaccines><next generation vaccines><next pandemic><novel CoV><novel corona virus><novel coronavirus><novel vaccines><pan CoV vaccine><pan coronavirus vaccine><panCoV vaccine><pancoronavirus vaccine><pandemic concern><pandemic potential><pandemic risk><pandemic threat><plasmid vaccine><product development><programs><response><scaffold><scaffolding><structural biology><thymus derived lymphocyte><universal CoV vaccine><universal coronavirus vaccine><vaccine against coronavirus><vaccine candidate><vaccine candidate against coronavirus><vaccine development><vaccine platform><vector><vector vaccine><virtual><virus pathogenesis><β CoV><β coronavirus><βCoV>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

James J Manfredi

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,679,816

FY 2025

Project Title

Mutant p53 in Tumorigenesis, Invasion, and Metastasis

Grant Number:

1P01CA291694-01A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2025

End Date:

7/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROGRAM SUMMARY The p53 protein has been extensively studied for its tumor suppressor activity in human cancer. Missense mutation of the TP53 gene is a common event in tumors. This contrasts with other tumor suppressors where deletion or loss of expression is more prevalent. Studies in genetically e...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CHARLES E. CHALFANT

UNIVERSITY OF VIRGINIA, CHARLOTTESVILLE, VA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,663,053

FY 2025

Project Title

Ceramide-Directed Therapeutics for Treatment of AML

Grant Number:

1P01CA302570-01

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY Through three inter-related and inter-dependent Projects and four essential Cores, our team will define the biological basis of dysfunctional sphingolipid metabolism in AML and, in that process, validate new therapeutic targets for pharmacological treatment approaches. The premise of...

Research Terms

<21+ years old><AML - Acute Myeloid Leukemia><Acute Myeloblastic Leukemia><Acute Myelocytic Leukemia><Acute Myelogenous Leukemia><Acute leukemia><Adult><Adult Human><Alaska><Arizona><Biochemical><Biodistribution><Bioenergetics><Bioinformatics><Biological><Biological Markers><Cancer Center><Cancers><Cell Communication and Signaling><Cell Death><Cell Line><Cell Signaling><Cell model><CellLine><Cellular model><Ceramides><Cessation of life><Chemotherapy Protocol><Chemotherapy Regimen><Chemotherapy-Oncologic Procedure><Classification Scheme><Clinical><Combination Chemotherapy Regimen><Complement><Complement Proteins><Data><Death><Dependence><Development><Diagnostic><Disease><Disease Outcome><Disorder><Dose><Drug Delivery><Drug Delivery Systems><Drug Kinetics><Drug Metabolic Detoxication><Drug Metabolic Detoxification><Drug Therapy><Drug resistance><Dysfunction><Enzyme Gene><Enzymes><Event><Functional disorder><GEM model><GEMM model><Genetically Engineered Mouse><Genomics><Goals><Heterogeneity><Human><Intermediary Metabolism><Interruption><Intracellular Communication and Signaling><Investigation><Investigational Drugs><Investigational New Drugs><Link><Lipids><MSKCC><Malignant Neoplasms><Malignant Tumor><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Mediating><Memorial Sloan-Kettering Cancer Center><Metabolic><Metabolic Drug Detoxications><Metabolic Processes><Metabolism><Metabolism of Toxic Agents><Mitochondria><Modern Man><Molecular><Nanotechnology><Oncologist><Oral><Outcome><P01 Mechanism><P01 Program><PDX model><Pathogenesis><Pathway interactions><Patient derived xenograft><Patients><Pharmacokinetics><Pharmacological Treatment><Pharmacotherapy><Phosphorylation><Physiopathology><Population><Pre-Clinical Model><Preclinical Models><Predisposition><Process><Prognostic Marker><Program Project Grant><Program Research Project Grants><Protein Phosphorylation><Proteomics><Publishing><Quimioterapia><Refractory><Regimen><Relapse><Research Program Projects><Resistance><Sampling><Scientist><Signal Transduction><Signal Transduction Systems><Signaling><Sphingolipids><Sphingomyelins><Strains Cell Lines><Survival Rate><Susceptibility><System><Systems Biology><Testing><Therapeutic><Toxicology><Treatment Efficacy><Treatment outcome><Universities><Validation><Virginia><acute granulocytic leukemia><acute granulocytic leukemia cell><acute myeloblastic leukemia cell><acute myelocytic leukemia cell><acute myelogenous leukemia cell><acute myeloid leukemia><acute myeloid leukemia cell><acute nonlymphocytic leukemia cell><adulthood><bio-markers><biologic><biologic marker><biological signal transduction><biomarker><cancer chemotherapy><ceramide 1-phosphate><clinical translation><clinically translatable><combat><combinatorial><complementation><cultured cell line><delivery vector><delivery vehicle><determine efficacy><detoxification><developmental><drug intervention><drug resistant><drug treatment><druggable target><effective therapy><effective treatment><efficacious therapy><efficacious treatment><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><evaluate efficacy><examine efficacy><functional genomics><genetically engineered mouse model><genetically engineered murine model><improved><inhibitor><innovate><innovation><innovative><intervention efficacy><leukemia><lipidomics><malignancy><metabolism measurement><metabolomics><metabonomics><mitochondrial><molecular targeted therapeutics><molecular targeted therapies><molecular targeted treatment><nano><nano tech><nano technology><nano-technological><nanotech><nanotechnological><necrocytosis><neoplasm/cancer><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><pathophysiology><pathway><patient derived xenograft model><pharmaceutical intervention><pharmacological intervention><pharmacological therapy><pharmacology intervention><pharmacology treatment><pharmacotherapeutics><pre-clinical><precision medicine><precision-based medicine><preclinical><predictive biological marker><predictive biomarkers><predictive marker><predictive molecular biomarker><prognostic biomarker><prognostic indicator><programs><resistance to Drug><resistance to therapy><resistant><resistant to Drug><resistant to therapy><sphingosine 1-phosphate><standard of care><synergism><targeted agent><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic efficacy><therapeutic resistance><therapeutic target><therapy efficacy><therapy resistant><treatment resistance><validations><virtual>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Thomas P. Loughran

UNIVERSITY OF VIRGINIA, CHARLOTTESVILLE, VA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,663,053

FY 2025

Project Title

Ceramide-Directed Therapeutics for Treatment of AML

Grant Number:

1P01CA302570-01

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY Through three inter-related and inter-dependent Projects and four essential Cores, our team will define the biological basis of dysfunctional sphingolipid metabolism in AML and, in that process, validate new therapeutic targets for pharmacological treatment approaches. The premise of...

Research Terms

<21+ years old><AML - Acute Myeloid Leukemia><Acute Myeloblastic Leukemia><Acute Myelocytic Leukemia><Acute Myelogenous Leukemia><Acute leukemia><Adult><Adult Human><Alaska><Arizona><Biochemical><Biodistribution><Bioenergetics><Bioinformatics><Biological><Biological Markers><Cancer Center><Cancers><Cell Communication and Signaling><Cell Death><Cell Line><Cell Signaling><Cell model><CellLine><Cellular model><Ceramides><Cessation of life><Chemotherapy Protocol><Chemotherapy Regimen><Chemotherapy-Oncologic Procedure><Classification Scheme><Clinical><Combination Chemotherapy Regimen><Complement><Complement Proteins><Data><Death><Dependence><Development><Diagnostic><Disease><Disease Outcome><Disorder><Dose><Drug Delivery><Drug Delivery Systems><Drug Kinetics><Drug Metabolic Detoxication><Drug Metabolic Detoxification><Drug Therapy><Drug resistance><Dysfunction><Enzyme Gene><Enzymes><Event><Functional disorder><GEM model><GEMM model><Genetically Engineered Mouse><Genomics><Goals><Heterogeneity><Human><Intermediary Metabolism><Interruption><Intracellular Communication and Signaling><Investigation><Investigational Drugs><Investigational New Drugs><Link><Lipids><MSKCC><Malignant Neoplasms><Malignant Tumor><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Mediating><Memorial Sloan-Kettering Cancer Center><Metabolic><Metabolic Drug Detoxications><Metabolic Processes><Metabolism><Metabolism of Toxic Agents><Mitochondria><Modern Man><Molecular><Nanotechnology><Oncologist><Oral><Outcome><P01 Mechanism><P01 Program><PDX model><Pathogenesis><Pathway interactions><Patient derived xenograft><Patients><Pharmacokinetics><Pharmacological Treatment><Pharmacotherapy><Phosphorylation><Physiopathology><Population><Pre-Clinical Model><Preclinical Models><Predisposition><Process><Prognostic Marker><Program Project Grant><Program Research Project Grants><Protein Phosphorylation><Proteomics><Publishing><Quimioterapia><Refractory><Regimen><Relapse><Research Program Projects><Resistance><Sampling><Scientist><Signal Transduction><Signal Transduction Systems><Signaling><Sphingolipids><Sphingomyelins><Strains Cell Lines><Survival Rate><Susceptibility><System><Systems Biology><Testing><Therapeutic><Toxicology><Treatment Efficacy><Treatment outcome><Universities><Validation><Virginia><acute granulocytic leukemia><acute granulocytic leukemia cell><acute myeloblastic leukemia cell><acute myelocytic leukemia cell><acute myelogenous leukemia cell><acute myeloid leukemia><acute myeloid leukemia cell><acute nonlymphocytic leukemia cell><adulthood><bio-markers><biologic><biologic marker><biological signal transduction><biomarker><cancer chemotherapy><ceramide 1-phosphate><clinical translation><clinically translatable><combat><combinatorial><complementation><cultured cell line><delivery vector><delivery vehicle><determine efficacy><detoxification><developmental><drug intervention><drug resistant><drug treatment><druggable target><effective therapy><effective treatment><efficacious therapy><efficacious treatment><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><evaluate efficacy><examine efficacy><functional genomics><genetically engineered mouse model><genetically engineered murine model><improved><inhibitor><innovate><innovation><innovative><intervention efficacy><leukemia><lipidomics><malignancy><metabolism measurement><metabolomics><metabonomics><mitochondrial><molecular targeted therapeutics><molecular targeted therapies><molecular targeted treatment><nano><nano tech><nano technology><nano-technological><nanotech><nanotechnological><necrocytosis><neoplasm/cancer><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><pathophysiology><pathway><patient derived xenograft model><pharmaceutical intervention><pharmacological intervention><pharmacological therapy><pharmacology intervention><pharmacology treatment><pharmacotherapeutics><pre-clinical><precision medicine><precision-based medicine><preclinical><predictive biological marker><predictive biomarkers><predictive marker><predictive molecular biomarker><prognostic biomarker><prognostic indicator><programs><resistance to Drug><resistance to therapy><resistant><resistant to Drug><resistant to therapy><sphingosine 1-phosphate><standard of care><synergism><targeted agent><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic efficacy><therapeutic resistance><therapeutic target><therapy efficacy><therapy resistant><treatment resistance><validations><virtual>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Susan M Chang

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,654,906

FY 2025

Project Title

Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management

Grant Number:

5P01CA118816-17

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2007

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL: PROJECT ABSTRACT The overall goal of this renewal P01 proposal is to identify imaging and genomic signatures of brain tumor heterogeneity and evolution to optimize patient management of the two most common primary brain tumors in adults: glioblastoma and meningioma. The hallmark of glioblas...

Research Terms

<2-ketoglutarate><2-oxoglutarate><21+ years old><3-D Imaging><3D imaging><Acceleration><Achievement><Achievement Attainment><Address><Adult><Adult Human><Alanine><Automobile Driving><Biological><Biological Markers><Brain Neoplasia><Brain Neoplasms><Brain Tumors><Categories><Cell Line><CellLine><Characteristics><Classification><Clinical><Clinical Services><DNA Methylation><DNA mutation><Development><Disease><Disorder><Early treatment><Evaluation><Evolution><FKHL16><FOXM1><FOXM1 gene><FOXM1B><Forkhead Box M1><Forkhead Box M1B Transcription Factor><Forkhead, Drosophila, Homolog-Like 16><Fostering><Gene Expression><Genetic Change><Genetic defect><Genetic mutation><Genomics><Glial Cell Tumors><Glial Neoplasm><Glial Tumor><Glioblastoma><Glioma><Glutamates><Goals><Grade IV Astrocytic Neoplasm><Grade IV Astrocytic Tumor><Grade IV Astrocytoma><Grant><Grouping><HFH11><Heterogeneity><Human><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Intracranial Central Nervous System Neoplasms><Intracranial Central Nervous System Tumors><Intracranial Neoplasms><Intracranial Tumor><Intratumoral heterogeneity><Investigators><Knowledge><L-Glutamate><Label><Leadership><Lesion><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Merlin><Metabolic><Modeling><Modern Man><Moesin-Ezrin-Radixin-Like Protein><Molecular><Monitor><Mutate><Mutation><NF2><NF2 Gene Product><NF2 gene><NMR Imaging><NMR Tomography><Neurofibromatosis 2 Gene Product><Neurofibromatosis 2 Genes><Neurofibromatosis Type 2 Protein><Neurofibromin 2><Neuroglial Neoplasm><Neuroglial Tumor><Newly Diagnosed><Nuclear Magnetic Resonance Imaging><Operative Procedures><Operative Surgical Procedures><Organoids><Outcome><Patient Care><Patient Care Delivery><Patient imaging><Patients><Primary Brain Neoplasms><Primary Brain Tumors><Property><Pyruvate><Radiation><Recurrence><Recurrent><Research><Research Personnel><Research Resources><Researchers><Resistance><Resources><Role><Sampling><Schwannomerlin><Schwannomin><Schwannomin Protein><Strains Cell Lines><Surgical><Surgical Interventions><Surgical Procedure><System><Systematics><TRIDENT gene><TRIDENT protein><Techniques><Technology><Therapeutic><Three-Dimensional Imaging><Time><Tissue Sample><Translating><Translations><Tumor Pathology><Work><Zeugmatography><adulthood><alpha ketoglutarate><bio-markers><biologic><biologic marker><biomarker><cancer cell metabolism><cancer imaging><cancer metabolism><care for patients><care of patients><caring for patients><clinical applicability><clinical application><clinical translation><clinical validation><clinically translatable><cultured cell line><developmental><driving><early therapy><experience><expression subtypes><genome mutation><genomic data><genomic dataset><genomic signature><glial-derived tumor><glioblastoma multiforme><glutamatergic><groupings><heterogeneity in tumors><image-based method><imaging><imaging biomarker><imaging in patients><imaging marker><imaging method><imaging modality><imaging on patients><imaging probe><imaging scientist><imaging-based biological marker><imaging-based biomarker><imaging-based marker><improved><individual patient><innovate><innovation><innovative><insight><intra-tumoral heterogeneity><intratumor heterogeneity><meningioma><metabolic imaging><molecular imaging><molecular sub-types><molecular subsets><molecular subtypes><molecule imaging><multidisciplinary><multiparametric imaging><neuroglia neoplasm><neuroglia tumor><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapeutic target><new therapeutics><new therapy><new therapy approaches><new therapy target><new treatment approach><new treatment strategy><next generation therapeutics><nf 2 Genes><non-invasive imaging><noninvasive imaging><novel><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapeutic target><novel therapeutics><novel therapy><novel therapy approach><novel therapy target><oncologic imaging><oncology imaging><pre-clinical><pre-clinical evaluation><preclinical><preclinical evaluation><prognostic><promoter><promotor><resistant><response><response to therapy><response to treatment><social role><spatial and temporal><spatial temporal><spatiotemporal><spongioblastoma multiforme><standard care><standard treatment><success><surgery><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic response><therapeutic target><therapy response><translation><translational cancer research><treatment response><treatment responsiveness><tumor><tumor cell metabolism><tumor diagnosis><tumor heterogeneity><tumor imaging><tumor metabolism><tumors in the brain><α-ketoglutarate><α-oxoglutarate><αKG>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Janine Marie Lupo

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,654,906

FY 2025

Project Title

Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management

Grant Number:

5P01CA118816-17

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2007

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL: PROJECT ABSTRACT The overall goal of this renewal P01 proposal is to identify imaging and genomic signatures of brain tumor heterogeneity and evolution to optimize patient management of the two most common primary brain tumors in adults: glioblastoma and meningioma. The hallmark of glioblas...

Research Terms

<2-ketoglutarate><2-oxoglutarate><21+ years old><3-D Imaging><3D imaging><Acceleration><Achievement><Achievement Attainment><Address><Adult><Adult Human><Alanine><Automobile Driving><Biological><Biological Markers><Brain Neoplasia><Brain Neoplasms><Brain Tumors><Categories><Cell Line><CellLine><Characteristics><Classification><Clinical><Clinical Services><DNA Methylation><DNA mutation><Development><Disease><Disorder><Early treatment><Evaluation><Evolution><FKHL16><FOXM1><FOXM1 gene><FOXM1B><Forkhead Box M1><Forkhead Box M1B Transcription Factor><Forkhead, Drosophila, Homolog-Like 16><Fostering><Gene Expression><Genetic Change><Genetic defect><Genetic mutation><Genomics><Glial Cell Tumors><Glial Neoplasm><Glial Tumor><Glioblastoma><Glioma><Glutamates><Goals><Grade IV Astrocytic Neoplasm><Grade IV Astrocytic Tumor><Grade IV Astrocytoma><Grant><Grouping><HFH11><Heterogeneity><Human><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Intracranial Central Nervous System Neoplasms><Intracranial Central Nervous System Tumors><Intracranial Neoplasms><Intracranial Tumor><Intratumoral heterogeneity><Investigators><Knowledge><L-Glutamate><Label><Leadership><Lesion><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Merlin><Metabolic><Modeling><Modern Man><Moesin-Ezrin-Radixin-Like Protein><Molecular><Monitor><Mutate><Mutation><NF2><NF2 Gene Product><NF2 gene><NMR Imaging><NMR Tomography><Neurofibromatosis 2 Gene Product><Neurofibromatosis 2 Genes><Neurofibromatosis Type 2 Protein><Neurofibromin 2><Neuroglial Neoplasm><Neuroglial Tumor><Newly Diagnosed><Nuclear Magnetic Resonance Imaging><Operative Procedures><Operative Surgical Procedures><Organoids><Outcome><Patient Care><Patient Care Delivery><Patient imaging><Patients><Primary Brain Neoplasms><Primary Brain Tumors><Property><Pyruvate><Radiation><Recurrence><Recurrent><Research><Research Personnel><Research Resources><Researchers><Resistance><Resources><Role><Sampling><Schwannomerlin><Schwannomin><Schwannomin Protein><Strains Cell Lines><Surgical><Surgical Interventions><Surgical Procedure><System><Systematics><TRIDENT gene><TRIDENT protein><Techniques><Technology><Therapeutic><Three-Dimensional Imaging><Time><Tissue Sample><Translating><Translations><Tumor Pathology><Work><Zeugmatography><adulthood><alpha ketoglutarate><bio-markers><biologic><biologic marker><biomarker><cancer cell metabolism><cancer imaging><cancer metabolism><care for patients><care of patients><caring for patients><clinical applicability><clinical application><clinical translation><clinical validation><clinically translatable><cultured cell line><developmental><driving><early therapy><experience><expression subtypes><genome mutation><genomic data><genomic dataset><genomic signature><glial-derived tumor><glioblastoma multiforme><glutamatergic><groupings><heterogeneity in tumors><image-based method><imaging><imaging biomarker><imaging in patients><imaging marker><imaging method><imaging modality><imaging on patients><imaging probe><imaging scientist><imaging-based biological marker><imaging-based biomarker><imaging-based marker><improved><individual patient><innovate><innovation><innovative><insight><intra-tumoral heterogeneity><intratumor heterogeneity><meningioma><metabolic imaging><molecular imaging><molecular sub-types><molecular subsets><molecular subtypes><molecule imaging><multidisciplinary><multiparametric imaging><neuroglia neoplasm><neuroglia tumor><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapeutic target><new therapeutics><new therapy><new therapy approaches><new therapy target><new treatment approach><new treatment strategy><next generation therapeutics><nf 2 Genes><non-invasive imaging><noninvasive imaging><novel><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapeutic target><novel therapeutics><novel therapy><novel therapy approach><novel therapy target><oncologic imaging><oncology imaging><pre-clinical><pre-clinical evaluation><preclinical><preclinical evaluation><prognostic><promoter><promotor><resistant><response><response to therapy><response to treatment><social role><spatial and temporal><spatial temporal><spatiotemporal><spongioblastoma multiforme><standard care><standard treatment><success><surgery><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic response><therapeutic target><therapy response><translation><translational cancer research><treatment response><treatment responsiveness><tumor><tumor cell metabolism><tumor diagnosis><tumor heterogeneity><tumor imaging><tumor metabolism><tumors in the brain><α-ketoglutarate><α-oxoglutarate><αKG>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Daniel B Vigneron

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,654,906

FY 2025

Project Title

Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management

Grant Number:

5P01CA118816-17

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2007

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL: PROJECT ABSTRACT The overall goal of this renewal P01 proposal is to identify imaging and genomic signatures of brain tumor heterogeneity and evolution to optimize patient management of the two most common primary brain tumors in adults: glioblastoma and meningioma. The hallmark of glioblas...

Research Terms

<2-ketoglutarate><2-oxoglutarate><21+ years old><3-D Imaging><3D imaging><Acceleration><Achievement><Achievement Attainment><Address><Adult><Adult Human><Alanine><Automobile Driving><Biological><Biological Markers><Brain Neoplasia><Brain Neoplasms><Brain Tumors><Categories><Cell Line><CellLine><Characteristics><Classification><Clinical><Clinical Services><DNA Methylation><DNA mutation><Development><Disease><Disorder><Early treatment><Evaluation><Evolution><FKHL16><FOXM1><FOXM1 gene><FOXM1B><Forkhead Box M1><Forkhead Box M1B Transcription Factor><Forkhead, Drosophila, Homolog-Like 16><Fostering><Gene Expression><Genetic Change><Genetic defect><Genetic mutation><Genomics><Glial Cell Tumors><Glial Neoplasm><Glial Tumor><Glioblastoma><Glioma><Glutamates><Goals><Grade IV Astrocytic Neoplasm><Grade IV Astrocytic Tumor><Grade IV Astrocytoma><Grant><Grouping><HFH11><Heterogeneity><Human><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Intracranial Central Nervous System Neoplasms><Intracranial Central Nervous System Tumors><Intracranial Neoplasms><Intracranial Tumor><Intratumoral heterogeneity><Investigators><Knowledge><L-Glutamate><Label><Leadership><Lesion><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Merlin><Metabolic><Modeling><Modern Man><Moesin-Ezrin-Radixin-Like Protein><Molecular><Monitor><Mutate><Mutation><NF2><NF2 Gene Product><NF2 gene><NMR Imaging><NMR Tomography><Neurofibromatosis 2 Gene Product><Neurofibromatosis 2 Genes><Neurofibromatosis Type 2 Protein><Neurofibromin 2><Neuroglial Neoplasm><Neuroglial Tumor><Newly Diagnosed><Nuclear Magnetic Resonance Imaging><Operative Procedures><Operative Surgical Procedures><Organoids><Outcome><Patient Care><Patient Care Delivery><Patient imaging><Patients><Primary Brain Neoplasms><Primary Brain Tumors><Property><Pyruvate><Radiation><Recurrence><Recurrent><Research><Research Personnel><Research Resources><Researchers><Resistance><Resources><Role><Sampling><Schwannomerlin><Schwannomin><Schwannomin Protein><Strains Cell Lines><Surgical><Surgical Interventions><Surgical Procedure><System><Systematics><TRIDENT gene><TRIDENT protein><Techniques><Technology><Therapeutic><Three-Dimensional Imaging><Time><Tissue Sample><Translating><Translations><Tumor Pathology><Work><Zeugmatography><adulthood><alpha ketoglutarate><bio-markers><biologic><biologic marker><biomarker><cancer cell metabolism><cancer imaging><cancer metabolism><care for patients><care of patients><caring for patients><clinical applicability><clinical application><clinical translation><clinical validation><clinically translatable><cultured cell line><developmental><driving><early therapy><experience><expression subtypes><genome mutation><genomic data><genomic dataset><genomic signature><glial-derived tumor><glioblastoma multiforme><glutamatergic><groupings><heterogeneity in tumors><image-based method><imaging><imaging biomarker><imaging in patients><imaging marker><imaging method><imaging modality><imaging on patients><imaging probe><imaging scientist><imaging-based biological marker><imaging-based biomarker><imaging-based marker><improved><individual patient><innovate><innovation><innovative><insight><intra-tumoral heterogeneity><intratumor heterogeneity><meningioma><metabolic imaging><molecular imaging><molecular sub-types><molecular subsets><molecular subtypes><molecule imaging><multidisciplinary><multiparametric imaging><neuroglia neoplasm><neuroglia tumor><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapeutic target><new therapeutics><new therapy><new therapy approaches><new therapy target><new treatment approach><new treatment strategy><next generation therapeutics><nf 2 Genes><non-invasive imaging><noninvasive imaging><novel><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapeutic target><novel therapeutics><novel therapy><novel therapy approach><novel therapy target><oncologic imaging><oncology imaging><pre-clinical><pre-clinical evaluation><preclinical><preclinical evaluation><prognostic><promoter><promotor><resistant><response><response to therapy><response to treatment><social role><spatial and temporal><spatial temporal><spatiotemporal><spongioblastoma multiforme><standard care><standard treatment><success><surgery><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic response><therapeutic target><therapy response><translation><translational cancer research><treatment response><treatment responsiveness><tumor><tumor cell metabolism><tumor diagnosis><tumor heterogeneity><tumor imaging><tumor metabolism><tumors in the brain><α-ketoglutarate><α-oxoglutarate><αKG>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Devanand Sarkar

VIRGINIA COMMONWEALTH UNIVERSITY, RICHMOND, VA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,646,688

FY 2025

Project Title

ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular carcinoma (ELEVATE)

Grant Number:

5P01CA275740-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/8/2024

End Date:

7/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL: SUMMARY Hepatocellular carcinoma (HCC), the primary malignancy of hepatocytes, is a diagnosis with bleak outcomes. With the alarming rise in global obesity incidence, obesity-induced non-alcoholic steatohepatitis (NASH) is becoming a leading cause of HCC. HCC is usually diagnosed at an adva...

Research Terms

<Anti-VEGF><Anti-VEGF Humanized Monoclonal Antibody><Anti-VEGF RhuMAb><Antibodies><Avian Myelocytomatosis Viral Oncogene Homolog><BAY 54-9085><Bile Acids><Bioinformatics><Bioinformatics core><Bioinformatics research core><Bioinformatics resource core><Biology><Biometrics><Biometry><Biostatistics><Biostatistics Core><Bystander Effect><Cancers><Cell Communication and Signaling><Cell Compartmentation><Cell Compartmentations><Cell Signaling><Checkpoint inhibitor><Chromosomal, Gene, or Protein Abnormality><Clinical><Clinical Treatment Moab><Cytogenetic or Molecular Genetic Abnormality><Cytotoxic cell><Development><Diagnosis><Diet rich in fats and sugars><Drug resistance><Edg Receptors><Evaluation><Exhibits><FDA approved><Gene Amplification><Gene Transcription><Generalized Growth><Genetic Abnormality><Genetic Determinism><Genetic Transcription><Goals><Grant><Growth><Hepatic Cells><Hepatic Parenchymal Cell><Hepatocarcinoma><Hepatocarcinoma model><Hepatocellular Carcinoma><Hepatocellular cancer><Hepatocyte><Hepatology><Hepatoma><History><Human><IL-15><IL-24 protein><IL10B><IL15><IL15 Protein><IL24><IL24 gene><Immune Surveillance><Immune checkpoint inhibitor><Immune mediated therapy><Immune system><Immunologic Stimulation><Immunologic Surveillance><Immunological Stimulation><Immunologically Directed Therapy><Immunostimulation><Immunosurveillance><Immunotherapy><Incidence><Inflammatory><Interleukin-15><Interleukin-15 Precursor><Interleukin-24><Intracellular Communication and Signaling><K lymphocyte><Liver><Liver Cells><Liver Cells Carcinoma><Lung Neoplasms><Lung Tumor><MDA7><MDA7 Protein><MGC9721><MYC gene><Malignant Neoplasms><Malignant Tumor><Medicinal Chemistry><Melanoma Differentiation Associated Protein 7><Melanoma differentiation associated gene - 7><Mice><Mice Mammals><MoAb VEGF><Mob-5><Modality><Modern Man><Molecular><Molecular Abnormality><Monoclonal Antibodies><Monoclonal Antibody Anti-VEGF><Murine><Mus><Myeloid Cells><NASH><NK Cells><Natural Killer Cells><Obesity><Outcome><PD-1 antibody><PD-L1 antibody><PD1 antibody><PTK Inhibitors><Pathogenesis><Pathologic><Pathology><Pathway interactions><Patients><Pharmaceutic Chemistry><Pharmaceutical Chemistry><Physiology><Play><Pre-Clinical Model><Preclinical Models><Preclinical data><Predisposition><Primary carcinoma of the liver cells><Prostate Neoplasms><Prostate Tumor><Prostatic Neoplasia><Prostatic Neoplasms><Protein Tyrosine Kinase Inhibitors><Pulmonary Neoplasms><RNA Expression><Recombinant Humanized Anti-VEGF Monoclonal Antibody><Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor><Recording of previous events><Resistance><RhuMAb VEGF><Risk><Role><S1P Receptor><ST16><ST16 Protein><SYS-TX><Salaries><Seminal><Short interfering RNA><Signal Transduction><Signal Transduction Systems><Signaling><Sorafenib><Sphingosine-1-Phosphate Receptor><Suppression of Tumorigenicity 16 Protein><Susceptibility><Systemic Therapy><TATA Box Binding Protein-Associated Factor><TATA Box Binding Protein-Like Proteins><TATA-Associated Factors><TATA-Binding Protein Associated Factors><TATA-Binding Protein-Related Factors><TBP-Associated Factor Gene><TBP-Associated Factors><TBP-Like Protein><TBP-Like TLP><TBP-Related Factor><TK Inhibitors><Testing><Therapeutic><Tissue Growth><Transcription><Treatment Efficacy><Tyrosine Kinase Inhibitor><Unresectable><Vaccines><Viral hepatitis><Wages><aPD-1><aPD-L1><aPD-L1 antibodies><aPD1><acetyl-LDL receptor><acetylated LDL receptor><adiposity><antagonism><antagonist><anti programmed cell death 1><anti programmed cell death ligand 1><anti programmed cell death protein ligand 1><anti-PD-(L)1><anti-PD-1><anti-PD-1 Ab><anti-PD-1 antibodies><anti-PD-1 monoclonal antibodies><anti-PD-L1><anti-PD-L1 antibodies><anti-PD-L1 monoclonal antibodies><anti-PD1><anti-PD1 Ab><anti-PD1 antibodies><anti-PD1 monoclonal antibodies><anti-PDL-1><anti-PDL1><anti-PDL1 antibodies><anti-cancer immunotherapy><anti-programmed cell death protein 1><anti-programmed cell death protein 1 antibodies><anti-programmed death-1 antibody><antiPD-1><antiPD-L1><anticancer immunotherapy><bevacizumab><biological signal transduction><cancer immunotherapy><combinatorial><corpulence><cytokine><develop therapy><developmental><diet high in fat and sugar><drug resistant><effective therapy><effective treatment><genetic determinant><hepatic body system><hepatic organ system><hepatitis virus infection><hepatocellular carcinoma cancer model><hepatocellular carcinoma model><high-fat/sugar diet><histories><immune check point inhibitor><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immuno therapy><immunotherapy for cancer><immunotherapy of cancer><improved><in vivo><inhibitor><innovate><innovation><innovative><intervention development><intervention efficacy><liver cancer model><liver carcinoma><mAbs><malignancy><mda-7 gene product><mda-7 protein><molecular aberrations><monoclonal Abs><mouse model><murine model><myc Oncogenes><nano particle><nano particle delivery><nano-sized particle><nanoparticle><nanoparticle delivered><nanoparticle delivery><nanosized particle><natural gene amplification><neoplasm/cancer><new approaches><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><non-alcohol induced steatohepatitis><non-alcoholic steato-hepatitis><non-alcoholic steatohepatitis><nonalcoholic steato-hepatitis><nonalcoholic steatohepatitis><novel><novel approaches><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel strategies><novel strategy><novel therapeutics><novel therapy><ontogeny><overexpress><overexpression><pathway><preclinical findings><preclinical information><programs><prototype><resistance to Drug><resistant><resistant to Drug><response><rhuMabVEGF><scavenger receptor><siRNA><site targeted delivery><social role><standard of care><targeted delivery><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic efficacy><therapeutic target><therapeutically effective><therapy development><therapy efficacy><treatment development><tumor><αPD-1><αPD-L1><αPD-L1 antibodies><αPD1><αPDL1>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joann B. Sweasy

UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,593,786

FY 2025

Project Title

Buffett Cancer Center Support Grant

Grant Number:

5P30CA036727-39

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/5/1997

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY The Fred & Pamela Buffett Cancer Center (Buffett Cancer Center or BCC), an NCI-designated Cancer Center since 1984, is committed to basic, translational, clinical and population science research, comprehensive educational programs, and outreach to underserved communities in our catch...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Hongbo R Luo

BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,578,863

FY 2025

Project Title

Novel Strategies to Improve Blood Transfusion Practice

Grant Number:

5P01HL158688-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/15/2022

End Date:

7/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary Optimizing blood cell support for specific patient groups and clinical settings is an emerging priority in transfusion medicine. Patients undergoing hematopoietic cell transplantation (HCT) require significant transfusion support (including red blood cells, platelets, and granulocyte...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ana Ponce Kiess

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,569,180

FY 2025

Project Title

Imaging, Dosimetry and Radiobiology for α-particle Emitter Radiopharmaceutical Therapy

Grant Number:

5P01CA272222-03

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Treatment for almost all patients with metastatic cancer has become a balance between managing often severe, treatment-induced toxicity and preventing cancer progression. Progression leads to increasingly toxic combination regimens until the patient succumbs either to treatment toxicity or to diseas...

Research Terms

<3-D CRT><3-D Imaging><3-Dimensional Conformal Radiation Therapy><3-dimensional conformal ablation><3D imaging><3D-CRT><Adoption><Alpha Particle Emitter><Alpha Particle Radiation><Alpha Radiation><Biological><Cancer Biology><Cancer Patient><Cancer Treatment><Cancers><Caring><Cell Body><Cell surface><Cells><Clinical Trials><Clinical Trials Design><Combined Modality Therapy><Conformal Radiotherapy><Conformal Therapy><DNA><DNA mutation><Data><Deoxyribonucleic Acid><Disease Progression><Disseminated Malignant Neoplasm><Dose><Drug Kinetics><Drugs><Electrons><Equilibrium><Evaluation><Genetic Change><Genetic defect><Genetic mutation><High Linear Energy Transfer Radiation><High-LET Radiation><Human Experimentation><Image><Kinetics><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Measures><Medication><Metastasis><Metastasize><Metastatic Cancer><Metastatic Lesion><Metastatic Malignant Neoplasm><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Methodology><Methods><Modality><Modeling><Multimodal Therapy><Multimodal Treatment><Mutation><Negative Beta Particle><Negatrons><Neoplasm Metastasis><Normal Tissue><Normal tissue morphology><Organ><P01 Mechanism><P01 Program><Pathway interactions><Patients><Pharmaceutical Preparations><Pharmacokinetics><Phase><Physics><Predisposition><Program Project Grant><Program Research Project Grants><Radiation><Radiation Biology><Radiation Conformal Therapy><Radioactive><Radiobiology><Radiopharmaceutical Compound><Radiopharmaceuticals><Regimen><Research Program Projects><Rest><Risk><Scheme><Secondary Neoplasm><Secondary Tumor><Susceptibility><Testing><Therapeutic><Therapeutic Agents><Three-Dimensional Imaging><Time><Toxic effect><Toxicities><Translating><Treatment Efficacy><Treatment-related toxicity><Tumor Biology><Tumor Cell Biology><Tumor Tissue><Work><absorption><anti-cancer therapy><balance><balance function><biologic><biomarker identification><cancer metastasis><cancer progression><cancer therapy><cancer-directed therapy><cell killing><chemotherapy><combination therapy><combined modality treatment><combined treatment><conformal radiation><conformal radiation therapy><dosimetry><drug/agent><effective therapy><effective treatment><genome mutation><identification of biomarkers><identification of new biomarkers><imaging><improved><improved outcome><individual patient><intervention efficacy><malignancy><marker identification><meter><multi-modal therapy><multi-modal treatment><neoplasm progression><neoplasm/cancer><neoplastic progression><particle><pathway><precision medicine><precision-based medicine><prevent><preventing><programs><quantitative imaging><radiation delivery><radioactive drugs><radiotherapeutic drugs><repair><repaired><resistance mechanism><resistant mechanism><response><response to therapy><response to treatment><side effect><synergism><therapeutic efficacy><therapeutic response><therapeutic toxicity><therapy associated toxicity><therapy efficacy><therapy related toxicity><therapy responders><therapy response><therapy toxicity><treatment planning><treatment responders><treatment response><treatment responsiveness><treatment toxicity><treatment-associated toxicity><trend><tumor><tumor cell metastasis><tumor progression><α Particle Emitter><α Particles>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Edward A Fisher

NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,567,925

FY 2025

Project Title

Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases

Grant Number:

5P01HL131481-09

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2017

End Date:

4/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Summary: Overall This Program Project grant has unveiled key roles for macrophage metabolism, depot- and cue-dependent molecular re-programming and intraorgan communications in cardiometabolic dysfunction. The Program Project team will build upon these discoveries and forge new directions. Macrophag...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

W Sean Davidson

UNIVERSITY OF CINCINNATI, CINCINNATI, OH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,561,009

FY 2025

Project Title

Multi-disciplinary Approaches to HDL Structure, Assembly, and Functional Heterogeneity

Grant Number:

5P01HL128203-08

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2016

End Date:

7/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

SUMMARY (Entire PPG) The development of new cardioprotective drugs and accurate metrics for cardiovascular risk is being hindered, we believe, by the failure to correctly identify the cardioprotective forms of high-density lipoprotein (HDL) and inadequate knowledge about the mechanisms that remove ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MARY E CHOI

WEILL MEDICAL COLL OF CORNELL UNIV, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,543,097

FY 2025

Project Title

Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers

Grant Number:

5P01HL114501-10

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/6/2013

End Date:

4/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ ABSTRACT Cigarette smoking is the greatest known single risk factor for the development of lung disease, being a dominant risk for the development of both emphysema and idiopathic pulmonary fibrosis. We have assembled a team of investigators who have worked synergistically to better...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CLAUDIO SOTO

UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, HOUSTON, TX

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,528,112

FY 2025

Project Title

Pathogenesis, Transmission and Detection of Zoonotic Prion Diseases

Grant Number:

5P01AI077774-14

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/15/2008

End Date:

2/28/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT Prion diseases are a group of infectious neurodegenerative disorders affecting humans and other mammals, which are transmitted by an unconventional proteinaceous infectious agent termed prion. CWD is so far the only prion disease of wild animals; it is highly contagious and the exact origin...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JAMES L. M. FERRARA

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,520,987

FY 2025

Project Title

Cellular and Molecular Studies of Bone Marrow Transplant

Grant Number:

5P01CA039542-36

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/1997

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL ABSTRACT Graft-versus-host disease (GVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic cell transplant (HCT) and prevents this curative therapy from wider application in cancer patients. This P01 consists of three projects and two cores and its goal is to s...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Sean R Stowell

BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,514,657

FY 2025

Project Title

Leveraging New Approaches to Unravel ABO Blood Group Immunity and Incompatibility

Grant Number:

5P01HL171803-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2024

End Date:

7/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Summary: ABO(H) blood group antigens and corresponding anti-ABO(H) alloantibodies were discovered over a century ago as the first polymorphisms in the human population and continue to be the most common immunological barrier to transfusion and transplantation. However, despite the fundamental nature...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Leandro C Cerchietti

WEILL MEDICAL COLL OF CORNELL UNIV, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,474,764

FY 2025

Project Title

Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche

Grant Number:

5P01CA272295-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/12/2024

End Date:

7/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL: ABSTRACT Diffuse large B-cell lymphoma (DLBCL) is an aggressiveand clinically heterogeneous malignancy derived from B-cells transiting the germinal center (GC) reaction. Indeed, the biological heterogeneity of DLBCL aligns with a continuum of developmental states within and subsequent to th...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CHRISTOPHER R FLOWERS

WEILL MEDICAL COLL OF CORNELL UNIV, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,474,764

FY 2025

Project Title

Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche

Grant Number:

5P01CA272295-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/12/2024

End Date:

7/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL: ABSTRACT Diffuse large B-cell lymphoma (DLBCL) is an aggressiveand clinically heterogeneous malignancy derived from B-cells transiting the germinal center (GC) reaction. Indeed, the biological heterogeneity of DLBCL aligns with a continuum of developmental states within and subsequent to th...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Michael T Ferdig

UNIVERSITY OF NOTRE DAME, NOTRE DAME, IN

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,465,529

FY 2025

Project Title

Harnessing the Power of Experimental Genetic Crosses to Probe Drug Resistance in Malaria

Grant Number:

5P01AI127338-07

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2017

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT Genetic crosses coupled with linkage mapping have provided an outstandingly successful approach for locating the genetic determinants of biomedically important traits such as drug resistance and host specificity in P. falciparum malaria. In the initial funding period of this Program Project...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ashley M Vaughan

UNIVERSITY OF NOTRE DAME, NOTRE DAME, IN

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,465,529

FY 2025

Project Title

Harnessing the Power of Experimental Genetic Crosses to Probe Drug Resistance in Malaria

Grant Number:

5P01AI127338-07

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2017

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT Genetic crosses coupled with linkage mapping have provided an outstandingly successful approach for locating the genetic determinants of biomedically important traits such as drug resistance and host specificity in P. falciparum malaria. In the initial funding period of this Program Project...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

VISHWA DEEP DIXIT

YALE UNIVERSITY, NEW HAVEN, CT

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,410,195

FY 2025

Project Title

Competing Renewal P01

Grant Number:

5P01AG051459-09

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2016

End Date:

5/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY – OVERALL Age-related inflammation and accumulation of ectopic lipid in multiple organs in elderly is associated with emergence of chronic diseases. The integration of neural and immunometabolic inputs that control organismal aging are largely unknown. The current program project gra...

Research Terms

<21+ years old><ACRP30 protein><Adipocytes><Adipose Cell><Adipose tissue><Adult><Adult Human><Affect><Affinity><Aging><Agonist><Autoregulation><Behavior><Behavioral><Binding><Biological><Body System><Body Tissues><Caloric Restriction><Cell Communication and Signaling><Cell Signaling><Chronic Disease><Chronic Illness><Closure by Ligation><Complex><Consumption><DNA Synthesis Factor><Data><Development><EPH- and ELK-Related Tyrosine Kinase><EPH-and ELK-Related Kinase><Elderly><Endocrine><Endocrine Gland Secretion><Endothelial Cell Growth Factor><Energy Expenditure><Energy Metabolism><Ephrin Type-A Receptor 8><Ephrin Type-A Receptor 8 Precursor><Epithelium><Evaluation><FGF><FGF Receptors><FGF-21><FGF-R><FGFR><Fasting><Fat Cells><Fatty Tissue><Fibroblast Growth Factor><Fibroblast Growth Factor Gene Family><Fibroblast Growth Factor Receptor Family><Fibroblast Growth Factor Receptors><Fibroblast Growth Regulatory Factor><Generalized Growth><Generations><Gerontology><Goals><Growth><Health><Health Promotion><Homeostasis><Hormones><Human><Hypothalamic structure><Hypothalamus><Immune><Immunes><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologics><Impairment><Inflammaging><Inflammation><Intermediary Metabolism><Intracellular Communication and Signaling><Investigators><KO mice><Knock-out Mice><Knockout Mice><Knowledge><Length of Life><Leptin><Ligands><Ligation><Lipids><Lipocytes><Liver><Longevity><Lymphopoiesis><Mature Lipocyte><Mature fat cell><Mediating><Medical center><Membrane><Metabolic><Metabolic Diseases><Metabolic Disorder><Metabolic Processes><Metabolic dysfunction><Metabolism><Mice><Mice Mammals><Modality><Modeling><Modern Man><Molecular><Molecular Interaction><Murine><Mus><Nature><Nerve Cells><Nerve Unit><Neural Cell><Neurocyte><Neurons><Null Mouse><Ob Gene Product><Ob Protein><Obese Gene Product><Obese Protein><Organ><Organ System><P01 Mechanism><P01 Program><Pathway interactions><Physiologic><Physiological><Physiological Homeostasis><Program Project Grant><Program Research Project Grants><Protein Tyrosine Kinase><Protein Tyrosine Kinase EEK><Proteins><Receptor Protein><Regulation><Research><Research Personnel><Research Program Projects><Researchers><Risk Factors><Role><Salutogenesis><Signal Transduction><Signal Transduction Systems><Signaling><Structure><Sympathetic Nervous System><Testing><Texas><Therapeutic Hormone><Thesaurismosis><Thymus><Thymus Gland><Thymus Proper><Thymus Reticuloendothelial System><Tissue Growth><Tissues><Translations><Tyrosine Kinase><Tyrosine-Protein Kinase Receptor EEK><Tyrosine-Specific Protein Kinase><Tyrosylprotein Kinase><Universities><Variant><Variation><adipocyte complement-related protein 30-kDa><adipocyte, C1q and collagen domain containing protein><adiponectin><adipose><adulthood><advanced age><age associated><age associated chronic condition><age associated chronic disease><age associated chronic disorder><age associated chronic health condition><age associated chronic illness><age associated disease><age associated disorder><age associated impairment><age correlated><age dependent><age dependent disease><age dependent disorder><age dependent impairment><age linked><age related><age related chronic condition><age related chronic disease><age related chronic disorder><age related chronic health condition><age related chronic illness><age related human disease><age specific><age-related disease><age-related disorder><age-related impairment><age-related inflammation><aged mice><aged mouse><aging associated inflammation><aging process><anti aging drug><anti aging medicine><antiaging drug><antiaging medicine><apM-1 protein><apM1 (adipose-specific) protein><attenuation of senescence><biologic><biological signal transduction><burden of disease><burden of illness><calorie restriction><chronic disorder><decrease senescence><delay senescence><developmental><disease burden><drug target for longevity><elderly mice><energy balance><enhance healthspan><extend healthspan><extending healthy lifespan><fasted><fasts><fat metabolism><fatty acid oxidation><fibroblast growth factor 21><geriatric><gerontologic><geroprotectant><geroprotective><geroprotector><glucose metabolism><hallmarks of aging><healthspan><healthspan extension><healthy life span><hepatic body system><hepatic organ system><hydroxyaryl protein kinase><hypothalamic><immune senescence><immunosenescence><improve healthspan><improved><increase healthspan><inflamm-ageing><inflamm-aging><inflammation associated with aging><insulin sensitivity><ketogenesis><life span><lifespan><lipid metabolism><longevity drug><longevity focused drug><longevity pharmaceutical><lymphocytopoiesis><member><membrane structure><metabolism disorder><mouse model><murine model><neural><neuronal><new approaches><novel><novel approaches><novel strategies><novel strategy><old mice><ontogeny><overexpress><overexpression><pathway><pharmacologic><pillars of aging><pre-clinical><preclinical><programs><prolong healthspan><promote healthspan><promoting health><receptor><recruit><reduce senescence><reducing cellular senescence><repress senescence><response><senescence><senescence mitigation><senescent><senior citizen><skills><social role><suppress senescence><translation><tyrosyl protein kinase><white adipose tissue><yellow adipose tissue>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Henry M. Colecraft

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,396,905

FY 2025

Project Title

Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease

Grant Number:

5P01HL164319-03

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/15/2023

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

SUMMARY Heart disease is the leading cause of death in the United States and worldwide, with a worsening trajectory due to increasingly aging populations. Precise understanding of the molecular mechanisms underlying normal cardiac physiology, and how they are compromised in disease, is critical for ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joseph C. Wu

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,369,947

FY 2025

Project Title

Multiscale Systems to Elucidate Susceptibility and Cardioprotective Mechanisms in Cardio-oncology

Grant Number:

5P01HL141084-07

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2019

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY (OVERALL) The overarching goal of this Program Project Grant (PPG) is to elucidate mechanisms of cardiotoxicity and to develop a platform to test cardiotoxicity of new cancer therapeutics. Project 1 (Moslehi) will use a combination of mouse- and cell-based models to address the centr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CHARLES L. SAWYERS

SLOAN-KETTERING INST CAN RESEARCH, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,357,014

FY 2025

Project Title

Leveraging Observational (Real World) Data to Advance Precision Oncology

Grant Number:

5P01CA275746-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/3/2024

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Precision oncology is a firmly established pillar in the practice of cancer medicine, but we now recognize new challenges to its broad implementation. These include: (i) heterogeneity in response to precision oncology drugs in patients with identical driver mutations, (ii) differences in driver muta...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Clifton David Fuller

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,341,478

FY 2025

Project Title

OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORship

Grant Number:

5P01CA285249-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2024

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT: OVERALL Oropharyngeal cancer (OPC) is rising in epidemic proportions, largely owing to rise in highly curable oncogenic human papillomavirus (HPV) attributable disease. HPV-associated OPC is often diagnosed in young individuals presenting with near normal functional status and high quality...

Research Terms

<21+ years old><3-D CRT><3-Dimensional Conformal Radiation Therapy><3-dimensional conformal ablation><3D-CRT><Active Follow-up><Adult><Adult Human><Adverse Experience><Adverse event><After Care><After-Treatment><Aftercare><Age><Anti-EGFR Monoclonal Antibody><Anti-Epidermal Growth Factor Receptor Monoclonal Antibody><CDDP><Cancer Control><Cancer Control Science><Cancer Patient><Cancer Survivor><Cancer Survivorship><Cancer Treatment><Cancers><Cessation of life><Cetuximab><Chronic disability><Cis-diammine-dichloroplatinum><Cis-diamminedichloridoplatinum><Cis-diamminedichloro Platinum (II)><Cis-dichloroammine Platinum (II)><Cis-platinous Diamine Dichloride><Cis-platinum II><Cis-platinum II Diamine Dichloride><Cisplatin><Cisplatina><Cisplatinum><Clinical><Clinical Markers><Cohort Studies><Collection><Complex><Concurrent Studies><Conformal Radiotherapy><Conformal Therapy><Cranial Nerve Disorders><Cranial Neuropathies><Cranial nerve diseases><Cysplatyna><Data Collection><Data Set><Death><Deglutition><Deglutition Disorders><Development><Diagnosis><Diagnostic><Dichlorodiammineplatinum><Disabling><Disease><Disorder><Dose><Dysphagia><Early Diagnosis><Eating><Enrollment><Epidemic><Failure><Food Intake><Functional Imaging><H+ element><HPV><HPV + oropharyngeal carcinoma><HPV mediated oropharynx cancer><HPV oropharyngeal cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV+ OPC><HPV+ oropharyngeal cancer><HPV-OPC><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related oropharyngeal cancer><Head and Neck Cancer><Head and Neck Carcinoma><Health><Health Care Systems><Human Papilloma Virus><Human Papillomavirus><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-associated oropharyngeal cancer><Hydrogen Ions><IMRT><Image><Incidence><Individual><Infectious Human Wart Virus><Inferior><Inferior Maxillary Bone><Infrastructure><Injury><Institution><Intensity Modulated RT><Intensity Modulated Radiation Therapy><Intensity-Modulated Radiotherapy><Investigation><Investigators><Link><Long-Term Survivors><Long-Term Survivorship><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Head and Neck Neoplasm><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Managed Care><Mandible><Measures><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Meta-Analysis><Modernization><Morbidity><Morbidity - disease rate><NMR Imaging><NMR Tomography><Nerve><Nervus Cranialis Disorders><Normal Tissue><Normal tissue morphology><Nuclear Magnetic Resonance Imaging><Oncogenic><Operative Procedures><Operative Surgical Procedures><Oral><Oropharnyx Cancers><Oropharyngeal><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx><Oropharynx Cancer><Oropharynx Carcinoma><Oropharynxs><Osteoradionecrosis><Outcome><P01 Mechanism><P01 Program><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patients><Performance Status><Persistent disability><Persons><Peyrone's Chloride><Peyrone's Salt><Phenotype><Physiologic Imaging><Platinum Diamminodichloride><Population><Precision Health><Precision care><Probability><Program Project Grant><Program Research Project Grants><Protons><Publishing><QOL><Quality of life><Questionnaires><RTOG><Radiation><Radiation Conformal Therapy><Radiation Therapy Oncology Group><Radiation therapy><Radiotherapeutics><Radiotherapy><Randomization trial><Registries><Regrets><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Research Program Projects><Research Resources><Researchers><Resource Allocation><Resources><Risk><Robotics><SYS-TX><Staging><Stimulus><Surgical><Surgical Interventions><Surgical Procedure><Survivors><Swallowing><Swallowing Disorders><Symptoms><Systemic Therapy><Techniques><Testing><Therapeutic><Time><Tobacco><Toxic effect><Toxicities><Unemployment><United States><Zeugmatography><active followup><adulthood><ages><anti-cancer therapy><cancer survivor care><cancer survivorship care><cancer therapy><cancer-directed therapy><cis dichlorodiammineplatinum><cis platinum compound><cis-Diaminedichloroplatinum><cis-Diamminedichloroplatinum><cis-Diamminedichloroplatinum(II)><cis-Dichlorodiammineplatinum(II)><cis-Platinum><clinic ready><clinical biomarkers><clinical care><clinical ready><clinically useful biomarkers><cohort><conformal radiation><conformal radiation therapy><cost><data integration><data streams><developmental><disease control><disorder control><early detection><enroll><evidence base><follow up><follow-up><followed up><followup><functional status><head/neck cancer><human papillomavirus mediated oropharynx cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus+ oropharyngeal cancer><imaging><imaging study><improved><individualized care><individualized management><individualized patient care><individualized patient management><injuries><jobless><joblessness><malignancy><malignant head and neck tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><mandibular><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oral pharyngeal><out of work><personalized care><personalized clinical management><personalized disease management><personalized management><personalized patient care><phase 3 trial><phase III trial><physiological imaging><post treatment><precision management><programs><prospective><radiation treatment><randomized trial><recruit><research and methods><side effect><surgery><survivorship><treatment strategy><treatment with radiation><unemployed><wart virus>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Katherine Arnold Hutcheson

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,341,478

FY 2025

Project Title

OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORship

Grant Number:

5P01CA285249-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2024

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT: OVERALL Oropharyngeal cancer (OPC) is rising in epidemic proportions, largely owing to rise in highly curable oncogenic human papillomavirus (HPV) attributable disease. HPV-associated OPC is often diagnosed in young individuals presenting with near normal functional status and high quality...

Research Terms

<21+ years old><3-D CRT><3-Dimensional Conformal Radiation Therapy><3-dimensional conformal ablation><3D-CRT><Active Follow-up><Adult><Adult Human><Adverse Experience><Adverse event><After Care><After-Treatment><Aftercare><Age><Anti-EGFR Monoclonal Antibody><Anti-Epidermal Growth Factor Receptor Monoclonal Antibody><CDDP><Cancer Control><Cancer Control Science><Cancer Patient><Cancer Survivor><Cancer Survivorship><Cancer Treatment><Cancers><Cessation of life><Cetuximab><Chronic disability><Cis-diammine-dichloroplatinum><Cis-diamminedichloridoplatinum><Cis-diamminedichloro Platinum (II)><Cis-dichloroammine Platinum (II)><Cis-platinous Diamine Dichloride><Cis-platinum II><Cis-platinum II Diamine Dichloride><Cisplatin><Cisplatina><Cisplatinum><Clinical><Clinical Markers><Cohort Studies><Collection><Complex><Concurrent Studies><Conformal Radiotherapy><Conformal Therapy><Cranial Nerve Disorders><Cranial Neuropathies><Cranial nerve diseases><Cysplatyna><Data Collection><Data Set><Death><Deglutition><Deglutition Disorders><Development><Diagnosis><Diagnostic><Dichlorodiammineplatinum><Disabling><Disease><Disorder><Dose><Dysphagia><Early Diagnosis><Eating><Enrollment><Epidemic><Failure><Food Intake><Functional Imaging><H+ element><HPV><HPV + oropharyngeal carcinoma><HPV mediated oropharynx cancer><HPV oropharyngeal cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV+ OPC><HPV+ oropharyngeal cancer><HPV-OPC><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related oropharyngeal cancer><Head and Neck Cancer><Head and Neck Carcinoma><Health><Health Care Systems><Human Papilloma Virus><Human Papillomavirus><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-associated oropharyngeal cancer><Hydrogen Ions><IMRT><Image><Incidence><Individual><Infectious Human Wart Virus><Inferior><Inferior Maxillary Bone><Infrastructure><Injury><Institution><Intensity Modulated RT><Intensity Modulated Radiation Therapy><Intensity-Modulated Radiotherapy><Investigation><Investigators><Link><Long-Term Survivors><Long-Term Survivorship><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Head and Neck Neoplasm><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Managed Care><Mandible><Measures><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Meta-Analysis><Modernization><Morbidity><Morbidity - disease rate><NMR Imaging><NMR Tomography><Nerve><Nervus Cranialis Disorders><Normal Tissue><Normal tissue morphology><Nuclear Magnetic Resonance Imaging><Oncogenic><Operative Procedures><Operative Surgical Procedures><Oral><Oropharnyx Cancers><Oropharyngeal><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx><Oropharynx Cancer><Oropharynx Carcinoma><Oropharynxs><Osteoradionecrosis><Outcome><P01 Mechanism><P01 Program><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patients><Performance Status><Persistent disability><Persons><Peyrone's Chloride><Peyrone's Salt><Phenotype><Physiologic Imaging><Platinum Diamminodichloride><Population><Precision Health><Precision care><Probability><Program Project Grant><Program Research Project Grants><Protons><Publishing><QOL><Quality of life><Questionnaires><RTOG><Radiation><Radiation Conformal Therapy><Radiation Therapy Oncology Group><Radiation therapy><Radiotherapeutics><Radiotherapy><Randomization trial><Registries><Regrets><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Research Program Projects><Research Resources><Researchers><Resource Allocation><Resources><Risk><Robotics><SYS-TX><Staging><Stimulus><Surgical><Surgical Interventions><Surgical Procedure><Survivors><Swallowing><Swallowing Disorders><Symptoms><Systemic Therapy><Techniques><Testing><Therapeutic><Time><Tobacco><Toxic effect><Toxicities><Unemployment><United States><Zeugmatography><active followup><adulthood><ages><anti-cancer therapy><cancer survivor care><cancer survivorship care><cancer therapy><cancer-directed therapy><cis dichlorodiammineplatinum><cis platinum compound><cis-Diaminedichloroplatinum><cis-Diamminedichloroplatinum><cis-Diamminedichloroplatinum(II)><cis-Dichlorodiammineplatinum(II)><cis-Platinum><clinic ready><clinical biomarkers><clinical care><clinical ready><clinically useful biomarkers><cohort><conformal radiation><conformal radiation therapy><cost><data integration><data streams><developmental><disease control><disorder control><early detection><enroll><evidence base><follow up><follow-up><followed up><followup><functional status><head/neck cancer><human papillomavirus mediated oropharynx cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus+ oropharyngeal cancer><imaging><imaging study><improved><individualized care><individualized management><individualized patient care><individualized patient management><injuries><jobless><joblessness><malignancy><malignant head and neck tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><mandibular><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oral pharyngeal><out of work><personalized care><personalized clinical management><personalized disease management><personalized management><personalized patient care><phase 3 trial><phase III trial><physiological imaging><post treatment><precision management><programs><prospective><radiation treatment><randomized trial><recruit><research and methods><side effect><surgery><survivorship><treatment strategy><treatment with radiation><unemployed><wart virus>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

STEPHEN Y LAI

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,341,478

FY 2025

Project Title

OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORship

Grant Number:

5P01CA285249-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2024

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT: OVERALL Oropharyngeal cancer (OPC) is rising in epidemic proportions, largely owing to rise in highly curable oncogenic human papillomavirus (HPV) attributable disease. HPV-associated OPC is often diagnosed in young individuals presenting with near normal functional status and high quality...

Research Terms

<21+ years old><3-D CRT><3-Dimensional Conformal Radiation Therapy><3-dimensional conformal ablation><3D-CRT><Active Follow-up><Adult><Adult Human><Adverse Experience><Adverse event><After Care><After-Treatment><Aftercare><Age><Anti-EGFR Monoclonal Antibody><Anti-Epidermal Growth Factor Receptor Monoclonal Antibody><CDDP><Cancer Control><Cancer Control Science><Cancer Patient><Cancer Survivor><Cancer Survivorship><Cancer Treatment><Cancers><Cessation of life><Cetuximab><Chronic disability><Cis-diammine-dichloroplatinum><Cis-diamminedichloridoplatinum><Cis-diamminedichloro Platinum (II)><Cis-dichloroammine Platinum (II)><Cis-platinous Diamine Dichloride><Cis-platinum II><Cis-platinum II Diamine Dichloride><Cisplatin><Cisplatina><Cisplatinum><Clinical><Clinical Markers><Cohort Studies><Collection><Complex><Concurrent Studies><Conformal Radiotherapy><Conformal Therapy><Cranial Nerve Disorders><Cranial Neuropathies><Cranial nerve diseases><Cysplatyna><Data Collection><Data Set><Death><Deglutition><Deglutition Disorders><Development><Diagnosis><Diagnostic><Dichlorodiammineplatinum><Disabling><Disease><Disorder><Dose><Dysphagia><Early Diagnosis><Eating><Enrollment><Epidemic><Failure><Food Intake><Functional Imaging><H+ element><HPV><HPV + oropharyngeal carcinoma><HPV mediated oropharynx cancer><HPV oropharyngeal cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV+ OPC><HPV+ oropharyngeal cancer><HPV-OPC><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related oropharyngeal cancer><Head and Neck Cancer><Head and Neck Carcinoma><Health><Health Care Systems><Human Papilloma Virus><Human Papillomavirus><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-associated oropharyngeal cancer><Hydrogen Ions><IMRT><Image><Incidence><Individual><Infectious Human Wart Virus><Inferior><Inferior Maxillary Bone><Infrastructure><Injury><Institution><Intensity Modulated RT><Intensity Modulated Radiation Therapy><Intensity-Modulated Radiotherapy><Investigation><Investigators><Link><Long-Term Survivors><Long-Term Survivorship><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Head and Neck Neoplasm><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Managed Care><Mandible><Measures><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Meta-Analysis><Modernization><Morbidity><Morbidity - disease rate><NMR Imaging><NMR Tomography><Nerve><Nervus Cranialis Disorders><Normal Tissue><Normal tissue morphology><Nuclear Magnetic Resonance Imaging><Oncogenic><Operative Procedures><Operative Surgical Procedures><Oral><Oropharnyx Cancers><Oropharyngeal><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx><Oropharynx Cancer><Oropharynx Carcinoma><Oropharynxs><Osteoradionecrosis><Outcome><P01 Mechanism><P01 Program><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patients><Performance Status><Persistent disability><Persons><Peyrone's Chloride><Peyrone's Salt><Phenotype><Physiologic Imaging><Platinum Diamminodichloride><Population><Precision Health><Precision care><Probability><Program Project Grant><Program Research Project Grants><Protons><Publishing><QOL><Quality of life><Questionnaires><RTOG><Radiation><Radiation Conformal Therapy><Radiation Therapy Oncology Group><Radiation therapy><Radiotherapeutics><Radiotherapy><Randomization trial><Registries><Regrets><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Research Program Projects><Research Resources><Researchers><Resource Allocation><Resources><Risk><Robotics><SYS-TX><Staging><Stimulus><Surgical><Surgical Interventions><Surgical Procedure><Survivors><Swallowing><Swallowing Disorders><Symptoms><Systemic Therapy><Techniques><Testing><Therapeutic><Time><Tobacco><Toxic effect><Toxicities><Unemployment><United States><Zeugmatography><active followup><adulthood><ages><anti-cancer therapy><cancer survivor care><cancer survivorship care><cancer therapy><cancer-directed therapy><cis dichlorodiammineplatinum><cis platinum compound><cis-Diaminedichloroplatinum><cis-Diamminedichloroplatinum><cis-Diamminedichloroplatinum(II)><cis-Dichlorodiammineplatinum(II)><cis-Platinum><clinic ready><clinical biomarkers><clinical care><clinical ready><clinically useful biomarkers><cohort><conformal radiation><conformal radiation therapy><cost><data integration><data streams><developmental><disease control><disorder control><early detection><enroll><evidence base><follow up><follow-up><followed up><followup><functional status><head/neck cancer><human papillomavirus mediated oropharynx cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus+ oropharyngeal cancer><imaging><imaging study><improved><individualized care><individualized management><individualized patient care><individualized patient management><injuries><jobless><joblessness><malignancy><malignant head and neck tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><mandibular><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oral pharyngeal><out of work><personalized care><personalized clinical management><personalized disease management><personalized management><personalized patient care><phase 3 trial><phase III trial><physiological imaging><post treatment><precision management><programs><prospective><radiation treatment><randomized trial><recruit><research and methods><side effect><surgery><survivorship><treatment strategy><treatment with radiation><unemployed><wart virus>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DANIEL A PORTNOY

UNIVERSITY OF CALIFORNIA BERKELEY, BERKELEY, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,325,406

FY 2025

Project Title

The intersection of innate and adaptive immunity to intracellular pathogens

Grant Number:

5P01AI063302-22

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/30/2004

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary/Abstract (Overall) This application is a competitive renewal of a program project grant entitled, “The intersection of innate and adaptive immunity to intracellular pathogens.” A major goal of this P01 is to identify and characterize innate immune pathways that are triggered, avoided...

Research Terms

<APF-1><ATP-Dependent Proteolysis Factor 1><Active Follow-up><Address><Adjuvant><Affect><Anti-Bacterial Response><Antibacterial Response><Antibodies><Autophagocytosis><BSL-3 facility><BSL3 facility><Bacteria><Bacterial DNA><Bacterial Infections><Brain><Brain Nervous System><Cell Body><Cells><Cells Placenta-Tissue><Classification><Collaborations><Communicable Diseases><Communities><Complex><Cyclicity><Cytosol><DNA><Data><Dedications><Defense Mechanisms><Deoxyribonucleic Acid><Dinucleoside Phosphates><Disease><Disorder><ELF3><ELF3 gene><EPR-1><ERT gene><ERT protein><ESE-1><ESX><Encephalon><Engineering><Enzyme Gene><Enzymes><Foundations><Future><Goals><HMG-20><High Mobility Protein 20><IFN><IL-1><IL-1ra><IL1><IL1 febrile inhibitor><IL1RN><Immune><Immune response><Immune system><Immunes><Immunity><Immunobiology><Immunophysiology><Infection><Infectious Diseases><Infectious Disorder><Initiation Factors><Innate Immune Response><Innate Immune System><Innate Immunity><Interferon Type I><Interferons><Interleukin I><Interleukin-1><Interleukin-1 Receptor Antagonist><International><Intranasal Administration><Intranasal Drug Administration><Invaded><Investigation><Knowledge><L monocytogenes><L pneumophila><L. monocytogenes><L. pneumophila><Legionella pneumophila><Listeria monocytogenes><Lymphocyte-Stimulating Hormone><M tb><M tuberculosis><M tuberculosis infection><M. tb><M. tb infection><M. tuberculosis><M. tuberculosis infection><M.tb infection><M.tuberculosis infection><MTB infection><MTB vaccine><Macrophage Cell Factor><Mediating><Membrane><Microbiology><Modeling><Mycobacterium tuberculosis><Mycobacterium tuberculosis (MTB) infection><Mycobacterium tuberculosis infection><Native Immunity><Natural Immunity><Non-Specific Immunity><Nonspecific Immunity><Normal Placentoma><Oral><P01 Mechanism><P01 Program><Pathogenesis><Pathogenicity Factors><Pathway interactions><Peptide Initiation Factors><Perforation><Periodicity><Phagosomes><Placenta><Placenta Embryonic Tissue><Placentome><Play><Position><Positioning Attribute><Production><Program Project Grant><Program Research Project Grants><Proteins><Receptor Protein><Research><Research Program Projects><Research Resources><Research Support><Resources><Rhythmicity><Role><System><Systematics><T Helper Factor><T-Cells><T-Lymphocyte><TB infection><TB vaccine><Therapeutic><Translating><Translation Initiation Factor><Translational Initiation Factor><Tuberculosis><Tuberculosis Vaccines><Ubiquitin><Vaccine for TB><Vaccine for Tuberculosis><Vaccines><Viral Diseases><Virulence><Virulence Factors><Virulent><Virus Diseases><active followup><adaptive immune response><adaptive immunity><anakinra><anti-TB vaccine><anti-viral immunity><antiviral immunity><autophagy><bacteria infection><bacteria pathogen><bacterial disease><bacterial pathogen><biosafety level 3 facility><burden of disease><burden of illness><collaborative approach><design><designing><detection platform><detection system><develop a vaccine><develop vaccines><development of a vaccine><dinucleotide><disease burden><disseminated TB><disseminated tuberculosis><extracellular><follow up><follow-up><followed up><followup><global health><host response><immune system response><immunogenicity><immunoresponse><improved><infection due to Mycobacterium tuberculosis><innate immune pathways><innovate><innovation><innovative><insight><interleukin 1 receptor antagonist protein><lymphocyte activating factor><meeting><meetings><membrane structure><mtb><mutant><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><new vaccines><next generation vaccines><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><novel vaccines><outcome following vaccination><outcome following vaccine><pathogen><pathogenic bacteria><pathway><prevent><preventing><programs><psychological defense mechanism><receptor><response><result following vaccination><result following vaccine><social role><success><synergism><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><thymus derived lymphocyte><tuberculosis infection><tuberculous spondyloarthropathy><urine IL-1 inhibitor><urine interleukin 1 inhibitor><urine-derived IL1 inhibitor><vaccination outcome><vaccination result><vaccine against M. tuberculosis><vaccine against Mtb><vaccine against Mycobacterium tuberculosis><vaccine against TB><vaccine against tuberculosis><vaccine candidates against tuberculosis><vaccine development><vaccine outcome><vaccine result><vaccine strategy><vector><viral infection><virus infection><virus-induced disease>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CHANCE MARION JOHN LUCKEY

UNIVERSITY OF VIRGINIA, CHARLOTTESVILLE, VA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,322,945

FY 2025

Project Title

Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion

Grant Number:

5P01HL169552-03

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2023

End Date:

6/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Alloimmunization to transfused RBCs remains a major problem for the large number of patients who require transfusion (approximately 1 out of 70 people (~5,000,000 patients) annually in the USA alone). Although a barrier to transfusion in multiple settings, alloimmunization is particularly problemati...

Research Terms

<(IFN) α><(IFN)-α><(IFN)α><ADORA1 gene><ADORA2B gene><Acute><Address><Adenosine><Adora1><Adora2b><Alferon><Alloantibodies><Alloantigen><Alloimmunization><Antibodies><Antigen-Presenting Cells><Antigens><B-Cells><B-Lymphocytes><B-cell><Biology><Blood><Blood Group Antigens><Blood Reticuloendothelial System><Blood Transfusion><Blood erythrocyte><Blood reticulocyte><Cell Communication and Signaling><Cell Signaling><Chronic><Clinical><Collection><Data><Data Bases><Databases><Diffusely basophilic erythrocyte><Erythrocyte Transfusion><Erythrocytes><Erythrocytic><Expression Signature><Gene Expression><Gene Expression Profile><Gene variant><Genetic Determinism><Genetic Polymorphism><Genetic predisposing factor><Goals><Hb SS disease><HbSS disease><Hemoglobin S Disease><Hemoglobin sickle cell disease><Hemoglobin sickle cell disorder><Human><IFN Alpha><IFN α><IFN-α><IFNa><IFNα><Immune reaction><Immunize><Immunology><Individual><Inflammation><Interferon Alfa-n3><Interferon-α><Intracellular Communication and Signaling><Isoantibodies><Leukocyte Interferon><Life><Link><Lupus Erythematosus Disseminatus><Lymphoblast Interferon><Lymphoblastoid Interferon><Marrow erythrocyte><Marrow reticulocyte><Methods><Mice><Mice Mammals><Mitochondria><Modeling><Modern Man><Modification><Molecular><Monitor><Murine><Mus><Nucleic Acids><Pathology><Pathway interactions><Patients><Pattern><Persons><Phenotype><Polychromatophilic Erythrocyte><Population><Pre-Clinical Model><Preclinical Models><Predisposing Factor><Production><Purine Receptors><Purinergic Receptors><Purinoceptor><Red Blood Cell Transfusion><Red Blood Cells><Red Cell><Regulation><Research><Research Resources><Research Specimen><Resources><Reticulocytes><Risk><Risk Factors><Role><SLE><Sampling><Sickle Cell Anemia><Signal Induction><Signal Pathway><Signal Transduction><Signal Transduction Systems><Signaling><Specimen><Structure><Systemic Lupus Erythematosus><Systemic Lupus Erythematous><Systemic Lupus Erythmatosus><TLR7><TLR7 gene><Technology><Testing><Therapeutic Intervention><Time><Toll-Like Receptor 7><Transfusion><Translating><accessory cell><allelic variant><antagonism><antagonist><biological signal transduction><blood corpuscles><clinical practice><cohort><cytokine><data base><design><designing><develop therapy><disseminated lupus erythematosus><ecto-nucleotidase><entire genome><experiment><experimental research><experimental study><experiments><full genome><gain of function><gene expression pattern><gene expression signature><genetic determinant><genetic risk factor><genetic variant><genome sequencing><genomic variant><global gene expression><global transcription profile><human model><human study><human subject><immunogen><immunoreaction><inherited factor><innate immune pathways><intervention development><intervention therapy><mitochondrial><model of human><mouse model><murine model><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><pathway><polymorphism><prevent><preventing><programs><responders and non-responders><responders from non-responders><responders or non-responders><responders versus non-responders><responders vs non-responders><responders/nonresponders><response><scRNA sequencing><scRNA-seq><sickle cell disease><sickle cell disorder><sickle disease><sicklemia><single cell RNA-seq><single cell RNAseq><single cell analysis><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><social role><synergism><systemic lupus erythematosis><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutically effective><therapy development><transcriptional profile><transcriptional signature><transcriptome><transcriptomics><translational genomics><translational model><treatment development><whole genome>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alexander Bukreyev

UNIVERSITY OF TEXAS MED BR GALVESTON, GALVESTON, TX

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,295,613

FY 2025

Project Title

Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

Grant Number:

5P01AI150585-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2021

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL: PROJECT SUMMARY/ABSTRACT The central hypothesis of the proposed P01 Program is that Ebola virus infection leads to cell-type specific transcriptional, posttranscriptional, and posttranslational alterations that create aberrant counterproductive responses of immune cells, leading to a dysreg...

Research Terms

<2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Acute><Address><Africa><Alternate Splicing><Alternative RNA Splicing><Alternative Splicing><Apoptosis><Apoptosis Pathway><Basal Transcription Factor><Basal transcription factor genes><Behavior><Belgian Congo><Bioinformatics><Body Tissues><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 virus><COVID-19 years><COVID19 virus><CV-19><Cell Body><Cells><Cessation of life><CoV-2><CoV2><Collaborations><Communication><Complex><Coronavirus Infectious Disease 2019><Data><Death><Democratic Republic of the Congo><Dendritic Cells><Development><Disease Outbreaks><EBOV><EBOV GP><Ebola Hemorrhagic Fever><Ebola Virus Disease><Ebola disease><Ebola virus><Ebola virus GP gene product><Ebola virus envelope glycoprotein><Ebola-like Viruses><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Event><Experimental Designs><Frankfurt-Marburg Syndrome Virus><GP Ebola virus><Gene Expression><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Genetic Transcription><HDAC><HDAC Proteins><Histone Deacetylase><Homolog of Drosophila TOLL><Human><IFN><Immune><Immune Tolerance><Immune response><Immunes><Immunoglobulin Enhancer-Binding Protein><Immunologic Tolerance><Individual><Infection><Inflammation><Interferons><Investigation><Knowledge><Lassa fever virus><Lassa virus><Lead><Lymphocytopenia><Lymphopenia><Marburg><Marburg virus><Marburg-like Viruses><Marburgvirus><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Massive Parallel Sequencing><Massively Parallel DNA Sequencing><Massively Parallel Sequencing><Modeling><Modern Man><Modification><Molecular><NF-kB><NF-kappa B><NF-kappaB><NFKB><Non-Polyadenylated RNA><Nuclear Factor kappa B><Nuclear Transcription Factor NF-kB><Orthoebolavirus><Orthomarburgvirus><Outbreaks><Outcome><P01 Mechanism><P01 Program><Paint><Pathogenesis><Pathogenicity><Pathologic><Pb element><Phosphorylation><Population><Post-Translational Modification Protein/Amino Acid Biochemistry><Post-Translational Modifications><Post-Translational Protein Modification><Post-Translational Protein Processing><Posttranslational Modifications><Posttranslational Protein Processing><Program Project Grant><Program Research Project Grants><Programmed Cell Death><Protein Modification><Protein Phosphorylation><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><RNA><RNA Expression><RNA Gene Products><Research><Research Grants><Research Program Projects><Research Project Grants><Research Projects><Ribonucleic Acid><Role><Running><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Strategic Planning><T-Cells><T-Lymphocyte><TLR4><TLR4 gene><Testing><Tissues><Toll Homologue><Transcription><Transcription Factor NF-kB><Transcription Factor Proto-Oncogene><Transcription factor genes><Translation Alteration><Ubiquitilation><Ubiquitination><Ubiquitinoylation><Validation><Veiled Cells><Viral Diseases><Viral Hemorrhagic Fevers><Virus><Virus Diseases><Work><Wuhan coronavirus><Zaire><antagonism><antagonist><cell type><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 virus><coronavirus infectious disease-19><cytokine><developmental><epidemic virus><epigenetically><experiment><experimental research><experimental study><experiments><gene product><hCoV19><heavy metal Pb><heavy metal lead><hemorrhagic fever><host response><immune system response><immune system tolerance><immune unresponsiveness><immunological paralysis><immunoresponse><improved outcome><individual response><individualized response><kappa B Enhancer Binding Protein><mRNA Translation><medical countermeasure><nCoV2><network models><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><non-human primate><nonhuman primate><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><nuclear factor kappa beta><outbreak containment><outbreak control><outbreak mitigation><posttranscriptional><programs><proteogenomics><response><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><social role><thymus derived lymphocyte><toll-like receptor 4><tool><transcription factor><ubiquination><ubiquitin conjugation><validations><viral infection><virus infection><virus-induced disease>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mariano A. Garcia-Blanco

UNIVERSITY OF TEXAS MED BR GALVESTON, GALVESTON, TX

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,295,613

FY 2025

Project Title

Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

Grant Number:

5P01AI150585-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2021

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL: PROJECT SUMMARY/ABSTRACT The central hypothesis of the proposed P01 Program is that Ebola virus infection leads to cell-type specific transcriptional, posttranscriptional, and posttranslational alterations that create aberrant counterproductive responses of immune cells, leading to a dysreg...

Research Terms

<2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Acute><Address><Africa><Alternate Splicing><Alternative RNA Splicing><Alternative Splicing><Apoptosis><Apoptosis Pathway><Basal Transcription Factor><Basal transcription factor genes><Behavior><Belgian Congo><Bioinformatics><Body Tissues><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 virus><COVID-19 years><COVID19 virus><CV-19><Cell Body><Cells><Cessation of life><CoV-2><CoV2><Collaborations><Communication><Complex><Coronavirus Infectious Disease 2019><Data><Death><Democratic Republic of the Congo><Dendritic Cells><Development><Disease Outbreaks><EBOV><EBOV GP><Ebola Hemorrhagic Fever><Ebola Virus Disease><Ebola disease><Ebola virus><Ebola virus GP gene product><Ebola virus envelope glycoprotein><Ebola-like Viruses><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Event><Experimental Designs><Frankfurt-Marburg Syndrome Virus><GP Ebola virus><Gene Expression><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Genetic Transcription><HDAC><HDAC Proteins><Histone Deacetylase><Homolog of Drosophila TOLL><Human><IFN><Immune><Immune Tolerance><Immune response><Immunes><Immunoglobulin Enhancer-Binding Protein><Immunologic Tolerance><Individual><Infection><Inflammation><Interferons><Investigation><Knowledge><Lassa fever virus><Lassa virus><Lead><Lymphocytopenia><Lymphopenia><Marburg><Marburg virus><Marburg-like Viruses><Marburgvirus><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Massive Parallel Sequencing><Massively Parallel DNA Sequencing><Massively Parallel Sequencing><Modeling><Modern Man><Modification><Molecular><NF-kB><NF-kappa B><NF-kappaB><NFKB><Non-Polyadenylated RNA><Nuclear Factor kappa B><Nuclear Transcription Factor NF-kB><Orthoebolavirus><Orthomarburgvirus><Outbreaks><Outcome><P01 Mechanism><P01 Program><Paint><Pathogenesis><Pathogenicity><Pathologic><Pb element><Phosphorylation><Population><Post-Translational Modification Protein/Amino Acid Biochemistry><Post-Translational Modifications><Post-Translational Protein Modification><Post-Translational Protein Processing><Posttranslational Modifications><Posttranslational Protein Processing><Program Project Grant><Program Research Project Grants><Programmed Cell Death><Protein Modification><Protein Phosphorylation><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><RNA><RNA Expression><RNA Gene Products><Research><Research Grants><Research Program Projects><Research Project Grants><Research Projects><Ribonucleic Acid><Role><Running><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Strategic Planning><T-Cells><T-Lymphocyte><TLR4><TLR4 gene><Testing><Tissues><Toll Homologue><Transcription><Transcription Factor NF-kB><Transcription Factor Proto-Oncogene><Transcription factor genes><Translation Alteration><Ubiquitilation><Ubiquitination><Ubiquitinoylation><Validation><Veiled Cells><Viral Diseases><Viral Hemorrhagic Fevers><Virus><Virus Diseases><Work><Wuhan coronavirus><Zaire><antagonism><antagonist><cell type><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 virus><coronavirus infectious disease-19><cytokine><developmental><epidemic virus><epigenetically><experiment><experimental research><experimental study><experiments><gene product><hCoV19><heavy metal Pb><heavy metal lead><hemorrhagic fever><host response><immune system response><immune system tolerance><immune unresponsiveness><immunological paralysis><immunoresponse><improved outcome><individual response><individualized response><kappa B Enhancer Binding Protein><mRNA Translation><medical countermeasure><nCoV2><network models><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><non-human primate><nonhuman primate><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><nuclear factor kappa beta><outbreak containment><outbreak control><outbreak mitigation><posttranscriptional><programs><proteogenomics><response><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><social role><thymus derived lymphocyte><toll-like receptor 4><tool><transcription factor><ubiquination><ubiquitin conjugation><validations><viral infection><virus infection><virus-induced disease>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Zhiyuan Shen

RUTGERS BIOMEDICAL AND HEALTH SCIENCES, Newark, NJ

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,291,219

FY 2025

Project Title

Mechanisms of the BRCA-network in tumorigenesis and therapeutic response

Grant Number:

5P01CA250957-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2021

End Date:

4/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Mechanisms of the BRCA-network in Tumorigenesis and Therapeutic Response (OVERALL) Abstract: The faithful repair of DNA damage and efficient resolution of stalled replication forks are fundamental mechanisms by which mammalian cells maintain DNA sequence fidelity and chromosomal integrity during DNA...

Research Terms

<53BP1><Ablation><Address><Area><BARD-1><BARD1><BARD1 gene><BRCA 1/2 mutations><BRCA mutants><BRCA mutations><BRCA1><BRCA1 Associated RING Domain 1 Protein><BRCA1 Gene Product><BRCA1 Protein><BRCA1 gene><BRCA1-Associated RING Domain 1><BRCA1/2 mutations><BRCA1/2mut><BRCA2><BRCA2 gene><BRCAmut><Basic Mechanisms of SUMOylation><Breast Cancer><Breast Cancer 1 Gene><Breast Cancer 1 Gene Product><Breast Cancer 2 Gene><Breast Cancer Type 1 Susceptibility Gene><Breast Cancer Type 1 Susceptibility Protein><Breast Cancer Type 2 Susceptibility Gene><Breast Neoplasms><Breast Tumors><Breast-Ovarian Cancer Protein><Cancer Treatment><Cancers><Cell Body><Cells><Chromatin><Chromosomal Stability><Chromosome Stabilities><Chromosomes><Clinical><Collaborations><Complex><DNA Alteration><DNA Damage><DNA Damage Repair><DNA Injury><DNA Repair><DNA Replication><DNA Sequence><DNA Sequence Alteration><DNA Synthesis><DNA biosynthesis><DNA mutation><DNA replication fork><Data><Defect><Development><Drugs><Dysfunction><E3 Ligase><E3 Ubiquitin Ligase><Early Onset Gene Breast Cancer 1><Early Onset Gene Breast Cancer 2><Early Onset Protein Breast Cancer 1><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><FANCD1><Functional disorder><GEM model><GEMM model><Generations><Genes><Genetic><Genetic Alteration><Genetic Change><Genetic defect><Genetic mutation><Genetically Engineered Mouse><Genetics-Mutagenesis><Genome Instability><Genomic Instability><Genomics><Goals><Hereditary Breast Cancer 1><Hereditary Breast Cancer 2><Human><Hypothetical Protein KIAA0259 Gene><Impairment><In Vitro><Investigators><KIAA0259 Gene><Kinetics><MCM10><MCM10 gene><Malignant Breast Neoplasm><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Mammalian Cell><Mammary Cancer><Mammary Neoplasms><Mediating><Medication><Medulloblastoma><Methods><Methylation><Mice><Mice Mammals><Modeling><Modern Man><Molecular><Molecular Tumor Suppression><Murine><Mus><Mutagenesis><Mutagenesis Molecular Biology><Mutation><Oncogenesis><P01 Mechanism><P01 Program><PALB2><PALB2 gene><PARP Inhibitor><PARP-1 inhibitor><PARPi><Pathway interactions><Pattern><Pharmaceutical Preparations><Physiopathology><Poly(ADP-ribose) Polymerase Inhibitor><Poly(ADP-ribose) polymerase 1 inhibitor><Program Project Grant><Program Research Project Grants><Proteins><RNF53><Recurrence><Recurrent><Regulation><Research><Research Personnel><Research Program Projects><Researchers><Resolution><Resource Sharing><Role><SUMOylation><Sequence Alteration><Site><Structure><Sumoylation Pathway><TOP1><TOP1 gene><TOPBP1><TOPBP1 Gene><TP53BP1><Therapeutic><Topoisomerase (DNA) II Binding Protein Gene><Tumor Suppression><Ubiquitilation><Ubiquitin Protein Ligase><Ubiquitin-Protein Ligase Complexes><Ubiquitin-Protein Ligase E3><Ubiquitination><Ubiquitinoylation><Unscheduled DNA Synthesis><anti-cancer therapy><base><bases><brca 1 gene><brca 2 gene><cancer therapy><cancer-directed therapy><chemotherapy><design><designing><developmental><drug/agent><epigenetically><gene network><genetically engineered mouse model><genetically engineered murine model><genome integrity><genome mutation><genomic alteration><genomic integrity><genomic signature><genomic tools><homologous recombination><improved><improved outcome><inhibitor><insight><interdisciplinary approach><interest><loss of function><malignancy><malignant breast tumor><mammary tumor><member><mouse model><multidisciplinary approach><murine model><mutations in BRCA><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><p202><p53-binding protein 1><p53BP1><partner and localizer of BRCA2><pathophysiology><pathway><predictive tools><programs><public health relevance><recruit><repair><repaired><replication fork><replication stress><resolutions><response><response to therapy><response to treatment><social role><success><synthetic lethal interaction><synthetic lethality><targeted cancer therapy><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic response><therapy response><tool><treatment response><treatment responsiveness><tumor><tumorigenesis><ubiquination><ubiquitin conjugation><ubiquitin-protein ligase>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Noel Todd Brewer

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,232,676

FY 2025

Project Title

Program Project – Improving Provider Announcement Communication Training (IMPACT)

Grant Number:

5P01CA250989-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/23/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Provider recommendations are uniquely powerful in improving health care use. However, primary care teams and healthcare systems experience challenges with clinical communication, and many questions remain unanswered about how to increase the potency of provider recommendations. We propose the P01 Pr...

Research Terms

<0-11 years old><Acceleration><Address><Administrative Coordination><Adolescent><Adolescent Youth><Adoption><Age><Application Context><Area><Behavioral><Cancer Control><Cancer Control Science><Child><Child Care><Child Youth><Children (0-21)><Clinic><Clinical><Communication><Data><Data Collection><Data Management Core><Decision Aid><Education for Intervention><Educational Intervention><Effectiveness><Evolution><Family><Goals><Health Care><Health Care Systems><Instruction Intervention><Intervention><NCI Organization><National Cancer Institute><National Cancer Program><Outcome><P01 Mechanism><P01 Program><Perception><Population><Primary Care><Program Project Grant><Program Research Project Grants><Provider><Puericulture><R-Series Research Projects><R01 Mechanism><R01 Program><Recommendation><Research Activity><Research Grants><Research Program Projects><Research Project Grants><Research Projects><Research Resources><Resources><Role><Rural><Survey Instrument><Surveys><System><Training><Training Activity><Training Intervention><Training Programs><Work><ages><budget impact><clinical implementation><contextual factors><cost><cost effectiveness><data management and coordinating center><data management center><experience><financial incentive><financial reward><improved><insight><instructional intervention><juvenile><juvenile human><kids><member><monetary incentive><novel><population health><primary care services><primary care team><programs><randomized, clinical trials><rural area><rural location><rural region><social role><support tools><synergism><training module><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

BRUCE A BEUTLER

UT SOUTHWESTERN MEDICAL CENTER, DALLAS, TX

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,198,935

FY 2025

Project Title

Modulation of NOD Strain Diabetes by ENU-Induced Mutations

Grant Number:

5P01AI165026-03

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/13/2023

End Date:

5/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT This P01 proposal offers a fresh approach to understanding the genetics of an extremely important polygenic autoimmune disease: type 1 diabetes (T1D), which affects nearly three children out of every thousand in North America, and many more around the world. T1D occurs with ...

Research Terms

<0-11 years old><1-Ethyl-1-nitrosourea><18 year old><18 years of age><Acceleration><Affect><Alleles><Allelomorphs><Animals><Antigenic Determinants><Apoptotic><Archives><Assay><Autoantigens><Autoimmune Diabetes><Autoimmune Diseases><Autologous Antigens><B-Cells><B-Lymphocytes><B-cell><B9 endocrine pancreas><Beta Cell><Binding Determinants><Bioassay><Biological Assay><Blood><Blood Precursor Cell><Blood Reticuloendothelial System><Body Tissues><Breeding><Brittle Diabetes Mellitus><CD152><CD152 Antigen><CD152 Gene><CRISPR approach><CRISPR based approach><CRISPR method><CRISPR methodology><CRISPR technique><CRISPR technology><CRISPR tools><CRISPR-CAS-9><CRISPR-based method><CRISPR-based technique><CRISPR-based technology><CRISPR-based tool><CRISPR/CAS approach><CRISPR/Cas method><CRISPR/Cas technology><CRISPR/Cas9><CRISPR/Cas9 technology><CTLA 4><CTLA-4 Gene><CTLA4><CTLA4 gene><CTLA4-TM><Cachectin Receptors><Cas nuclease technology><Causality><Cell Body><Cell Communication and Signaling><Cell Count><Cell Number><Cell Signaling><Cells><Child><Child Youth><Childhood><Children (0-21)><Clustered Regularly Interspaced Short Palindromic Repeats approach><Clustered Regularly Interspaced Short Palindromic Repeats method><Clustered Regularly Interspaced Short Palindromic Repeats methodology><Clustered Regularly Interspaced Short Palindromic Repeats technique><Clustered Regularly Interspaced Short Palindromic Repeats technology><Code><Coding System><Collaborations><Complex><Cryofixation><Cryopreservation><Cytotoxic T-Lymphocyte Protein 4><Cytotoxic T-Lymphocyte-Associated Antigen 4><Cytotoxic T-Lymphocyte-Associated Protein 4><Cytotoxic T-Lymphocyte-Associated Serine Esterase-4><DNA><DNA mutation><DNase-I Footprinting><Data><Data Bases><Databases><Date of birth><Deoxyribonucleic Acid><Development><Diabetes Mellitus><Disease><Disease remission><Disorder><Documentation><Drugs><ENU><Endocrine Pancreas><Epitopes><Ethylnitrosourea><Etiology><Exhibits><Expenditure><Female><Frequencies><Functional RNA><Funding><Genes><Genetic><Genetic Change><Genetic Diseases><Genetic defect><Genetic mutation><Genetics-Mutagenesis><Genome><Genomic DNA><Genotoxins><Genotype><Germ Lines><Guidelines><Hematopoietic Progenitor Cells><Hematopoietic stem cells><Human><IDDM><Immune><Immune system><Immunes><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologics><Inbred NOD Mice><Inbreeding><Individual><Induced DNA Alteration><Induced Mutation><Induced Sequence Alteration><Influentials><Insulin Cell><Insulin Secreting Cell><Insulin-Dependent Diabetes Mellitus><Intellectual Property><Intracellular Communication and Signaling><Ions><Islands of Langerhans><Islet Cell><Islets of Langerhans><Juvenile-Onset Diabetes Mellitus><Ketosis-Prone Diabetes Mellitus><Knock-out><Knockout><Laboratories><Light><Maps><Measures><Medical><Medication><Meiosis><Metabolic><Methodology><Methods><Mice><Mice Mammals><Missense Mutation><Modern Man><Modification><Molecular><Monitor><Murine><Mus><Mutagenesis><Mutagenesis Molecular Biology><Mutagens><Mutant Strains Mice><Mutation><N-Ethyl-N-nitrosourea><N-ethyl-N-nitroso-urea><N-terminal><NH2-terminal><NIH><NOD Mouse><National Institutes of Health><Nesidioblasts><Nitrosoethylurea><Non obese><Non-Obese Diabetic Mice><Noncoding RNA><Nonobese><Nonobese Diabetic Mouse><Nontranslated RNA><North America><Nucleotides><Ortholog><Orthologous Gene><Pancreatic Islets><Paris><Paris, France><Pars endocrina pancreatis><Pathogenesis><Pathogenicity><Patients><Pedigree><Penetrance><Peptides><Persons><Pharmaceutical Preparations><Phenotype><Photoradiation><Pilot Projects><Point Mutation><Predisposition><Progress Reports><Protein Overexpression><Proteins><Proteomics><Publications><RNA Splicing><Recovery><Regulatory T-Lymphocyte><Remission><Research Design><Resolution><Resource Sharing><Sampling><Scientific Publication><Self-Antigens><Signal Transduction><Signal Transduction Systems><Signaling><Site><Splice-Junction Mutation><Splice-Site Mutation><Splicing><Stress><Study Type><Sudden-Onset Diabetes Mellitus><Sum><Susceptibility><T cell receptor repertoire sequencing><T cell receptor sequencing><T cell response><T-Cells><T-Lymphocyte><T-cell receptor repertoire><T1 DM><T1 diabetes><T1D><T1DM><TCR repertoire><TCR repertoire sequencing><TCR sequencing><TCR-seq><TCRseq><TNF Receptor Family Protein><TNF Receptor Superfamily><TNF Receptors><TNFR><Technology><Testing><Therapeutic><Thymus><Thymus Gland><Thymus Proper><Thymus Reticuloendothelial System><Tissues><Treg><Tumor Necrosis Factor Receptor><Tumor Necrosis Factor Receptor Family><Tumor Necrosis Factor Receptor Superfamily><Type 1 Diabetes Mellitus><Type 1 diabetes><Type I Diabetes Mellitus><United States National Institutes of Health><Untranslated RNA><Work><Writing><age 18 years><animation><autoimmune condition><autoimmune disorder><autoimmune reactivity><autoimmunity disease><autoreactivity><biological signal transduction><blood cell progenitor><blood progenitor><blood stem cell><blood-forming stem cell><causation><cell type><cold preservation><cold storage><conditional knock-out><conditional knockout><cytotoxic T-lymphocyte antigen 4><data base><data dissemination><developmental><diabetes><diabetes pathogenesis><diabetic><disease causation><drug/agent><eighteen year old><eighteen years of age><epigenetic regulation><exome sequencing><exome-seq><forward genetics><gDNA><genetic condition><genetic disorder><genetic pedigree><genome mutation><genotoxic agent><global gene expression><global transcription profile><hematopoietic progenitor><hematopoietic stem progenitor cell><hemopoietic progenitor><hemopoietic stem cell><insight><insulin dependent diabetes><insulin dependent type 1><insulin sensitivity><insulitis><juvenile diabetes><juvenile diabetes mellitus><ketosis prone diabetes><kids><male><meeting><meetings><meiotic><member><missense single nucleotide polymorphism><missense single nucleotide variant><missense variant><molecular sequence database><mouse genome><mouse mutant><mutant><non-obese diabetic (NOD) mice><noncoding><nonobese diabetic (NOD) mice><novel><pediatric><pedigree structure><phospho-proteomics><phosphoproteomics><pilot study><prevent><preventing><protein protein interaction><regulatory T-cells><resolutions><response><screening><screenings><semen cryopreservation><sequence database><sequencing database><sperm cell cryopreservation><sperm cryopreservation><sperm freezing><spermatozoa cryopreservation><study design><success><technology platform><technology system><thymus derived lymphocyte><transcriptome><transcriptomics><type I diabetes><type one diabetes><youngster><β-cell><β-cells><βCell><♀><♂>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jennifer Foulke-Abel

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,122,332

FY 2025

Project Title

Pathogenesis of E. coli and Shigella infections in human enteroid models

Grant Number:

5P01AI125181-10

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2016

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Pathogenesis of E. coli and Shigella Infections in Human Enteroid Models Overall Description / Summary This first renewal of a funded program Project Grant (PPG) is to continue progress in understanding the pathophysiology and identification of ways to interfere with diarrhea caused by Shigella an...

Research Terms

<3-D><3-Dimensional><3D><Acceleration><Address><Attention><Attenuated Vaccines><Bacillary Dysentery><Biological Response Modifiers><Biomodulators><Blood Neutrophil><Blood Polymorphonuclear Neutrophil><Blood leukocyte><Cell Body><Cell Communication><Cell Function><Cell Interaction><Cell Locomotion><Cell Migration><Cell Movement><Cell Physiology><Cell Process><Cell model><Cell-to-Cell Interaction><Cells><Cellular Function><Cellular Migration><Cellular Motility><Cellular Physiology><Cellular Process><Cellular biology><Cellular model><Childhood><Clinical><Co-culture><Cocultivation><Coculture><Coculture Techniques><Collaborations><Communicable Diseases><Culture Media><Dendritic Cells><Development><Diarrhea><Diarrheagenic E coli><Diarrheagenic E. coli><Diarrheagenic Escherichia coli><Disease><Disorder><Dysfunction><E coli><E-Mail><E. coli><EAEC><EAggEC><ETEC><Electronic Mail><Email><Enteral><Enteric><Enterotoxins><Environment><Epithelium><Escherichia coli><Esteroproteases><Exposure to><Functional disorder><Funding><Gastroenterology><Glycoproteins><Goals><Goblet Cells><History><Human><Human Resources><Immune><Immune Evasion><Immune Mediators><Immune Mediators/Modulators><Immune system><Immunes><Immunology><Infectious Diseases><Infectious Disorder><International><Intestinal><Intestines><Investigators><Laboratories><Leukocytes><Leukocytes Reticuloendothelial System><Live-attenuated Vaccine><M cell><Macrophage><Manpower><Marrow Neutrophil><Marrow leukocyte><Maryland><Measurement><Methodology><Methods><Microbiology><Modeling><Modern Man><Molecular><Mucins><Mucosa><Mucosal Tissue><Mucous Membrane><Mucus Glycoprotein><Mφ><Neutrophilic Granulocyte><Neutrophilic Leukocyte><Organism><P01 Mechanism><P01 Program><Pathogenesis><Peptidases><Peptide Hydrolases><Phagocytes><Phagocytic Cell><Phone><Physiology><Physiopathology><Polymorphonuclear Cell><Polymorphonuclear Leukocytes><Polymorphonuclear Neutrophils><Porosity><Production><Program Project Grant><Program Research Project Grants><Protease Gene><Proteases><Proteinases><Proteolytic Enzymes><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Reagent><Recording of previous events><Research><Research Grants><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Researchers><Role><Scientific Publication><Serine Endopeptidases><Serine Protease><Serine Protein Hydrolases><Serine Proteinases><Shigella><Shigella Dysentery><Shigella Infections><Shigella Vaccines><Subcellular Process><System><T-Cells><T-Lymphocyte><Telephone><Universities><Veiled Cells><Virginia><White Blood Cells><White Cell><Work><amebocyte><anti-microbial peptide><bacteria pathogen><bacterial pathogen><bowel><bowel inflammation><cell biology><cell motility><cytokine><developmental><diarrheal disease><diarrheal illness><e-Visit><eVisit><electronic communication><electronic visit><enteral pathogen><enteric pathogen><enteroaggregative E coli><enteroaggregative E. coli><enteroaggregative Escherichia coli><enteropathogen><enterotoxigenic E coli><enterotoxigenic E. coli><enterotoxigenic E.coli><enterotoxigenic Escherichia coli><experience><growth media><gut inflammation><histories><human model><immune evasive><improved><inflamed bowel><inflamed gut><inflamed intestine><insight><intestinal inflammation><intestinal pathogen><intestine pathogen><intraepithelial><live vaccine><live vaccines><living system><meeting><meetings><model of human><monolayer><neutrophil><novel><pathogen><pathogenic bacteria><pathophysiology><pediatric><personnel><pre-clinical><preclinical><programs><response><scaffold><scaffolding><shear stress><shigellosis><social role><three dimensional><thymus derived lymphocyte><tool><transcytosis><white blood cell><white blood corpuscle>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JAMES B KAPER

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,122,332

FY 2025

Project Title

Pathogenesis of E. coli and Shigella infections in human enteroid models

Grant Number:

5P01AI125181-10

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2016

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Pathogenesis of E. coli and Shigella Infections in Human Enteroid Models Overall Description / Summary This first renewal of a funded program Project Grant (PPG) is to continue progress in understanding the pathophysiology and identification of ways to interfere with diarrhea caused by Shigella an...

Research Terms

<3-D><3-Dimensional><3D><Acceleration><Address><Attention><Attenuated Vaccines><Bacillary Dysentery><Biological Response Modifiers><Biomodulators><Blood Neutrophil><Blood Polymorphonuclear Neutrophil><Blood leukocyte><Cell Body><Cell Communication><Cell Function><Cell Interaction><Cell Locomotion><Cell Migration><Cell Movement><Cell Physiology><Cell Process><Cell model><Cell-to-Cell Interaction><Cells><Cellular Function><Cellular Migration><Cellular Motility><Cellular Physiology><Cellular Process><Cellular biology><Cellular model><Childhood><Clinical><Co-culture><Cocultivation><Coculture><Coculture Techniques><Collaborations><Communicable Diseases><Culture Media><Dendritic Cells><Development><Diarrhea><Diarrheagenic E coli><Diarrheagenic E. coli><Diarrheagenic Escherichia coli><Disease><Disorder><Dysfunction><E coli><E-Mail><E. coli><EAEC><EAggEC><ETEC><Electronic Mail><Email><Enteral><Enteric><Enterotoxins><Environment><Epithelium><Escherichia coli><Esteroproteases><Exposure to><Functional disorder><Funding><Gastroenterology><Glycoproteins><Goals><Goblet Cells><History><Human><Human Resources><Immune><Immune Evasion><Immune Mediators><Immune Mediators/Modulators><Immune system><Immunes><Immunology><Infectious Diseases><Infectious Disorder><International><Intestinal><Intestines><Investigators><Laboratories><Leukocytes><Leukocytes Reticuloendothelial System><Live-attenuated Vaccine><M cell><Macrophage><Manpower><Marrow Neutrophil><Marrow leukocyte><Maryland><Measurement><Methodology><Methods><Microbiology><Modeling><Modern Man><Molecular><Mucins><Mucosa><Mucosal Tissue><Mucous Membrane><Mucus Glycoprotein><Mφ><Neutrophilic Granulocyte><Neutrophilic Leukocyte><Organism><P01 Mechanism><P01 Program><Pathogenesis><Peptidases><Peptide Hydrolases><Phagocytes><Phagocytic Cell><Phone><Physiology><Physiopathology><Polymorphonuclear Cell><Polymorphonuclear Leukocytes><Polymorphonuclear Neutrophils><Porosity><Production><Program Project Grant><Program Research Project Grants><Protease Gene><Proteases><Proteinases><Proteolytic Enzymes><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Reagent><Recording of previous events><Research><Research Grants><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Researchers><Role><Scientific Publication><Serine Endopeptidases><Serine Protease><Serine Protein Hydrolases><Serine Proteinases><Shigella><Shigella Dysentery><Shigella Infections><Shigella Vaccines><Subcellular Process><System><T-Cells><T-Lymphocyte><Telephone><Universities><Veiled Cells><Virginia><White Blood Cells><White Cell><Work><amebocyte><anti-microbial peptide><bacteria pathogen><bacterial pathogen><bowel><bowel inflammation><cell biology><cell motility><cytokine><developmental><diarrheal disease><diarrheal illness><e-Visit><eVisit><electronic communication><electronic visit><enteral pathogen><enteric pathogen><enteroaggregative E coli><enteroaggregative E. coli><enteroaggregative Escherichia coli><enteropathogen><enterotoxigenic E coli><enterotoxigenic E. coli><enterotoxigenic E.coli><enterotoxigenic Escherichia coli><experience><growth media><gut inflammation><histories><human model><immune evasive><improved><inflamed bowel><inflamed gut><inflamed intestine><insight><intestinal inflammation><intestinal pathogen><intestine pathogen><intraepithelial><live vaccine><live vaccines><living system><meeting><meetings><model of human><monolayer><neutrophil><novel><pathogen><pathogenic bacteria><pathophysiology><pediatric><personnel><pre-clinical><preclinical><programs><response><scaffold><scaffolding><shear stress><shigellosis><social role><three dimensional><thymus derived lymphocyte><tool><transcytosis><white blood cell><white blood corpuscle>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

James P. Nataro

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,122,332

FY 2025

Project Title

Pathogenesis of E. coli and Shigella infections in human enteroid models

Grant Number:

5P01AI125181-10

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2016

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Pathogenesis of E. coli and Shigella Infections in Human Enteroid Models Overall Description / Summary This first renewal of a funded program Project Grant (PPG) is to continue progress in understanding the pathophysiology and identification of ways to interfere with diarrhea caused by Shigella an...

Research Terms

<3-D><3-Dimensional><3D><Acceleration><Address><Attention><Attenuated Vaccines><Bacillary Dysentery><Biological Response Modifiers><Biomodulators><Blood Neutrophil><Blood Polymorphonuclear Neutrophil><Blood leukocyte><Cell Body><Cell Communication><Cell Function><Cell Interaction><Cell Locomotion><Cell Migration><Cell Movement><Cell Physiology><Cell Process><Cell model><Cell-to-Cell Interaction><Cells><Cellular Function><Cellular Migration><Cellular Motility><Cellular Physiology><Cellular Process><Cellular biology><Cellular model><Childhood><Clinical><Co-culture><Cocultivation><Coculture><Coculture Techniques><Collaborations><Communicable Diseases><Culture Media><Dendritic Cells><Development><Diarrhea><Diarrheagenic E coli><Diarrheagenic E. coli><Diarrheagenic Escherichia coli><Disease><Disorder><Dysfunction><E coli><E-Mail><E. coli><EAEC><EAggEC><ETEC><Electronic Mail><Email><Enteral><Enteric><Enterotoxins><Environment><Epithelium><Escherichia coli><Esteroproteases><Exposure to><Functional disorder><Funding><Gastroenterology><Glycoproteins><Goals><Goblet Cells><History><Human><Human Resources><Immune><Immune Evasion><Immune Mediators><Immune Mediators/Modulators><Immune system><Immunes><Immunology><Infectious Diseases><Infectious Disorder><International><Intestinal><Intestines><Investigators><Laboratories><Leukocytes><Leukocytes Reticuloendothelial System><Live-attenuated Vaccine><M cell><Macrophage><Manpower><Marrow Neutrophil><Marrow leukocyte><Maryland><Measurement><Methodology><Methods><Microbiology><Modeling><Modern Man><Molecular><Mucins><Mucosa><Mucosal Tissue><Mucous Membrane><Mucus Glycoprotein><Mφ><Neutrophilic Granulocyte><Neutrophilic Leukocyte><Organism><P01 Mechanism><P01 Program><Pathogenesis><Peptidases><Peptide Hydrolases><Phagocytes><Phagocytic Cell><Phone><Physiology><Physiopathology><Polymorphonuclear Cell><Polymorphonuclear Leukocytes><Polymorphonuclear Neutrophils><Porosity><Production><Program Project Grant><Program Research Project Grants><Protease Gene><Proteases><Proteinases><Proteolytic Enzymes><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Reagent><Recording of previous events><Research><Research Grants><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Researchers><Role><Scientific Publication><Serine Endopeptidases><Serine Protease><Serine Protein Hydrolases><Serine Proteinases><Shigella><Shigella Dysentery><Shigella Infections><Shigella Vaccines><Subcellular Process><System><T-Cells><T-Lymphocyte><Telephone><Universities><Veiled Cells><Virginia><White Blood Cells><White Cell><Work><amebocyte><anti-microbial peptide><bacteria pathogen><bacterial pathogen><bowel><bowel inflammation><cell biology><cell motility><cytokine><developmental><diarrheal disease><diarrheal illness><e-Visit><eVisit><electronic communication><electronic visit><enteral pathogen><enteric pathogen><enteroaggregative E coli><enteroaggregative E. coli><enteroaggregative Escherichia coli><enteropathogen><enterotoxigenic E coli><enterotoxigenic E. coli><enterotoxigenic E.coli><enterotoxigenic Escherichia coli><experience><growth media><gut inflammation><histories><human model><immune evasive><improved><inflamed bowel><inflamed gut><inflamed intestine><insight><intestinal inflammation><intestinal pathogen><intestine pathogen><intraepithelial><live vaccine><live vaccines><living system><meeting><meetings><model of human><monolayer><neutrophil><novel><pathogen><pathogenic bacteria><pathophysiology><pediatric><personnel><pre-clinical><preclinical><programs><response><scaffold><scaffolding><shear stress><shigellosis><social role><three dimensional><thymus derived lymphocyte><tool><transcytosis><white blood cell><white blood corpuscle>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

BOGDAN A CZERNIAK

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,108,734

FY 2025

Project Title

Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy.

Grant Number:

1P01CA296429-01A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall Summary This P01 program project is focused on bladder cancer, a common human malignancy with significant morbidity and mortality in the United States and across the world. The goal is to develop new and more effective therapies for both early and advanced disease. This goal will be accompli...

Research Terms

<9-cis-Retinoic Acid Receptor><Acids><Address><Baltimore><Bioinformatics core><Bioinformatics research core><Bioinformatics resource core><Biostatistics Core><Bladder><Bladder Cancer><Bladder Urinary System><Calcium-Binding Proteins><Cancer Induction><Cancers><Clinical><Collaborations><DNA Therapy><Development><Disease><Disease Resistance><Disorder><Down-Regulation><EGF Receptor><EGFR><ERBB Protein><Early Diagnosis><Early treatment><Epidermal Growth Factor Receptor><Epidermal Growth Factor Receptor Kinase><Epidermal Growth Factor Receptor Protein-Tyrosine Kinase><Epidermal Growth Factor-Urogastrone Receptors><Evolution><Gene Expression><Gene Transcription><Gene Transfer Clinical><Genes><Genetic Intervention><Genetic Transcription><Goals><HER1><HUMPPARG><Human><IFN><Immune><Immunes><Individual><Institution><Interferons><Investigation><Investigators><LPA Receptors><Lead><Lysophosphatidic Acid Receptors><MDACC><MEKs><Malignant Bladder Neoplasm><Malignant Cell><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Bladder><Malignant neoplasm of urinary bladder><Maps><Maryland><Mediating><Modern Man><Molecular><Molecular Fingerprinting><Molecular Profiling><Morbidity><Morbidity - disease rate><Mucosa><Mucosal Tissue><Mucous Membrane><NR1C3><New York><Nuclear Receptors><Organ><P01 Mechanism><P01 Program><PPARG><PPARG gene><PPARG1><PPARG2><Pathology><Pattern><Pb element><Phase><Phenotype><Prevention><Preventive><Program Project Grant><Program Research Project Grants><Publications><RNA Expression><RXR><RXR Protein><Receptor Signaling><Research Personnel><Research Program Projects><Researchers><Retinoic Acid Agent><Retinoic Acid Receptor RXR><Retinoic Acid and Derivatives><Retinoid X Receptors><Retinoids><Rice><Role><Sampling><Scientific Publication><Scientist><TGF-alpha Receptor><Therapeutic><Transcription><Transforming Growth Factor alpha Receptor><United States><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Urinary Bladder Cancer><Urinary Bladder Malignant Tumor><Urogastrone Receptor><Urothelium><Work><advanced disease><advanced illness><c-erbB-1><c-erbB-1 Protein><cancer cell><carcinogenesis><developmental><early detection><early therapy><effective therapy><effective treatment><entire genome><erbB-1><erbB-1 Proto-Oncogene Protein><erbBl><full genome><gene repair therapy><gene therapy><gene-based therapy><genetic therapy><genome profiling><genomic profiling><genomic therapy><heavy metal Pb><heavy metal lead><improved><interferon therapy><malignancy><molecular profile><molecular signature><mortality><multidisciplinary><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><patient population><programs><proto-oncogene protein c-erbB-1><resistance to disease><resistance to therapy><resistant disease><resistant to disease><resistant to therapy><response><response to therapy><response to treatment><social role><synergism><therapeutic resistance><therapeutic response><therapy resistant><therapy response><treatment resistance><treatment response><treatment responsiveness><tumor><urinary bladder><whole genome>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

David J. McConkey

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,108,734

FY 2025

Project Title

Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy.

Grant Number:

1P01CA296429-01A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall Summary This P01 program project is focused on bladder cancer, a common human malignancy with significant morbidity and mortality in the United States and across the world. The goal is to develop new and more effective therapies for both early and advanced disease. This goal will be accompli...

Research Terms

<9-cis-Retinoic Acid Receptor><Acids><Address><Baltimore><Bioinformatics core><Bioinformatics research core><Bioinformatics resource core><Biostatistics Core><Bladder><Bladder Cancer><Bladder Urinary System><Calcium-Binding Proteins><Cancer Induction><Cancers><Clinical><Collaborations><DNA Therapy><Development><Disease><Disease Resistance><Disorder><Down-Regulation><EGF Receptor><EGFR><ERBB Protein><Early Diagnosis><Early treatment><Epidermal Growth Factor Receptor><Epidermal Growth Factor Receptor Kinase><Epidermal Growth Factor Receptor Protein-Tyrosine Kinase><Epidermal Growth Factor-Urogastrone Receptors><Evolution><Gene Expression><Gene Transcription><Gene Transfer Clinical><Genes><Genetic Intervention><Genetic Transcription><Goals><HER1><HUMPPARG><Human><IFN><Immune><Immunes><Individual><Institution><Interferons><Investigation><Investigators><LPA Receptors><Lead><Lysophosphatidic Acid Receptors><MDACC><MEKs><Malignant Bladder Neoplasm><Malignant Cell><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Bladder><Malignant neoplasm of urinary bladder><Maps><Maryland><Mediating><Modern Man><Molecular><Molecular Fingerprinting><Molecular Profiling><Morbidity><Morbidity - disease rate><Mucosa><Mucosal Tissue><Mucous Membrane><NR1C3><New York><Nuclear Receptors><Organ><P01 Mechanism><P01 Program><PPARG><PPARG gene><PPARG1><PPARG2><Pathology><Pattern><Pb element><Phase><Phenotype><Prevention><Preventive><Program Project Grant><Program Research Project Grants><Publications><RNA Expression><RXR><RXR Protein><Receptor Signaling><Research Personnel><Research Program Projects><Researchers><Retinoic Acid Agent><Retinoic Acid Receptor RXR><Retinoic Acid and Derivatives><Retinoid X Receptors><Retinoids><Rice><Role><Sampling><Scientific Publication><Scientist><TGF-alpha Receptor><Therapeutic><Transcription><Transforming Growth Factor alpha Receptor><United States><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Urinary Bladder Cancer><Urinary Bladder Malignant Tumor><Urogastrone Receptor><Urothelium><Work><advanced disease><advanced illness><c-erbB-1><c-erbB-1 Protein><cancer cell><carcinogenesis><developmental><early detection><early therapy><effective therapy><effective treatment><entire genome><erbB-1><erbB-1 Proto-Oncogene Protein><erbBl><full genome><gene repair therapy><gene therapy><gene-based therapy><genetic therapy><genome profiling><genomic profiling><genomic therapy><heavy metal Pb><heavy metal lead><improved><interferon therapy><malignancy><molecular profile><molecular signature><mortality><multidisciplinary><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><patient population><programs><proto-oncogene protein c-erbB-1><resistance to disease><resistance to therapy><resistant disease><resistant to disease><resistant to therapy><response><response to therapy><response to treatment><social role><synergism><therapeutic resistance><therapeutic response><therapy resistant><therapy response><treatment resistance><treatment response><treatment responsiveness><tumor><urinary bladder><whole genome>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jianyi Zhang

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,067,432

FY 2025

Project Title

Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury

Grant Number:

5P01HL160476-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2022

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT Mechanisms that govern cardiomyocyte proliferation and remuscularization following ventricular injury Program Overall The overall goal for the treatment of myocardial infarction is to replace the scar tissue caused by ischemic injury with functional cardiac muscle. Since adult mammalian car...

Research Terms

<21+ years old><Acceleration><Acute myocardial infarct><Acute myocardial infarction><Address><Adult><Adult Human><Animals><Applications Grants><Bioinformatics><Biomedical Engineering><Birth><Blood Vessels><Body Tissues><Cardiac><Cardiac Failure Congestive><Cardiac Muscle Cells><Cardiac Myocytes><Cardiac infarction><Cardiocyte><Cardiovascular><Cardiovascular Body System><Cardiovascular Organ System><Cardiovascular system><Cell Body><Cell Communication and Signaling><Cell Cycle><Cell Cycle Arrest><Cell Cycle Control><Cell Cycle Regulation><Cell Division Cycle><Cell Signaling><Cell Therapy><Cells><Chronic><Cicatrix><Clinical Research><Clinical Study><Closure by Ligation><Collaborations><Complement><Complement Proteins><Congestive Heart Failure><Data><Dimensions><EVI16><Ecotropic Viral Integration Site 16><Engraftment><Family suidae><Future><GLI Family Gene><GLI Family Protein><GLI Protein><GLI gene><GLI1><GLI1 Gene><GLI1 Protein><Glioma Associated Oncogene Homolog 1 Protein><Glioma Associated Oncogene Homolog Protein><Glioma-Associated Oncogene Homolog><Glioma-associated oncogene><Goals><Grant Proposals><Heart><Heart Decompensation><Heart Injuries><Heart Muscle Cells><Heart Vascular><Heart failure><Heart myocyte><Hedgehog (Hh) signal transduction pathway><Human><Hypoxia><Hypoxic><Infarction><Injury><Intermediary Metabolism><Intracellular Communication and Signaling><Investigators><L-Proline><LV remodeling><Laboratories><Left Ventricles><Left Ventricular Remodeling><Left ventricular structure><Ligation><Mammalia><Mammalian Cell><Mammals><Mediating><Metabolic Processes><Metabolism><Mice><Mice Mammals><Mitochondria><Modern Man><Molecular><Murine><Mus><Muscle><Muscle Cells><Muscle Tissue><Myocardial><Myocardial Infarct><Myocardial Infarction><Myocardium><Myocytes><Neonatal><Non-Polyadenylated RNA><O element><O2 element><Oxygen><Oxygen Deficiency><P01 Mechanism><P01 Program><Parturition><Pathway interactions><Patients><Pigs><Production><Program Project Grant><Program Research Project Grants><Proliferating><Proline><Public Health><RNA><RNA Gene Products><Records><Regulation><Research><Research Personnel><Research Program Projects><Researchers><Ribonucleic Acid><Role><SHH><SHH gene><SOX4><SOX4 gene><SRY-Box 4><SRY-Related HMG-Box Gene 4><Scars><Science><Signal Pathway><Signal Transduction><Signal Transduction Systems><Signaling><Sonic Hedgehog><Suidae><Swine><Testing><Time><Tissues><Transplantation><Treatment Protocols><Treatment Regimen><Treatment Schedule><Ventricular><Viral Vector><Work><adulthood><angiogenesis><bio-engineered><bio-engineers><bioengineering><biological engineering><biological signal transduction><cardiac failure><cardiac function><cardiac infarct><cardiac injury><cardiac muscle><cardiac regeneration><cardiac repair><cardiomyocyte><cell based intervention><cell mediated intervention><cell mediated therapies><cell-based therapeutic><cell-based therapy><cellular therapeutic><cellular therapy><chronic heart failure><circulatory system><clinical relevance><clinically relevant><complementation><coronary attack><coronary infarct><coronary infarction><experiment><experimental research><experimental study><experiments><function of the heart><gain of function><genetic approach><genetic strategy><glioma associated oncogene 1><glioma associated oncogene family zinc finger 1><heart attack><heart function><heart infarct><heart infarction><heart muscle><heart regeneration><heart repair><hedgehog signaling><hedgehog signaling pathway><hh signaling pathway><hiPSC><human iPS><human iPSC><human induced pluripotent cell><human induced pluripotent stem cells><human inducible pluripotent stem cells><human inducible stem cells><in vivo><induced human pluripotent stem cells><infarct><injured><injuries><injury and repair><ischemia injury><ischemic injury><left ventricle remodeling><loss of function><member><mitochondrial><muscular><neovascularization><overexpress><overexpression><oxidative DNA damage><pathway><pig model><piglet model><porcine><porcine model><postnatal><programs><repair><repaired><smoothened signaling pathway><social role><suid><swine model><synergism><transplant><vascular>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LAURA D ATTARDI

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,023,000

FY 2025

Project Title

Pancreatic Cancer Development: Genetic and Immune Regulation

Grant Number:

5P01CA244114-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2021

End Date:

7/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Abstract (Overall): Pancreatic Ductal Adenocarcinoma (PDAC) is a deadly disease whose mechanisms of development remain incompletely understood. Evidence suggests that pancreatic cancers may arise from acinar cells undergoing a process called acinar to ductal metaplasia (ADM) or from ductal cells to ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Seung K Kim

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$2,023,000

FY 2025

Project Title

Pancreatic Cancer Development: Genetic and Immune Regulation

Grant Number:

5P01CA244114-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2021

End Date:

7/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Abstract (Overall): Pancreatic Ductal Adenocarcinoma (PDAC) is a deadly disease whose mechanisms of development remain incompletely understood. Evidence suggests that pancreatic cancers may arise from acinar cells undergoing a process called acinar to ductal metaplasia (ADM) or from ductal cells to ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lee Ratner

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,971,061

FY 2025

Project Title

Retrovirus Models of Cancer

Grant Number:

2P01CA100730-21

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/21/2003

End Date:

8/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY This competitive renewal application (P01CA100730) seeks funds to continue our highly integrated studies of retrovirus models to elucidate cellular mechanisms of lymphocyte transformation and associated lymphoproliferative disease. Infection of CD4+ T-cells with the human ret...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jerzy W Kupiec-Weglinski

UNIVERSITY OF CALIFORNIA LOS ANGELES, LOS ANGELES, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,939,440

FY 2025

Project Title

Innate-Adaptive Immunoregulation in Liver Transplant Ischemia/Reperfusion Injury

Grant Number:

5P01AI120944-09

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2017

End Date:

7/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – ABSTRACT Orthotopic liver transplantation (OLT) is the accepted treatment in patients with end-stage liver failure and those with tumors of hepatic origin. However, the organ shortage has prompted the use of extended criteria donors, which are particularly susceptible to ischemia-reperfusi...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

SUZANNE J. BAKER

ST. JUDE CHILDREN'S RESEARCH HOSPITAL, MEMPHIS, TN

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,864,889

FY 2025

Project Title

NORMAL & NEOPLASTIC GROWTH IN THE BRAIN

Grant Number:

5P01CA096832-20

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/1/2003

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall Program Summary Brain tumors are the most common pediatric solid malignancies, and the leading cause of cancer-related death in children. The long-term goal of this Program Project is to improve understanding and treatment of diffuse intrinsic pontine glioma (DIPG) and medulloblastoma (MB), ...

Research Terms

<0-11 years old><1-Phosphatidylinositol 3-Kinase><ACTRI><ACVR1><ACVR1 gene><ACVRLK2><ALK2><Activin A Receptor, Type II-Like Kinase 2 Gene><Activin Receptor-Like Kinase 2 Gene><Address><Antibody-drug conjugates><Automobile Driving><Basic Research><Basic Science><Biologic Models><Biological Models><Biometrics><Biometry><Biostatistics><Blood - brain barrier anatomy><Blood-Brain Barrier><Brain><Brain Neoplasia><Brain Neoplasms><Brain Nervous System><Brain Tumors><Cancer Cause><Cancer Etiology><Cancers><Cell Body><Cell Lineage><Cell membrane><Cells><Child><Child Youth><Childhood><Childhood Brain Neoplasm><Childhood Brain Tumor><Childhood Cancers><Childhood Glioma><Childhood Neoplasm><Childhood Tumor><Children (0-21)><Clinical Trials><Collaborations><Competence><Complex><Cytoplasmic Membrane><DIPG><DNA mutation><Data><Development><Developmental Process><Diffuse intrinsic pontine glioma><Disease><Disorder><Drug Combinations><Drugs><Dysfunction><EC 2.1.1><Encephalon><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Experimental Designs><FDA approved><FK506 Binding Protein 12-Rapamycin Associated Protein 1><FKBP12 Rapamycin Complex Associated Protein 1><FLJ21080><FRAP1><FRAP1 gene><FRAP2><Functional dependence><Functional disorder><Funding><Generalized Growth><Genes><Genetic Change><Genetic defect><Genetic mutation><Germ Lines><Goals><Growth><H3 K27M mutant><H3 K27M mutation><H3K27M mutant><H3K27M mutation><Hemato-Encephalic Barrier><Heterogeneity><Hind Brain><Immune mediated therapy><Immunologically Directed Therapy><Immunotherapy><Investigators><Maintenance><Malignant><Malignant - descriptor><Malignant Childhood Neoplasm><Malignant Childhood Tumor><Malignant Neoplasms><Malignant Pediatric Neoplasm><Malignant Pediatric Tumor><Malignant Tumor><Malignant childhood cancer><Maps><Mechanistic Target of Rapamycin><Medication><Medulloblastoma><Methyltransferase><Model System><Molecular><Morbidity><Morbidity - disease rate><Mutate><Mutation><NGS data><Neoplasms><Oncogenesis><PDX model><PI-3 Kinase><PI3-Kinase><PI3CG><PI3KGamma><PI3k><PIK3><PIK3CG><PIK3CG gene><Paper><Pathogenesis><Pathway interactions><Patient derived xenograft><Pediatric Glioma><Pediatric Neoplasm><Pediatric Tumor><Pediatric high-grade glioma><Pharmaceutical Preparations><Phenotype><Phosphatidylinositol 3-Kinase><Phosphatidylinositol-3-OH Kinase><Phosphoinositide 3-Hydroxykinase><Physiopathology><Plasma Membrane><Play><Preclinical Testing><Predisposition><Predisposition gene><Productivity><Proteome><PtdIns 3-Kinase><Publishing><RAFT1><Regulation><Research Personnel><Research Resources><Researchers><Resources><Rhombencephalon><Role><SHH><SHH gene><SKR1><SMYD3><SMYD3 gene><Seminal><Series><Solid><Sonic Hedgehog><Source><Study models><Susceptibility><Susceptibility Gene><Techniques><Testing><Therapeutic><Therapeutic Intervention><Tissue Growth><Transcriptional Control><Transcriptional Regulation><Translating><Translational Regulation><Translations><Tumor Subtype><Type I Gene Activin A Receptor><Type I Phosphatidylinositol Kinase><Type III Phosphoinositide 3-Kinase><Variant><Variation><Work><ZMYND1><ZNFN3A1><antibody assay><antibody based test><antibody test><biological adaptation to stress><bloodbrain barrier><cancer death in children><cancer in a child><cancer in children><cancer mortality in children><cancer predisposition><cancer related death in children><child with cancer><childhood cancer death><childhood cancer mortality><childhood malignancy><data integration><developmental><driving><drug detection><drug testing><drug/agent><epigenetically><epigenome><experience><experiment><experimental research><experimental study><experiments><genome mutation><global gene expression><global transcription profile><hindbrain><human disease><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><improved><inhibitor><insight><intervention therapy><kids><loss of function><mTOR><mTOR inhibition><malignancy><mammalian target of rapamycin><member><methylase><mortality><neoplasia><neoplasm/cancer><neoplastic growth><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation sequence data><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oligodendrocyte lineage><ontogeny><pathophysiology><pathway><patient derived xenograft model><pediatric><pediatric brain neoplasm><pediatric brain tumor><pediatric cancer><pediatric malignancy><plasmalemma><pre-clinical testing><predisposing gene><programs><reactioncrisis><response><response to therapy><response to treatment><social role><spatial and temporal><spatial temporal><spatiotemporal><stress response><stressreaction><success><susceptibility allele><susceptibility locus><susceptibility variant><therapeutic evaluation><therapeutic response><therapeutic target><therapeutic testing><therapy response><transcriptome><translation><translational impact><transmethylase><treatment response><treatment responsiveness><tumor><tumor initiation><tumorigenesis><tumors in children><tumors in the brain><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kari C. Nadeau

HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH, BOSTON, MA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,819,783

FY 2025

Project Title

Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)

Grant Number:

5P01HL152953-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2021

End Date:

7/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT: OVERALL COMPONENT Exposure to air pollution from automobile exhaust and forest fires is a significant, rapidly growing global public health burden that contributes to cardiopulmonary pathogenesis. Produced by epithelial and inflammatory cells, interleukin-1 beta (IL-1β) is key to this infl...

Research Terms

<0-11 years old><Acute><Adolescent><Adolescent Youth><Affect><Age><Air Pollution><Asthma><Automobile Exhaust><Beta Proprotein Interleukin 1><Biological><Biological Markers><Biotech><Biotechnology><Blood><Blood Pressure><Blood Reticuloendothelial System><Blood Vessels><Body Tissues><Bronchial Asthma><Cardiac><Cardiac Diseases><Cardiac Disorders><Cardiac health><Cardiopulmonary><Cardiovascular Diseases><Cell Body><Cells><Child><Child Youth><Children (0-21)><Chronic><Clinical><Complex><Cor pulmonale><Data><Dependence><Development><Diesel Exhaust><Disease><Disorder><Drugs><Ensure><Environmental Exposure><Environmental Pollution><Epithelium><Equipment><Ethnic Origin><Ethnicity><Exposure to><Future><Gender><Goals><Health><Heart><Heart Diseases><Heart health><Human><IL-1 beta><IL-1 β><IL-1-b><IL-1β><IL1-Beta><IL1-β><IL1B Protein><IL1F2><IL1β><Immune><Immune Diseases><Immune Disorders><Immune Dysfunction><Immune System Diseases><Immune System Disorder><Immune System Dysfunction><Immune System and Related Disorders><Immunes><Immunologic Diseases><Immunological Diseases><Immunological Dysfunction><Immunological System Dysfunction><Individual><Inflammasome><Inflammation><Inflammatory><Inflammatory Response><Interleukin 1beta><Interleukin Activation><Interleukin-1 beta><Interleukin-1β><Investigation><Investigators><Knowledge><Ligands><Link><Lung><Lung Diseases><Lung Respiratory System><Medication><Mentors><Modeling><Modern Man><Molecular><Monitor><Outcome><P01 Mechanism><P01 Program><PM2.5><Particulate Matter><Pathogenesis><Pathology><Pathway interactions><Pharmaceutical Preparations><Policies><Pollution><Preinterleukin 1 Beta><Program Project Grant><Program Research Project Grants><Proteomics><Public Health><Pulmonary Diseases><Pulmonary Disorder><Pulmonary Heart Disease><Pulmonary Heart Disorder><Regulation><Research Personnel><Research Program Projects><Research Resources><Researchers><Resources><Sampling><Shapes><Sum><System><Systems Biology><Testing><Tissues><Toxic effect><Toxicities><Training><Wildfire><ages><air treatment><antagonism><antagonist><auto exhaust><bio-markers><biologic><biologic marker><biomarker><blood pressure elevation><cardiopulmonary disease><cardiopulmonary disorder><cardiopulmonary system><cardiovascular disorder><clinical applicability><clinical application><clinical investigation><cohort><data sharing><developmental><disease of the lung><disease risk><disorder of the lung><disorder risk><drug/agent><effective therapy><effective treatment><elevated blood pressure><environmental contamination><experiment><experimental research><experimental study><experiments><fine particles><fine particulate matter><forest fires><global health><heart cell><heart disorder><iPS><iPSC><iPSCs><immunopathology><improved><increase in blood pressure><increased blood pressure><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><inflammation marker><inflammatory marker><innovate><innovation><innovative><juvenile><juvenile human><kids><lung disorder><lung health><multidisciplinary><novel><pathway><personalization of treatment><personalized medicine><personalized therapy><personalized treatment><pollutant><prevent><preventing><programs><pulmonary><pulmonary health><response><success><synergism><vascular><vehicular exhaust><wild fire><wildland fire><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Xu Cao

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,789,175

FY 2025

Project Title

Skeleton and Joint Degeneration with Aging

Grant Number:

5P01AG066603-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

1/15/2021

End Date:

12/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT Decreased mobility significantly increases the risk of many chronic diseases leading to an acceleration of the normal aging process. Skeletal degeneration, particularly of the spine and joints, are among the most prevalent diseases leading to a decline in mobility and to fra...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

HIDEKAZU TSUKAMOTO

UNIVERSITY OF SOUTHERN CALIFORNIA, Los Angeles, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,666,183

FY 2025

Project Title

Southern California Research Center for ALPD and Cirrhosis

Grant Number:

5P50AA011999-27

Activity Code:

P50

Mechanism:

Research Centers

Agency:

NIH

Start Date:

12/31/1998

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL - SUMMARY Alcohol-associated liver and pancreatic diseases (ALPD) and cirrhosis constitute leading metabolic diseases caused by alcohol use disorder around the globe. The Southern California Research Center for ALPD and Cirrhosis unifies 60 investigators from six academic institutions in Sou...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

E. Antonio Chiocca

BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,654,855

FY 2025

Project Title

Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas

Grant Number:

5P01CA163205-13

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/7/2013

End Date:

8/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY Glioblastoma (GBM) and recurrent GBM (rGBM) is arguably one of the most fatal of cancers: it remains impervious to treatment with the current standard of care (SOC) therapies and numerous clinical trials (including immunotherapy) have failed to meet end points for FDA approva...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JAMES R FUCHS

OHIO STATE UNIVERSITY, Columbus, OH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,640,056

FY 2025

Project Title

Discovery of Anticancer Agents of Diverse Natural Origin

Grant Number:

2P01CA125066-16

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2007

End Date:

8/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY In this Program Project Grant (PPG) renewal application, the applicant group is representative of three primary institutions, the Ohio State University (OSU), the University of Illinois at Chicago (UIC), and the University of North Carolina at Greensboro (UNCG). The participa...

Research Terms

<Anti-Cancer Agents><Anti-cancer natural products><Anti-tumor Natural Products><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Assay><Binding Proteins><Bioassay><Biological><Biological Assay><Biological Testing><Biometrics><Biometry><Biostatistics><Blue-Green Algae><Blue-Green Bacteria><Cancer Drug><Cancer Treatment><Cancer cell line><Cancers><Cell Body><Cells><Central Neurofibromatosis><Cessation of life><Chemical Fractionation><Chemicals><Chemistry><Chemoresistance><Chicago><Children's Hospital><Collection><Communication><Comprehensive Cancer Center><Consultations><Country><Coupled><Cyanobacterium><Cyanophyceae><Cyanophyta><Death><Decision Making><Developing Countries><Developing Nations><Development><Disease><Disorder><Doctor of Philosophy><Drug Industry><Drug Kinetics><Evaluation><FRACN><Fiber><Fibroblasts><Filamentous Fungi><Formulation><Fractionation><Fractionation Radiotherapy><Funding><General Taxonomy><Genes><Genomics><Goals><Heterograft><Heterologous Transplantation><Higher Plants><Human Resources><Illinois><In Vitro><Institution><Intermediary Metabolism><Investigators><Lead><Less-Developed Countries><Less-Developed Nations><Libraries><Lichen - organism><Lichens><Ligand Binding Protein><Ligand Binding Protein Gene><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Manpower><Marketing><Medicinal Chemistry><Metabolic Processes><Metabolism><Methods><Modeling><Modification><Molds><NCI Organization><National Cancer Institute><Natural Compound><Natural Products><Natural anti-cancer agents><Natural antineoplastic agents><Natural chemotherapeutic agents><Natural chemotherapeutic products><Natural product anti-neoplastics><Neoplastic Disease Chemotherapeutic Agents><Neurofibromatosis 2><Neurofibromatosis II><Neurofibromatosis Type 2s><North Carolina><Ohio><Organism><P01 Mechanism><P01 Program><Participant><Pb element><Pediatric Hospitals><Ph.D.><PhD><Pharmaceutic Chemistry><Pharmaceutic Industry><Pharmaceutical Chemistry><Pharmaceutical Industry><Pharmacokinetics><Plants><Play><Principal Investigator><Process><Program Project Grant><Program Research Project Grants><Protein Binding><Proteomics><Provider><Regimen><Research><Research Personnel><Research Program Projects><Research Resources><Researchers><Resistance><Resources><Role><Sampling><Solubility><Structure><Taxonomy><Testing><Therapeutic><Third-World Countries><Third-World Nations><Toxicology><Tracheophyta><Tumor-Specific Treatment Agents><Type 2 Neurofibromatosis><Type II Neurofibromatosis><Under-Developed Countries><Under-Developed Nations><United States><Universities><Vascular Plant><Woman><Work><Xenograft><Xenograft procedure><Xenotransplantation><acoustic neurofibromatosis><analog><anti-cancer drug><anti-cancer therapy><anti-tumor drug><anticancer activity><biologic><bound protein><cancer therapy><cancer-directed therapy><chemoresistant><chemotherapeutic agent><chemotherapeutic compounds><chemotherapeutic drugs><chemotherapeutic medications><chemotherapy resistance><chemotherapy resistant><computerized><consultation><data management><depository><developing country><developing nation><developmental><drug development><drug discovery><experience><fungus><heavy metal Pb><heavy metal lead><in vitro testing><in vivo><in vivo Bioassay><literature survey><living system><malignancy><meeting><meetings><men><naturally occurring compound><naturally occurring product><neoplasm/cancer><new anti-cancer agent><new anticancer agent><new anticancer drug><new antineoplastic><new cancer drug><novel><novel anti-cancer agent><novel anti-cancer drug><novel anticancer agent><novel anticancer drug><novel antineoplastic><novel cancer drug><personnel><programs><repository><resistant><scale up><social role><tumor><tumor growth><xeno-transplant><xeno-transplantation>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alan Douglas Kinghorn

OHIO STATE UNIVERSITY, Columbus, OH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,640,056

FY 2025

Project Title

Discovery of Anticancer Agents of Diverse Natural Origin

Grant Number:

2P01CA125066-16

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2007

End Date:

8/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY In this Program Project Grant (PPG) renewal application, the applicant group is representative of three primary institutions, the Ohio State University (OSU), the University of Illinois at Chicago (UIC), and the University of North Carolina at Greensboro (UNCG). The participa...

Research Terms

<Anti-Cancer Agents><Anti-cancer natural products><Anti-tumor Natural Products><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Assay><Binding Proteins><Bioassay><Biological><Biological Assay><Biological Testing><Biometrics><Biometry><Biostatistics><Blue-Green Algae><Blue-Green Bacteria><Cancer Drug><Cancer Treatment><Cancer cell line><Cancers><Cell Body><Cells><Central Neurofibromatosis><Cessation of life><Chemical Fractionation><Chemicals><Chemistry><Chemoresistance><Chicago><Children's Hospital><Collection><Communication><Comprehensive Cancer Center><Consultations><Country><Coupled><Cyanobacterium><Cyanophyceae><Cyanophyta><Death><Decision Making><Developing Countries><Developing Nations><Development><Disease><Disorder><Doctor of Philosophy><Drug Industry><Drug Kinetics><Evaluation><FRACN><Fiber><Fibroblasts><Filamentous Fungi><Formulation><Fractionation><Fractionation Radiotherapy><Funding><General Taxonomy><Genes><Genomics><Goals><Heterograft><Heterologous Transplantation><Higher Plants><Human Resources><Illinois><In Vitro><Institution><Intermediary Metabolism><Investigators><Lead><Less-Developed Countries><Less-Developed Nations><Libraries><Lichen - organism><Lichens><Ligand Binding Protein><Ligand Binding Protein Gene><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Manpower><Marketing><Medicinal Chemistry><Metabolic Processes><Metabolism><Methods><Modeling><Modification><Molds><NCI Organization><National Cancer Institute><Natural Compound><Natural Products><Natural anti-cancer agents><Natural antineoplastic agents><Natural chemotherapeutic agents><Natural chemotherapeutic products><Natural product anti-neoplastics><Neoplastic Disease Chemotherapeutic Agents><Neurofibromatosis 2><Neurofibromatosis II><Neurofibromatosis Type 2s><North Carolina><Ohio><Organism><P01 Mechanism><P01 Program><Participant><Pb element><Pediatric Hospitals><Ph.D.><PhD><Pharmaceutic Chemistry><Pharmaceutic Industry><Pharmaceutical Chemistry><Pharmaceutical Industry><Pharmacokinetics><Plants><Play><Principal Investigator><Process><Program Project Grant><Program Research Project Grants><Protein Binding><Proteomics><Provider><Regimen><Research><Research Personnel><Research Program Projects><Research Resources><Researchers><Resistance><Resources><Role><Sampling><Solubility><Structure><Taxonomy><Testing><Therapeutic><Third-World Countries><Third-World Nations><Toxicology><Tracheophyta><Tumor-Specific Treatment Agents><Type 2 Neurofibromatosis><Type II Neurofibromatosis><Under-Developed Countries><Under-Developed Nations><United States><Universities><Vascular Plant><Woman><Work><Xenograft><Xenograft procedure><Xenotransplantation><acoustic neurofibromatosis><analog><anti-cancer drug><anti-cancer therapy><anti-tumor drug><anticancer activity><biologic><bound protein><cancer therapy><cancer-directed therapy><chemoresistant><chemotherapeutic agent><chemotherapeutic compounds><chemotherapeutic drugs><chemotherapeutic medications><chemotherapy resistance><chemotherapy resistant><computerized><consultation><data management><depository><developing country><developing nation><developmental><drug development><drug discovery><experience><fungus><heavy metal Pb><heavy metal lead><in vitro testing><in vivo><in vivo Bioassay><literature survey><living system><malignancy><meeting><meetings><men><naturally occurring compound><naturally occurring product><neoplasm/cancer><new anti-cancer agent><new anticancer agent><new anticancer drug><new antineoplastic><new cancer drug><novel><novel anti-cancer agent><novel anti-cancer drug><novel anticancer agent><novel anticancer drug><novel antineoplastic><novel cancer drug><personnel><programs><repository><resistant><scale up><social role><tumor><tumor growth><xeno-transplant><xeno-transplantation>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

NICHOLAS H. OBERLIES

OHIO STATE UNIVERSITY, Columbus, OH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,640,056

FY 2025

Project Title

Discovery of Anticancer Agents of Diverse Natural Origin

Grant Number:

2P01CA125066-16

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2007

End Date:

8/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY In this Program Project Grant (PPG) renewal application, the applicant group is representative of three primary institutions, the Ohio State University (OSU), the University of Illinois at Chicago (UIC), and the University of North Carolina at Greensboro (UNCG). The participa...

Research Terms

<Anti-Cancer Agents><Anti-cancer natural products><Anti-tumor Natural Products><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Assay><Binding Proteins><Bioassay><Biological><Biological Assay><Biological Testing><Biometrics><Biometry><Biostatistics><Blue-Green Algae><Blue-Green Bacteria><Cancer Drug><Cancer Treatment><Cancer cell line><Cancers><Cell Body><Cells><Central Neurofibromatosis><Cessation of life><Chemical Fractionation><Chemicals><Chemistry><Chemoresistance><Chicago><Children's Hospital><Collection><Communication><Comprehensive Cancer Center><Consultations><Country><Coupled><Cyanobacterium><Cyanophyceae><Cyanophyta><Death><Decision Making><Developing Countries><Developing Nations><Development><Disease><Disorder><Doctor of Philosophy><Drug Industry><Drug Kinetics><Evaluation><FRACN><Fiber><Fibroblasts><Filamentous Fungi><Formulation><Fractionation><Fractionation Radiotherapy><Funding><General Taxonomy><Genes><Genomics><Goals><Heterograft><Heterologous Transplantation><Higher Plants><Human Resources><Illinois><In Vitro><Institution><Intermediary Metabolism><Investigators><Lead><Less-Developed Countries><Less-Developed Nations><Libraries><Lichen - organism><Lichens><Ligand Binding Protein><Ligand Binding Protein Gene><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Manpower><Marketing><Medicinal Chemistry><Metabolic Processes><Metabolism><Methods><Modeling><Modification><Molds><NCI Organization><National Cancer Institute><Natural Compound><Natural Products><Natural anti-cancer agents><Natural antineoplastic agents><Natural chemotherapeutic agents><Natural chemotherapeutic products><Natural product anti-neoplastics><Neoplastic Disease Chemotherapeutic Agents><Neurofibromatosis 2><Neurofibromatosis II><Neurofibromatosis Type 2s><North Carolina><Ohio><Organism><P01 Mechanism><P01 Program><Participant><Pb element><Pediatric Hospitals><Ph.D.><PhD><Pharmaceutic Chemistry><Pharmaceutic Industry><Pharmaceutical Chemistry><Pharmaceutical Industry><Pharmacokinetics><Plants><Play><Principal Investigator><Process><Program Project Grant><Program Research Project Grants><Protein Binding><Proteomics><Provider><Regimen><Research><Research Personnel><Research Program Projects><Research Resources><Researchers><Resistance><Resources><Role><Sampling><Solubility><Structure><Taxonomy><Testing><Therapeutic><Third-World Countries><Third-World Nations><Toxicology><Tracheophyta><Tumor-Specific Treatment Agents><Type 2 Neurofibromatosis><Type II Neurofibromatosis><Under-Developed Countries><Under-Developed Nations><United States><Universities><Vascular Plant><Woman><Work><Xenograft><Xenograft procedure><Xenotransplantation><acoustic neurofibromatosis><analog><anti-cancer drug><anti-cancer therapy><anti-tumor drug><anticancer activity><biologic><bound protein><cancer therapy><cancer-directed therapy><chemoresistant><chemotherapeutic agent><chemotherapeutic compounds><chemotherapeutic drugs><chemotherapeutic medications><chemotherapy resistance><chemotherapy resistant><computerized><consultation><data management><depository><developing country><developing nation><developmental><drug development><drug discovery><experience><fungus><heavy metal Pb><heavy metal lead><in vitro testing><in vivo><in vivo Bioassay><literature survey><living system><malignancy><meeting><meetings><men><naturally occurring compound><naturally occurring product><neoplasm/cancer><new anti-cancer agent><new anticancer agent><new anticancer drug><new antineoplastic><new cancer drug><novel><novel anti-cancer agent><novel anti-cancer drug><novel anticancer agent><novel anticancer drug><novel antineoplastic><novel cancer drug><personnel><programs><repository><resistant><scale up><social role><tumor><tumor growth><xeno-transplant><xeno-transplantation>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Todd Michael Brusko

UNIVERSITY OF FLORIDA, GAINESVILLE, FL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,630,863

FY 2025

Project Title

Immune Function and the Progression to Type 1 Diabetes

Grant Number:

5P01AI042288-27

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/30/1997

End Date:

5/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Type 1 diabetes (T1D) is a disorder that arises following the autoimmune destruction of insulin producing pancreatic β-cells. Previous studies, including nearly 120 peer reviewed-articles supported by this P01 over the current grant cycle, have demonstrated that individuals with or at increased-risk...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MELANIE E. BENNETT

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,560,928

FY 2025

Project Title

Harnessing a Two-State FEP LHS to Optimize Engagement and Prevent Disengagement in CSC

Grant Number:

5P01MH139228-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2024

End Date:

7/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall Component - Abstract This Program Project Grant entitled Harnessing a Two-State FEP LHS to Optimize Engagement and Prevent Disengagement in CSC will leverage Connection Learning Healthcare System (CLHS) - a two-state learning healthcare system and Early Psychosis Intervention Network (EPINET...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MONICA E CALKINS

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,560,928

FY 2025

Project Title

Harnessing a Two-State FEP LHS to Optimize Engagement and Prevent Disengagement in CSC

Grant Number:

5P01MH139228-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2024

End Date:

7/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall Component - Abstract This Program Project Grant entitled Harnessing a Two-State FEP LHS to Optimize Engagement and Prevent Disengagement in CSC will leverage Connection Learning Healthcare System (CLHS) - a two-state learning healthcare system and Early Psychosis Intervention Network (EPINET...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Steven A Yukl

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,550,033

FY 2025

Project Title

The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound

Grant Number:

5P01AI169606-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2022

End Date:

4/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Abstract: While the latent and intact HIV reservoirs pose theoretical barriers to cure, it is also critical to understand those cells that are reactivated and/or express HIV in vivo, which contribute to immune activation and may have more potential to initiate rebound after ART interruption. However...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Grace C. John-Stewart

UNIVERSITY OF WASHINGTON, SEATTLE, WA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,508,882

FY 2025

Project Title

Drug, microbiome, and immune determinants of birth and neurodevelopmental outcomes in children with exposure to HIV infection

Grant Number:

4P01HD107669-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/4/2025

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Children exposed to HIV in utero but who are not infected (HEU) have been shown to have compromised growth, neurodevelopmental delays, and increased morbidity and mortality. It is critical to define mechanisms for these differences. This P01 proposes to conduct 3 Projects to examine the influence of...

Research Terms

<0-11 years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Anti-Retroviral Agents><Area><Biologic Factor><Biological><Biological Factors><Biological Specimen Banks><Biological Substance Banks><Biometrics><Biometry><Biostatistics><Birth><Brain><Brain Nervous System><Breast Milk><Breastmilk><CMV><Child><Child Youth><Children (0-21)><Communication><Cytomegalovirus><Data><Detection><Development><Discipline of obstetrics><Drugs><Encephalon><Enrollment><Ensure><Epidemiology><Evaluation><Exposure to><Funding><GI microbiome><Generalized Growth><Grant><Growth><Gynecology><HCMV><HIV><HIV Infections><HIV Seroprevalence><HTLV-III Infections><HTLV-III-LAV Infections><Hair><History><Human Immunodeficiency Viruses><Human Milk><Human Mother's Milk><Human T-Lymphotropic Virus Type III Infections><Immune><Immune Cell Activation><Immunes><Immunology><Infant><Intervention><Investigators><Kenya><LAV-HTLV-III><Leadership><Life><Lymphadenopathy-Associated Virus><Mammary Gland Milk><Measurement><Medication><Mentors><Morbidity><Morbidity - disease rate><Mother's Milk><Mother-to-child HIV transmission><Neural Development><Neurocognition><Neurocognitive><Neuroimmune><Obstetrics><Outcome><P01 Mechanism><P01 Program><Parturition><Pediatrics><Perinatal><Peripartum><Pharmaceutical Preparations><Population><Prevention><Program Project Grant><Program Research Project Grants><Recording of previous events><Research><Research Design><Research Personnel><Research Program Projects><Researchers><Role><Salivary Gland Viruses><Scientist><Site><Standardization><Structure><Study Type><Tissue Growth><Training><Treatment Protocols><Treatment Regimen><Treatment Schedule><Viral Burden><Viral Load><Viral Load result><Virus-HIV><anti-retroviral><antiretroviral therapy><antiretroviral treatment><biologic><biological specimen repository><biosample repository><biospecimen bank><biospecimen repository><cohort><cytomegalovirus group><design><designing><developmental><digestive tract microbiome><drug/agent><enroll><enteric microbiome><epidemiologic><epidemiological><exposed in utero><fecal microbiome><fetal exposure><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><histories><human milk oligosaccharides><immune activation><in utero><in utero exposure><insight><interest><intestinal biome><intestinal microbiome><intra-uterine environmental exposure><intrauterine environmental exposure><kids><maternal milk><meeting><meetings><microbiome><mortality><neurodevelopment><next generation><novel><ontogeny><prenatal exposure><prenatally exposed><programs><social factors><social role><specimen bank><specimen repository><stool microbiome><stool-associated microbiome><study design><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John Kinuthia

UNIVERSITY OF WASHINGTON, SEATTLE, WA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,508,882

FY 2025

Project Title

Drug, microbiome, and immune determinants of birth and neurodevelopmental outcomes in children with exposure to HIV infection

Grant Number:

4P01HD107669-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/4/2025

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Children exposed to HIV in utero but who are not infected (HEU) have been shown to have compromised growth, neurodevelopmental delays, and increased morbidity and mortality. It is critical to define mechanisms for these differences. This P01 proposes to conduct 3 Projects to examine the influence of...

Research Terms

<0-11 years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Anti-Retroviral Agents><Area><Biologic Factor><Biological><Biological Factors><Biological Specimen Banks><Biological Substance Banks><Biometrics><Biometry><Biostatistics><Birth><Brain><Brain Nervous System><Breast Milk><Breastmilk><CMV><Child><Child Youth><Children (0-21)><Communication><Cytomegalovirus><Data><Detection><Development><Discipline of obstetrics><Drugs><Encephalon><Enrollment><Ensure><Epidemiology><Evaluation><Exposure to><Funding><GI microbiome><Generalized Growth><Grant><Growth><Gynecology><HCMV><HIV><HIV Infections><HIV Seroprevalence><HTLV-III Infections><HTLV-III-LAV Infections><Hair><History><Human Immunodeficiency Viruses><Human Milk><Human Mother's Milk><Human T-Lymphotropic Virus Type III Infections><Immune><Immune Cell Activation><Immunes><Immunology><Infant><Intervention><Investigators><Kenya><LAV-HTLV-III><Leadership><Life><Lymphadenopathy-Associated Virus><Mammary Gland Milk><Measurement><Medication><Mentors><Morbidity><Morbidity - disease rate><Mother's Milk><Mother-to-child HIV transmission><Neural Development><Neurocognition><Neurocognitive><Neuroimmune><Obstetrics><Outcome><P01 Mechanism><P01 Program><Parturition><Pediatrics><Perinatal><Peripartum><Pharmaceutical Preparations><Population><Prevention><Program Project Grant><Program Research Project Grants><Recording of previous events><Research><Research Design><Research Personnel><Research Program Projects><Researchers><Role><Salivary Gland Viruses><Scientist><Site><Standardization><Structure><Study Type><Tissue Growth><Training><Treatment Protocols><Treatment Regimen><Treatment Schedule><Viral Burden><Viral Load><Viral Load result><Virus-HIV><anti-retroviral><antiretroviral therapy><antiretroviral treatment><biologic><biological specimen repository><biosample repository><biospecimen bank><biospecimen repository><cohort><cytomegalovirus group><design><designing><developmental><digestive tract microbiome><drug/agent><enroll><enteric microbiome><epidemiologic><epidemiological><exposed in utero><fecal microbiome><fetal exposure><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><histories><human milk oligosaccharides><immune activation><in utero><in utero exposure><insight><interest><intestinal biome><intestinal microbiome><intra-uterine environmental exposure><intrauterine environmental exposure><kids><maternal milk><meeting><meetings><microbiome><mortality><neurodevelopment><next generation><novel><ontogeny><prenatal exposure><prenatally exposed><programs><social factors><social role><specimen bank><specimen repository><stool microbiome><stool-associated microbiome><study design><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DALTON CHEKOKO WAMALWA

UNIVERSITY OF WASHINGTON, SEATTLE, WA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,508,882

FY 2025

Project Title

Drug, microbiome, and immune determinants of birth and neurodevelopmental outcomes in children with exposure to HIV infection

Grant Number:

4P01HD107669-02

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/4/2025

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Children exposed to HIV in utero but who are not infected (HEU) have been shown to have compromised growth, neurodevelopmental delays, and increased morbidity and mortality. It is critical to define mechanisms for these differences. This P01 proposes to conduct 3 Projects to examine the influence of...

Research Terms

<0-11 years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Anti-Retroviral Agents><Area><Biologic Factor><Biological><Biological Factors><Biological Specimen Banks><Biological Substance Banks><Biometrics><Biometry><Biostatistics><Birth><Brain><Brain Nervous System><Breast Milk><Breastmilk><CMV><Child><Child Youth><Children (0-21)><Communication><Cytomegalovirus><Data><Detection><Development><Discipline of obstetrics><Drugs><Encephalon><Enrollment><Ensure><Epidemiology><Evaluation><Exposure to><Funding><GI microbiome><Generalized Growth><Grant><Growth><Gynecology><HCMV><HIV><HIV Infections><HIV Seroprevalence><HTLV-III Infections><HTLV-III-LAV Infections><Hair><History><Human Immunodeficiency Viruses><Human Milk><Human Mother's Milk><Human T-Lymphotropic Virus Type III Infections><Immune><Immune Cell Activation><Immunes><Immunology><Infant><Intervention><Investigators><Kenya><LAV-HTLV-III><Leadership><Life><Lymphadenopathy-Associated Virus><Mammary Gland Milk><Measurement><Medication><Mentors><Morbidity><Morbidity - disease rate><Mother's Milk><Mother-to-child HIV transmission><Neural Development><Neurocognition><Neurocognitive><Neuroimmune><Obstetrics><Outcome><P01 Mechanism><P01 Program><Parturition><Pediatrics><Perinatal><Peripartum><Pharmaceutical Preparations><Population><Prevention><Program Project Grant><Program Research Project Grants><Recording of previous events><Research><Research Design><Research Personnel><Research Program Projects><Researchers><Role><Salivary Gland Viruses><Scientist><Site><Standardization><Structure><Study Type><Tissue Growth><Training><Treatment Protocols><Treatment Regimen><Treatment Schedule><Viral Burden><Viral Load><Viral Load result><Virus-HIV><anti-retroviral><antiretroviral therapy><antiretroviral treatment><biologic><biological specimen repository><biosample repository><biospecimen bank><biospecimen repository><cohort><cytomegalovirus group><design><designing><developmental><digestive tract microbiome><drug/agent><enroll><enteric microbiome><epidemiologic><epidemiological><exposed in utero><fecal microbiome><fetal exposure><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><histories><human milk oligosaccharides><immune activation><in utero><in utero exposure><insight><interest><intestinal biome><intestinal microbiome><intra-uterine environmental exposure><intrauterine environmental exposure><kids><maternal milk><meeting><meetings><microbiome><mortality><neurodevelopment><next generation><novel><ontogeny><prenatal exposure><prenatally exposed><programs><social factors><social role><specimen bank><specimen repository><stool microbiome><stool-associated microbiome><study design><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Megan A. M0reno

UNIVERSITY OF WISCONSIN-MADISON, MADISON, WI

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,491,340

FY 2025

Project Title

A longitudinal study investigating TDM and adolescent health and development: Brain, Behavior and well-Being

Grant Number:

5P01HD109850-04

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/12/2022

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Modified Project Summary/Abstract Section – Overall Program This P01 project grant will establish a fully integrated interdisciplinary program of research Projects and Scientific Cores that are essential to develop a fundamental understanding of the complex interplay between adolescent health and d...

Research Terms

<12-20 years old><Address><Adolescence><Adolescent><Adolescent Behavior><Adolescent Development><Adolescent Risk Behavior><Adolescent Youth><Affect><Area><Behavior><Benefits and Risks><Big Data><BigData><Biometrics><Biometry><Biostatistics><Brain><Brain Nervous System><Cognition><Collaborations><Communities><Complex><Consumption><Data><Data Collection><Data Reporting><Development><Developmental Process><Ecological momentary assessment><Elements><Emotional><Emotional well being><Encephalon><Ensure><Feels well><Functional MRI><Functional Magnetic Resonance Imaging><Funding><Future><Generalized Growth><Generations><Goals><Grant><Growth><Health><Health behavior><Individual><Information and Media><Infrastructure><Institution><Interdisciplinary Research><Interdisciplinary Study><Intervention><Interview><Investigators><Knowledge><Longitudinal Studies><Measures><Mental Health><Mental Hygiene><Methodology><Methods><Modeling><Modernization><Multidisciplinary Collaboration><Multidisciplinary Research><Neural Development><Normal mental condition><Normal mental state><Normal psyche><Outcome><P01 Mechanism><P01 Program><Participant><Patient Self-Report><Perception><Personal Satisfaction><Prevention><Process><Program Project Grant><Program Research Project Grants><Psychological Health><Psychological Well Being><Research><Research Personnel><Research Program Projects><Research Resources><Researchers><Resources><Risk Behaviors><Risky Behavior><Schools><Science><Self-Report><Sense of well-being><Source><Structure><Students><Survey Instrument><Surveys><Technology><Textiles><Time><Tissue Growth><Universities><Well in self><Wisconsin><Work><Youth Risk Behavior><adolescence (12-20)><adolescent health><adolescent health outcomes><adolescent risk taking><alcohol behavior><alcohol induced behavior><alcohol related behavior><at risk behavior><behavioral health><clinical translation><clinically translatable><data integration><data representation><data representations><developmental><digital media><digital technology><emotion regulation><emotional regulation><emotional wellbeing><emotional wellness><engaging with social media><ethanol behavior><ethanol induced behavior><ethanol related behavior><experience><fMRI><fabric><health related behavior><improved><innovate><innovation><innovative><interdisciplinary approach><interest><juvenile><juvenile human><long-term study><longitudinal design><longitudinal experimental design><longitudinal outcome studies><longitudinal research design><longitudinal study design><media consumption><media use><meeting><meetings><mental well-being><mental wellbeing><mental wellness><multidisciplinary approach><neurodevelopment><novel><ontogeny><peer><programs><psychological wellbeing><psychological wellness><public health relevance><recruit><risk behavior in youth><self wellness><sense of wellbeing><social media><social media activity><social media engagement><social media use><surveillance data><synergism><theories><tool><utilize social media><well-being><wellbeing>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jessica Chubak

KAISER FOUNDATION RESEARCH INSTITUTE, Oakland, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,473,690

FY 2025

Project Title

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

Grant Number:

5P01CA233432-06

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of t...

Research Terms

<0-11 years old><21+ years old><Accident and Emergency department><Active Follow-up><Acute><Address><Adolescent><Adolescent Youth><Adolescent and Young Adult><Adolescent and young adult cancer patients><Adolescent and young adult cancer population><Adolescent and young adult oncology patients><Adolescent and young adults with cancer><Adult><Adult Human><Adverse Late Effects><Advocate><After Care><After-Treatment><Aftercare><Age><Ambulatory Surgery><Ambulatory Surgical Procedures><Ancillary Services><Area><Biometrics><Biometry><Biostatistics><Breast><California><Cancer Patient><Cancer Survivor><Cancer Treatment><Cancers><Cardiovascular Diseases><Caring><Child><Child Youth><Childhood><Children (0-21)><Chronic><Colon or Rectum><Colorectal><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counseling><Data><Diagnosis><Disparities><Disparity><ED visit><ER visit><Emergency Department><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room><Emergency room visit><Employment><Endocrine Diseases><Endocrine Diseases and Manifestations><Endocrine System Diseases><Epidemiologist><Ethnic Origin><Ethnicity><Face><Family><Fecundability><Fecundity><Fertility><Financial Hardship><Germinoblastic Sarcoma><Germinoblastoma><Goals><Guidelines><Health><Health Care><Health Care Utilization><Health Insurance><Health Resources><Health Services><Health system><Hepatic Disorder><Home><Hospital Admission><Hospitalization><Incidence><Individual><Inpatients><Insurance><Insurance Coverage><Insurance Status><Interdisciplinary Research><Interdisciplinary Study><Investigators><Kidney Diseases><Knowledge><Late Effects><Life><Link><Liver diseases><Lymphoma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Testicular Neoplasm><Malignant Testicular Tumor><Malignant Tumor><Malignant Tumor of the Testis><Malignant neoplasm of testis><Medical><Multidisciplinary Collaboration><Multidisciplinary Research><NCCN><NCI Organization><National Cancer Institute><National Comprehensive Cancer Network><Neighborhoods><Nephropathy><North Carolina><Older Population><Oncologist><Out-patients><Outcome><Outpatient Surgery><Outpatients><Patient Preferences><Patient-Centered Care><Patients><Persons><Phase><Population><Population Database><Population Surveillance><Preservation Technique><Provider><Puberty><Public Health Surveillance><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Recommendation><Renal Disease><Reporting><Reproductive Health Services><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resource Sharing><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Reticulolymphosarcoma><Risk><Second Cancer><Second Primary Cancers><Secondary Malignancy><Secondary Malignant Neoplasm><Socio-economic status><Socioeconomic Status><Specialist><Survey Instrument><Surveys><Testicular Cancer><Testis Cancer><United States><Universities><University resources><Utah><Visit><active followup><adult youth><adulthood><aged><ages><anti-cancer therapy><barrier to care><barrier to health care><barrier to treatment><cancer among adolescent and young adults><cancer care><cancer diagnosis><cancer registry><cancer therapy><cancer type><cancer-directed therapy><cardiovascular disorder><care coordination><care preference><career><childbearing age><clinical care><colorectum><coordinating care><data harmonization><data resource><endocrine disorder><evidence base><experience><faces><facial><fertile age><fertility preservation><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><harmonized data><health care service use><health care service utilization><health care settings><health insurance plan><hepatic disease><hepatopathy><higher education><homes><improved><improved outcome><integrated care><integrated health care><integrated model of care><interest><juvenile><juvenile human><kidney disorder><kids><liver disorder><malignancy><multidisciplinary><neglect><neoplasm registry><neoplasm/cancer><obstacle to care><obstacle to health care><older adult><older adulthood><older groups><older individuals><older person><pediatric><population health><post treatment><preservation><preserve fertility><programs><racial><racial background><racial origin><renal disorder><reproductive age><reproductive years><secondary cancer><socio-economic position><socioeconomic position><survivorship><young adult><young adult age><young adulthood><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Erin Elizabeth Hahn

KAISER FOUNDATION RESEARCH INSTITUTE, Oakland, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,473,690

FY 2025

Project Title

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

Grant Number:

5P01CA233432-06

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of t...

Research Terms

<0-11 years old><21+ years old><Accident and Emergency department><Active Follow-up><Acute><Address><Adolescent><Adolescent Youth><Adolescent and Young Adult><Adolescent and young adult cancer patients><Adolescent and young adult cancer population><Adolescent and young adult oncology patients><Adolescent and young adults with cancer><Adult><Adult Human><Adverse Late Effects><Advocate><After Care><After-Treatment><Aftercare><Age><Ambulatory Surgery><Ambulatory Surgical Procedures><Ancillary Services><Area><Biometrics><Biometry><Biostatistics><Breast><California><Cancer Patient><Cancer Survivor><Cancer Treatment><Cancers><Cardiovascular Diseases><Caring><Child><Child Youth><Childhood><Children (0-21)><Chronic><Colon or Rectum><Colorectal><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counseling><Data><Diagnosis><Disparities><Disparity><ED visit><ER visit><Emergency Department><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room><Emergency room visit><Employment><Endocrine Diseases><Endocrine Diseases and Manifestations><Endocrine System Diseases><Epidemiologist><Ethnic Origin><Ethnicity><Face><Family><Fecundability><Fecundity><Fertility><Financial Hardship><Germinoblastic Sarcoma><Germinoblastoma><Goals><Guidelines><Health><Health Care><Health Care Utilization><Health Insurance><Health Resources><Health Services><Health system><Hepatic Disorder><Home><Hospital Admission><Hospitalization><Incidence><Individual><Inpatients><Insurance><Insurance Coverage><Insurance Status><Interdisciplinary Research><Interdisciplinary Study><Investigators><Kidney Diseases><Knowledge><Late Effects><Life><Link><Liver diseases><Lymphoma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Testicular Neoplasm><Malignant Testicular Tumor><Malignant Tumor><Malignant Tumor of the Testis><Malignant neoplasm of testis><Medical><Multidisciplinary Collaboration><Multidisciplinary Research><NCCN><NCI Organization><National Cancer Institute><National Comprehensive Cancer Network><Neighborhoods><Nephropathy><North Carolina><Older Population><Oncologist><Out-patients><Outcome><Outpatient Surgery><Outpatients><Patient Preferences><Patient-Centered Care><Patients><Persons><Phase><Population><Population Database><Population Surveillance><Preservation Technique><Provider><Puberty><Public Health Surveillance><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Recommendation><Renal Disease><Reporting><Reproductive Health Services><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resource Sharing><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Reticulolymphosarcoma><Risk><Second Cancer><Second Primary Cancers><Secondary Malignancy><Secondary Malignant Neoplasm><Socio-economic status><Socioeconomic Status><Specialist><Survey Instrument><Surveys><Testicular Cancer><Testis Cancer><United States><Universities><University resources><Utah><Visit><active followup><adult youth><adulthood><aged><ages><anti-cancer therapy><barrier to care><barrier to health care><barrier to treatment><cancer among adolescent and young adults><cancer care><cancer diagnosis><cancer registry><cancer therapy><cancer type><cancer-directed therapy><cardiovascular disorder><care coordination><care preference><career><childbearing age><clinical care><colorectum><coordinating care><data harmonization><data resource><endocrine disorder><evidence base><experience><faces><facial><fertile age><fertility preservation><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><harmonized data><health care service use><health care service utilization><health care settings><health insurance plan><hepatic disease><hepatopathy><higher education><homes><improved><improved outcome><integrated care><integrated health care><integrated model of care><interest><juvenile><juvenile human><kidney disorder><kids><liver disorder><malignancy><multidisciplinary><neglect><neoplasm registry><neoplasm/cancer><obstacle to care><obstacle to health care><older adult><older adulthood><older groups><older individuals><older person><pediatric><population health><post treatment><preservation><preserve fertility><programs><racial><racial background><racial origin><renal disorder><reproductive age><reproductive years><secondary cancer><socio-economic position><socioeconomic position><survivorship><young adult><young adult age><young adulthood><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LAWRENCE H KUSHI

KAISER FOUNDATION RESEARCH INSTITUTE, Oakland, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,473,690

FY 2025

Project Title

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

Grant Number:

5P01CA233432-06

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of t...

Research Terms

<0-11 years old><21+ years old><Accident and Emergency department><Active Follow-up><Acute><Address><Adolescent><Adolescent Youth><Adolescent and Young Adult><Adolescent and young adult cancer patients><Adolescent and young adult cancer population><Adolescent and young adult oncology patients><Adolescent and young adults with cancer><Adult><Adult Human><Adverse Late Effects><Advocate><After Care><After-Treatment><Aftercare><Age><Ambulatory Surgery><Ambulatory Surgical Procedures><Ancillary Services><Area><Biometrics><Biometry><Biostatistics><Breast><California><Cancer Patient><Cancer Survivor><Cancer Treatment><Cancers><Cardiovascular Diseases><Caring><Child><Child Youth><Childhood><Children (0-21)><Chronic><Colon or Rectum><Colorectal><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counseling><Data><Diagnosis><Disparities><Disparity><ED visit><ER visit><Emergency Department><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room><Emergency room visit><Employment><Endocrine Diseases><Endocrine Diseases and Manifestations><Endocrine System Diseases><Epidemiologist><Ethnic Origin><Ethnicity><Face><Family><Fecundability><Fecundity><Fertility><Financial Hardship><Germinoblastic Sarcoma><Germinoblastoma><Goals><Guidelines><Health><Health Care><Health Care Utilization><Health Insurance><Health Resources><Health Services><Health system><Hepatic Disorder><Home><Hospital Admission><Hospitalization><Incidence><Individual><Inpatients><Insurance><Insurance Coverage><Insurance Status><Interdisciplinary Research><Interdisciplinary Study><Investigators><Kidney Diseases><Knowledge><Late Effects><Life><Link><Liver diseases><Lymphoma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Testicular Neoplasm><Malignant Testicular Tumor><Malignant Tumor><Malignant Tumor of the Testis><Malignant neoplasm of testis><Medical><Multidisciplinary Collaboration><Multidisciplinary Research><NCCN><NCI Organization><National Cancer Institute><National Comprehensive Cancer Network><Neighborhoods><Nephropathy><North Carolina><Older Population><Oncologist><Out-patients><Outcome><Outpatient Surgery><Outpatients><Patient Preferences><Patient-Centered Care><Patients><Persons><Phase><Population><Population Database><Population Surveillance><Preservation Technique><Provider><Puberty><Public Health Surveillance><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Recommendation><Renal Disease><Reporting><Reproductive Health Services><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resource Sharing><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Reticulolymphosarcoma><Risk><Second Cancer><Second Primary Cancers><Secondary Malignancy><Secondary Malignant Neoplasm><Socio-economic status><Socioeconomic Status><Specialist><Survey Instrument><Surveys><Testicular Cancer><Testis Cancer><United States><Universities><University resources><Utah><Visit><active followup><adult youth><adulthood><aged><ages><anti-cancer therapy><barrier to care><barrier to health care><barrier to treatment><cancer among adolescent and young adults><cancer care><cancer diagnosis><cancer registry><cancer therapy><cancer type><cancer-directed therapy><cardiovascular disorder><care coordination><care preference><career><childbearing age><clinical care><colorectum><coordinating care><data harmonization><data resource><endocrine disorder><evidence base><experience><faces><facial><fertile age><fertility preservation><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><harmonized data><health care service use><health care service utilization><health care settings><health insurance plan><hepatic disease><hepatopathy><higher education><homes><improved><improved outcome><integrated care><integrated health care><integrated model of care><interest><juvenile><juvenile human><kidney disorder><kids><liver disorder><malignancy><multidisciplinary><neglect><neoplasm registry><neoplasm/cancer><obstacle to care><obstacle to health care><older adult><older adulthood><older groups><older individuals><older person><pediatric><population health><post treatment><preservation><preserve fertility><programs><racial><racial background><racial origin><renal disorder><reproductive age><reproductive years><secondary cancer><socio-economic position><socioeconomic position><survivorship><young adult><young adult age><young adulthood><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Theresa H M Keegan

KAISER FOUNDATION RESEARCH INSTITUTE, Oakland, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,473,690

FY 2025

Project Title

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

Grant Number:

5P01CA233432-06

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of t...

Research Terms

<0-11 years old><21+ years old><Accident and Emergency department><Active Follow-up><Acute><Address><Adolescent><Adolescent Youth><Adolescent and Young Adult><Adolescent and young adult cancer patients><Adolescent and young adult cancer population><Adolescent and young adult oncology patients><Adolescent and young adults with cancer><Adult><Adult Human><Adverse Late Effects><Advocate><After Care><After-Treatment><Aftercare><Age><Ambulatory Surgery><Ambulatory Surgical Procedures><Ancillary Services><Area><Biometrics><Biometry><Biostatistics><Breast><California><Cancer Patient><Cancer Survivor><Cancer Treatment><Cancers><Cardiovascular Diseases><Caring><Child><Child Youth><Childhood><Children (0-21)><Chronic><Colon or Rectum><Colorectal><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counseling><Data><Diagnosis><Disparities><Disparity><ED visit><ER visit><Emergency Department><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room><Emergency room visit><Employment><Endocrine Diseases><Endocrine Diseases and Manifestations><Endocrine System Diseases><Epidemiologist><Ethnic Origin><Ethnicity><Face><Family><Fecundability><Fecundity><Fertility><Financial Hardship><Germinoblastic Sarcoma><Germinoblastoma><Goals><Guidelines><Health><Health Care><Health Care Utilization><Health Insurance><Health Resources><Health Services><Health system><Hepatic Disorder><Home><Hospital Admission><Hospitalization><Incidence><Individual><Inpatients><Insurance><Insurance Coverage><Insurance Status><Interdisciplinary Research><Interdisciplinary Study><Investigators><Kidney Diseases><Knowledge><Late Effects><Life><Link><Liver diseases><Lymphoma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Testicular Neoplasm><Malignant Testicular Tumor><Malignant Tumor><Malignant Tumor of the Testis><Malignant neoplasm of testis><Medical><Multidisciplinary Collaboration><Multidisciplinary Research><NCCN><NCI Organization><National Cancer Institute><National Comprehensive Cancer Network><Neighborhoods><Nephropathy><North Carolina><Older Population><Oncologist><Out-patients><Outcome><Outpatient Surgery><Outpatients><Patient Preferences><Patient-Centered Care><Patients><Persons><Phase><Population><Population Database><Population Surveillance><Preservation Technique><Provider><Puberty><Public Health Surveillance><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Recommendation><Renal Disease><Reporting><Reproductive Health Services><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resource Sharing><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Reticulolymphosarcoma><Risk><Second Cancer><Second Primary Cancers><Secondary Malignancy><Secondary Malignant Neoplasm><Socio-economic status><Socioeconomic Status><Specialist><Survey Instrument><Surveys><Testicular Cancer><Testis Cancer><United States><Universities><University resources><Utah><Visit><active followup><adult youth><adulthood><aged><ages><anti-cancer therapy><barrier to care><barrier to health care><barrier to treatment><cancer among adolescent and young adults><cancer care><cancer diagnosis><cancer registry><cancer therapy><cancer type><cancer-directed therapy><cardiovascular disorder><care coordination><care preference><career><childbearing age><clinical care><colorectum><coordinating care><data harmonization><data resource><endocrine disorder><evidence base><experience><faces><facial><fertile age><fertility preservation><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><harmonized data><health care service use><health care service utilization><health care settings><health insurance plan><hepatic disease><hepatopathy><higher education><homes><improved><improved outcome><integrated care><integrated health care><integrated model of care><interest><juvenile><juvenile human><kidney disorder><kids><liver disorder><malignancy><multidisciplinary><neglect><neoplasm registry><neoplasm/cancer><obstacle to care><obstacle to health care><older adult><older adulthood><older groups><older individuals><older person><pediatric><population health><post treatment><preservation><preserve fertility><programs><racial><racial background><racial origin><renal disorder><reproductive age><reproductive years><secondary cancer><socio-economic position><socioeconomic position><survivorship><young adult><young adult age><young adulthood><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Hazel B Nichols

KAISER FOUNDATION RESEARCH INSTITUTE, Oakland, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,473,690

FY 2025

Project Title

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

Grant Number:

5P01CA233432-06

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of t...

Research Terms

<0-11 years old><21+ years old><Accident and Emergency department><Active Follow-up><Acute><Address><Adolescent><Adolescent Youth><Adolescent and Young Adult><Adolescent and young adult cancer patients><Adolescent and young adult cancer population><Adolescent and young adult oncology patients><Adolescent and young adults with cancer><Adult><Adult Human><Adverse Late Effects><Advocate><After Care><After-Treatment><Aftercare><Age><Ambulatory Surgery><Ambulatory Surgical Procedures><Ancillary Services><Area><Biometrics><Biometry><Biostatistics><Breast><California><Cancer Patient><Cancer Survivor><Cancer Treatment><Cancers><Cardiovascular Diseases><Caring><Child><Child Youth><Childhood><Children (0-21)><Chronic><Colon or Rectum><Colorectal><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counseling><Data><Diagnosis><Disparities><Disparity><ED visit><ER visit><Emergency Department><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room><Emergency room visit><Employment><Endocrine Diseases><Endocrine Diseases and Manifestations><Endocrine System Diseases><Epidemiologist><Ethnic Origin><Ethnicity><Face><Family><Fecundability><Fecundity><Fertility><Financial Hardship><Germinoblastic Sarcoma><Germinoblastoma><Goals><Guidelines><Health><Health Care><Health Care Utilization><Health Insurance><Health Resources><Health Services><Health system><Hepatic Disorder><Home><Hospital Admission><Hospitalization><Incidence><Individual><Inpatients><Insurance><Insurance Coverage><Insurance Status><Interdisciplinary Research><Interdisciplinary Study><Investigators><Kidney Diseases><Knowledge><Late Effects><Life><Link><Liver diseases><Lymphoma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Testicular Neoplasm><Malignant Testicular Tumor><Malignant Tumor><Malignant Tumor of the Testis><Malignant neoplasm of testis><Medical><Multidisciplinary Collaboration><Multidisciplinary Research><NCCN><NCI Organization><National Cancer Institute><National Comprehensive Cancer Network><Neighborhoods><Nephropathy><North Carolina><Older Population><Oncologist><Out-patients><Outcome><Outpatient Surgery><Outpatients><Patient Preferences><Patient-Centered Care><Patients><Persons><Phase><Population><Population Database><Population Surveillance><Preservation Technique><Provider><Puberty><Public Health Surveillance><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Recommendation><Renal Disease><Reporting><Reproductive Health Services><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resource Sharing><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Reticulolymphosarcoma><Risk><Second Cancer><Second Primary Cancers><Secondary Malignancy><Secondary Malignant Neoplasm><Socio-economic status><Socioeconomic Status><Specialist><Survey Instrument><Surveys><Testicular Cancer><Testis Cancer><United States><Universities><University resources><Utah><Visit><active followup><adult youth><adulthood><aged><ages><anti-cancer therapy><barrier to care><barrier to health care><barrier to treatment><cancer among adolescent and young adults><cancer care><cancer diagnosis><cancer registry><cancer therapy><cancer type><cancer-directed therapy><cardiovascular disorder><care coordination><care preference><career><childbearing age><clinical care><colorectum><coordinating care><data harmonization><data resource><endocrine disorder><evidence base><experience><faces><facial><fertile age><fertility preservation><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><harmonized data><health care service use><health care service utilization><health care settings><health insurance plan><hepatic disease><hepatopathy><higher education><homes><improved><improved outcome><integrated care><integrated health care><integrated model of care><interest><juvenile><juvenile human><kidney disorder><kids><liver disorder><malignancy><multidisciplinary><neglect><neoplasm registry><neoplasm/cancer><obstacle to care><obstacle to health care><older adult><older adulthood><older groups><older individuals><older person><pediatric><population health><post treatment><preservation><preserve fertility><programs><racial><racial background><racial origin><renal disorder><reproductive age><reproductive years><secondary cancer><socio-economic position><socioeconomic position><survivorship><young adult><young adult age><young adulthood><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

GEETANJALI CHANDER

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,303,302

FY 2025

Project Title

Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua

Grant Number:

5P01AA029544-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Established in 2011, the Alcohol Research Consortium in HIV (ARCH) conducts high impact epidemiological and intervention studies that address relationships between at-risk alcohol use and AUD, the HIV Care Continuum (HIV-CC) and health outcomes. ARCH is embedded in and has capitalized on the researc...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MARY E MCCAUL

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,303,302

FY 2025

Project Title

Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua

Grant Number:

5P01AA029544-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Established in 2011, the Alcohol Research Consortium in HIV (ARCH) conducts high impact epidemiological and intervention studies that address relationships between at-risk alcohol use and AUD, the HIV Care Continuum (HIV-CC) and health outcomes. ARCH is embedded in and has capitalized on the researc...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Eva Morava-Kozicz

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,270,237

FY 2025

Project Title

Investigation of Neural Pathogenic Mechanisms Associated with Congenital Disorders of Glycosylation

Grant Number:

1P01NS138003-01A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2025

End Date:

6/30/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Program Summary This Program Project grant will use multiple model systems and approaches to address the pathogenic mechanisms associated with neural disease in the Congenital Disorders of Glycosylation (CDG), with the long- term goals of elucidating how glycosylation regulates neural function. Near...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Richard Steet

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,270,237

FY 2025

Project Title

Investigation of Neural Pathogenic Mechanisms Associated with Congenital Disorders of Glycosylation

Grant Number:

1P01NS138003-01A1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2025

End Date:

6/30/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Program Summary This Program Project grant will use multiple model systems and approaches to address the pathogenic mechanisms associated with neural disease in the Congenital Disorders of Glycosylation (CDG), with the long- term goals of elucidating how glycosylation regulates neural function. Near...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

RONALD A COHEN

UNIVERSITY OF FLORIDA, GAINESVILLE, FL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,265,431

FY 2025

Project Title

Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection

Grant Number:

5P01AA029543-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

As persons living with HIV (PLWH) live longer, approximately 50% will experience HIV-related cognitive dysfunction, which may affect daily activities, contribute to morbidity and mortality, and increase the likelihood of HIV transmission. Alcohol consumption among PLWH may further exacerbate long-te...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Robert L Cook

UNIVERSITY OF FLORIDA, GAINESVILLE, FL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,265,431

FY 2025

Project Title

Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection

Grant Number:

5P01AA029543-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

As persons living with HIV (PLWH) live longer, approximately 50% will experience HIV-related cognitive dysfunction, which may affect daily activities, contribute to morbidity and mortality, and increase the likelihood of HIV transmission. Alcohol consumption among PLWH may further exacerbate long-te...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Varan Govind

UNIVERSITY OF FLORIDA, GAINESVILLE, FL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,265,431

FY 2025

Project Title

Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection

Grant Number:

5P01AA029543-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

As persons living with HIV (PLWH) live longer, approximately 50% will experience HIV-related cognitive dysfunction, which may affect daily activities, contribute to morbidity and mortality, and increase the likelihood of HIV transmission. Alcohol consumption among PLWH may further exacerbate long-te...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

IAIN A. DRUMMOND

MOUNT DESERT ISLAND BIOLOGICAL LAB, SALSBURY COVE, ME

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,265,252

FY 2025

Project Title

The MDIBL Center for Comparative Biology of Tissue Repair, Regeneration and Aging

Grant Number:

5P30GM154610-02

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/5/2024

End Date:

6/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY Limited regeneration of damaged organs and tissues in humans leads to chronic disease and degeneration, while in many invertebrates and lower vertebrates, cellular regeneration repairs and preserves tissue function throughout the lifespan. COBRE Phases I and II Comparative Bi...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rafick Pierre Sekaly

EMORY UNIVERSITY, ATLANTA, GA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,227,889

FY 2025

Project Title

Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir

Grant Number:

5P01AI178376-03

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/3/2023

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT – ADMINISTRATIVE CORE The Administrative core of the P01 program grant entitled “Multi-OMIcs identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir “ (Multiomics Immunity Reservoir- MOIR) will provide s...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Karen MacDonell

FLORIDA STATE UNIVERSITY, TALLAHASSEE, FL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,189,597

FY 2025

Project Title

SHARE Program: Innovations in Translational Behavioral Science to Improve Self-management of HIV and Alcohol Reaching Emerging adults

Grant Number:

5P01AA029547-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The purpose of the SHARE P01 research program project is to address HIV and alcohol use around three themes; 1) Emerging adulthood (ages 18 -29); 2) Self-management of HIV and alcohol; and 3) Translational behavioral science. Emerging adulthood is a developmental stage marked by significant changes ...

Research Terms

<21+ years old><AIDS Virus><AIDS/HIV><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adult><Adult Human><Age><Alcohol Chemical Class><Alcohol Drinking><Alcohol consumption><Alcohols><Basic Behavioral Science><Behavior><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Sciences><Behavioral Therapy><Behavioral Treatment><Behavioral trial><Big Data><BigData><Caring><Chronic Disease><Chronic Illness><Communities><Competence><Conditioning Therapy><Data Science Core><Data Science Resource Core><Decision Making><Development><Diagnosis><Disease Progression><Electronic Health Record><Ensure><Epidemic><EtOH drinking><EtOH use><Face><Feedback><Florida><Foundations><Goals><HIV><HIV Infections><HIV diagnosis><HIV/AIDS><HTLV-III Infections><HTLV-III-LAV Infections><Health><High-Risk Sex><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Individual><Intervention><Intervention Strategies><LAV-HTLV-III><Life Style><Lifestyle><Link><Literature><Lymphadenopathy-Associated Virus><Mental Health><Mental Hygiene><Methods><Modeling><Monitor><Motivation><NIH><National Institutes of Health><Neurocognition><Outcome><P01 Mechanism><P01 Program><Persons><Phase><Physical activity><Problem Solving><Program Project Grant><Program Research Project Grants><Psychological Health><Psychological reinforcement><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Reinforcement><Research><Research Grants><Research Program Projects><Research Project Grants><Research Projects><Risk Behaviors><Risk Taking><Risky Behavior><Role><Self Management><Self-control as a personality trait><Sleep><Stress><Substance abuse problem><Technology><Testing><Tobacco><Translating><Translations><Transmission><United States><United States National Institutes of Health><Unprotected Sex><Unsafe Sex><Viral><Viral Burden><Viral Load><Viral Load result><Virus-HIV><Work><Youth><Youth 10-21><abuse of substances><adulthood><adulthood transition><age group><ages><alcohol co-morbidity><alcohol comorbidity><alcohol ingestion><alcohol intake><alcohol monitoring><alcohol product use><alcohol use><alcoholic beverage consumption><alcoholic drink intake><at risk behavior><behavior intervention><behavioral intervention><chronic disorder><co-morbid><co-morbidity><community academic collaboration><community academic partnership><community academic research partnership><community engagement><community university partnership><comorbidity><comparative effectiveness trial><condomless intercourse><condomless sex><develop therapy><developmental><drug adherence><drug compliance><early adulthood><efficacious intervention><electronic health care record><electronic health medical record><electronic health plan record><electronic health registry><electronic medical health record><emerging adult><emerging adulthood><engagement with communities><ethanol consumption><ethanol drinking><ethanol ingestion><ethanol intake><ethanol product use><ethanol use><expectation><faces><facial><improved><innovate><innovation><innovative><intervention design><intervention development><intervention program><later in life><later life><manage symptom><medication adherence><medication compliance><new technology><novel technologies><older adult><older adulthood><physical conditioning><physical health><programs><psychosocial><recruit><scale up><secondary analysis><self control><skills><social><social role><substance abuse><substance use><substance using><symptom management><therapy design><therapy development><transition from adolescence to adulthood><transition into adulthood><transition to adulthood><translation><translational pipeline><translational spectrum><translational study><transmission process><treatment as prevention><treatment design><treatment development><treatment-based prevention><unprotected intercourse><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

SYLVIE NAAR

FLORIDA STATE UNIVERSITY, TALLAHASSEE, FL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,189,597

FY 2025

Project Title

SHARE Program: Innovations in Translational Behavioral Science to Improve Self-management of HIV and Alcohol Reaching Emerging adults

Grant Number:

5P01AA029547-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The purpose of the SHARE P01 research program project is to address HIV and alcohol use around three themes; 1) Emerging adulthood (ages 18 -29); 2) Self-management of HIV and alcohol; and 3) Translational behavioral science. Emerging adulthood is a developmental stage marked by significant changes ...

Research Terms

<21+ years old><AIDS Virus><AIDS/HIV><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adult><Adult Human><Age><Alcohol Chemical Class><Alcohol Drinking><Alcohol consumption><Alcohols><Basic Behavioral Science><Behavior><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Sciences><Behavioral Therapy><Behavioral Treatment><Behavioral trial><Big Data><BigData><Caring><Chronic Disease><Chronic Illness><Communities><Competence><Conditioning Therapy><Data Science Core><Data Science Resource Core><Decision Making><Development><Diagnosis><Disease Progression><Electronic Health Record><Ensure><Epidemic><EtOH drinking><EtOH use><Face><Feedback><Florida><Foundations><Goals><HIV><HIV Infections><HIV diagnosis><HIV/AIDS><HTLV-III Infections><HTLV-III-LAV Infections><Health><High-Risk Sex><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Individual><Intervention><Intervention Strategies><LAV-HTLV-III><Life Style><Lifestyle><Link><Literature><Lymphadenopathy-Associated Virus><Mental Health><Mental Hygiene><Methods><Modeling><Monitor><Motivation><NIH><National Institutes of Health><Neurocognition><Outcome><P01 Mechanism><P01 Program><Persons><Phase><Physical activity><Problem Solving><Program Project Grant><Program Research Project Grants><Psychological Health><Psychological reinforcement><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Reinforcement><Research><Research Grants><Research Program Projects><Research Project Grants><Research Projects><Risk Behaviors><Risk Taking><Risky Behavior><Role><Self Management><Self-control as a personality trait><Sleep><Stress><Substance abuse problem><Technology><Testing><Tobacco><Translating><Translations><Transmission><United States><United States National Institutes of Health><Unprotected Sex><Unsafe Sex><Viral><Viral Burden><Viral Load><Viral Load result><Virus-HIV><Work><Youth><Youth 10-21><abuse of substances><adulthood><adulthood transition><age group><ages><alcohol co-morbidity><alcohol comorbidity><alcohol ingestion><alcohol intake><alcohol monitoring><alcohol product use><alcohol use><alcoholic beverage consumption><alcoholic drink intake><at risk behavior><behavior intervention><behavioral intervention><chronic disorder><co-morbid><co-morbidity><community academic collaboration><community academic partnership><community academic research partnership><community engagement><community university partnership><comorbidity><comparative effectiveness trial><condomless intercourse><condomless sex><develop therapy><developmental><drug adherence><drug compliance><early adulthood><efficacious intervention><electronic health care record><electronic health medical record><electronic health plan record><electronic health registry><electronic medical health record><emerging adult><emerging adulthood><engagement with communities><ethanol consumption><ethanol drinking><ethanol ingestion><ethanol intake><ethanol product use><ethanol use><expectation><faces><facial><improved><innovate><innovation><innovative><intervention design><intervention development><intervention program><later in life><later life><manage symptom><medication adherence><medication compliance><new technology><novel technologies><older adult><older adulthood><physical conditioning><physical health><programs><psychosocial><recruit><scale up><secondary analysis><self control><skills><social><social role><substance abuse><substance use><substance using><symptom management><therapy design><therapy development><transition from adolescence to adulthood><transition into adulthood><transition to adulthood><translation><translational pipeline><translational spectrum><translational study><transmission process><treatment as prevention><treatment design><treatment development><treatment-based prevention><unprotected intercourse><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JANOS ZEMPLENI

UNIVERSITY OF NEBRASKA LINCOLN, LINCOLN, NE

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,169,372

FY 2025

Project Title

Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules

Grant Number:

5P30GM154608-02

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/15/2024

End Date:

5/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

In less than 20 years, the prevalence of obesity increased from 30.5% to 42.4%, and the prevalence of severe obesity increased from 4.7% to 9.2%. The mission of the Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules (NPOD) is to prevent, treat and cure obesity and co-mo...

Research Terms

<21+ years old><ASCVD><Adult><Adult Human><Age><American><Applications Grants><Appointment><Asian><Atherosclerosis><Atherosclerotic Cardiovascular Disease><Biochemical Pathway><Black><Black race><COBRE><Cardiovascular Diseases><Center of Biomedical Research Excellence><Centers of Research Excellence><Clinical><Diabetes Mellitus><Diet><Disease><Disorder><Electronic Health Record><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Ethnic Origin><Ethnicity><Faculty><Faculty Recruitment><Food><Foundations><Friends><Funding><Future><Generalized Growth><Grant><Grant Proposals><Growth><Gustation><Health><Health Care Systems><Hepatic Disorder><Hispanic><Home><Industry><Inflammation><Institution><Intervention><Investigators><Investments><Iowa><Kansas><Lead><Leadership><Link><Liver diseases><Medical Care Costs><Medical center><Metabolic Networks><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Mission><Morbid Obesity><NIDDK><NIGMS><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institute of General Medical Sciences><National Institutes of Health><Nebraska><Non-Hispanic><Nonhispanic><Not Hispanic or Latino><Nutrient><Nutrition><Obesity><P01 Mechanism><P01 Program><Pb element><Phase><Physical activity><Pilot Projects><Prevalence><Program Project Grant><Program Research Project Grants><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Grants><Research Infrastructure><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Researchers><Sampling><Scientific Publication><Secure><Services><Severe obesity><Sight><Taste><Taste Perception><Tissue Growth><United States><United States National Institutes of Health><Universities><Vision><Work><adiposity><adulthood><ages><associate faculty><associate professor><atheromatosis><atherosclerotic disease><atherosclerotic vascular disease><base><bases><cardiovascular disorder><child adiposity><child obesity><childhood adiposity><childhood obesity><co-morbid><co-morbidity><comorbidity><corpulence><cost><diabetes><dietary><diets><disease prevention><disorder prevention><electronic health care record><electronic health medical record><electronic health plan record><electronic health registry><electronic medical health record><epigenetically><ethnic minority><extreme obesity><fatty liver disease><gustatory perception><gustatory processing><gustatory response><heavy metal Pb><heavy metal lead><hepatic disease><hepatopathy><homes><liver disorder><medical costs><medical expenses><member><mid-career faculty><midcareer faculty><obese children><obesity during childhood><obesity in children><obesity prevention><ontogeny><pediatric obesity><pilot study><prevent><prevent obesity><preventing><programs><racial><racial background><racial origin><recruit teachers><sq. ft><square foot><success><taste processing><taste response><teacher recruitment><tool><visual function>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Justin D. Lathia

CLEVELAND CLINIC LERNER COM-CWRU, CLEVELAND, OH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,138,914

FY 2025

Project Title

Sex-based Differences in Glioma

Grant Number:

5P01CA245705-06

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/14/2020

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY Glioblastoma (GBM), the most common primary malignant brain tumor, remains uniformly lethal despite aggressive therapies. Epidemiological data demonstrate an increased incidence of cancer in males across many tumors including GBM, genomic analyses have identified sex-specific molecul...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Karen L Cropsey

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,028,772

FY 2025

Project Title

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)

Grant Number:

5P01AA029540-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) The overall aims of the Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) are to (Aim 1) test the effectiveness of a transdiagnostic model, Common Elements Treatment Approach (CETA), to reduce unhealthy alcohol use and improve HIV c...

Research Terms

<21+ years old><AIDS><AIDS Virus><AIDS/HIV><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Adherence><Adult><Adult Human><Alabama><Alcohol Chemical Class><Alcohol Drinking><Alcohol consumption><Alcohols><Anxiety><Apache><Application Context><Arizona><Assess implementation><Back><Businesses><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Caring><Clinic><Clinical><Clinical Treatment><Clinical effectiveness><Cognition Therapy><Cognitive Psychotherapy><Cognitive Therapy><Cognitive treatment><Collaborations><Communities><Complex><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counselor><Data><Data Analyses><Data Analysis><Data Collection><Data Element><Deep South><Demographic Factors><Diagnostic><Dorsum><Education for Intervention><Educational Intervention><Elements><Epidemic><EtOH drinking><EtOH use><Evidence based intervention><Face><Funding><Geographic Area><Geographic Locations><Geographic Region><Geographical Location><HIV><HIV/AIDS><Health Care Providers><Health Personnel><Human Immunodeficiency Viruses><Human Resources><Implementation assessment><Incidence><Infectious Diseases / Laboratory><Infectious Diseases Research><Instruction Intervention><Interpersonal Violence><Intervention><Investigators><Knowledge><LAV-HTLV-III><LMIC><Licensing><Lymphadenopathy-Associated Virus><Manpower><Mental Depression><Mental Health><Mental Hygiene><Mental disorders><Mental health disorders><Methods><Modeling><Monitor><NIAAA><NIH><National Institute on Alcohol Abuse and Alcoholism><National Institutes of Health><Northern Rhodesia><Outcome><Pain><Painful><Participant><Persons><Prevalence><Prevention><Professional counselor><Protocol><Protocols documentation><Provider><Psychiatric Disease><Psychiatric Disorder><Psychological Health><Psychologist><Public Sector><R-Series Research Projects><R01 Mechanism><R01 Program><Randomized Controlled Clinical Trials><Randomized, Controlled Trials><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Rural><Rural Population><Rural group><Rural people><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Sahara><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Structure><Telemedicine><Training><Training Intervention><Translating><Treatment outcome><United States><United States National Institutes of Health><Viral><Virus-HIV><Washington><Zambia><addiction><addictive disorder><adulthood><alcohol co-morbidity><alcohol comorbidity><alcohol ingestion><alcohol intake><alcohol misuse><alcohol product use><alcohol use><alcoholic beverage consumption><alcoholic drink intake><alleviate symptom><ameliorating symptom><antiretroviral therapy><antiretroviral treatment><behavioral health><behavioral health intervention><brief alcohol intervention><brief intervention><brief therapy><brief treatment><career><clinical intervention><clinical therapy><co-morbid><co-morbidity><cognitive behavior intervention><cognitive behavior modification><cognitive behavior therapy><cognitive behavioral intervention><cognitive behavioral modification><cognitive behavioral therapy><cognitive behavioral treatment><common treatment><community clinic><comorbidity><compare effectiveness><contextual factors><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><cost><cost effective><data harmonization><data interpretation><decrease symptom><depression><design><designing><effectiveness testing><ethanol consumption><ethanol drinking><ethanol ingestion><ethanol intake><ethanol misuse><ethanol product use><ethanol use><evaluate implementation><evaluation of implementation><faces><facial><fewer symptoms><geographic site><harmonized data><health care personnel><health care worker><health provider><health workforce><implementation determinants><implementation evaluation><implementation factors><improved><instructional intervention><low and middle-income countries><medical personnel><mental illness><mortality><participant enrollment><patient enrollment><peer><personnel><pilot test><population based><post-trauma stress><post-traumatic stress><post-traumatic stress symptoms><post-traumatic symptoms><posttrauma stress><posttraumatic stress><posttraumatic stress symptoms><posttraumatic symptoms><programs><psychiatric illness><psychological disorder><randomized control clinical trial><randomized control trial><reduce symptoms><relieves symptoms><response><rural individual><screening><screenings><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><sex><substance use><substance using><suicidal risk><suicide risk><symptom alleviation><symptom reduction><symptom relief><synergism><therapy adherence><therapy compliance><treatment as prevention><treatment effect><treatment provider><treatment-based prevention><trial design><trial regimen><trial treatment><unhealthy alcohol use>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Michael Jeffrey Vinikoor

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,028,772

FY 2025

Project Title

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)

Grant Number:

5P01AA029540-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) The overall aims of the Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) are to (Aim 1) test the effectiveness of a transdiagnostic model, Common Elements Treatment Approach (CETA), to reduce unhealthy alcohol use and improve HIV c...

Research Terms

<21+ years old><AIDS><AIDS Virus><AIDS/HIV><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Adherence><Adult><Adult Human><Alabama><Alcohol Chemical Class><Alcohol Drinking><Alcohol consumption><Alcohols><Anxiety><Apache><Application Context><Arizona><Assess implementation><Back><Businesses><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Caring><Clinic><Clinical><Clinical Treatment><Clinical effectiveness><Cognition Therapy><Cognitive Psychotherapy><Cognitive Therapy><Cognitive treatment><Collaborations><Communities><Complex><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counselor><Data><Data Analyses><Data Analysis><Data Collection><Data Element><Deep South><Demographic Factors><Diagnostic><Dorsum><Education for Intervention><Educational Intervention><Elements><Epidemic><EtOH drinking><EtOH use><Evidence based intervention><Face><Funding><Geographic Area><Geographic Locations><Geographic Region><Geographical Location><HIV><HIV/AIDS><Health Care Providers><Health Personnel><Human Immunodeficiency Viruses><Human Resources><Implementation assessment><Incidence><Infectious Diseases / Laboratory><Infectious Diseases Research><Instruction Intervention><Interpersonal Violence><Intervention><Investigators><Knowledge><LAV-HTLV-III><LMIC><Licensing><Lymphadenopathy-Associated Virus><Manpower><Mental Depression><Mental Health><Mental Hygiene><Mental disorders><Mental health disorders><Methods><Modeling><Monitor><NIAAA><NIH><National Institute on Alcohol Abuse and Alcoholism><National Institutes of Health><Northern Rhodesia><Outcome><Pain><Painful><Participant><Persons><Prevalence><Prevention><Professional counselor><Protocol><Protocols documentation><Provider><Psychiatric Disease><Psychiatric Disorder><Psychological Health><Psychologist><Public Sector><R-Series Research Projects><R01 Mechanism><R01 Program><Randomized Controlled Clinical Trials><Randomized, Controlled Trials><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Rural><Rural Population><Rural group><Rural people><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Sahara><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Structure><Telemedicine><Training><Training Intervention><Translating><Treatment outcome><United States><United States National Institutes of Health><Viral><Virus-HIV><Washington><Zambia><addiction><addictive disorder><adulthood><alcohol co-morbidity><alcohol comorbidity><alcohol ingestion><alcohol intake><alcohol misuse><alcohol product use><alcohol use><alcoholic beverage consumption><alcoholic drink intake><alleviate symptom><ameliorating symptom><antiretroviral therapy><antiretroviral treatment><behavioral health><behavioral health intervention><brief alcohol intervention><brief intervention><brief therapy><brief treatment><career><clinical intervention><clinical therapy><co-morbid><co-morbidity><cognitive behavior intervention><cognitive behavior modification><cognitive behavior therapy><cognitive behavioral intervention><cognitive behavioral modification><cognitive behavioral therapy><cognitive behavioral treatment><common treatment><community clinic><comorbidity><compare effectiveness><contextual factors><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><cost><cost effective><data harmonization><data interpretation><decrease symptom><depression><design><designing><effectiveness testing><ethanol consumption><ethanol drinking><ethanol ingestion><ethanol intake><ethanol misuse><ethanol product use><ethanol use><evaluate implementation><evaluation of implementation><faces><facial><fewer symptoms><geographic site><harmonized data><health care personnel><health care worker><health provider><health workforce><implementation determinants><implementation evaluation><implementation factors><improved><instructional intervention><low and middle-income countries><medical personnel><mental illness><mortality><participant enrollment><patient enrollment><peer><personnel><pilot test><population based><post-trauma stress><post-traumatic stress><post-traumatic stress symptoms><post-traumatic symptoms><posttrauma stress><posttraumatic stress><posttraumatic stress symptoms><posttraumatic symptoms><programs><psychiatric illness><psychological disorder><randomized control clinical trial><randomized control trial><reduce symptoms><relieves symptoms><response><rural individual><screening><screenings><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><sex><substance use><substance using><suicidal risk><suicide risk><symptom alleviation><symptom reduction><symptom relief><synergism><therapy adherence><therapy compliance><treatment as prevention><treatment effect><treatment provider><treatment-based prevention><trial design><trial regimen><trial treatment><unhealthy alcohol use>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ARNOLD LOUIE

UNIVERSITY OF FLORIDA, GAINESVILLE, FL

Good lead · 66/100

Likely hiring

Large award

Active award

$1,380,576

FY 2026

Project Title

Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression

Grant Number:

5R01AI173238-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

1/25/2023

End Date:

12/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary/Abstract In P01 AI123036, we were able to generate an algorithm that ranked single agents for Mycobacterium tuberculosis (MTB), identified promising 2-drug combinations and, with a completely novel mathematical approach, identified 3-drug regimens predicted to be significantly better...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Michael N. Neely

UNIVERSITY OF FLORIDA, GAINESVILLE, FL

Good lead · 66/100

Likely hiring

Large award

Active award

$1,380,576

FY 2026

Project Title

Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression

Grant Number:

5R01AI173238-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

1/25/2023

End Date:

12/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary/Abstract In P01 AI123036, we were able to generate an algorithm that ranked single agents for Mycobacterium tuberculosis (MTB), identified promising 2-drug combinations and, with a completely novel mathematical approach, identified 3-drug regimens predicted to be significantly better...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kenneth Zaret

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Good lead · 66/100

Likely hiring

Above-average budget

Recent

Active award

$676,155

FY 2026

Project Title

Transcription Factors Overcoming Chromatin Barriers to Control Cell Fate

Grant Number:

5R35GM153180-03

Activity Code:

R35

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/1/2024

End Date:

2/28/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Project summary (updated): The goal of this proposal is to reveal mechanisms by which gene regulatory proteins overcome chromosome structural barriers, to change cell fates. The work will provide foundational insight into gene regulation and more efficient ways to generate new cell types for therap...

Research Terms

<21+ years old><ATAC><Adult><Adult Human><Amino Acids><Basal Transcription Factor><Basal transcription factor genes><Binding><Biochemical><Body Tissues><Cancers><Categories><Cell Body><Cell Culture Techniques><Cell Fate Control><Cell Fate Regulation><Cell Reprogramming><Cells><Childhood><Chromatin><Chromosomes><DNA><DNA Nucleases><DNase><Deoxyribonucleases><Deoxyribonucleic Acid><Disease><Disorder><Enabling Factors><Event><Gene Action Regulation><Gene Down-Regulation><Gene Expression Regulation><Gene Regulation><Gene Regulation Process><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Genes><Genetic><Genetic Transcription><Genomics><Goals><Grant><Heterochromatin><Histones><Human><Human Development><In Vitro><LPTN><Licensing Factor><Malignant Neoplasms><Malignant Tumor><Mice><Mice Mammals><Modern Man><Molecular Interaction><Murine><Mus><Natural regeneration><Nucleosomes><Peptide Domain><Protein Domains><Proteins><RNA Expression><Regeneration><Regulatory Protein><Research><Resistance><SCM-1><SCM-1a><SCM1><SCYC1><Technology><Tertiary Protein Structure><Therapeutic><Tissues><Transcription><Transcription Factor Proto-Oncogene><Transcription Repression><Transcription factor genes><Update><Work><XCL1><XCL1 gene><adulthood><aminoacid><cell culture><cell cultures><cell type><cellular reprogramming><disease model><disorder model><gene repression><genetic approach><genetic regulatory protein><genetic strategy><improved><in vivo><insight><knock-down><knockdown><long read seq><long-read sequencing><long-read transcript sequencing><malignancy><neoplasm/cancer><pediatric><programs><reconstitute><reconstitution><regenerate><regulatory gene product><resistant><single molecule><transcription factor>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ROBERT D HARVEY

UNIVERSITY OF NEVADA RENO, RENO, NV

Good lead · 62/100

Large award

Very recent

Active award

Team-scale grant

$2,202,799

FY 2026

Project Title

Nevada Center of Biomedical Research Excellence in Molecular and Cellular Signal Transduction in the Cardiovascular System

Grant Number:

5P20GM130459-08

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

1/1/2019

End Date:

2/28/2029

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Project Summary - Overall This Phase II Center of Biomedical Research Excellence (COBRE) proposal aims to sustain and enhance an interdisciplinary research Center within the University of Nevada, Reno (UNR) focused on fundamental molecular and cellular signal transduction mechanisms within the cardi...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KENNETH MICHAEL CUMMINGS

MEDICAL UNIVERSITY OF SOUTH CAROLINA, CHARLESTON, SC

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$994,502

FY 2025

Project Title

Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study

Grant Number:

3P01CA200512-10S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/19/2016

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

OVERALL SUMMARY/ABSTRACT The proposed renewal of this P01 builds upon the longstanding International Tobacco Control (ITC) Policy Evaluation Project, which has used cross-country comparisons and a common mediation model to evaluate the behavioral impacts of national-level tobacco control policies. T...

Research Terms

<21+ years old><Address><Adolescent and Young Adult><Adult><Adult Human><Affect><Age Years><Australia><Behavior><Behavioral><Canada><Causality><Cigarette><Country><County><Cross Sectional Analysis><Cross-Sectional Analyses><Cross-Sectional Studies><Cross-Sectional Survey><Data><Data Management Core><Disease Frequency Surveys><Dissemination and Implementation><Doctor of Philosophy><Emerging Tobacco Products><England><Etiology><Funding Agency><Funding Source><Future><Goals><Health><Health Policy><Industry><International><Intervention><Japan><Marketing><Mediation><Methods><Modeling><Monitor><Negotiating><Negotiation><New Zealand><Nicotine><Perception><Ph.D.><PhD><Policies><Policy Analyses><Policy Analysis><Policy Maker><Population><Population Forecasts><Population Projection><Price><Probabilistic Models><Probability Models><Public Health><Public Policy><Republic of Korea><Research><Resource Sharing><Scanning><Science><Series><South Korea><Statistical Models><Structure><Survey Instrument><Surveys><Testing><Tobacco><Tobacco Consumption><Tobacco Industry><Tobacco smoke><Tobacco use><Translating><United States><Work><Youth><Youth 10-21><access restrictions><adult youth><adulthood><cannabis legalization><causation><cigarette smoking><cigarette use><cohort><consumer behavior><data hub><data management><data management and coordinating center><data management center><design><designing><disease causation><experience><health care policy><heat-not-burn><heated tobacco products><innovate><innovation><innovative><legal marijuana><legalized cannabis><legalized marijuana><marijuana legalization><method development><multidisciplinary><nicotine consumption><nicotine use><operation><operations><policy evaluation><population health><pricing><programs><public policy on tobacco><regulate tobacco><response><sharing hub><statistical linear mixed models><statistical linear models><tobacco company><tobacco control><tobacco control policy><tobacco policy><tobacco product use><tobacco products><tobacco regulation><tobacco regulatory efforts><tobacco user><trend><uptake><vaping nicotine><vapor><young adult><young adult age><young adulthood><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

GEOFFREY T FONG

MEDICAL UNIVERSITY OF SOUTH CAROLINA, CHARLESTON, SC

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$994,502

FY 2025

Project Title

Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study

Grant Number:

3P01CA200512-10S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/19/2016

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

OVERALL SUMMARY/ABSTRACT The proposed renewal of this P01 builds upon the longstanding International Tobacco Control (ITC) Policy Evaluation Project, which has used cross-country comparisons and a common mediation model to evaluate the behavioral impacts of national-level tobacco control policies. T...

Research Terms

<21+ years old><Address><Adolescent and Young Adult><Adult><Adult Human><Affect><Age Years><Australia><Behavior><Behavioral><Canada><Causality><Cigarette><Country><County><Cross Sectional Analysis><Cross-Sectional Analyses><Cross-Sectional Studies><Cross-Sectional Survey><Data><Data Management Core><Disease Frequency Surveys><Dissemination and Implementation><Doctor of Philosophy><Emerging Tobacco Products><England><Etiology><Funding Agency><Funding Source><Future><Goals><Health><Health Policy><Industry><International><Intervention><Japan><Marketing><Mediation><Methods><Modeling><Monitor><Negotiating><Negotiation><New Zealand><Nicotine><Perception><Ph.D.><PhD><Policies><Policy Analyses><Policy Analysis><Policy Maker><Population><Population Forecasts><Population Projection><Price><Probabilistic Models><Probability Models><Public Health><Public Policy><Republic of Korea><Research><Resource Sharing><Scanning><Science><Series><South Korea><Statistical Models><Structure><Survey Instrument><Surveys><Testing><Tobacco><Tobacco Consumption><Tobacco Industry><Tobacco smoke><Tobacco use><Translating><United States><Work><Youth><Youth 10-21><access restrictions><adult youth><adulthood><cannabis legalization><causation><cigarette smoking><cigarette use><cohort><consumer behavior><data hub><data management><data management and coordinating center><data management center><design><designing><disease causation><experience><health care policy><heat-not-burn><heated tobacco products><innovate><innovation><innovative><legal marijuana><legalized cannabis><legalized marijuana><marijuana legalization><method development><multidisciplinary><nicotine consumption><nicotine use><operation><operations><policy evaluation><population health><pricing><programs><public policy on tobacco><regulate tobacco><response><sharing hub><statistical linear mixed models><statistical linear models><tobacco company><tobacco control><tobacco control policy><tobacco policy><tobacco product use><tobacco products><tobacco regulation><tobacco regulatory efforts><tobacco user><trend><uptake><vaping nicotine><vapor><young adult><young adult age><young adulthood><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Andrew Hyland

MEDICAL UNIVERSITY OF SOUTH CAROLINA, CHARLESTON, SC

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$994,502

FY 2025

Project Title

Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study

Grant Number:

3P01CA200512-10S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/19/2016

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

OVERALL SUMMARY/ABSTRACT The proposed renewal of this P01 builds upon the longstanding International Tobacco Control (ITC) Policy Evaluation Project, which has used cross-country comparisons and a common mediation model to evaluate the behavioral impacts of national-level tobacco control policies. T...

Research Terms

<21+ years old><Address><Adolescent and Young Adult><Adult><Adult Human><Affect><Age Years><Australia><Behavior><Behavioral><Canada><Causality><Cigarette><Country><County><Cross Sectional Analysis><Cross-Sectional Analyses><Cross-Sectional Studies><Cross-Sectional Survey><Data><Data Management Core><Disease Frequency Surveys><Dissemination and Implementation><Doctor of Philosophy><Emerging Tobacco Products><England><Etiology><Funding Agency><Funding Source><Future><Goals><Health><Health Policy><Industry><International><Intervention><Japan><Marketing><Mediation><Methods><Modeling><Monitor><Negotiating><Negotiation><New Zealand><Nicotine><Perception><Ph.D.><PhD><Policies><Policy Analyses><Policy Analysis><Policy Maker><Population><Population Forecasts><Population Projection><Price><Probabilistic Models><Probability Models><Public Health><Public Policy><Republic of Korea><Research><Resource Sharing><Scanning><Science><Series><South Korea><Statistical Models><Structure><Survey Instrument><Surveys><Testing><Tobacco><Tobacco Consumption><Tobacco Industry><Tobacco smoke><Tobacco use><Translating><United States><Work><Youth><Youth 10-21><access restrictions><adult youth><adulthood><cannabis legalization><causation><cigarette smoking><cigarette use><cohort><consumer behavior><data hub><data management><data management and coordinating center><data management center><design><designing><disease causation><experience><health care policy><heat-not-burn><heated tobacco products><innovate><innovation><innovative><legal marijuana><legalized cannabis><legalized marijuana><marijuana legalization><method development><multidisciplinary><nicotine consumption><nicotine use><operation><operations><policy evaluation><population health><pricing><programs><public policy on tobacco><regulate tobacco><response><sharing hub><statistical linear mixed models><statistical linear models><tobacco company><tobacco control><tobacco control policy><tobacco policy><tobacco product use><tobacco products><tobacco regulation><tobacco regulatory efforts><tobacco user><trend><uptake><vaping nicotine><vapor><young adult><young adult age><young adulthood><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KENNETH MICHAEL CUMMINGS

MEDICAL UNIVERSITY OF SOUTH CAROLINA, CHARLESTON, SC

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$922,161

FY 2025

Project Title

Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study

Grant Number:

5P01CA200512-10

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/19/2016

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

OVERALL SUMMARY/ABSTRACT The proposed renewal of this P01 builds upon the longstanding International Tobacco Control (ITC) Policy Evaluation Project, which has used cross-country comparisons and a common mediation model to evaluate the behavioral impacts of national-level tobacco control policies. T...

Research Terms

<21+ years old><Address><Adolescent and Young Adult><Adult><Adult Human><Affect><Age Years><Australia><Behavior><Behavioral><Canada><Causality><Cigarette><Country><County><Cross Sectional Analysis><Cross-Sectional Analyses><Cross-Sectional Studies><Cross-Sectional Survey><Data><Data Management Core><Disease Frequency Surveys><Dissemination and Implementation><Doctor of Philosophy><Emerging Tobacco Products><England><Etiology><Funding Agency><Funding Source><Future><Goals><Health><Health Policy><Industry><International><Intervention><Japan><Marketing><Mediation><Methods><Modeling><Monitor><Negotiating><Negotiation><New Zealand><Nicotine><Perception><Ph.D.><PhD><Policies><Policy Analyses><Policy Analysis><Policy Maker><Population><Population Forecasts><Population Projection><Price><Probabilistic Models><Probability Models><Public Health><Public Policy><Republic of Korea><Research><Resource Sharing><Scanning><Science><Series><South Korea><Statistical Models><Structure><Survey Instrument><Surveys><Testing><Tobacco><Tobacco Consumption><Tobacco Industry><Tobacco smoke><Tobacco use><Translating><United States><Work><Youth><Youth 10-21><access restrictions><adult youth><adulthood><cannabis legalization><causation><cigarette smoking><cigarette use><cohort><consumer behavior><data hub><data management><data management and coordinating center><data management center><design><designing><disease causation><experience><health care policy><heat-not-burn><heated tobacco products><innovate><innovation><innovative><legal marijuana><legalized cannabis><legalized marijuana><marijuana legalization><method development><multidisciplinary><nicotine consumption><nicotine use><operation><operations><policy evaluation><population health><pricing><programs><public policy on tobacco><regulate tobacco><response><sharing hub><statistical linear mixed models><statistical linear models><tobacco company><tobacco control><tobacco control policy><tobacco policy><tobacco product use><tobacco products><tobacco regulation><tobacco regulatory efforts><tobacco user><trend><uptake><vaping nicotine><vapor><young adult><young adult age><young adulthood><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

GEOFFREY T FONG

MEDICAL UNIVERSITY OF SOUTH CAROLINA, CHARLESTON, SC

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$922,161

FY 2025

Project Title

Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study

Grant Number:

5P01CA200512-10

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/19/2016

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

OVERALL SUMMARY/ABSTRACT The proposed renewal of this P01 builds upon the longstanding International Tobacco Control (ITC) Policy Evaluation Project, which has used cross-country comparisons and a common mediation model to evaluate the behavioral impacts of national-level tobacco control policies. T...

Research Terms

<21+ years old><Address><Adolescent and Young Adult><Adult><Adult Human><Affect><Age Years><Australia><Behavior><Behavioral><Canada><Causality><Cigarette><Country><County><Cross Sectional Analysis><Cross-Sectional Analyses><Cross-Sectional Studies><Cross-Sectional Survey><Data><Data Management Core><Disease Frequency Surveys><Dissemination and Implementation><Doctor of Philosophy><Emerging Tobacco Products><England><Etiology><Funding Agency><Funding Source><Future><Goals><Health><Health Policy><Industry><International><Intervention><Japan><Marketing><Mediation><Methods><Modeling><Monitor><Negotiating><Negotiation><New Zealand><Nicotine><Perception><Ph.D.><PhD><Policies><Policy Analyses><Policy Analysis><Policy Maker><Population><Population Forecasts><Population Projection><Price><Probabilistic Models><Probability Models><Public Health><Public Policy><Republic of Korea><Research><Resource Sharing><Scanning><Science><Series><South Korea><Statistical Models><Structure><Survey Instrument><Surveys><Testing><Tobacco><Tobacco Consumption><Tobacco Industry><Tobacco smoke><Tobacco use><Translating><United States><Work><Youth><Youth 10-21><access restrictions><adult youth><adulthood><cannabis legalization><causation><cigarette smoking><cigarette use><cohort><consumer behavior><data hub><data management><data management and coordinating center><data management center><design><designing><disease causation><experience><health care policy><heat-not-burn><heated tobacco products><innovate><innovation><innovative><legal marijuana><legalized cannabis><legalized marijuana><marijuana legalization><method development><multidisciplinary><nicotine consumption><nicotine use><operation><operations><policy evaluation><population health><pricing><programs><public policy on tobacco><regulate tobacco><response><sharing hub><statistical linear mixed models><statistical linear models><tobacco company><tobacco control><tobacco control policy><tobacco policy><tobacco product use><tobacco products><tobacco regulation><tobacco regulatory efforts><tobacco user><trend><uptake><vaping nicotine><vapor><young adult><young adult age><young adulthood><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Andrew Hyland

MEDICAL UNIVERSITY OF SOUTH CAROLINA, CHARLESTON, SC

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$922,161

FY 2025

Project Title

Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study

Grant Number:

5P01CA200512-10

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/19/2016

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

OVERALL SUMMARY/ABSTRACT The proposed renewal of this P01 builds upon the longstanding International Tobacco Control (ITC) Policy Evaluation Project, which has used cross-country comparisons and a common mediation model to evaluate the behavioral impacts of national-level tobacco control policies. T...

Research Terms

<21+ years old><Address><Adolescent and Young Adult><Adult><Adult Human><Affect><Age Years><Australia><Behavior><Behavioral><Canada><Causality><Cigarette><Country><County><Cross Sectional Analysis><Cross-Sectional Analyses><Cross-Sectional Studies><Cross-Sectional Survey><Data><Data Management Core><Disease Frequency Surveys><Dissemination and Implementation><Doctor of Philosophy><Emerging Tobacco Products><England><Etiology><Funding Agency><Funding Source><Future><Goals><Health><Health Policy><Industry><International><Intervention><Japan><Marketing><Mediation><Methods><Modeling><Monitor><Negotiating><Negotiation><New Zealand><Nicotine><Perception><Ph.D.><PhD><Policies><Policy Analyses><Policy Analysis><Policy Maker><Population><Population Forecasts><Population Projection><Price><Probabilistic Models><Probability Models><Public Health><Public Policy><Republic of Korea><Research><Resource Sharing><Scanning><Science><Series><South Korea><Statistical Models><Structure><Survey Instrument><Surveys><Testing><Tobacco><Tobacco Consumption><Tobacco Industry><Tobacco smoke><Tobacco use><Translating><United States><Work><Youth><Youth 10-21><access restrictions><adult youth><adulthood><cannabis legalization><causation><cigarette smoking><cigarette use><cohort><consumer behavior><data hub><data management><data management and coordinating center><data management center><design><designing><disease causation><experience><health care policy><heat-not-burn><heated tobacco products><innovate><innovation><innovative><legal marijuana><legalized cannabis><legalized marijuana><marijuana legalization><method development><multidisciplinary><nicotine consumption><nicotine use><operation><operations><policy evaluation><population health><pricing><programs><public policy on tobacco><regulate tobacco><response><sharing hub><statistical linear mixed models><statistical linear models><tobacco company><tobacco control><tobacco control policy><tobacco policy><tobacco product use><tobacco products><tobacco regulation><tobacco regulatory efforts><tobacco user><trend><uptake><vaping nicotine><vapor><young adult><young adult age><young adulthood><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Roger L Shapiro

HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH, BOSTON, MA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$762,247

FY 2025

Project Title

Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV

Grant Number:

5P01HD107670-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/24/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overall Project Summary/Abstract Antiretroviral treatment (ART) options for pregnant women and children living with HIV have fallen behind those for adults, reflecting the substantial research gap for modern ART regimens in these groups. Safety and efficacy studies of specific ART regimens in pregna...

Research Terms

<0-11 years old><21+ years old><AIDS Virus><AIDS test><AIDS/HIV test><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adult><Adult Human><Bechuanaland><Birth><Birth Defects><Botswana><Child><Child Youth><Children (0-21)><Clinical Trials><Collaborations><Congenital Abnormality><Congenital Anatomical Abnormality><Congenital Defects><Congenital Deformity><Congenital Malformation><Data><Data Sources><Development><Diagnosis><Exposure to><Funding><Gestation><HIV><HIV test><HIV vaccine><HIV-1><HIV-1 test><HIV-2 test><HIV-I><HIV/AIDS Vaccines><HIV1><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Viruses><Human immunodeficiency virus 1><Human immunodeficiency virus test><Immune><Immune response><Immunes><Infant><Infection><Infrastructure><Investigators><LAV-HTLV-III><Laboratories><Lymphadenopathy-Associated Virus><Measures><Messenger RNA><Methodology><Modernization><NIH><National Institutes of Health><Neural Tube Defects><Neural Tube Developmental Defects><Outcome><Parturition><Performance><Pregnancy><Pregnant Women><Principal Investigator><RNA vaccine><RNA-based vaccine><Reporting><Research><Research Personnel><Research Priority><Research Specimen><Researchers><Series><Specimen><Surveillance Program><System><Techniques><Treatment Protocols><Treatment Regimen><Treatment Schedule><United States National Institutes of Health><Validation><Viral reservoir><Virus reservoir><Virus-HIV><Weight><Woman><Work><adulthood><antiretroviral therapy><antiretroviral treatment><chromosomal location><chromosomal position><chromosome location><cohort><data management><data sharing><developmental><efficacy study><expectant mother><expectant women><expecting mother><expecting women><experience><forging><high risk infant><host response><human immunodeficiency virus vaccine><immune system response><immunoresponse><individuals who are pregnant><infancy><infantile><kids><mRNA><mRNA vaccine><mRNA-based vaccine><maternal weight><neonate><new approaches><novel approaches><novel strategies><novel strategy><pediatric HIV><pediatric HIV disease><pediatric HIV infection><pediatric human immunodeficiency virus><pediatric human immunodeficiency virus disease><pediatric human immunodeficiency virus infection><people who are pregnant><point of care><point-of-care diagnostics><precision medicine><precision-based medicine><pregnant females><pregnant mothers><pregnant people><pregnant populations><programs><safety study><therapy optimization><those who are pregnant><treatment guidelines><treatment optimization><treatment strategy><validations><vulnerable infant><weights><women who are pregnant><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mark N Wu

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 60/100

Likely hiring

Large award

Active award

$1,151,469

FY 2025

Project Title

Cross-Species Analyses of the Molecular and Circuit Basis ofSleep

Grant Number:

5R35NS122181-05

Activity Code:

R35

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2021

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Summary Sleep is an enigmatic behavior that is conserved across the animal kingdom. The mechanisms underlying the regulation of sleep remain poorly understood, and the function of sleep is even more elusive. Yet, dysregulation of sleep is a major cause of human morbidity, and understanding why we sl...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PERIANNAN KUPPUSAMY

DARTMOUTH COLLEGE, HANOVER, NH

Good lead · 60/100

Likely hiring

Above-average budget

Active award

$637,034

FY 2026

Project Title

EPR scanner for tumor oximetry in the clinic

Grant Number:

5R01CA269234-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

1/1/2023

End Date:

12/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY This academic-industrial partnership (AIP) proposal seeks to develop a robust and easy-to-use clinical scanner for tumor oxygen measurement (oximetry) in cancer patients. By knowing quantitative tumor oxygen levels in real time, radiotherapy could be better planned and delivered at t...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Benjamin Gaston

INDIANA UNIVERSITY INDIANAPOLIS, INDIANAPOLIS, IN

Good lead · 58/100

Likely hiring

Large award

Team-scale grant

$2,408,164

FY 2025

Project Title

Scientific innovation for personalized severe asthma management

Grant Number:

5P01HL158507-05

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2021

End Date:

4/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT Our overall goal is to characterize the cell biology and physiology of recently identified mechanisms underlying severe asthma. Severe asthma is a disabling obstructive lung disease that accounts for the majority of the morbidity and mortality associated with asthma; it acco...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

RONALD ANTHONY DEPINHO

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Good lead · 58/100

Likely hiring

Large award

Team-scale grant

$2,385,495

FY 2025

Project Title

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

Grant Number:

5P01CA117969-20

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

12/1/2005

End Date:

3/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall - Abstract/Summary. This multi-disciplinary team focuses on the role of oncogenic Kras (Kras*) in pancreatic ductal adenocarcinoma (PDAC) with an emphasis on understanding the interplay between Kras* cancer cells and the tumor microenvironment (TME). Our objectives are to ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Girardin Jean-Louis

UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, CORAL GABLES, FL

Good lead · 58/100

Training-friendly

Solid budget

Very recent

Active award

$336,898

FY 2026

Project Title

Promoting Academic Workforce Development in Behavioral Medicine and Sleep Disorders Research

Grant Number:

5R25HL105444-17

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/20/2010

End Date:

12/31/2028

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

The overarching goal of the UM Behavioral Medicine and Sleep Disorders (BSM) Institute is to continue building capacity to address a critical deficiency in the academic workforce. This will be achieved by providing a congruent mentored learning experience to an additional cadre of junior faculty pur...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Tatjana Rundek

UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, CORAL GABLES, FL

Good lead · 58/100

Training-friendly

Solid budget

Very recent

Active award

$336,898

FY 2026

Project Title

Promoting Academic Workforce Development in Behavioral Medicine and Sleep Disorders Research

Grant Number:

5R25HL105444-17

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/20/2010

End Date:

12/31/2028

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

The overarching goal of the UM Behavioral Medicine and Sleep Disorders (BSM) Institute is to continue building capacity to address a critical deficiency in the academic workforce. This will be achieved by providing a congruent mentored learning experience to an additional cadre of junior faculty pur...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jeffrey S. Miller

UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MN

Good lead · 54/100

Likely hiring

Above-average budget

Active award

$928,524

FY 2025

Project Title

Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors

Grant Number:

5R35CA283892-03

Activity Code:

R35

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

During the last 2.5 decades, I have led clinical efforts to develop novel NK cell immunotherapy strategies to treat cancer by advancing lab-based discoveries in the areas of natural killer (NK) cell and IL-15 biology. This work has been supported by a continuously funded and recently renewed NCI P01...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MICHAEL H NATHANSON

YALE UNIVERSITY, NEW HAVEN, CT

Good lead · 54/100

Likely hiring

Above-average budget

Active award

$659,865

FY 2025

Project Title

ITPR3 and aberrant mitochondrial calcium signaling in alcoholic hepatitis

Grant Number:

1R01AA031217-01A1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/16/2025

End Date:

7/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Excessive alcohol intake is the third leading cause of preventable death in the US and is the leading risk factor for death globally among people aged 15–49 years. Moreover, cirrhosis-related mortality among people aged 25–34 years has been increasing by >10% per year in recent years, and this is dr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Paul Garrity

BRANDEIS UNIVERSITY, WALTHAM, MA

Good lead · 54/100

Likely hiring

Above-average budget

Active award

$557,735

FY 2025

Project Title

Molecular and cellular determinants of Drosophila larva thermotaxis

Grant Number:

5R01GM130842-06

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/15/2019

End Date:

5/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY: Molecular and cellular determinants of Drosophila larva thermotaxis How nervous systems integrate internal and peripheral sensory inputs to maintain physiological homeostasis is a major question in neuroscience and physiology. Such integration is particularly salient in the control ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ARAVINTHAN D. SAMUEL

BRANDEIS UNIVERSITY, WALTHAM, MA

Good lead · 54/100

Likely hiring

Above-average budget

Active award

$557,735

FY 2025

Project Title

Molecular and cellular determinants of Drosophila larva thermotaxis

Grant Number:

5R01GM130842-06

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/15/2019

End Date:

5/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY: Molecular and cellular determinants of Drosophila larva thermotaxis How nervous systems integrate internal and peripheral sensory inputs to maintain physiological homeostasis is a major question in neuroscience and physiology. Such integration is particularly salient in the control ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Roger L Shapiro

HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH, BOSTON, MA

Good lead · 54/100

Likely hiring

Solid budget

Active award

Team-scale grant

$431,126

FY 2025

Project Title

Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV

Grant Number:

3P01HD107670-05S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/24/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Project 1: Project Summary/Abstract, Tsepamo Plus (Project 1) Antiretroviral treatment (ART) guidelines depend upon safety and efficacy data in pregnancy, especially in resource-limited settings where programs rely on a single ART regimen as first-line treatment for all pregnant and non-pregnant adu...

Research Terms

<0-11 years old><0-4 weeks old><21+ years old><3TC><AIDS><AIDS Virus><AIDS test><AIDS/HIV test><AZT><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Adopted><Adult><Adult Human><Adverse Experience><Adverse event><Africa><African><Age><Anti-Retroviral Agents><Award><Azidothymidine><Bechuanaland><Binding><Birth><Birth Defects><Birth Intervals><Birth Spacing><Botswana><Cessation of life><Child><Child Youth><Children (0-21)><Clinical><Clinical Trials><Complex><Conceptions><Congenital Abnormality><Congenital Anatomical Abnormality><Congenital Defects><Congenital Deformity><Congenital Malformation><Country><Data><Data Bases><Databases><Death><Diagnosis><Diagnostic><Diagnostic tests><Discipline of obstetrics><Dose><Drugs><Enrollment><Evaluation><Exclusion><Fetomaternal Transmission><Folate><Folic Acid><Funding><Gestation><Goals><Guidelines><HIV><HIV Infections><HIV diagnosis><HIV test><HIV-1><HIV-1 test><HIV-2 test><HIV-I><HIV1><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Status Index><Health Status Indicators><Hospital Admission><Hospitalization><Hospitals><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Human immunodeficiency virus 1><Human immunodeficiency virus test><Immune><Immunes><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologics><Incidence><Infant><Infection><Infrastructure><Intake><International><Kaletra><LAV-HTLV-III><Laboratories><Lamivudine><Life><Link><Lopinavir/Ritonavir><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Maternal-Fetal Transmission><Measures><Medication><Methodology><Modeling><Modernization><Modification><Molecular Interaction><Mothers><Multiple Pregnancy><Multiple gestation pregnancy><Neonatal Mortality><Neural Tube Defects><Neural Tube Developmental Defects><Nevirapine><New Agents><Newborn Infant><Newborns><Non-Polyadenylated RNA><Obstetrics><Outcome><P01 Mechanism><P01 Program><Parturition><Patients><Pattern><Performance><Perinatal><Peripartum><Pharmaceutical Preparations><Position><Positioning Attribute><PrEP><Pregnancy><Pregnancy Outcome><Pregnant Women><Premature Birth><Prematurely delivering><Preterm Birth><Prevalence><Productivity><Program Effectiveness><Program Project Grant><Program Research Project Grants><Pteroylglutamic Acid><Publications><RNA><RNA Gene Products><RNA vaccine><RNA-based vaccine><Rain><Recommendation><Regimen><Reporting><Research><Research Design><Research Program Projects><Research Specimen><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Ribonucleic Acid><Risk><Safety><Scientific Publication><Seasons><Series><Site><Specimen><Study Type><System><Target Populations><Tenofovir><Testing><Time><Treatment Failure><Treatment Protocols><Treatment Regimen><Treatment Schedule><Treatment outcome><Update><Validation><Viral><Viral reservoir><Viramune><Viread><Virus reservoir><Virus-HIV><Visit><Vitamin M><Weight><Weight Gain><Weight Increase><Woman><ZDV><Zidovudine><adulthood><adverse birth outcomes><age group><ages><anti-retroviral><antiretroviral therapy><antiretroviral treatment><assess effectiveness><azidodeoxythymidine><barrier to testing><beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine><birthing individual><birthing patient><birthing people><body weight gain><body weight increase><cohort><compare treatment><cost><data base><death among neonates><death among newborns><death in neonates><death in newborn><determine effectiveness><diagnostic approach><diagnostic strategy><dietary><drug/agent><effectiveness assessment><effectiveness evaluation><emtricitabine><enroll><evaluate effectiveness><examine effectiveness><expectant mother><expectant women><expecting mother><expecting women><experience><high risk><high risk infant><hurdle to testing><implementation research><improved><in utero><in utero transmission><individual who gives birth><individuals who are pregnant><infancy><infant outcome><infantile><kids><mRNA vaccine><mRNA-based vaccine><maternal hypertension><maternal to fetal transmission><maternal weight><mortality among neonates><mortality among newborns><mortality in neonates><mortality in newborns><neonatal death><neonatal demise><neonate><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><newborn child><newborn children><newborn death><newborn mortality><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><obstacle to testing><patient who gives birth><pediatric HIV disease><pediatric HIV infection><pediatric human immunodeficiency virus disease><pediatric human immunodeficiency virus infection><people giving birth><people who are pregnant><people who birth><people who give birth><point of care><point of care testing><point-of-care diagnostics><pre-exposure prophylaxis><precision medicine><precision-based medicine><pregnant><pregnant females><pregnant mothers><pregnant people><pregnant populations><premature childbirth><premature delivery><preterm delivery><program costs><programs><rainfall><randomized, clinical trials><screening><screenings><secondary analysis><stillbirth><stillborn><study design><surveillance study><testing barrier><testing hurdle><testing obstacle><therapy failure><those who are pregnant><timeline><transmission during pregnancy><treatment comparison><treatment guidelines><treatment program><treatment strategy><trial comparing><validations><viral rebound><virus rebound><vitamin Bc><vulnerable infant><weights><women who are pregnant><wt gain><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Seth Michael Rubin

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 50/100

Likely hiring

Active award

Team-scale grant

$87,708

FY 2026

Project Title

Determining and targeting mechanisms controlling cancer cell division

Grant Number:

3P01CA254867-04S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/25/2022

End Date:

2/28/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

OVERALL SUMMARY The Cyclin D-Cdk4/6-Rb-E2F pathway integrates external and internal signals to control cell cycle progression at the G1/S transition of the cell cycle. Alterations in the Cyclin D-Cdk4/6-Rb-E2F pathway are found in the vast majority of human cancers. These alterations are thought to ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jan M Skotheim

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 50/100

Likely hiring

Active award

Team-scale grant

$87,708

FY 2026

Project Title

Determining and targeting mechanisms controlling cancer cell division

Grant Number:

3P01CA254867-04S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/25/2022

End Date:

2/28/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

OVERALL SUMMARY The Cyclin D-Cdk4/6-Rb-E2F pathway integrates external and internal signals to control cell cycle progression at the G1/S transition of the cell cycle. Alterations in the Cyclin D-Cdk4/6-Rb-E2F pathway are found in the vast majority of human cancers. These alterations are thought to ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Keri C Hornbuckle

UNIVERSITY OF IOWA, IOWA CITY, IA

Good lead · 48/100

Large award

Active award

Team-scale grant

$3,068,799

FY 2026

Project Title

Iowa Superfund Research Program: Airborne PCBs: Sources, Exposures, Toxicities, Remediation

Grant Number:

5P42ES013661-21

Activity Code:

P42

Mechanism:

Research Centers

Agency:

NIH

Start Date:

5/12/2006

End Date:

1/31/2030

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

The Iowa Superfund Research Program (ISRP) is a center of research excellence focused on polychlorinated biphenyls (PCBs). PCBs mixtures called Aroclors were added to thousands of products, including construction materials, until their sales were banned more than 40 years ago. Today, people are stil...

Research Terms

<12-20 years old><Address><Adolescence><Adolescent><Adolescent Youth><Air><Bacteria><Biological><COBRE><Center of Biomedical Research Excellence><Centers of Research Excellence><Chemicals><Collaborations><Communities><Complex><Construction Materials><Data Science><Environmental Health><Environmental Health Science><Exposure to><Feedback><Funding><Gases><Goals><Government><Health><Human><Hydrogen Oxide><Individual><Indoor environment><Inhalation><Inhalation Exposure><Inhaling><Intervention><Investigators><Iowa><Leadership><Measures><Metabolic><Methods><Modern Man><Molecular><Neural Development><Oregon><P01 Mechanism><P01 Program><PCBs><Personal Satisfaction><Persons><Phase><Poison><Polychlorinated Biphenyls><Polychlorobiphenyl Compounds><Population><Program Project Grant><Program Research Project Grants><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Recommendation><Research><Research Activity><Research Grants><Research Personnel><Research Priority><Research Program Projects><Research Project Grants><Research Projects><Research Support><Researchers><Risk><Risk Assessment><Risk Factors><Route><Sales><Sampling><Schools><Scientist><Site><Soil><Source><Superfund><System><Techniques><Testing><Toxic Chemical><Toxic Substance><Toxic effect><Toxicities><Training><Training Programs><Translational Research><Translational Science><Vermont><Water><Water contamination><adolescence (12-20)><biologic><building materials><career><collaboration with communities><community collaboration><community engagement><community-based collaboration><contaminated water><cost effective><design><designing><engagement with communities><exposed human population><fat metabolism><fungus><human exposure><improved><innovate><innovation><innovative><juvenile><juvenile human><lipid metabolism><member><microbial><neurodevelopment><new approaches><new technology><novel><novel approaches><novel strategies><novel strategy><novel technologies><polychlorobiphenyl><prevent><preventing><programs><recruit><remediation><skills><superfund chemical><superfund site><toxic compound><translation research><translational investigation><well-being><wellbeing>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Adam David Hoppe

SOUTH DAKOTA STATE UNIVERSITY, BROOKINGS, SD

Good lead · 48/100

Large award

Active award

Team-scale grant

$2,147,910

FY 2026

Project Title

BioSystems Networks and Translational Research - Insights into Inflammation (BioSNTR-II)

Grant Number:

5P20GM135008-05

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

3/20/2022

End Date:

1/31/2027

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY – OVERALL The goal of this proposal is a coordinated, synergized, and integrated COBRE research program, called the “BioSystems Networks and Translational Research – Insights into Inflammation (BioSNTR-II),” at South Dakota State University (SDSU), Brookings, SD. Our research objecti...

Research Terms

<(TNF)-α><APF-1><ATP-Dependent Proteolysis Factor 1><Acceleration><Animals><Area><Bioinformatics><Biologic Sciences><Biological Sciences><Biomedical Research><Bioscience><Biotech><Biotechnology><Body Tissues><COBRE><CRISPR><CRISPR imaging><CRISPR/Cas system><Cachectin><Cell Body><Cell Communication><Cell Communication and Signaling><Cell Death><Cell Function><Cell Interaction><Cell Physiology><Cell Process><Cell Signaling><Cell-to-Cell Interaction><Cells><Cellular Function><Cellular Physiology><Cellular Process><Center for Translational Science Activities><Center of Biomedical Research Excellence><Centers of Research Excellence><Cilia><Clinic><Clustered Regularly Interspaced Short Palindromic Repeats><Clustered Regularly Interspaced Short Palindromic Repeats imaging><Communication><Cytokine Signal Transduction><Cytokine Signaling><Development><Development and Research><Disease><Disorder><Education><Educational aspects><Environment><Evaluation><Event><Faculty><Fostering><Funding><Gene Transcription><Generalized Growth><Genes><Genetic Transcription><Genomics><Goals><Grant><Growth><HMG-20><Health><High Mobility Protein 20><Human><Immune infiltrates><Inflammation><Inflammatory><Inflammatory Response><Intracellular Communication and Signaling><Investigators><Investments><Knowledge><Labor Forces><Life Sciences><Lymphangiogeneses><Lymphangiogenesis><Lymphatic><Macrophage><Macrophage Cell Biology><Macrophage-Derived TNF><Mentors><Microscopy><Mission><Modern Man><Molecular><Monocyte-Derived TNF><Mφ><NGS Method><NGS system><NIH><National Institutes of Health><Network Analysis><Optics><P01 Mechanism><P01 Program><Pathway Analysis><Pathway interactions><Performance><Personnel Management><Pilot Projects><Plants><Private Sector><Process><Program Project Grant><Program Research Project Grants><Proteins><Proteomics><Public Health><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><RNA Expression><RNA Seq><RNA sequencing><RNAseq><Records><Regulation><Research><Research Grants><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Research Resources><Researchers><Resolution><Resources><Role><Senior Scientist><Signal Transduction><Signal Transduction Systems><Signaling><South Dakota><Subcellular Process><TNF><TNF A><TNF Alpha><TNF gene><TNF-α><TNFA><TNFα><Technology><Technology Transfer><Tissue Growth><Tissues><Training Support><Transcription><Translational Research><Translational Science><Translations><Tumor Necrosis Factor><Tumor Necrosis Factor-alpha><Ubiquitin><United States National Institutes of Health><Universities><University adminstration><Work><biological signal transduction><career><cohort><developmental><experience><formative assessment><formative evaluation><full professor><global gene expression><global transcription profile><immune cell infiltrate><improved><innovate><innovation><innovative><insight><instrumentation><interdisciplinary approach><medical college><medical schools><model development><model developments><multidisciplinary approach><necrocytosis><next gen sequencing><next generation sequencing><nextgen sequencing><ontogeny><optical><pathway><pilot study><programs><research and development><resolutions><school of medicine><senior faculty><social role><success><synergism><tenure process><tenure track><transcriptome><transcriptome sequencing><transcriptomic sequencing><transcriptomics><translation><translation research><translational investigation><translational research center><translational sciences center>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Douglas W Leaman

AUBURN UNIVERSITY AT MONTGOMERY, MONTGOMERY, AL

Good lead · 48/100

Above-average budget

Recent

Active award

Team-scale grant

$554,945

FY 2026

Project Title

BRE-SPAD at Auburn University at Montgomery

Grant Number:

1UC2GM162936-01

Activity Code:

UC2

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/18/2026

End Date:

2/28/2031

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY Auburn University at Montgomery (AUM) is an institution of emerging excellence that has highlighted biomedical sciences as a targeted growth/investment area. Coupled with the completion and recent occupancy of a new $37M science building that has greatly enhanced and expanded our bio...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mrinal Varma

AUBURN UNIVERSITY AT MONTGOMERY, MONTGOMERY, AL

Good lead · 48/100

Above-average budget

Recent

Active award

Team-scale grant

$554,945

FY 2026

Project Title

BRE-SPAD at Auburn University at Montgomery

Grant Number:

1UC2GM162936-01

Activity Code:

UC2

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/18/2026

End Date:

2/28/2031

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY Auburn University at Montgomery (AUM) is an institution of emerging excellence that has highlighted biomedical sciences as a targeted growth/investment area. Coupled with the completion and recent occupancy of a new $37M science building that has greatly enhanced and expanded our bio...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mary K Kochlefl

XAVIER UNIVERSITY, CINCINNATI, OH

Good lead · 48/100

Solid budget

Very recent

Active award

Team-scale grant

$389,203

FY 2026

Project Title

Building Capacity in Biomedical Research at Xavier University

Grant Number:

1UC2GM162888-01

Activity Code:

UC2

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/7/2026

End Date:

1/31/2031

Why this may be worth a closer look

• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Given recent commitments and existing strengths, Xavier University, a doctoral/professional university in Cincinnati, Ohio, is poised to significantly increase biomedical research and grant seeking. In fall 2027, Xavier will open the first Jesuit Catholic College of Osteopathic Medicine (COM) in the...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kathryn B Anderson

UPSTATE MEDICAL UNIVERSITY, SYRACUSE, NY

Good lead · 46/100

Likely hiring

Solid budget

Active award

$427,769

FY 2025

Project Title

Defining correlates of protection from dengue illness in a long-term cohort study of multigenerational house-holds in Thailand

Grant Number:

5R01AI175941-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/10/2023

End Date:

6/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY Dengue viruses (DENV) cause a significant and unchecked burden of human death and disease, with vaccine development hindered by critical gaps in our understanding of how multi-serotypic protection against DENV is generated, sustained, and subsequently identified in immunological assa...

Research Terms

<0-11 years old><7S Gamma Globulin><Acute><Address><Antibodies><Antibody titer measurement><Antigens><Arboviral><Arboviruses><Area><Arthropod-Borne Viruses><Benchmarking><Best Practice Analysis><Breakbone Fever Virus><Breast Feeding><Breast fed><Breastfed><Breastfeeding><Cessation of life><Child><Child Youth><Children (0-21)><Clinical><Cohort Studies><Communicable Diseases><Concurrent Studies><Custom><DENV><DENV infection><DENV vaccine><Death><Dengue><Dengue Infection><Dengue Vaccine><Dengue Virus><Dengue fever virus><Dengue virus infection><Dengue virus vaccine><Development><Diagnostic><Disease><Disorder><Enrollment><Environment><Exposure to><Family><Flavivirus><Funding><Future><Generations><Goals><Group B Arbovirus><Health><History><Household><Human><Humoral Immunities><IgG><Immune><Immune mediated therapy><Immunes><Immunity><Immunochemical Immunologic><Immunoglobulin G><Immunologic><Immunological><Immunologically><Immunologically Directed Therapy><Immunologics><Immunology procedure><Immunotherapy><Incidence><Individual><Infant><Infection><Infectious Diseases><Infectious Disorder><Japanese B Encephalitis Virus><Japanese encephalitis virus><Kinetics><Knowledge><Locales><Long-term Follow-up><Long-term cohort study><Longitudinal cohort study><Malaria><Maps><Maternal Immunity><Maternally-Acquired Immunity><Math Models><Mediating><Mission><Modeling><Modern Man><Mothers><NIAID><NIH><National Institute of Allergy and Infectious Disease><National Institutes of Health><Orthoflavivirus><Outcome><Paludism><Pathogenesis><Phenotype><Plasmodium Infections><Population Surveillance><Pregnant Women><Public Health Surveillance><Recording of previous events><Research><Research Specimen><Risk><Safety><Saliva><Sampling><Serotyping><Shapes><Specimen><Techniques><Testing><Thailand><Time><Triage><United States National Institutes of Health><VAC-TX><Vaccinated><Vaccination><Vaccine Therapy><Vaccines><Viral Diseases><Virus Diseases><ZIKV><ZIKV infected><ZIKV infection><ZIKV positive><Zika Virus><Zika virus infection><antibody titering><antibody-based immunity><benchmark><cohort><cross reactivity><customs><dengue viral infection><develop a vaccine><develop vaccines><development of a vaccine><developmental><efficacy trial><enroll><expectant mother><expectant women><expectation><expecting mother><expecting women><histories><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunogen><immunogenicity><immunologic assay><immunologic assay/test><individuals who are pregnant><infected with ZIKV><infected with zika><innovate><innovation><innovative><kids><long-term followup><mathematic model><mathematical model><mathematical modeling><people who are pregnant><placental transfer><pregnant females><pregnant mothers><pregnant people><pregnant populations><prenatal><prevent><preventing><primary outcome><protective effect><secondary infection><seroconversion><severe dengue><therapeutic vaccination><those who are pregnant><tool><unborn><vaccine against DENV><vaccine against dengue><vaccine candidate against dengue><vaccine development><viral infection><viral transmission><virus infection><virus transmission><virus-induced disease><ward><women who are pregnant><youngster><zika infected><zika infection><zika viral infection><zikav>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Christopher Mark Norris

UNIVERSITY OF KENTUCKY, LEXINGTON, KY

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$230,000

FY 2025

Project Title

Strategies for Targeting Astrocyte Reactivity in Alzheimer's Disease and Related Dementias

Grant Number:

3P01AG078116-03S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2022

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

CM Norris Parent P01 – ABSTRACT SUMMARY This P01— Strategies for Targeting Astrocyte Reactivity in AD and ADRD (STAR-ADRD) addresses the (patho)physiologic roles of reactive astrocytes in Alzheimer’s disease (AD) and related dementias (ADRD). Though highly significant to many disease phenotypes, ast...

Research Terms

<2-photon><2-photon microscopy><AAV delivered><AAV delivery><AAV-based delivery><AAV-based viral delivery><AAV-mediated delivery><ABCC9><ABCC9 gene><AD dementia><AD model><AD related dementia><ADRD><Address><Adeno-associated-virus-based delivery><Aging><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Amyloid beta-Protein><Alzheimer's Disease><Alzheimer's amyloid><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease model><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid beta-Protein><Amyloid β><Amyloid β-Peptide><Amyloid β-Protein><Animals><Area><Astrocytes><Astrocytus><Astroglia><Autopsy><Aβ><Behavioral><Biochemical Pathway><Biological Markers><Biometrics><Biometry><Biostatistics><Blood Vessels><Body Tissues><Brain Pathology><Brain Vascular><Brain Vascular Disorders><CLG4B><CRSP130><CRSP133><CRSP3><CRSP3 gene><Calibration><Categories><Cell Body><Cells><Cerebral small vessel disease><Cerebrovascular Disease><Cerebrovascular Disorders><Cofactor Required for Sp1 Transcriptional Activation Subunit 3><Comment><Commentary><Complex><Consultations><Coupling><Craniotomy><DRIP130><Data Analyses><Data Analysis><Dementia><Department chair><Diabetes Mellitus><Disease><Disorder><Dysfunction><EEG><Editorial Comment><Electroencephalogram><Electroencephalography><Electrophysiology><Electrophysiology (science)><Ensure><Environment><Fluorescence><Functional disorder><Funding><Funding Agency><Funding Source><GELB><Glutamate Translocase><Glutamate Transport Glycoprotein><Glutamate Transporter><Glutamates><Goals><Health><Human><Image><Impairment><Insulin Receptor><Insulin Receptor Protein-Tyrosine Kinase><Insulin-Dependent Tyrosine Protein Kinase><Intermediary Metabolism><Intervention><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Kentucky><L-Glutamate><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Letters><Liquid substance><MMP9><MMP9 gene><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Measures><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Medicine><Metabolic><Metabolic Networks><Metabolic Processes><Metabolism><Mice><Mice Mammals><Microelectrodes><Microscope><Miniaturized Electrodes><Modeling><Modern Man><Monitor><Murine><Mus><NIH><NMR Imaging><NMR Tomography><National Institutes of Health><Nerve Cells><Nerve Unit><Neural Cell><Neurocyte><Neurons><Neurophysiology / Electrophysiology><Nuclear Magnetic Resonance Imaging><Nutritional Science><Obesity><Optics><P01 Mechanism><P01 Program><Parents><Pathologic><Pathology><Performance><Pharmacology><Phenotype><Physics><Physiologic><Physiological><Physiopathology><Position><Positioning Attribute><Primary Senile Degenerative Dementia><Procedures><Program Project Grant><Program Research Project Grants><Progress Reports><Property><Published Comment><Receptor Signaling><Recommendation><Research><Research Priority><Research Program Projects><Research Resources><Resources><Role><SUR2><Secure><Source><Statistical Data Analyses><Statistical Data Analysis><Statistical Data Interpretation><Structure><Techniques><Technology><Testing><Time><Tissues><United States National Institutes of Health><Universities><Viewpoint><Zeugmatography><a beta peptide><abeta><adeno-associated viral vector delivery><adeno-associated virus delivery><adeno-associated virus mediated delivery><adenovirus mediated delivery><adiposity><alzheimer model><amyloid beta><amyloid-b protein><astrocytic glia><awake><beta amyloid fibril><bio-markers><biologic marker><biomarker><biomarker validation><brain vascular disease><brain vascular dysfunction><cell type><cerebral small vessel disorder><cerebral vascular><cerebral vascular disease><cerebral vascular dysfunction><cerebro-vascular><cerebrovascular><cerebrovascular dysfunction><college><collegiate><consultation><corpulence><cost><data integration><data interpretation><data management><data pipeline><delivered with AAV><delivery with AAV><design><designing><diabetes><disease phenotype><electrophysiological><experiment><experimental research><experimental study><experiments><fluid><foot><glutamatergic><hippocampal sclerosis><human data><human subject><imaging><imaging capabilities><impression><in vivo><innovate><innovation><innovative><insight><insulin signaling><intracranial vascular dysfunction><knock-down><knockdown><liquid><marker validation><microscope imaging><microscopic imaging><microscopy imaging><mouse model><murine model><nano-sized sensors><nanosensing><nanosensors><necropsy><neural network><neuro-vascular coupling><neuro-vascular unit><neurochemical><neurochemistry><neuronal><neurovascular coupling><neurovascular unit><nutrition science><optical><overexpress><overexpression><parent><pathophysiology><postmortem><pre-clinical><preclinical><prevent><preventing><primary degenerative dementia><programs><ratiometric><senile dementia of the Alzheimer type><skull incision><social role><soluble amyloid precursor protein><statistical analysis><success><two photon excitation microscopy><two photon microscopy><two-photon><vascular><vibration>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joann B. Sweasy

UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$191,875

FY 2025

Project Title

Buffett Cancer Center Support Grant

Grant Number:

3P30CA036727-39S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/5/1997

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY The Fred & Pamela Buffett Cancer Center (Buffett Cancer Center or BCC), an NCI-designated Cancer Center since 1984, is committed to basic, translational, clinical and population science research, comprehensive educational programs, and outreach to underserved communities in our catch...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jessica Chubak

KAISER FOUNDATION RESEARCH INSTITUTE, Oakland, CA

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$154,093

FY 2025

Project Title

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

Grant Number:

3P01CA233432-06S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of t...

Research Terms

<0-11 years old><21+ years old><Accident and Emergency department><Active Follow-up><Acute><Address><Adolescent><Adolescent Youth><Adolescent and Young Adult><Adolescent and young adult cancer patients><Adolescent and young adult cancer population><Adolescent and young adult oncology patients><Adolescent and young adults with cancer><Adult><Adult Human><Adverse Late Effects><Advocate><After Care><After-Treatment><Aftercare><Age><Ambulatory Surgery><Ambulatory Surgical Procedures><Ancillary Services><Area><Biometrics><Biometry><Biostatistics><Breast><California><Cancer Patient><Cancer Survivor><Cancer Treatment><Cancers><Cardiovascular Diseases><Caring><Child><Child Youth><Childhood><Children (0-21)><Chronic><Colon or Rectum><Colorectal><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counseling><Data><Diagnosis><Disparities><Disparity><ED visit><ER visit><Emergency Department><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room><Emergency room visit><Employment><Endocrine Diseases><Endocrine Diseases and Manifestations><Endocrine System Diseases><Epidemiologist><Ethnic Origin><Ethnicity><Face><Family><Fecundability><Fecundity><Fertility><Financial Hardship><Germinoblastic Sarcoma><Germinoblastoma><Goals><Guidelines><Health><Health Care><Health Care Utilization><Health Insurance><Health Resources><Health Services><Health system><Hepatic Disorder><Home><Hospital Admission><Hospitalization><Incidence><Individual><Inpatients><Insurance><Insurance Coverage><Insurance Status><Interdisciplinary Research><Interdisciplinary Study><Investigators><Kidney Diseases><Knowledge><Late Effects><Life><Link><Liver diseases><Lymphoma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Testicular Neoplasm><Malignant Testicular Tumor><Malignant Tumor><Malignant Tumor of the Testis><Malignant neoplasm of testis><Medical><Multidisciplinary Collaboration><Multidisciplinary Research><NCCN><NCI Organization><National Cancer Institute><National Comprehensive Cancer Network><Neighborhoods><Nephropathy><North Carolina><Older Population><Oncologist><Out-patients><Outcome><Outpatient Surgery><Outpatients><Patient Preferences><Patient-Centered Care><Patients><Persons><Phase><Population><Population Database><Population Surveillance><Preservation Technique><Provider><Puberty><Public Health Surveillance><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Recommendation><Renal Disease><Reporting><Reproductive Health Services><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resource Sharing><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Reticulolymphosarcoma><Risk><Second Cancer><Second Primary Cancers><Secondary Malignancy><Secondary Malignant Neoplasm><Socio-economic status><Socioeconomic Status><Specialist><Survey Instrument><Surveys><Testicular Cancer><Testis Cancer><United States><Universities><University resources><Utah><Visit><active followup><adult youth><adulthood><aged><ages><anti-cancer therapy><barrier to care><barrier to health care><barrier to treatment><cancer among adolescent and young adults><cancer care><cancer diagnosis><cancer registry><cancer therapy><cancer type><cancer-directed therapy><cardiovascular disorder><care coordination><care preference><career><childbearing age><clinical care><colorectum><coordinating care><data harmonization><data resource><endocrine disorder><evidence base><experience><faces><facial><fertile age><fertility preservation><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><harmonized data><health care service use><health care service utilization><health care settings><health insurance plan><hepatic disease><hepatopathy><higher education><homes><improved><improved outcome><integrated care><integrated health care><integrated model of care><interest><juvenile><juvenile human><kidney disorder><kids><liver disorder><malignancy><multidisciplinary><neglect><neoplasm registry><neoplasm/cancer><obstacle to care><obstacle to health care><older adult><older adulthood><older groups><older individuals><older person><pediatric><population health><post treatment><preservation><preserve fertility><programs><racial><racial background><racial origin><renal disorder><reproductive age><reproductive years><secondary cancer><socio-economic position><socioeconomic position><survivorship><young adult><young adult age><young adulthood><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Erin Elizabeth Hahn

KAISER FOUNDATION RESEARCH INSTITUTE, Oakland, CA

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$154,093

FY 2025

Project Title

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

Grant Number:

3P01CA233432-06S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of t...

Research Terms

<0-11 years old><21+ years old><Accident and Emergency department><Active Follow-up><Acute><Address><Adolescent><Adolescent Youth><Adolescent and Young Adult><Adolescent and young adult cancer patients><Adolescent and young adult cancer population><Adolescent and young adult oncology patients><Adolescent and young adults with cancer><Adult><Adult Human><Adverse Late Effects><Advocate><After Care><After-Treatment><Aftercare><Age><Ambulatory Surgery><Ambulatory Surgical Procedures><Ancillary Services><Area><Biometrics><Biometry><Biostatistics><Breast><California><Cancer Patient><Cancer Survivor><Cancer Treatment><Cancers><Cardiovascular Diseases><Caring><Child><Child Youth><Childhood><Children (0-21)><Chronic><Colon or Rectum><Colorectal><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counseling><Data><Diagnosis><Disparities><Disparity><ED visit><ER visit><Emergency Department><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room><Emergency room visit><Employment><Endocrine Diseases><Endocrine Diseases and Manifestations><Endocrine System Diseases><Epidemiologist><Ethnic Origin><Ethnicity><Face><Family><Fecundability><Fecundity><Fertility><Financial Hardship><Germinoblastic Sarcoma><Germinoblastoma><Goals><Guidelines><Health><Health Care><Health Care Utilization><Health Insurance><Health Resources><Health Services><Health system><Hepatic Disorder><Home><Hospital Admission><Hospitalization><Incidence><Individual><Inpatients><Insurance><Insurance Coverage><Insurance Status><Interdisciplinary Research><Interdisciplinary Study><Investigators><Kidney Diseases><Knowledge><Late Effects><Life><Link><Liver diseases><Lymphoma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Testicular Neoplasm><Malignant Testicular Tumor><Malignant Tumor><Malignant Tumor of the Testis><Malignant neoplasm of testis><Medical><Multidisciplinary Collaboration><Multidisciplinary Research><NCCN><NCI Organization><National Cancer Institute><National Comprehensive Cancer Network><Neighborhoods><Nephropathy><North Carolina><Older Population><Oncologist><Out-patients><Outcome><Outpatient Surgery><Outpatients><Patient Preferences><Patient-Centered Care><Patients><Persons><Phase><Population><Population Database><Population Surveillance><Preservation Technique><Provider><Puberty><Public Health Surveillance><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Recommendation><Renal Disease><Reporting><Reproductive Health Services><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resource Sharing><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Reticulolymphosarcoma><Risk><Second Cancer><Second Primary Cancers><Secondary Malignancy><Secondary Malignant Neoplasm><Socio-economic status><Socioeconomic Status><Specialist><Survey Instrument><Surveys><Testicular Cancer><Testis Cancer><United States><Universities><University resources><Utah><Visit><active followup><adult youth><adulthood><aged><ages><anti-cancer therapy><barrier to care><barrier to health care><barrier to treatment><cancer among adolescent and young adults><cancer care><cancer diagnosis><cancer registry><cancer therapy><cancer type><cancer-directed therapy><cardiovascular disorder><care coordination><care preference><career><childbearing age><clinical care><colorectum><coordinating care><data harmonization><data resource><endocrine disorder><evidence base><experience><faces><facial><fertile age><fertility preservation><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><harmonized data><health care service use><health care service utilization><health care settings><health insurance plan><hepatic disease><hepatopathy><higher education><homes><improved><improved outcome><integrated care><integrated health care><integrated model of care><interest><juvenile><juvenile human><kidney disorder><kids><liver disorder><malignancy><multidisciplinary><neglect><neoplasm registry><neoplasm/cancer><obstacle to care><obstacle to health care><older adult><older adulthood><older groups><older individuals><older person><pediatric><population health><post treatment><preservation><preserve fertility><programs><racial><racial background><racial origin><renal disorder><reproductive age><reproductive years><secondary cancer><socio-economic position><socioeconomic position><survivorship><young adult><young adult age><young adulthood><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LAWRENCE H KUSHI

KAISER FOUNDATION RESEARCH INSTITUTE, Oakland, CA

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$154,093

FY 2025

Project Title

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

Grant Number:

3P01CA233432-06S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of t...

Research Terms

<0-11 years old><21+ years old><Accident and Emergency department><Active Follow-up><Acute><Address><Adolescent><Adolescent Youth><Adolescent and Young Adult><Adolescent and young adult cancer patients><Adolescent and young adult cancer population><Adolescent and young adult oncology patients><Adolescent and young adults with cancer><Adult><Adult Human><Adverse Late Effects><Advocate><After Care><After-Treatment><Aftercare><Age><Ambulatory Surgery><Ambulatory Surgical Procedures><Ancillary Services><Area><Biometrics><Biometry><Biostatistics><Breast><California><Cancer Patient><Cancer Survivor><Cancer Treatment><Cancers><Cardiovascular Diseases><Caring><Child><Child Youth><Childhood><Children (0-21)><Chronic><Colon or Rectum><Colorectal><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counseling><Data><Diagnosis><Disparities><Disparity><ED visit><ER visit><Emergency Department><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room><Emergency room visit><Employment><Endocrine Diseases><Endocrine Diseases and Manifestations><Endocrine System Diseases><Epidemiologist><Ethnic Origin><Ethnicity><Face><Family><Fecundability><Fecundity><Fertility><Financial Hardship><Germinoblastic Sarcoma><Germinoblastoma><Goals><Guidelines><Health><Health Care><Health Care Utilization><Health Insurance><Health Resources><Health Services><Health system><Hepatic Disorder><Home><Hospital Admission><Hospitalization><Incidence><Individual><Inpatients><Insurance><Insurance Coverage><Insurance Status><Interdisciplinary Research><Interdisciplinary Study><Investigators><Kidney Diseases><Knowledge><Late Effects><Life><Link><Liver diseases><Lymphoma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Testicular Neoplasm><Malignant Testicular Tumor><Malignant Tumor><Malignant Tumor of the Testis><Malignant neoplasm of testis><Medical><Multidisciplinary Collaboration><Multidisciplinary Research><NCCN><NCI Organization><National Cancer Institute><National Comprehensive Cancer Network><Neighborhoods><Nephropathy><North Carolina><Older Population><Oncologist><Out-patients><Outcome><Outpatient Surgery><Outpatients><Patient Preferences><Patient-Centered Care><Patients><Persons><Phase><Population><Population Database><Population Surveillance><Preservation Technique><Provider><Puberty><Public Health Surveillance><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Recommendation><Renal Disease><Reporting><Reproductive Health Services><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resource Sharing><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Reticulolymphosarcoma><Risk><Second Cancer><Second Primary Cancers><Secondary Malignancy><Secondary Malignant Neoplasm><Socio-economic status><Socioeconomic Status><Specialist><Survey Instrument><Surveys><Testicular Cancer><Testis Cancer><United States><Universities><University resources><Utah><Visit><active followup><adult youth><adulthood><aged><ages><anti-cancer therapy><barrier to care><barrier to health care><barrier to treatment><cancer among adolescent and young adults><cancer care><cancer diagnosis><cancer registry><cancer therapy><cancer type><cancer-directed therapy><cardiovascular disorder><care coordination><care preference><career><childbearing age><clinical care><colorectum><coordinating care><data harmonization><data resource><endocrine disorder><evidence base><experience><faces><facial><fertile age><fertility preservation><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><harmonized data><health care service use><health care service utilization><health care settings><health insurance plan><hepatic disease><hepatopathy><higher education><homes><improved><improved outcome><integrated care><integrated health care><integrated model of care><interest><juvenile><juvenile human><kidney disorder><kids><liver disorder><malignancy><multidisciplinary><neglect><neoplasm registry><neoplasm/cancer><obstacle to care><obstacle to health care><older adult><older adulthood><older groups><older individuals><older person><pediatric><population health><post treatment><preservation><preserve fertility><programs><racial><racial background><racial origin><renal disorder><reproductive age><reproductive years><secondary cancer><socio-economic position><socioeconomic position><survivorship><young adult><young adult age><young adulthood><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Theresa H M Keegan

KAISER FOUNDATION RESEARCH INSTITUTE, Oakland, CA

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$154,093

FY 2025

Project Title

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

Grant Number:

3P01CA233432-06S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of t...

Research Terms

<0-11 years old><21+ years old><Accident and Emergency department><Active Follow-up><Acute><Address><Adolescent><Adolescent Youth><Adolescent and Young Adult><Adolescent and young adult cancer patients><Adolescent and young adult cancer population><Adolescent and young adult oncology patients><Adolescent and young adults with cancer><Adult><Adult Human><Adverse Late Effects><Advocate><After Care><After-Treatment><Aftercare><Age><Ambulatory Surgery><Ambulatory Surgical Procedures><Ancillary Services><Area><Biometrics><Biometry><Biostatistics><Breast><California><Cancer Patient><Cancer Survivor><Cancer Treatment><Cancers><Cardiovascular Diseases><Caring><Child><Child Youth><Childhood><Children (0-21)><Chronic><Colon or Rectum><Colorectal><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counseling><Data><Diagnosis><Disparities><Disparity><ED visit><ER visit><Emergency Department><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room><Emergency room visit><Employment><Endocrine Diseases><Endocrine Diseases and Manifestations><Endocrine System Diseases><Epidemiologist><Ethnic Origin><Ethnicity><Face><Family><Fecundability><Fecundity><Fertility><Financial Hardship><Germinoblastic Sarcoma><Germinoblastoma><Goals><Guidelines><Health><Health Care><Health Care Utilization><Health Insurance><Health Resources><Health Services><Health system><Hepatic Disorder><Home><Hospital Admission><Hospitalization><Incidence><Individual><Inpatients><Insurance><Insurance Coverage><Insurance Status><Interdisciplinary Research><Interdisciplinary Study><Investigators><Kidney Diseases><Knowledge><Late Effects><Life><Link><Liver diseases><Lymphoma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Testicular Neoplasm><Malignant Testicular Tumor><Malignant Tumor><Malignant Tumor of the Testis><Malignant neoplasm of testis><Medical><Multidisciplinary Collaboration><Multidisciplinary Research><NCCN><NCI Organization><National Cancer Institute><National Comprehensive Cancer Network><Neighborhoods><Nephropathy><North Carolina><Older Population><Oncologist><Out-patients><Outcome><Outpatient Surgery><Outpatients><Patient Preferences><Patient-Centered Care><Patients><Persons><Phase><Population><Population Database><Population Surveillance><Preservation Technique><Provider><Puberty><Public Health Surveillance><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Recommendation><Renal Disease><Reporting><Reproductive Health Services><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resource Sharing><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Reticulolymphosarcoma><Risk><Second Cancer><Second Primary Cancers><Secondary Malignancy><Secondary Malignant Neoplasm><Socio-economic status><Socioeconomic Status><Specialist><Survey Instrument><Surveys><Testicular Cancer><Testis Cancer><United States><Universities><University resources><Utah><Visit><active followup><adult youth><adulthood><aged><ages><anti-cancer therapy><barrier to care><barrier to health care><barrier to treatment><cancer among adolescent and young adults><cancer care><cancer diagnosis><cancer registry><cancer therapy><cancer type><cancer-directed therapy><cardiovascular disorder><care coordination><care preference><career><childbearing age><clinical care><colorectum><coordinating care><data harmonization><data resource><endocrine disorder><evidence base><experience><faces><facial><fertile age><fertility preservation><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><harmonized data><health care service use><health care service utilization><health care settings><health insurance plan><hepatic disease><hepatopathy><higher education><homes><improved><improved outcome><integrated care><integrated health care><integrated model of care><interest><juvenile><juvenile human><kidney disorder><kids><liver disorder><malignancy><multidisciplinary><neglect><neoplasm registry><neoplasm/cancer><obstacle to care><obstacle to health care><older adult><older adulthood><older groups><older individuals><older person><pediatric><population health><post treatment><preservation><preserve fertility><programs><racial><racial background><racial origin><renal disorder><reproductive age><reproductive years><secondary cancer><socio-economic position><socioeconomic position><survivorship><young adult><young adult age><young adulthood><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Hazel B Nichols

KAISER FOUNDATION RESEARCH INSTITUTE, Oakland, CA

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$154,093

FY 2025

Project Title

Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers

Grant Number:

3P01CA233432-06S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2020

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – P01, Clinical Care Gaps and Unmet Needs in AYA Cancer Survivors This program of research focuses on cancer care and outcomes for people diagnosed with cancer during the adolescent and young adult (AYA) age range, from 15 to 39 years old. The clinical care and long- term surveillance of t...

Research Terms

<0-11 years old><21+ years old><Accident and Emergency department><Active Follow-up><Acute><Address><Adolescent><Adolescent Youth><Adolescent and Young Adult><Adolescent and young adult cancer patients><Adolescent and young adult cancer population><Adolescent and young adult oncology patients><Adolescent and young adults with cancer><Adult><Adult Human><Adverse Late Effects><Advocate><After Care><After-Treatment><Aftercare><Age><Ambulatory Surgery><Ambulatory Surgical Procedures><Ancillary Services><Area><Biometrics><Biometry><Biostatistics><Breast><California><Cancer Patient><Cancer Survivor><Cancer Treatment><Cancers><Cardiovascular Diseases><Caring><Child><Child Youth><Childhood><Children (0-21)><Chronic><Colon or Rectum><Colorectal><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counseling><Data><Diagnosis><Disparities><Disparity><ED visit><ER visit><Emergency Department><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room><Emergency room visit><Employment><Endocrine Diseases><Endocrine Diseases and Manifestations><Endocrine System Diseases><Epidemiologist><Ethnic Origin><Ethnicity><Face><Family><Fecundability><Fecundity><Fertility><Financial Hardship><Germinoblastic Sarcoma><Germinoblastoma><Goals><Guidelines><Health><Health Care><Health Care Utilization><Health Insurance><Health Resources><Health Services><Health system><Hepatic Disorder><Home><Hospital Admission><Hospitalization><Incidence><Individual><Inpatients><Insurance><Insurance Coverage><Insurance Status><Interdisciplinary Research><Interdisciplinary Study><Investigators><Kidney Diseases><Knowledge><Late Effects><Life><Link><Liver diseases><Lymphoma><Malignant Lymphoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Testicular Neoplasm><Malignant Testicular Tumor><Malignant Tumor><Malignant Tumor of the Testis><Malignant neoplasm of testis><Medical><Multidisciplinary Collaboration><Multidisciplinary Research><NCCN><NCI Organization><National Cancer Institute><National Comprehensive Cancer Network><Neighborhoods><Nephropathy><North Carolina><Older Population><Oncologist><Out-patients><Outcome><Outpatient Surgery><Outpatients><Patient Preferences><Patient-Centered Care><Patients><Persons><Phase><Population><Population Database><Population Surveillance><Preservation Technique><Provider><Puberty><Public Health Surveillance><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Recommendation><Renal Disease><Reporting><Reproductive Health Services><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resource Sharing><Respiratory Disease><Respiratory System Disease><Respiratory System Disorder><Reticulolymphosarcoma><Risk><Second Cancer><Second Primary Cancers><Secondary Malignancy><Secondary Malignant Neoplasm><Socio-economic status><Socioeconomic Status><Specialist><Survey Instrument><Surveys><Testicular Cancer><Testis Cancer><United States><Universities><University resources><Utah><Visit><active followup><adult youth><adulthood><aged><ages><anti-cancer therapy><barrier to care><barrier to health care><barrier to treatment><cancer among adolescent and young adults><cancer care><cancer diagnosis><cancer registry><cancer therapy><cancer type><cancer-directed therapy><cardiovascular disorder><care coordination><care preference><career><childbearing age><clinical care><colorectum><coordinating care><data harmonization><data resource><endocrine disorder><evidence base><experience><faces><facial><fertile age><fertility preservation><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><harmonized data><health care service use><health care service utilization><health care settings><health insurance plan><hepatic disease><hepatopathy><higher education><homes><improved><improved outcome><integrated care><integrated health care><integrated model of care><interest><juvenile><juvenile human><kidney disorder><kids><liver disorder><malignancy><multidisciplinary><neglect><neoplasm registry><neoplasm/cancer><obstacle to care><obstacle to health care><older adult><older adulthood><older groups><older individuals><older person><pediatric><population health><post treatment><preservation><preserve fertility><programs><racial><racial background><racial origin><renal disorder><reproductive age><reproductive years><secondary cancer><socio-economic position><socioeconomic position><survivorship><young adult><young adult age><young adulthood><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Louis M. Weiner

GEORGETOWN UNIVERSITY, WASHINGTON, DC

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$150,000

FY 2025

Project Title

Georgetown University Lombardi Comprehensive Cancer Center Support Grant

Grant Number:

3P30CA051008-31S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/2025

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Title: Transdisciplinary Research Targeting Metabolic Dysregulation to Improve Cancer and Aging Outcomes Abstract This application is being submitted in response to “Administrative Supplements to Advance Development of Transdisciplinary and Large-Scale Population Science and Cancer Control Research ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Taofeek K Owonikoko

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$149,999

FY 2025

Project Title

Neighborhoods, Stress and Cancer Outcomes Across the Cancer Control Continuum: Leveraging ecological theory and geospatial analytics to improve cancer prevention and outcomes (Project LEGO)

Grant Number:

3P30CA134274-18S3

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/8/2008

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT This application is being submitted in response to “Administrative supplements to advance development of transdisciplinary and large-scale population science and cancer control research projects.” There is a growing recognition that cancer risk and outcomes stem from complex, layered system...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JONATHAN W FRIEDBERG

UNIVERSITY OF ROCHESTER, ROCHESTER, NY

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$149,514

FY 2025

Project Title

Developing a P01 to Address Cognitive Impairment and Treatment Tolerability in Patients with Advanced Cancer

Grant Number:

3P30CA272302-01A1S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

3/15/2025

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT This application entitled “Developing a P01 to Address Cognitive Impairment and Treatment Tolerability in Patients with Advanced Cancer” is being submitted in response to “Administrative supplements to advance development of transdisciplinary and large-scale population science and cancer co...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Michelle C Janelsins

UNIVERSITY OF ROCHESTER, ROCHESTER, NY

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$149,514

FY 2025

Project Title

Developing a P01 to Address Cognitive Impairment and Treatment Tolerability in Patients with Advanced Cancer

Grant Number:

3P30CA272302-01A1S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

3/15/2025

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT This application entitled “Developing a P01 to Address Cognitive Impairment and Treatment Tolerability in Patients with Advanced Cancer” is being submitted in response to “Administrative supplements to advance development of transdisciplinary and large-scale population science and cancer co...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KAREN M. MUSTIAN

UNIVERSITY OF ROCHESTER, ROCHESTER, NY

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$149,514

FY 2025

Project Title

Developing a P01 to Address Cognitive Impairment and Treatment Tolerability in Patients with Advanced Cancer

Grant Number:

3P30CA272302-01A1S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

3/15/2025

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT This application entitled “Developing a P01 to Address Cognitive Impairment and Treatment Tolerability in Patients with Advanced Cancer” is being submitted in response to “Administrative supplements to advance development of transdisciplinary and large-scale population science and cancer co...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Supriya G. Mohile

UNIVERSITY OF ROCHESTER, ROCHESTER, NY

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$149,514

FY 2025

Project Title

Developing a P01 to Address Cognitive Impairment and Treatment Tolerability in Patients with Advanced Cancer

Grant Number:

3P30CA272302-01A1S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

3/15/2025

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT This application entitled “Developing a P01 to Address Cognitive Impairment and Treatment Tolerability in Patients with Advanced Cancer” is being submitted in response to “Administrative supplements to advance development of transdisciplinary and large-scale population science and cancer co...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Hui Zheng

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$104,795

FY 2025

Project Title

Lysosome Regulation and Signaling in Aging and Alzheimer's Disease

Grant Number:

3P01AG066606-05S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2021

End Date:

2/28/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

This is an equipment supplement application for a Program Project Grant (P01AG066606, June 1, 2021-February 28, 2026, PI: Zheng, Hui). The overarching goal of the parent P01 is to investigate the lysosome-to-nucleus signaling pathways regulating lysosomal homoeostasis in aging and Alzheimer’s diseas...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Karen L Cropsey

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$86,160

FY 2025

Project Title

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)

Grant Number:

3P01AA029540-05S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) The overall aims of the Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) are to (Aim 1) test the effectiveness of a transdiagnostic model, Common Elements Treatment Approach (CETA), to reduce unhealthy alcohol use and improve HIV c...

Research Terms

<21+ years old><AIDS><AIDS Virus><AIDS/HIV><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Adherence><Adult><Adult Human><Alabama><Alcohol Chemical Class><Alcohol Drinking><Alcohol consumption><Alcohols><Anxiety><Apache><Application Context><Arizona><Assess implementation><Back><Businesses><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Caring><Clinic><Clinical><Clinical Treatment><Clinical effectiveness><Cognition Therapy><Cognitive Psychotherapy><Cognitive Therapy><Cognitive treatment><Collaborations><Communities><Complex><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counselor><Data><Data Analyses><Data Analysis><Data Collection><Data Element><Deep South><Demographic Factors><Diagnostic><Dorsum><Education for Intervention><Educational Intervention><Elements><Epidemic><EtOH drinking><EtOH use><Evidence based intervention><Face><Funding><Geographic Area><Geographic Locations><Geographic Region><Geographical Location><HIV><HIV/AIDS><Health Care Providers><Health Personnel><Human Immunodeficiency Viruses><Human Resources><Implementation assessment><Incidence><Infectious Diseases / Laboratory><Infectious Diseases Research><Instruction Intervention><Interpersonal Violence><Intervention><Investigators><Knowledge><LAV-HTLV-III><LMIC><Licensing><Lymphadenopathy-Associated Virus><Manpower><Mental Depression><Mental Health><Mental Hygiene><Mental disorders><Mental health disorders><Methods><Modeling><Monitor><NIAAA><NIH><National Institute on Alcohol Abuse and Alcoholism><National Institutes of Health><Northern Rhodesia><Outcome><Pain><Painful><Participant><Persons><Prevalence><Prevention><Professional counselor><Protocol><Protocols documentation><Provider><Psychiatric Disease><Psychiatric Disorder><Psychological Health><Psychologist><Public Sector><R-Series Research Projects><R01 Mechanism><R01 Program><Randomized Controlled Clinical Trials><Randomized, Controlled Trials><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Rural><Rural Population><Rural group><Rural people><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Sahara><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Structure><Telemedicine><Training><Training Intervention><Translating><Treatment outcome><United States><United States National Institutes of Health><Viral><Virus-HIV><Washington><Zambia><addiction><addictive disorder><adulthood><alcohol co-morbidity><alcohol comorbidity><alcohol ingestion><alcohol intake><alcohol misuse><alcohol product use><alcohol use><alcoholic beverage consumption><alcoholic drink intake><alleviate symptom><ameliorating symptom><antiretroviral therapy><antiretroviral treatment><behavioral health><behavioral health intervention><brief alcohol intervention><brief intervention><brief therapy><brief treatment><career><clinical intervention><clinical therapy><co-morbid><co-morbidity><cognitive behavior intervention><cognitive behavior modification><cognitive behavior therapy><cognitive behavioral intervention><cognitive behavioral modification><cognitive behavioral therapy><cognitive behavioral treatment><common treatment><community clinic><comorbidity><compare effectiveness><contextual factors><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><cost><cost effective><data harmonization><data interpretation><decrease symptom><depression><design><designing><effectiveness testing><ethanol consumption><ethanol drinking><ethanol ingestion><ethanol intake><ethanol misuse><ethanol product use><ethanol use><evaluate implementation><evaluation of implementation><faces><facial><fewer symptoms><geographic site><harmonized data><health care personnel><health care worker><health provider><health workforce><implementation determinants><implementation evaluation><implementation factors><improved><instructional intervention><low and middle-income countries><medical personnel><mental illness><mortality><participant enrollment><patient enrollment><peer><personnel><pilot test><population based><post-trauma stress><post-traumatic stress><post-traumatic stress symptoms><post-traumatic symptoms><posttrauma stress><posttraumatic stress><posttraumatic stress symptoms><posttraumatic symptoms><programs><psychiatric illness><psychological disorder><randomized control clinical trial><randomized control trial><reduce symptoms><relieves symptoms><response><rural individual><screening><screenings><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><sex><substance use><substance using><suicidal risk><suicide risk><symptom alleviation><symptom reduction><symptom relief><synergism><therapy adherence><therapy compliance><treatment as prevention><treatment effect><treatment provider><treatment-based prevention><trial design><trial regimen><trial treatment><unhealthy alcohol use>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Michael Jeffrey Vinikoor

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$86,160

FY 2025

Project Title

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)

Grant Number:

3P01AA029540-05S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) The overall aims of the Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) are to (Aim 1) test the effectiveness of a transdiagnostic model, Common Elements Treatment Approach (CETA), to reduce unhealthy alcohol use and improve HIV c...

Research Terms

<21+ years old><AIDS><AIDS Virus><AIDS/HIV><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Adherence><Adult><Adult Human><Alabama><Alcohol Chemical Class><Alcohol Drinking><Alcohol consumption><Alcohols><Anxiety><Apache><Application Context><Arizona><Assess implementation><Back><Businesses><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Caring><Clinic><Clinical><Clinical Treatment><Clinical effectiveness><Cognition Therapy><Cognitive Psychotherapy><Cognitive Therapy><Cognitive treatment><Collaborations><Communities><Complex><Continuity of Care><Continuity of Patient Care><Continuum of Care><Counselor><Data><Data Analyses><Data Analysis><Data Collection><Data Element><Deep South><Demographic Factors><Diagnostic><Dorsum><Education for Intervention><Educational Intervention><Elements><Epidemic><EtOH drinking><EtOH use><Evidence based intervention><Face><Funding><Geographic Area><Geographic Locations><Geographic Region><Geographical Location><HIV><HIV/AIDS><Health Care Providers><Health Personnel><Human Immunodeficiency Viruses><Human Resources><Implementation assessment><Incidence><Infectious Diseases / Laboratory><Infectious Diseases Research><Instruction Intervention><Interpersonal Violence><Intervention><Investigators><Knowledge><LAV-HTLV-III><LMIC><Licensing><Lymphadenopathy-Associated Virus><Manpower><Mental Depression><Mental Health><Mental Hygiene><Mental disorders><Mental health disorders><Methods><Modeling><Monitor><NIAAA><NIH><National Institute on Alcohol Abuse and Alcoholism><National Institutes of Health><Northern Rhodesia><Outcome><Pain><Painful><Participant><Persons><Prevalence><Prevention><Professional counselor><Protocol><Protocols documentation><Provider><Psychiatric Disease><Psychiatric Disorder><Psychological Health><Psychologist><Public Sector><R-Series Research Projects><R01 Mechanism><R01 Program><Randomized Controlled Clinical Trials><Randomized, Controlled Trials><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Rural><Rural Population><Rural group><Rural people><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Sahara><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Structure><Telemedicine><Training><Training Intervention><Translating><Treatment outcome><United States><United States National Institutes of Health><Viral><Virus-HIV><Washington><Zambia><addiction><addictive disorder><adulthood><alcohol co-morbidity><alcohol comorbidity><alcohol ingestion><alcohol intake><alcohol misuse><alcohol product use><alcohol use><alcoholic beverage consumption><alcoholic drink intake><alleviate symptom><ameliorating symptom><antiretroviral therapy><antiretroviral treatment><behavioral health><behavioral health intervention><brief alcohol intervention><brief intervention><brief therapy><brief treatment><career><clinical intervention><clinical therapy><co-morbid><co-morbidity><cognitive behavior intervention><cognitive behavior modification><cognitive behavior therapy><cognitive behavioral intervention><cognitive behavioral modification><cognitive behavioral therapy><cognitive behavioral treatment><common treatment><community clinic><comorbidity><compare effectiveness><contextual factors><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><cost><cost effective><data harmonization><data interpretation><decrease symptom><depression><design><designing><effectiveness testing><ethanol consumption><ethanol drinking><ethanol ingestion><ethanol intake><ethanol misuse><ethanol product use><ethanol use><evaluate implementation><evaluation of implementation><faces><facial><fewer symptoms><geographic site><harmonized data><health care personnel><health care worker><health provider><health workforce><implementation determinants><implementation evaluation><implementation factors><improved><instructional intervention><low and middle-income countries><medical personnel><mental illness><mortality><participant enrollment><patient enrollment><peer><personnel><pilot test><population based><post-trauma stress><post-traumatic stress><post-traumatic stress symptoms><post-traumatic symptoms><posttrauma stress><posttraumatic stress><posttraumatic stress symptoms><posttraumatic symptoms><programs><psychiatric illness><psychological disorder><randomized control clinical trial><randomized control trial><reduce symptoms><relieves symptoms><response><rural individual><screening><screenings><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><sex><substance use><substance using><suicidal risk><suicide risk><symptom alleviation><symptom reduction><symptom relief><synergism><therapy adherence><therapy compliance><treatment as prevention><treatment effect><treatment provider><treatment-based prevention><trial design><trial regimen><trial treatment><unhealthy alcohol use>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Suresh S. Ramalingam

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$59,999

FY 2025

Project Title

Winship Cancer Institute Cancer Center Support Grant

Grant Number:

3P30CA138292-16S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/7/2009

End Date:

3/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY/ABSTRACT OVERALL The mission of Winship Cancer Institute of Emory University (Winship) is to discover cures for cancer and inspire hope. Winship is the only NCI-designated comprehensive cancer center in Georgia, the eighth most populous state in the United States, with the second hig...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Henry M. Colecraft

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$57,841

FY 2025

Project Title

Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease

Grant Number:

3P01HL164319-03S1

Activity Code:

P01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/15/2023

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

SUMMARY Heart disease is the leading cause of death in the United States and worldwide, with a worsening trajectory due to increasingly aging populations. Precise understanding of the molecular mechanisms underlying normal cardiac physiology, and how they are compromised in disease, is critical for ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

STEVEN FIERING

DARTMOUTH COLLEGE, HANOVER, NH

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$4,546,782

FY 2025

Project Title

New Hampshire IDeA Network of Biomedical Research Excellence (NH-INBRE)

Grant Number:

2P20GM103506-16

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2010

End Date:

5/31/2030

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Abstract This application for renewal of the grant supporting the New Hampshire IDeA Network of Biological Research Excellence (NH-INBRE) proposes to 1) support engagement of PUI-P students in biomedical research to expand research and career development.; 2) increase success obtaining external biom...

Research Terms

<2 year college><Administrator><Agriculture><Belief><Bioinformatics><Bioinformatics core><Bioinformatics research core><Bioinformatics resource core><Biologic Sciences><Biological Sciences><Biology><Biomedical Research><Biometrics><Biometry><Bioscience><Biostatistics><Budgets><COBRE><Center of Biomedical Research Excellence><Centers of Research Excellence><Characteristics><Chemistry><Cloud Computing><Cloud Infrastructure><Collaborations><Compensation><Data><Data Science><Data Science Core><Data Science Resource Core><Development><Development and Research><Education><Educational aspects><Educational process of instructing><Educational workshop><Eligibility><Eligibility Determination><Engineering><Enrollment><Equipment><Evaluation><Faculty><Faculty Education><Faculty Training><Fostering><Foundations><Funding><Goals><Grant><Health><Health Care><Home><Human><Human Resources><Infrastructure><Institution><Investigators><Investments><Laboratory Research><Leadership><Life Sciences><Manpower><Mentors><Modern Man><NIH><National Institutes of Health><New Hampshire><Ownership><P01 Mechanism><P01 Program><Phase><Pilot Projects><Principal Investigator><Process><Productivity><Program Project Grant><Program Research Project Grants><Protocol Screening><Psychology><R & D><R&D><Reproducibility><Research><Research Personnel><Research Program Projects><Research Resources><Research Support><Research Training><Researchers><Resources><Schools><Science><Scientist><Sight><Structure><Students><System><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Teaching><Time><Training><Training Activity><United States National Institutes of Health><Universities><Vision><Work><Workshop><biological research><career><career development><cloud based computing><cloud computer><college><college student><collegiate><community college><developmental><empowerment><enroll><expectation><faculty development><faculty professional development><higher education><homes><improved><instructor training><junior college><medical college><medical schools><peer><peer coaching><peer instruction><peer led team learning><peer mentoring><peer teaching><personnel><pilot study><primarily undergraduate institution><programs><research and development><school of medicine><student engagement><student mentoring><student motivation><student participation><student research><student-led learning><student-led research><success><support network><teacher development><training module><two year college><undergrad><undergraduate><undergraduate student><university student><visual function>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MELINDA K DUNCAN

UNIVERSITY OF DELAWARE, Newark, DE

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$4,360,371

FY 2025

Project Title

Delaware INBRE

Grant Number:

2P20GM103446-24

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

4/30/2030

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary The Delaware IDeA Network of Biomedical Research Excellence (DE-INBRE) catalyzes multidisciplinary biomedical research initiatives that build Delaware’s biomedical research capacity and workforce. The DE- INBRE network consists of five network partner institutions (NPIs): The Univers...

Research Terms

<2 year college><Abscission><Automobile Driving><Biomedical Research><COBRE><Center for Translational Science Activities><Center of Biomedical Research Excellence><Centers of Research Excellence><Child Health><Classification><Collaborations><Communities><Core Facility><Curriculum><Data><Data Science><Data Science Core><Data Science Resource Core><Data Set><Delaware><Development><Education and Training><Educational Curriculum><Educational workshop><Ensure><Excision><Extirpation><Faculty><Faculty Education><Faculty Training><Fostering><Funding><Future><Generations><Goals><Grant><HIPAA><Health><Health Care Systems><Health Insurance Portability and Accountability Act><Health Sciences><Infrastructure><Institution><Institutional Policy><Internships><Investigation><Investigators><Investments><Kennedy Kassebaum Act><Knowledge><Laboratories><Logistics><Low income><Medical><Mentors><Methodology><Methods><Minority><Mission><NIH><National Institutes of Health><P01 Mechanism><P01 Program><PL 104-191><PL104-191><Pilot Projects><Policies><Principal Investigator><Program Evaluation><Program Project Grant><Program Research Project Grants><Public Law 104-191><Publishing Peer Reviews><R-Series Research Projects><R01 Mechanism><R01 Program><Removal><Research><Research Activity><Research Grants><Research Infrastructure><Research Peer Review><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Research Resources><Research Support><Research Training><Researchers><Resource Sharing><Resources><Scholars Program><Scientist><Services><Students><Surgical Removal><System><Systematics><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Training><Training and Education><URM student><United States Health Insurance Portability and Accountability Act><United States National Institutes of Health><Universities><Work><Workshop><Writing><career><college><collegiate><community college><computational infrastructure><computational resources><computer infrastructure><computing resources><data sharing><developmental><driving><experience><faculty development><faculty professional development><faculty support><health care service><improved><innovate><innovation><innovative><instructor training><instrumentation><intern><investigator training><junior college><lesson plans><multidisciplinary><new technology><next generation><novel technologies><operation><operations><pilot study><primarily undergraduate institution><programs><research faculty><resection><student mentoring><student research><student-led learning><student-led research><success><synergism><teacher development><tool><translational research center><translational sciences center><two year college><undergrad><undergraduate><undergraduate research><undergraduate student><underrepresented minority student><voucher>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JASON L BURKHEAD

UNIVERSITY OF ALASKA FAIRBANKS, FAIRBANKS, AK

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$4,249,288

FY 2025

Project Title

Alaska INBRE 5 One Health

Grant Number:

2P20GM103395-24

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2001

End Date:

7/31/2030

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Alaska INBRE 5 enhances capacity to conduct biomedical and behavioral health training and research within its network of the three universities of the University of Alaska system, Iḷisaġvik College, Southcentral Foundation, and Alaska Native Tribal Health Consortium. Its Student Research Program off...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Peter R Hoffmann

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$4,211,541

FY 2025

Project Title

HAWAII INBRE V PROGRAM

Grant Number:

5P20GM103466-24

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

4/30/2028

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL SUMMARY The Hawaii Institutional Development Award (IDeA) Network of Biomedical Research Excellence (HI-INBRE) is a collaborative outreach partnership between the University of Hawaii at Manoa (UHM), the state’s Primarily Undergraduate Institutions (PUIs) and University of Hawaii Community C...

Research Terms

<2 year college><Applications Grants><Award><Bioinformatics><Biomedical Research><COBRE><Career Choice><Career Path><Center of Biomedical Research Excellence><Centers of Research Excellence><Clinical Research><Clinical Study><Collaborations><Communication><Communities><Curriculum><Data><Data Science><Data Science Core><Data Science Resource Core><Degree program><Development><Education><Educational Curriculum><Educational aspects><Educational process of instructing><Employment Opportunities><Faculty><Faculty Education><Faculty Training><Fostering><Funding><Funding Mechanisms><Goals><Grant Proposals><Hawaii><Health Benefit><Human><Infrastructure><Institution><Instruction><Investigators><Investments><Knowledge><Leadership><Mentors><Methodology><Modern Man><P01 Mechanism><P01 Program><Postbaccalaureate><Postdoc><Postdoctoral Fellow><Program Project Grant><Program Research Project Grants><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Recruitment Activity><Research><Research Associate><Research Design><Research Grants><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resource Sharing><Resources><Role><Science><Seasons><Structure><Student recruitment><Students><Study Type><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Teaching><Technology><Training><Translational Research Enterprise><Universities><Workforce Development><active recruitment><career><career aspiration><career development><career interest><career pathway><career track><certificate program><community college><data science education><data sharing><developmental><experience><faculty development><faculty professional development><faculty research><hands on research><health science research><improved><instructor training><instrumentation><interest><junior college><lesson plans><meeting><meetings><outreach><post-doc><post-doctoral><post-doctoral trainee><postbac><postbacc><primarily undergraduate institution><programs><research associates><social role><student research><student training><student-led research><study design><success><teacher development><translation research enterprise><translational research program><two year college><undergrad><undergraduate><undergraduate student>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mark L Lang

UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OKLAHOMA CITY, OK

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$4,207,418

FY 2025

Project Title

Oklahoma IDeA Network of Biomedical Research Excellence

Grant Number:

2P20GM103447-25

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/6/2001

End Date:

8/31/2030

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

This renewal application for the Oklahoma IDeA Network for Biomedical Research Excellence (OK-INBRE) proposes to further enhance the statewide research infrastructure and biomedical research capacity in Oklahoma by i.) enhancing and strengthening the research environment and building biomedical rese...

Research Terms

<2 year college><Accreditation><Aging><Arkansas><Autoimmune Status><Autoimmunity><Award><Basic Research><Basic Science><Biomedical Research><Caliber><Cancers><Collaborations><Communicable Diseases><Communication><Communities><Computational toolkit><Core Facility><Curriculum><Data Science><Development><Diabetes Mellitus><Education><Educational Curriculum><Educational aspects><Educational workshop><Eligibility><Eligibility Determination><Ensure><Environment><Equipment><Faculty><Foundations><Funding><Goals><Grant><Growth and Development><Growth and Development function><Health><Health Sciences><Health Status><Infectious Diseases><Infectious Disorder><Infrastructure><Institution><Instruction><Investigators><Investments><Leadership><Level of Health><Malignant Neoplasms><Malignant Tumor><Medical Research><Mentors><NIH><National Institutes of Health><Oklahoma><P01 Mechanism><P01 Program><Pilot Projects><Play><Process><Productivity><Program Project Grant><Program Research Project Grants><Proteomics><Protocol Screening><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Infrastructure><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resources><Role><Science><Services><Students><Technology><Training><United States National Institutes of Health><Universities><Work><Workshop><accredited><career><career development><cohort><college><collegiate><community college><computational toolbox><computational tools><computational toolset><computerized tools><developmental><diabetes><education resources><educational resources><experience><faculty research><faculty support><hands on research><health level><higher education><improved><institutional capacity><junior college><lesson plans><malignancy><multidisciplinary><neoplasm/cancer><next generation><outreach><pilot study><primarily undergraduate institution><programs><recruit><social role><success><summer undergraduate training><tribal college><tribal university><two year college><undergrad><undergraduate><undergraduate research experience><undergraduate research opportunities><undergraduate research programs><undergraduate student><undergraduate summer program><undergraduate summer research>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Trupti Joshi

MARSHALL UNIVERSITY, Huntington, WV

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$4,192,676

FY 2025

Project Title

West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE)

Grant Number:

5P20GM103434-25

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

7/31/2029

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

West Virginia has a history of a low success rate in obtaining grant funds from the National Institutes of Health and has been designated as an IDeA state. In this renewal application, Marshall University (MU), in partnership with West Virginia University (WVU), will continue to build on the success...

Research Terms

<2 year college><Award><Biomedical Research><COBRE><Cancers><Cardiovascular Diseases><Cellular biology><Center of Biomedical Research Excellence><Centers of Research Excellence><Collaborations><Core Facility><DNA Molecular Biology><Data Science><Development><Development and Research><Diabetes Mellitus><Educational workshop><Evaluation><Faculty><Funding><Grant><Health><History><Human><Infrastructure><Institution><Interdisciplinary Research><Interdisciplinary Study><Investigators><Knowledge><Lead><Malignant Neoplasms><Malignant Tumor><Mentors><Modern Man><Molecular><Molecular Biology><Multidisciplinary Collaboration><Multidisciplinary Research><NCRR><NIH><National Center for Research Resources><National Institutes of Health><Natural Products><Network Infrastructure><Obesity><P01 Mechanism><P01 Program><Pb element><Phase><Pilot Projects><Postdoc><Postdoctoral Fellow><Program Project Grant><Program Research Project Grants><Puerto Rico><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Associate><Research Grants><Research Infrastructure><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Research Support><Research Training><Researchers><Science><Structure><Students><Technology><Training><United States National Institutes of Health><Universities><West Virginia><Workshop><addiction><addictive disorder><adiposity><base><bases><cardiovascular disorder><career><career development><cell biology><community college><conference><convention><corpulence><developmental><diabetes><faculty research><graduate student><health science research><heavy metal Pb><heavy metal lead><histories><junior college><malignancy><multidisciplinary><naturally occurring product><neoplasm/cancer><pilot study><post-doc><post-doctoral><post-doctoral trainee><primarily undergraduate institution><programs><research and development><research associates><skills><student research><student-led research><success><summer research><summer student><summit><symposia><symposium><two year college><undergrad><undergraduate><undergraduate research experience><undergraduate research opportunities><undergraduate research programs><undergraduate student><virtual>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

EDIE C GOLDSMITH

UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, COLUMBIA, SC

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$4,147,083

FY 2025

Project Title

South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE)

Grant Number:

3P20GM103499-24S2

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

8/31/2026

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

The South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE) is a state-wide network whose goals are to enhance and strengthen the biomedical research culture and infrastructure at network institutions while increasing access to undergraduate research training opportunities for stud...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bongsup P Cho

UNIVERSITY OF RHODE ISLAND, KINGSTON, RI

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$4,119,364

FY 2025

Project Title

Rhode Island IDeA Network of Biomedical Research Excellence

Grant Number:

5P20GM103430-25

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

4/30/2029

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

The overarching goal of the Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) is to improve institutional capacity for biomedical research excellence and student experiential training in the State of Rhode Island. We will accomplish this goal by growing statewide institutional r...

Research Terms

<2 year college><Antibodies><Area><Award><Biological Agent><Biological Markers><Biological Products><Biomedical Research><Collaborations><Communities><Complement><Complement Proteins><Core Facility><Data Science><Destinations><Development><Development and Research><EXTMR><Equipment><Extramural><Extramural Activities><Faculty><Faculty Recruitment><Funding><Funding Mechanisms><Goals><Grant><Industry><Informatics><Infrastructure><Institution><Investigators><Investments><Jobs><Mentors><Molecular><NIH><National Institutes of Health><Occupations><Ointments><Organization administrative structures><Organizational Unit><P01 Mechanism><P01 Program><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Professional Positions><Program Development><Program Project Grant><Program Research Project Grants><R & D><R&D><Research><Research Associate><Research Personnel><Research Program Projects><Research Training><Researchers><Rhode Island><Salves><Structure><Students><Talents><Training><Training Programs><Unguents><United States National Institutes of Health><Universities><Wales><Workforce Development><bio-markers><biologic marker><biologics><biomarker><biomedical profession><biopharmaceutical><biotherapeutic agent><career><college><collegiate><community college><complementation><design><designing><developmental><experience><graduate student><improved><innovate><innovation><innovative><institutional capacity><instrument><junior college><novel><post-doc><post-doctoral><post-doctoral trainee><primarily undergraduate institution><programs><recruit><recruit teachers><research and development><research associates><student training><success><teacher recruitment><training opportunity><two year college><undergrad><undergraduate><undergraduate student><willingness>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Douglas E Wright

UNIVERSITY OF KANSAS MEDICAL CENTER, KANSAS CITY, KS

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$4,051,579

FY 2025

Project Title

Kansas IDeA Network of Biomedical Research Excellence 5

Grant Number:

5P20GM103418-25

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/18/2001

End Date:

4/30/2029

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT ABSTRACT- OVERALL The Kansas IDeA Network of Biomedical Research Excellence (K-INBRE) is a statewide network of universities in Kansas and Oklahoma that work cooperatively to improve biomedical research. The University of Kansas Medical Center (KUMC) is the Lead Institution and works closel...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ERIC C ROUCHKA

UNIVERSITY OF LOUISVILLE, LOUISVILLE, KY

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$4,034,092

FY 2025

Project Title

IDeA Networks of Biomedical Research Excellence in Kentucky

Grant Number:

5P20GM103436-25

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

4/30/2029

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

KY INBRE Overall Summary The Kentucky Institutional Development Award (IDeA) Network of Biomedical Research Excellence (KY INBRE) is a collaborative network of educational institutions working to build capacity for health-related and biomedical research in the Commonwealth of Kentucky. The KY INBRE...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JAMES A COFFMAN

MOUNT DESERT ISLAND BIOLOGICAL LAB, SALSBURY COVE, ME

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$3,986,822

FY 2025

Project Title

The Maine Biomedical Research Network (INBRE)

Grant Number:

5P20GM103423-25

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

4/30/2029

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

The Maine IDeA Network of Biomedical Research Excellence (ME-INBRE) is a statewide biomedical research network of public and private institutions led by the MDI Biological Laboratory (MDIBL). ME-INBRE consists of three private research institutes (MDIBL, The Jackson Laboratory, and MaineHealth Insti...

Research Terms

<2 year college><Adherence><Advisory Committees><Award><Bioinformatics core><Bioinformatics research core><Bioinformatics resource core><Biological><Biomedical Research><COBRE><Center of Biomedical Research Excellence><Centers of Research Excellence><Cloud Computing><Cloud Infrastructure><Collaborations><Communication><Communities><Community Outreach><Community of Practice><Complement><Complement Proteins><Complex><Core Facility><Data><Data Science><Data Science Core><Data Science Resource Core><Data Scientist><Development><Development and Research><Doctor of Philosophy><Educational workshop><Effectiveness><Ensure><Evaluation><Exposure to><Facility Accesses><Faculty><Fostering><Foundations><Funding><Goals><Grant><Growth and Development><Growth and Development function><Health><High School Student><Human><Infrastructure><Institution><Interdisciplinary Research><Interdisciplinary Study><Internet><Investigators><Laboratories><Leadership><Letters><Maine><Mentors><Mentorship><Mission><Modern Man><Multidisciplinary Collaboration><Multidisciplinary Research><NIH Program Announcements><New England><Northeastern United States><P01 Mechanism><P01 Program><Ph.D.><PhD><Pilot Projects><Play><Principal Investigator><Privatization><Program Announcement><Program Development><Program Project Grant><Program Research Project Grants><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Institute><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resources><Role><Science><Scientist><Secondary School Student><Secondary Student><Structure><Students><Talents><Task Forces><Technology><The Jackson Laboratory><Training><Universities><WWW><Work><Workshop><advisory team><assess effectiveness><biologic><biomedical data science><career><career development><cloud based computing><cloud computer><college><collegiate><community college><complementation><determine effectiveness><developmental><effectiveness assessment><effectiveness evaluation><evaluate effectiveness><examine effectiveness><experience><faculty research><formative assessment><formative evaluation><high schoolers><innovate><innovation><innovative><interest><junior college><literacy><multidisciplinary><outreach><pilot study><primarily undergraduate institution><programs><research and development><social role><student research><student-led research><two year college><undergrad><undergraduate><undergraduate research experience><undergraduate research opportunities><undergraduate research programs><undergraduate student><web><work group><working group><world wide web>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Carolyn Hovde Bohach

UNIVERSITY OF IDAHO, MOSCOW, ID

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$3,979,166

FY 2025

Project Title

Idaho INBRE Program

Grant Number:

2P20GM103408-24

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

8/31/2030

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

2P20GM103408-24 9047 Idaho INBRE Developmental Research Project Program (DRPP) Project Summary/Abstract The Developmental Research Project Program (DRPP) will select and support the most promising and meritorious emerging biomedical research in Idaho with emphasis on early stage investigators. The ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jonathan E. Baker

UNIVERSITY OF NEVADA RENO, RENO, NV

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$3,895,674

FY 2025

Project Title

Nevada IDeA Networks of Biomedical Research Excellence (INBRE)

Grant Number:

5P20GM103440-23

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2001

End Date:

3/31/2027

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall Network Organization and Management Plan – Abstract In this proposal the NV INBRE will continue to pursue the goals of enhancing biomedical research infrastructure, research competitiveness, training and workforce development throughout the state of Nevada. The specific focus of this researc...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jose R. Rodriguez-Medina

UNIVERSITY OF PUERTO RICO MED SCIENCES, SAN JUAN, PR

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$3,824,178

FY 2025

Project Title

Advancing Competitive Biomedical Research in Puerto Rico

Grant Number:

5P20GM103475-23

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/15/2001

End Date:

6/30/2027

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

- Overall The overall goal of the Puerto Rico IDeA Network of Biomedical Research Excellence is to augment research capacity in Puerto Rico at the Lead and Network institutions by enhancing the research infrastructure, providing support for meritorious research projects, and providing research exper...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

WU ZHOU

UNIVERSITY OF MISSISSIPPI MED CTR, JACKSON, MS

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$2,624,974

FY 2025

Project Title

Balance and Auditory Research Center (BARC)

Grant Number:

1P20GM156708-01

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2025

End Date:

7/31/2030

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary for the Balance and Auditory Research Center (BARC) Vestibular and auditory functions are fundamental to survival and quality of life. Childhood hearing loss is the most common congenital disorder, estimated to affect 2-3 in every 1000 births, and often co-morbid with vestibular impa...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

SIMON J FISHER

UNIVERSITY OF KENTUCKY, LEXINGTON, KY

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$2,234,231

FY 2025

Project Title

University of Kentucky Diabetes Prevention COBRE

Grant Number:

1P20GM156679-01

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2025

End Date:

7/31/2030

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT- OVERALL Prediabetes puts ~96 million US adults at very high risk of developing overt diabetes. Kentucky is a leading state for prediabetes, with 38% of our residents affected by this harbinger disease compared to 33% prevalence of prediabetes throughout the U.S. Under current standards of ...

Research Terms

<21+ years old><Abbreviations><Address><Adult><Adult Human><Affect><Amputation><Animals><Apoplexy><Appalachia><Appalachian><Appalachian Region><Area><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Blindness><Brain Vascular Accident><CDC2><CDC2 Protein Kinase><CDC2 gene><CDK1><COBRE><Cardiac Diseases><Cardiac Disorders><Caring><Catchment Area><Cause of Death><Cell Cycle Controller CDC2 Gene><Cell Cycle Controller cdc2><Cell Division Control Protein 2 Homolog><Cell Division Cycle 2><Cell Division Cycle 2 Protein><Center of Biomedical Research Excellence><Centers of Research Excellence><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Clinical><Clinical Research><Clinical Sciences><Clinical Study><Clinical and Translational Science Awards><Complement><Complement Proteins><Complications of Diabetes Mellitus><Country><Creativeness><Cyclin-Dependent Kinase 1><Data><Dedications><Development><Diabetes Complications><Diabetes Mellitus><Diabetes prevention><Diabetes-Related Complications><Diabetic Complications><Discipline><Disease><Disorder><Eligibility><Eligibility Determination><Ensure><Environment><Epidemic><Experimental Designs><Face><Faculty><Faculty Education><Faculty Recruitment><Faculty Training><Fostering><Foundations><Funding><Future><Goals><Grant><Health><Health Care><Health Sciences><Heart Diseases><Human><Individual><Infrastructure><Institution><Investigators><Kentucky><Kidney Failure><Kidney Insufficiency><Machine Learning><Medicine><Mentors><Metabolic syndrome><Methods><Mission><Modeling><Modern Man><NIH><National Institutes of Health><Outcome><P01 Mechanism><P01 Program><Phase><Phenotype><Position><Positioning Attribute><Prediabetes><Prediabetes syndrome><Prediabetic State><Prevalence><Preventative strategy><Prevention Research><Prevention strategy><Preventive strategy><Principal Investigator><Program Project Grant><Program Research Project Grants><Protocol Screening><R-Series Research Projects><R01 Mechanism><R01 Program><Renal Failure><Renal Insufficiency><Reporting><Reproducibility><Research><Research Grants><Research Personnel><Research Priority><Research Program Projects><Research Project Grants><Research Projects><Research Support><Researchers><Seasons><Secure><Stroke><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Technology><Training><United States National Institutes of Health><Universities><adulthood><brain attack><career development><cdc2 gene product><cdc2+ Protein><cdk1 Kinase><cerebral vascular accident><cerebrovascular accident><cohort><college><collegiate><complementation><conference><convention><creativity><developmental><diabetes><diabetes risk><equipment acquirement><equipment acquisition><equipment investment><equipment procurement><equipment purchase><equipment purchasing><experience><faces><facial><faculty development><faculty professional development><heart disorder><high risk><improved><innovate><innovation><innovative><instructor training><instrument acquisition><instrument investment><instrument procurement><instrument purchase><machine based learning><novel><p34 Protein Kinase><p34 Protein Kinase Gene><p34(CDC2) Gene><p34CDC2><peer coaching><peer instruction><peer led team learning><peer mentoring><peer teaching><pre-clinical><pre-clinical research><pre-diabetes><pre-diabetic><preclinical><preclinical research><prediabetic><programs><recruit teachers><response><skills><statistics><stroked><strokes><student training><success><summit><symposia><symposium><synergism><teacher development><teacher recruitment><tool><vision loss><visual loss>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Barbara Nikolajczyk

UNIVERSITY OF KENTUCKY, LEXINGTON, KY

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$2,234,231

FY 2025

Project Title

University of Kentucky Diabetes Prevention COBRE

Grant Number:

1P20GM156679-01

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2025

End Date:

7/31/2030

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT- OVERALL Prediabetes puts ~96 million US adults at very high risk of developing overt diabetes. Kentucky is a leading state for prediabetes, with 38% of our residents affected by this harbinger disease compared to 33% prevalence of prediabetes throughout the U.S. Under current standards of ...

Research Terms

<21+ years old><Abbreviations><Address><Adult><Adult Human><Affect><Amputation><Animals><Apoplexy><Appalachia><Appalachian><Appalachian Region><Area><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Blindness><Brain Vascular Accident><CDC2><CDC2 Protein Kinase><CDC2 gene><CDK1><COBRE><Cardiac Diseases><Cardiac Disorders><Caring><Catchment Area><Cause of Death><Cell Cycle Controller CDC2 Gene><Cell Cycle Controller cdc2><Cell Division Control Protein 2 Homolog><Cell Division Cycle 2><Cell Division Cycle 2 Protein><Center of Biomedical Research Excellence><Centers of Research Excellence><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Clinical><Clinical Research><Clinical Sciences><Clinical Study><Clinical and Translational Science Awards><Complement><Complement Proteins><Complications of Diabetes Mellitus><Country><Creativeness><Cyclin-Dependent Kinase 1><Data><Dedications><Development><Diabetes Complications><Diabetes Mellitus><Diabetes prevention><Diabetes-Related Complications><Diabetic Complications><Discipline><Disease><Disorder><Eligibility><Eligibility Determination><Ensure><Environment><Epidemic><Experimental Designs><Face><Faculty><Faculty Education><Faculty Recruitment><Faculty Training><Fostering><Foundations><Funding><Future><Goals><Grant><Health><Health Care><Health Sciences><Heart Diseases><Human><Individual><Infrastructure><Institution><Investigators><Kentucky><Kidney Failure><Kidney Insufficiency><Machine Learning><Medicine><Mentors><Metabolic syndrome><Methods><Mission><Modeling><Modern Man><NIH><National Institutes of Health><Outcome><P01 Mechanism><P01 Program><Phase><Phenotype><Position><Positioning Attribute><Prediabetes><Prediabetes syndrome><Prediabetic State><Prevalence><Preventative strategy><Prevention Research><Prevention strategy><Preventive strategy><Principal Investigator><Program Project Grant><Program Research Project Grants><Protocol Screening><R-Series Research Projects><R01 Mechanism><R01 Program><Renal Failure><Renal Insufficiency><Reporting><Reproducibility><Research><Research Grants><Research Personnel><Research Priority><Research Program Projects><Research Project Grants><Research Projects><Research Support><Researchers><Seasons><Secure><Stroke><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Technology><Training><United States National Institutes of Health><Universities><adulthood><brain attack><career development><cdc2 gene product><cdc2+ Protein><cdk1 Kinase><cerebral vascular accident><cerebrovascular accident><cohort><college><collegiate><complementation><conference><convention><creativity><developmental><diabetes><diabetes risk><equipment acquirement><equipment acquisition><equipment investment><equipment procurement><equipment purchase><equipment purchasing><experience><faces><facial><faculty development><faculty professional development><heart disorder><high risk><improved><innovate><innovation><innovative><instructor training><instrument acquisition><instrument investment><instrument procurement><instrument purchase><machine based learning><novel><p34 Protein Kinase><p34 Protein Kinase Gene><p34(CDC2) Gene><p34CDC2><peer coaching><peer instruction><peer led team learning><peer mentoring><peer teaching><pre-clinical><pre-clinical research><pre-diabetes><pre-diabetic><preclinical><preclinical research><prediabetic><programs><recruit teachers><response><skills><statistics><stroked><strokes><student training><success><summit><symposia><symposium><synergism><teacher development><teacher recruitment><tool><vision loss><visual loss>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JAMES Culvin MORRIS

CLEMSON UNIVERSITY, CLEMSON, SC

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$2,194,290

FY 2025

Project Title

COBRE: Eukaryotic Pathogens Innovation Center (EPIC)

Grant Number:

5P20GM146584-04

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/15/2022

End Date:

5/31/2027

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT Eukaryotic pathogens are the causative agents of some of the most devastating and intractable diseases of humans, including malaria, amebic dysentery, African sleeping sickness, Chagas disease, trichomoniasis, aspergillosis, cryptococcal fungal meningitis, toxoplasmosis and ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stephania A Cormier

LOUISIANA STATE UNIV A&M COL BATON ROUGE, BATON ROUGE, LA

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$2,171,800

FY 2025

Project Title

Center for Lung Biology and Disease

Grant Number:

5P20GM130555-07

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

1/2/2019

End Date:

6/30/2029

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

SUMMARY The Center for Lung Biology and Disease was established through a Phase I Centers of Biomedical Research Excellence (COBRE) award. Our Phase I proposal, aimed at providing Promising Junior Investigators (PJIs) an environment that maximizes their potential to contribute to advances in pulmona...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

TAMMY R DUGAS

LOUISIANA STATE UNIV A&M COL BATON ROUGE, BATON ROUGE, LA

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$2,171,800

FY 2025

Project Title

Center for Lung Biology and Disease

Grant Number:

5P20GM130555-07

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

1/2/2019

End Date:

6/30/2029

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

SUMMARY The Center for Lung Biology and Disease was established through a Phase I Centers of Biomedical Research Excellence (COBRE) award. Our Phase I proposal, aimed at providing Promising Junior Investigators (PJIs) an environment that maximizes their potential to contribute to advances in pulmona...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ana Navas-Acien

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$2,138,226

FY 2025

Project Title

Columbia University and Northern Plains Partnership for the Superfund Research Program

Grant Number:

5P42ES033719-04

Activity Code:

P42

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2022

End Date:

6/30/2027

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Summary Tribal lands are impacted by more than 15,000 hazardous waste sites and 7,000 abandoned mines that can disrupt the redox chemistry of aquifers and release toxic metals. In collaboration with tribal communities from North/South Dakota, we found that arsenic (As) and uranium (U) affect drinkin...

Research Terms

<21+ years old><Abscission><Address><Adsorption><Adult><Adult Human><Affect><Area><Arizona><Arsenic><Biological><Body Tissues><Cardiac Diseases><Cardiac Disorders><Cardiometabolic Disease><Cardiometabolic Disorder><Cardiovascular Diseases><Causality><Chemical Fractionation><Chemistry><Cheyenne><Childhood><Collaborations><Communities><Community Outreach><Conceptions><Congresses><Data><Data Analyses><Data Analysis><Data Management and Analysis Core><Data Management and Statistical Analysis Core><Data Management and Statistical Core><Diabetes Mellitus><Dietary Intervention><Distal><Elements><Ensure><Environment><Epidemic><Epidemiology><Etiology><Excision><Exposure to><Extirpation><FRACN><Fractionation><Fractionation Radiotherapy><Government><Hazardous Waste Sites><Health><Heart><Heart Diseases><Household><Human><Hydrogen Oxide><Indian Health Service><Indigenous><Institution><Intervention><Intervention Strategies><Isotopes><Joints><Knowledge><Laboratories><Life><Light><Longitudinal Studies><Maintenance><Measurement><Measures><Metal exposure><Metals><Mice><Mice Mammals><Modeling><Modern Man><Molecular><Molecular Fingerprinting><Molecular Profiling><Murine><Mus><Native American group><Native American individual><Native American people><Native American population><Native Americans><New Mexico><Northern Plains><Nutrition Interventions><Nutritional Interventions><Nutritional status><Oxidation-Reduction><P01 Mechanism><P01 Program><Pathway interactions><Photoradiation><Policies><Population><Prevention><Privatization><Program Project Grant><Program Research Project Grants><Recycling><Redox><Removal><Research><Research Activity><Research Ethics><Research Program Projects><Research Specimen><Resolution><Risk Reduction><Role><Rural><Rural Community><Sampling><Science><Scientist><Sioux><Sioux Indians><Source><South Dakota><Specimen><Superfund><Surgical Removal><System><Techniques><Technology><Tissue Sample><Tissues><Toxic effect><Toxicities><Training><Translational Research><Translational Science><Treatment Failure><Tribes><United States Indian Health Service><Universities><Uranium><Urine><Water><adulthood><amateur science><amateur scientists><arsenics><biologic><cardiometabolic><cardiometabolism><cardiovascular disorder><causation><citizen science><citizen scientists><civic science><community engagement><community partners><community-based partners><complex data><contaminated drinking water><continuous monitoring><crowd science><crowd-sourced science><data interpretation><data management><diabetes><diet intervention><disease causation><disease prevention><disorder prevention><drinking water><drinking water contamination><early life exposure><effective intervention><engagement with communities><epidemiologic><epidemiological><epigenomics><evidence base><experience><exposure to metal><ground water><groundwater><hazardous drinking><heart disorder><innovate><innovation><innovative><innovative technologies><long-term study><longitudinal design><longitudinal experimental design><longitudinal outcome studies><longitudinal research design><longitudinal study design><metabolism measurement><metabolomics><metabonomics><molecular profile><molecular signature><mouse model><multiomics><multiple omics><murine model><next generation><northern Native American><novel><oxidation reduction reaction><panomics><pathway><pediatric><photosynthetic bacteria><programs><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><remediation><resection><resolutions><risk-reducing><scientific citizenship><sioux community><social role><spatial and temporal><spatial temporal><spatiotemporal><stable isotope><success><superfund site><synergism><therapy failure><toxic metal><transcriptomics><translation research><translational investigation><tribal community><tribal lands><urinary><wasting><water quality><water sampling><well water>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stephen A Boppart

UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, CHAMPAIGN, IL

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$1,123,421

FY 2025

Project Title

Center for Label-free Imaging and Multiscale Biophotonics (CLIMB)

Grant Number:

5P41EB031772-04

Activity Code:

P41

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2022

End Date:

6/20/2027

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

SUMMARY The Center for Label-free Imaging and Multiscale Biophotonics (CLIMB) develops cutting-edge optical and computational imaging technologies for addressing grand challenges in biomedicine, including cancer and neurodegenerative diseases. Building upon the recent advances in interferometric, no...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAM M BRICKMAN

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 40/100

Solid budget

Recent

Active award

Team-scale grant

$258,256

FY 2026

Project Title

Enhancing Alzheimer's-related research in rural South Africa with portable MRI

Grant Number:

3UG3AG090558-02S1

Activity Code:

UG3

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2025

End Date:

1/31/2028

Project Abstract

PROJECT SUMMARY This project will incorporate portable, low-field brain magnetic resonance imaging (MRI) into a population- representative study of Alzheimer’s disease (AD) and related dementias (ADRD) in rural South Africa, transforming the ability to assess ADRD-related brain atrophy and cerebrova...

Research Terms

<21+ years old><AD and related dementia><AD dementia><AD related dementia><ADRD><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adult><Adult Human><Affect><Africa><African><Age><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><Amyloid><Amyloid Substance><Assay><Atrophic><Atrophy><Bioassay><Biological Assay><Biological Markers><Blood><Blood Plasma><Blood Reticuloendothelial System><Brain Vascular Disorders><Brain imaging><Cerebrovascular Disease><Cerebrovascular Disorders><Clinical><Clinical Data><Cognition><Cognitive><Collaborations><Communication><Communities><Community Health><Consensus><Coupled><Data><Data Collection><Dementia><Development><Diagnostic><Dysfunction><Ensure><Epidemiology><Functional disorder><Future><General Radiology><Goals><HIV><Health><Health Care Facility><Health Facilities><Human Immunodeficiency Viruses><Incidence><Incidental Findings><Infrastructure><Interview><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Investigators><LAV-HTLV-III><LMIC><Leadership><Longitudinal Studies><Longitudinal Surveys><Lumbar Puncture><Lymphadenopathy-Associated Virus><MR Imaging><MR Tomography><MRI><MRI Scans><MRIs><MT-bound tau><Magnetic Resonance Imaging><Magnetic Resonance Imaging Scan><Measurement><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Molecular><NMR Imaging><NMR Tomography><Nerve Degeneration><Neurologic Examination><Neuron Degeneration><Neurosciences><Nuclear Magnetic Resonance Imaging><Outcome><PET><PET Scan><PET imaging><PETSCAN><PETT><Participant><Pathogenesis><Phase><Physiopathology><Plasma><Plasma Serum><Population><Positron Emission Tomography Medical Imaging><Positron Emission Tomography Scan><Positron-Emission Tomography><Prevalence><Primary Senile Degenerative Dementia><Protocol><Protocols documentation><Publications><Rad.-PET><Radiology><Radiology Specialty><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Reticuloendothelial System, Serum, Plasma><Risk Factors><Rural><Scanning><Scientific Publication><Scientist><South Africa><South African><Spinal Puncture><Survey Instrument><Surveys><System><Technology><Testing><Universities><Virus-HIV><Wit><Work><Zeugmatography><adulthood><aged><ages><bio-markers><biologic marker><biomarker><brain MR imaging><brain MRI><brain atrophy><brain magnetic resonance imaging><brain vascular disease><brain vascular dysfunction><brain visualization><care facilities><cerebral MR imaging><cerebral MRI><cerebral atrophy><cerebral magnetic resonance imaging><cerebral vascular disease><cerebral vascular dysfunction><cerebrovascular dysfunction><cognitive assessment><cognitive testing><cohort><community-based health><computerized data processing><cortical atrophy><cost><data exchange><data processing><data transfer><data transmission><dementia risk><developmental><epidemiologic><epidemiological><global health><imaging study><informant><intracranial vascular dysfunction><long-term study><longitudinal outcome studies><longitudinal research study><low and middle-income countries><microtubule bound tau><microtubule-bound tau><neural degeneration><neural imaging><neuro-imaging><neurodegeneration><neurodegenerative><neuroimaging><neurological degeneration><neurological imaging><neuronal degeneration><pathophysiology><population based><portability><positron emission tomographic (PET) imaging><positron emission tomographic imaging><positron emitting tomography><primary degenerative dementia><regional atrophy><risk factor for dementia><risk for dementia><rural South Africa><rural area><rural locality><rural location><rural place><rural region><rural setting><senile dementia of the Alzheimer type><social determinants><social factors><social health determinants><sociodeterminant><tau><tau Proteins><tau factor><training opportunity><vascular component><vascular factor><τ Proteins>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Victor Mngomezulu

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 40/100

Solid budget

Recent

Active award

Team-scale grant

$258,256

FY 2026

Project Title

Enhancing Alzheimer's-related research in rural South Africa with portable MRI

Grant Number:

3UG3AG090558-02S1

Activity Code:

UG3

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2025

End Date:

1/31/2028

Project Abstract

PROJECT SUMMARY This project will incorporate portable, low-field brain magnetic resonance imaging (MRI) into a population- representative study of Alzheimer’s disease (AD) and related dementias (ADRD) in rural South Africa, transforming the ability to assess ADRD-related brain atrophy and cerebrova...

Research Terms

<21+ years old><AD and related dementia><AD dementia><AD related dementia><ADRD><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adult><Adult Human><Affect><Africa><African><Age><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><Amyloid><Amyloid Substance><Assay><Atrophic><Atrophy><Bioassay><Biological Assay><Biological Markers><Blood><Blood Plasma><Blood Reticuloendothelial System><Brain Vascular Disorders><Brain imaging><Cerebrovascular Disease><Cerebrovascular Disorders><Clinical><Clinical Data><Cognition><Cognitive><Collaborations><Communication><Communities><Community Health><Consensus><Coupled><Data><Data Collection><Dementia><Development><Diagnostic><Dysfunction><Ensure><Epidemiology><Functional disorder><Future><General Radiology><Goals><HIV><Health><Health Care Facility><Health Facilities><Human Immunodeficiency Viruses><Incidence><Incidental Findings><Infrastructure><Interview><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Investigators><LAV-HTLV-III><LMIC><Leadership><Longitudinal Studies><Longitudinal Surveys><Lumbar Puncture><Lymphadenopathy-Associated Virus><MR Imaging><MR Tomography><MRI><MRI Scans><MRIs><MT-bound tau><Magnetic Resonance Imaging><Magnetic Resonance Imaging Scan><Measurement><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Molecular><NMR Imaging><NMR Tomography><Nerve Degeneration><Neurologic Examination><Neuron Degeneration><Neurosciences><Nuclear Magnetic Resonance Imaging><Outcome><PET><PET Scan><PET imaging><PETSCAN><PETT><Participant><Pathogenesis><Phase><Physiopathology><Plasma><Plasma Serum><Population><Positron Emission Tomography Medical Imaging><Positron Emission Tomography Scan><Positron-Emission Tomography><Prevalence><Primary Senile Degenerative Dementia><Protocol><Protocols documentation><Publications><Rad.-PET><Radiology><Radiology Specialty><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Reticuloendothelial System, Serum, Plasma><Risk Factors><Rural><Scanning><Scientific Publication><Scientist><South Africa><South African><Spinal Puncture><Survey Instrument><Surveys><System><Technology><Testing><Universities><Virus-HIV><Wit><Work><Zeugmatography><adulthood><aged><ages><bio-markers><biologic marker><biomarker><brain MR imaging><brain MRI><brain atrophy><brain magnetic resonance imaging><brain vascular disease><brain vascular dysfunction><brain visualization><care facilities><cerebral MR imaging><cerebral MRI><cerebral atrophy><cerebral magnetic resonance imaging><cerebral vascular disease><cerebral vascular dysfunction><cerebrovascular dysfunction><cognitive assessment><cognitive testing><cohort><community-based health><computerized data processing><cortical atrophy><cost><data exchange><data processing><data transfer><data transmission><dementia risk><developmental><epidemiologic><epidemiological><global health><imaging study><informant><intracranial vascular dysfunction><long-term study><longitudinal outcome studies><longitudinal research study><low and middle-income countries><microtubule bound tau><microtubule-bound tau><neural degeneration><neural imaging><neuro-imaging><neurodegeneration><neurodegenerative><neuroimaging><neurological degeneration><neurological imaging><neuronal degeneration><pathophysiology><population based><portability><positron emission tomographic (PET) imaging><positron emission tomographic imaging><positron emitting tomography><primary degenerative dementia><regional atrophy><risk factor for dementia><risk for dementia><rural South Africa><rural area><rural locality><rural location><rural place><rural region><rural setting><senile dementia of the Alzheimer type><social determinants><social factors><social health determinants><sociodeterminant><tau><tau Proteins><tau factor><training opportunity><vascular component><vascular factor><τ Proteins>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stephen Tollman

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 40/100

Solid budget

Recent

Active award

Team-scale grant

$258,256

FY 2026

Project Title

Enhancing Alzheimer's-related research in rural South Africa with portable MRI

Grant Number:

3UG3AG090558-02S1

Activity Code:

UG3

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2025

End Date:

1/31/2028

Project Abstract

PROJECT SUMMARY This project will incorporate portable, low-field brain magnetic resonance imaging (MRI) into a population- representative study of Alzheimer’s disease (AD) and related dementias (ADRD) in rural South Africa, transforming the ability to assess ADRD-related brain atrophy and cerebrova...

Research Terms

<21+ years old><AD and related dementia><AD dementia><AD related dementia><ADRD><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adult><Adult Human><Affect><Africa><African><Age><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><Amyloid><Amyloid Substance><Assay><Atrophic><Atrophy><Bioassay><Biological Assay><Biological Markers><Blood><Blood Plasma><Blood Reticuloendothelial System><Brain Vascular Disorders><Brain imaging><Cerebrovascular Disease><Cerebrovascular Disorders><Clinical><Clinical Data><Cognition><Cognitive><Collaborations><Communication><Communities><Community Health><Consensus><Coupled><Data><Data Collection><Dementia><Development><Diagnostic><Dysfunction><Ensure><Epidemiology><Functional disorder><Future><General Radiology><Goals><HIV><Health><Health Care Facility><Health Facilities><Human Immunodeficiency Viruses><Incidence><Incidental Findings><Infrastructure><Interview><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Investigators><LAV-HTLV-III><LMIC><Leadership><Longitudinal Studies><Longitudinal Surveys><Lumbar Puncture><Lymphadenopathy-Associated Virus><MR Imaging><MR Tomography><MRI><MRI Scans><MRIs><MT-bound tau><Magnetic Resonance Imaging><Magnetic Resonance Imaging Scan><Measurement><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Molecular><NMR Imaging><NMR Tomography><Nerve Degeneration><Neurologic Examination><Neuron Degeneration><Neurosciences><Nuclear Magnetic Resonance Imaging><Outcome><PET><PET Scan><PET imaging><PETSCAN><PETT><Participant><Pathogenesis><Phase><Physiopathology><Plasma><Plasma Serum><Population><Positron Emission Tomography Medical Imaging><Positron Emission Tomography Scan><Positron-Emission Tomography><Prevalence><Primary Senile Degenerative Dementia><Protocol><Protocols documentation><Publications><Rad.-PET><Radiology><Radiology Specialty><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Reticuloendothelial System, Serum, Plasma><Risk Factors><Rural><Scanning><Scientific Publication><Scientist><South Africa><South African><Spinal Puncture><Survey Instrument><Surveys><System><Technology><Testing><Universities><Virus-HIV><Wit><Work><Zeugmatography><adulthood><aged><ages><bio-markers><biologic marker><biomarker><brain MR imaging><brain MRI><brain atrophy><brain magnetic resonance imaging><brain vascular disease><brain vascular dysfunction><brain visualization><care facilities><cerebral MR imaging><cerebral MRI><cerebral atrophy><cerebral magnetic resonance imaging><cerebral vascular disease><cerebral vascular dysfunction><cerebrovascular dysfunction><cognitive assessment><cognitive testing><cohort><community-based health><computerized data processing><cortical atrophy><cost><data exchange><data processing><data transfer><data transmission><dementia risk><developmental><epidemiologic><epidemiological><global health><imaging study><informant><intracranial vascular dysfunction><long-term study><longitudinal outcome studies><longitudinal research study><low and middle-income countries><microtubule bound tau><microtubule-bound tau><neural degeneration><neural imaging><neuro-imaging><neurodegeneration><neurodegenerative><neuroimaging><neurological degeneration><neurological imaging><neuronal degeneration><pathophysiology><population based><portability><positron emission tomographic (PET) imaging><positron emission tomographic imaging><positron emitting tomography><primary degenerative dementia><regional atrophy><risk factor for dementia><risk for dementia><rural South Africa><rural area><rural locality><rural location><rural place><rural region><rural setting><senile dementia of the Alzheimer type><social determinants><social factors><social health determinants><sociodeterminant><tau><tau Proteins><tau factor><training opportunity><vascular component><vascular factor><τ Proteins>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kathryn B Anderson

UPSTATE MEDICAL UNIVERSITY, SYRACUSE, NY

Exploratory lead · 36/100

Likely hiring

Active award

$94,253

FY 2025

Project Title

Defining correlates of protection from dengue illness in a long-term cohort study of multigenerational house-holds in Thailand

Grant Number:

3R01AI175941-03S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2025

End Date:

6/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY Dengue viruses (DENV) cause a significant and unchecked burden of human death and disease, with vaccine development hindered by critical gaps in our understanding of how multi-serotypic protection against DENV is generated, sustained, and subsequently identified in immunological assa...

Research Terms

<0-11 years old><7S Gamma Globulin><Acute><Address><Antibodies><Antibody titer measurement><Antigens><Arboviral><Arboviruses><Area><Arthropod-Borne Viruses><Benchmarking><Best Practice Analysis><Breakbone Fever Virus><Breast Feeding><Breast fed><Breastfed><Breastfeeding><Cessation of life><Child><Child Youth><Children (0-21)><Clinical><Cohort Studies><Communicable Diseases><Concurrent Studies><Custom><DENV><DENV infection><DENV vaccine><Death><Dengue><Dengue Infection><Dengue Vaccine><Dengue Virus><Dengue fever virus><Dengue virus infection><Dengue virus vaccine><Development><Diagnostic><Disease><Disorder><Enrollment><Environment><Exposure to><Family><Flavivirus><Funding><Future><Generations><Goals><Group B Arbovirus><Health><History><Household><Human><Humoral Immunities><IgG><Immune><Immune mediated therapy><Immunes><Immunity><Immunochemical Immunologic><Immunoglobulin G><Immunologic><Immunological><Immunologically><Immunologically Directed Therapy><Immunologics><Immunology procedure><Immunotherapy><Incidence><Individual><Infant><Infection><Infectious Diseases><Infectious Disorder><Japanese B Encephalitis Virus><Japanese encephalitis virus><Kinetics><Knowledge><Locales><Long-term Follow-up><Long-term cohort study><Longitudinal cohort study><Malaria><Maps><Maternal Immunity><Maternally-Acquired Immunity><Math Models><Mediating><Mission><Modeling><Modern Man><Mothers><NIAID><NIH><National Institute of Allergy and Infectious Disease><National Institutes of Health><Orthoflavivirus><Outcome><Paludism><Pathogenesis><Phenotype><Plasmodium Infections><Population Surveillance><Pregnant Women><Public Health Surveillance><Recording of previous events><Research><Research Specimen><Risk><Safety><Saliva><Sampling><Serotyping><Shapes><Specimen><Techniques><Testing><Thailand><Time><Triage><United States National Institutes of Health><VAC-TX><Vaccinated><Vaccination><Vaccine Therapy><Vaccines><Viral Diseases><Virus Diseases><ZIKV><ZIKV infected><ZIKV infection><ZIKV positive><Zika Virus><Zika virus infection><antibody titering><antibody-based immunity><benchmark><cohort><cross reactivity><customs><dengue viral infection><develop a vaccine><develop vaccines><development of a vaccine><developmental><efficacy trial><enroll><expectant mother><expectant women><expectation><expecting mother><expecting women><histories><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunogen><immunogenicity><immunologic assay><immunologic assay/test><individuals who are pregnant><infected with ZIKV><infected with zika><innovate><innovation><innovative><kids><long-term followup><mathematic model><mathematical model><mathematical modeling><people who are pregnant><placental transfer><pregnant females><pregnant mothers><pregnant people><pregnant populations><prenatal><prevent><preventing><primary outcome><protective effect><secondary infection><seroconversion><severe dengue><therapeutic vaccination><those who are pregnant><tool><unborn><vaccine against DENV><vaccine against dengue><vaccine candidate against dengue><vaccine development><viral infection><viral transmission><virus infection><virus transmission><virus-induced disease><ward><women who are pregnant><youngster><zika infected><zika infection><zika viral infection><zikav>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Matthew S. Gentry

UNIVERSITY OF FLORIDA, GAINESVILLE, FL

Exploratory lead · 36/100

Likely hiring

Active award

$74,309

FY 2025

Project Title

Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential

Grant Number:

3R35NS116824-06S1

Activity Code:

R35

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/15/2020

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Brain metabolism is a fundamental aspect of biology and human disease. The brain critically depends on glucose, consuming large quantities as the biochemical fuel for cognition, memory, and behavior. Fundamental aspects of brain metabolism have been extensively studied, but recent evidence regarding...

Research Terms

<12-20 years old><AD dementia><Abscission><Adolescence><Affect><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimers Dementia><Ataxia><Ataxy><Autoregulation><Behavior><Biochemical><Biology><Body Tissues><Brain><Brain Nervous System><Carbohydrates><Cell Communication and Signaling><Cell Function><Cell Physiology><Cell Process><Cell Signaling><Cellular Function><Cellular Metabolic Process><Cellular Physiology><Cellular Process><Cessation of life><Cognition><Complex><Comprehension><Consumption><Coordination Impairment><D-Glucan><D-Glucose><DNA mutation><Data><Death><Development><Dextrose><Diagnosis><Disease><Disease Progression><Disorder><Dyssynergia><Encephalon><Epilepsy, Progressive Myoclonic, Lafora><Event><Excision><Extirpation><Freedom><Funding><Genetic Change><Genetic defect><Genetic mutation><Glucose><Glycogen><Glycogen Storage Disease><Glycogenosis><Homeostasis><Intermediary Metabolism><Intracellular Communication and Signaling><Intractable Epilepsy><Knowledge><Lafora Body Disease><Lafora Disease><Lafora Type Progressive Myoclonic Epilepsy><Liberty><Memory><Metabolic><Metabolic Processes><Metabolism><Modality><Modeling><Molecular><Mutation><NINDS><National Institute of Neurological Diseases and Stroke><National Institute of Neurological Disorders and Stroke><Nerve Degeneration><Nervous System Diseases><Nervous System Disorder><Neurologic Disorders><Neurological Disorders><Neuron Degeneration><Patients><Physiological Homeostasis><Play><Primary Senile Degenerative Dementia><Refractory epilepsy><Removal><Research><Role><Seminal><Signal Transduction><Signal Transduction Systems><Signaling><Subcellular Process><Surgical Removal><Symptoms><Therapeutic><Tissues><Translating><Vegetative States><Work><adolescence (12-20)><autosome><biological signal transduction><biomarker development><brain metabolism><cell metabolism><cellular metabaolism><develop therapy><developmental><driving force><drug-resistant epilepsy><flexibility><flexible><genome mutation><glucose metabolism><glycogen metabolism><human disease><insight><intervention development><mouse model><murine model><neural degeneration><neurodegeneration><neurodegenerative><neurological degeneration><neurological disease><neuronal degeneration><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><polyglucosan><pre-clinical><preclinical><primary degenerative dementia><resection><senile dementia of the Alzheimer type><sex><social role><therapy development><tool><treatment development>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stephanie M Cologna

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Exploratory lead · 34/100

Large award

Active award

$1,481,999

FY 2025

Project Title

A dual-source ion mobility mass spectrometry system

Grant Number:

1S10OD036311-01A1

Activity Code:

S10

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/15/2025

End Date:

5/14/2026

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Abstract The enclosed application seeks to add a dual source ion mobility hybrid mass spectrometry system for biomedical research at the University of Illinois Chicago (UIC), a federally designated minority serving institution. This instrumentation would enable state-of-the art measurements for rese...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lawrence E Cornett

UNIV OF ARKANSAS FOR MED SCIS, LITTLE ROCK, AR

Exploratory lead · 32/100

Large award

Team-scale grant

$4,290,727

FY 2025

Project Title

Partnerships for Biomedical Research in Arkansas

Grant Number:

3P20GM103429-23S2

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

4/30/2026

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY/ABSTRACT The goal of the Arkansas IDeA Network of Biomedical Research Excellence (INBRE) is to expand biomedical research capacity in Arkansas. Scientific leadership for the network is provided by 2 research-intensive lead institutions: the University of Arkansas for Medical ...

Research Terms

<0-11 years old><Adherence><Advisory Committees><American><Arkansas><Award><Biomedical Research><COBRE><Center of Biomedical Research Excellence><Centers of Research Excellence><Child><Child Youth><Children (0-21)><Cloud Computing><Cloud Infrastructure><Collaborations><Communication><Core Facility><Coupled><Data><Data Analyses><Data Analysis><Data Science Core><Data Science Resource Core><Development><Diagnosis><EXTMR><Educational workshop><Effectiveness><Emergent Technologies><Emerging Technologies><Ensure><Evaluation><Extramural><Extramural Activities><Faculty><Faculty Education><Faculty Training><Funding><Future><Generalized Growth><Goals><Growth><Guidelines><Health><Home><Human><Institution><Investigators><Lead><Leadership><Medical><Mentors><Mentorship><Modern Man><Monitor><NIH><National Institutes of Health><Newsletter><Outcome><P01 Mechanism><P01 Program><Pb element><Periodicals><Policies><Principal Investigator><Procedures><Program Effectiveness><Program Evaluation><Program Project Grant><Program Research Project Grants><Research><Research Infrastructure><Research Institute><Research Personnel><Research Program Projects><Research Resources><Researchers><Resource Allocation><Resource Sharing><Resources><Role><Rural><Science><Scientific Advances and Accomplishments><Scientist><Services><Students><Survey Instrument><Surveys><Task Forces><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Technology><Tissue Growth><Training><Training Activity><United States National Institutes of Health><Universities><Visit><Workshop><advisory team><assess effectiveness><biomedical scientist><career><cloud based computing><cloud computer><college><collegiate><computational resources><computing resources><conference><convention><data interpretation><design><designing><determine effectiveness><developmental><effectiveness assessment><effectiveness evaluation><evaluate effectiveness><examine effectiveness><experience><faculty development><faculty mentor><faculty professional development><faculty research><faculty support><federal policy><heavy metal Pb><heavy metal lead><higher education><homes><human disease><improved><instructor training><kids><meeting><meetings><member><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><ontogeny><periodic><periodical><primarily undergraduate institution><programs><scientific accomplishments><scientific advances><skills><social media><social role><student engagement><student motivation><student participation><student training><success><summit><symposia><symposium><teacher development><training module><undergrad><undergraduate><undergraduate student><voucher><web site><website><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PAUL L SORGEN

UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE

Exploratory lead · 32/100

Large award

Team-scale grant

$3,929,652

FY 2025

Project Title

Nebraska Research Network in Functional Genomics

Grant Number:

3P20GM103427-23S3

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

4/30/2026

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Overall Component Project Summary The mission of the Nebraska IDeA Networks of Biomedical Research Excellence (NE-INBRE) is to stimulate and develop biomedical research capacity at institutions of higher education in Nebraska. The NE-INBRE is structured around two major components: primarily undergr...

Research Terms

<2 year college><Accountability><Achievement><Achievement Attainment><Advisory Committees><Area><Arts><Attitude><Award><Benchmarking><Best Practice Analysis><Biomedical Research><Cancer Biology><Cell Communication and Signaling><Cell Signaling><Collaborations><Communicable Diseases><Core Facility><Curriculum><Data Science><Development><Doctor of Philosophy><Educational Curriculum><Ensure><Evaluation><Evaluation Reports><Faculty><Feedback><Funding><Genomics><Goals><Grant><Guidelines><Health Occupations><Health Professions><Infectious Diseases><Infectious Disorder><Infrastructure><Institution><Intracellular Communication and Signaling><Investigators><Investments><Knowledge><Laboratories><Leadership><Left><Link><Measures><Medical center><Mentors><Microscopy><Mission><Modernization><Nebraska><Network-based><Organization Charts><Outcome><P01 Mechanism><P01 Program><Peer Review><Perception><Ph.D.><PhD><Policies><Privatization><Productivity><Program Project Grant><Program Research Project Grants><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Infrastructure><Research Institute><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Researchers><Resource Sharing><Saints><Scholars Program><Schools><Science><Scientific Publication><Signal Transduction><Signal Transduction Systems><Signaling><Structure><Students><Survey Instrument><Surveys><System><Task Forces><Technology><Training><Universities><advisory team><assess effectiveness><benchmark><biological signal transduction><career><career development><college><collegiate><community college><design><designing><determine effectiveness><developmental><effectiveness assessment><effectiveness evaluation><evaluate effectiveness><examine effectiveness><experience><faculty research><faculty support><functional genomics><graduate student><health science profession><higher education><interest><junior college><lesson plans><meeting><meetings><member><multidisciplinary><organizational structure><primarily undergraduate institution><programs><recruit><satisfaction><student engagement><student motivation><student participation><success><two year college><undergrad><undergraduate><undergraduate research><undergraduate research experience><undergraduate research opportunities><undergraduate research programs><undergraduate student>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Anna R Hemnes

VANDERBILT UNIVERSITY MEDICAL CENTER, NASHVILLE, TN

Exploratory lead · 30/100

Recent

Active award

Career award

$114,644

FY 2026

Project Title

Mentorship in Pulmonary Vascular Disease

Grant Number:

5K24HL155891-05

Activity Code:

K24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

1/1/2022

End Date:

12/31/2026

Project Abstract

Pulmonary arterial hypertension (PAH) is a rare lung disease characterized by progressive pulmonary vascular obliteration resulting in right ventricular failure and ultimately death. Throughout the last three decades there has been tremendous progress in understanding disease mechanisms that have le...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jeffrey A Henderson

BLACK HILLS CTR/AMERICAN INDIAN HEALTH, RAPID CITY, SD

Exploratory lead · 28/100

Above-average budget

Active award

$904,086

FY 2025

Project Title

Lakota Center for Health Research

Grant Number:

5S06GM146079-04

Activity Code:

S06

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/1/2022

End Date:

7/31/2026

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

Mitakuye Oyasin is a well-known Lakota phrase that means “we are all related.” This phrase is often used to signify the Lakota people’s appreciation for and relationship with the environment (Unci Maka or Grandmother Earth). This Native American Research Centers for Health (NARCH) XII program applic...

Research Terms

<2019 novel corona virus><2019 novel coronavirus><2019-nCoV><American Indian reservation><Arizona><COVID-19 virus><COVID19 virus><Cheyenne><Cities><CoV-2><CoV2><Communities><Coupled><Earth><Environment><Evaluation><Funding><Future><Health><Health Disparities Research><Health Inequity><Health disparities related research><Human><Indian reservation><Inequalities in Health><Inequities in Health><Inequity><Infrastructure><Intervention Trial><Interventional trial><Investigators><Lakota><Lakota Sioux><Modern Man><NARCH><Native American Research Center for Health><Non-Polyadenylated RNA><Northern Plains Tribe><P01 Mechanism><P01 Program><Persons><Planet Earth><Process><Productivity><Program Project Grant><Program Research Project Grants><R-Series Research Projects><R01 Mechanism><R01 Program><RNA><RNA Gene Products><Research><Research Grants><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Researchers><Ribonucleic Acid><Running><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Sioux><Sioux Indians><South Dakota><Testing><Teton Sioux><Teton Sioux Indian><Thinking><Translating><Trauma><Tribal group><Tribes><Universities><Woman><Wuhan coronavirus><biobank><biorepository><cease smoking><coronavirus disease 2019 virus><coronavirus disease-19 virus><design><designing><experience><hCoV19><health disparities science><health inequalities><improved><innovate><innovation><innovative><intimate partner violence><medical college><medical schools><member><mindfulness><nCoV2><nation reservation><phrases><pilot test><process improvement><programs><quit smoking><reservation community><school of medicine><sioux community><smoking cessation><stop smoking><thoughts><tribal people><tribal population><tribal reservation>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Heather Marie Gibson

WAYNE STATE UNIVERSITY, DETROIT, MI

Exploratory lead · 28/100

Solid budget

Active award

Team-scale grant

$413,265

FY 2025

Project Title

Disparities in Immuno-oncology Outcomes in Detroit (DIODE)

Grant Number:

5P20CA290450-02

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/5/2024

End Date:

8/31/2026

Project Abstract

This application will address breast cancer in high-risk groups among residents of metropolitan Detroit, specifically evaluating differences in genetic regulation of tumor immune response in HER2+ breast cancer as an example of the type of transdisciplinary work that will be catalyzed through the ro...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kristen S. Purrington

WAYNE STATE UNIVERSITY, DETROIT, MI

Exploratory lead · 28/100

Solid budget

Active award

Team-scale grant

$413,265

FY 2025

Project Title

Disparities in Immuno-oncology Outcomes in Detroit (DIODE)

Grant Number:

5P20CA290450-02

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/5/2024

End Date:

8/31/2026

Project Abstract

This application will address breast cancer in high-risk groups among residents of metropolitan Detroit, specifically evaluating differences in genetic regulation of tumor immune response in HER2+ breast cancer as an example of the type of transdisciplinary work that will be catalyzed through the ro...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MELINDA K DUNCAN

UNIVERSITY OF DELAWARE, Newark, DE

Exploratory lead · 28/100

Solid budget

Active award

Team-scale grant

$314,859

FY 2025

Project Title

Delaware INBRE

Grant Number:

3P20GM103446-24S1

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

4/30/2030

Project Abstract

Project Summary The Delaware IDeA Network of Biomedical Research Excellence (DE-INBRE) catalyzes multidisciplinary biomedical research initiatives that build Delaware’s biomedical research capacity and workforce. The DE- INBRE network consists of five network partner institutions (NPIs): The Univers...

Research Terms

<2 year college><Abscission><Automobile Driving><Biomedical Research><COBRE><Center for Translational Science Activities><Center of Biomedical Research Excellence><Centers of Research Excellence><Child Health><Classification><Collaborations><Communities><Core Facility><Curriculum><Data><Data Science><Data Science Core><Data Science Resource Core><Data Set><Delaware><Development><Education and Training><Educational Curriculum><Educational workshop><Ensure><Excision><Extirpation><Faculty><Faculty Education><Faculty Training><Fostering><Funding><Future><Generations><Goals><Grant><HIPAA><Health><Health Care Systems><Health Insurance Portability and Accountability Act><Health Sciences><Infrastructure><Institution><Institutional Policy><Internships><Investigation><Investigators><Investments><Kennedy Kassebaum Act><Knowledge><Laboratories><Logistics><Low income><Medical><Mentors><Methodology><Methods><Minority><Mission><NIH><National Institutes of Health><P01 Mechanism><P01 Program><PL 104-191><PL104-191><Pilot Projects><Policies><Principal Investigator><Program Evaluation><Program Project Grant><Program Research Project Grants><Public Law 104-191><Publishing Peer Reviews><R-Series Research Projects><R01 Mechanism><R01 Program><Removal><Research><Research Activity><Research Grants><Research Infrastructure><Research Peer Review><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Research Resources><Research Support><Research Training><Researchers><Resource Sharing><Resources><Scholars Program><Scientist><Services><Students><Surgical Removal><System><Systematics><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Training><Training and Education><URM student><United States Health Insurance Portability and Accountability Act><United States National Institutes of Health><Universities><Work><Workshop><Writing><career><college><collegiate><community college><computational infrastructure><computational resources><computer infrastructure><computing resources><data sharing><developmental><driving><experience><faculty development><faculty professional development><faculty support><health care service><improved><innovate><innovation><innovative><instructor training><instrumentation><intern><investigator training><junior college><lesson plans><multidisciplinary><new technology><next generation><novel technologies><operation><operations><pilot study><primarily undergraduate institution><programs><research faculty><resection><student mentoring><student research><student-led learning><student-led research><success><synergism><teacher development><tool><translational research center><translational sciences center><two year college><undergrad><undergraduate><undergraduate research><undergraduate student><underrepresented minority student><voucher>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Peter R Hoffmann

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 28/100

Solid budget

Active award

Team-scale grant

$313,000

FY 2025

Project Title

HAWAII INBRE V PROGRAM - Omics-driven study of microplastics' impact on primary human placental cells

Grant Number:

3P20GM103466-24S1

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2001

End Date:

4/30/2028

Project Abstract

OVERALL SUMMARY The Hawaii Institutional Development Award (IDeA) Network of Biomedical Research Excellence (HI-INBRE) is a collaborative outreach partnership between the University of Hawaii at Manoa (UHM), the state’s Primarily Undergraduate Institutions (PUIs) and University of Hawaii Community C...

Research Terms

<2 year college><Applications Grants><Award><Bioinformatics><Biomedical Research><COBRE><Career Choice><Career Path><Cell Body><Cells><Cells Placenta-Tissue><Center of Biomedical Research Excellence><Centers of Research Excellence><Clinical Research><Clinical Study><Collaborations><Communication><Communities><Curriculum><Data><Data Science><Data Science Core><Data Science Resource Core><Degree program><Development><Education><Educational Curriculum><Educational aspects><Educational process of instructing><Employment Opportunities><Faculty><Faculty Education><Faculty Training><Fostering><Funding><Funding Mechanisms><Goals><Grant Proposals><Hawaii><Health Benefit><Human><Infrastructure><Institution><Instruction><Investigators><Investments><Knowledge><Leadership><Mentors><Methodology><Modern Man><Normal Placentoma><P01 Mechanism><P01 Program><Placenta><Placenta Embryonic Tissue><Placentome><Plastics><Postbaccalaureate><Postdoc><Postdoctoral Fellow><Program Project Grant><Program Research Project Grants><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Recruitment Activity><Research><Research Associate><Research Design><Research Grants><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resource Sharing><Resources><Role><Science><Seasons><Structure><Student recruitment><Students><Study Type><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Teaching><Technology><Training><Translational Research Enterprise><Universities><Workforce Development><active recruitment><career><career aspiration><career development><career interest><career pathway><career track><certificate program><community college><data science education><data sharing><developmental><experience><faculty development><faculty professional development><faculty research><hands on research><health science research><improved><instructor training><instrumentation><interest><junior college><lesson plans><meeting><meetings><outreach><post-doc><post-doctoral><post-doctoral trainee><postbac><postbacc><primarily undergraduate institution><programs><research associates><social role><student research><student training><student-led research><study design><success><teacher development><translation research enterprise><translational research program><two year college><undergrad><undergraduate><undergraduate student>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Juan Pablo Lewinger

UNIVERSITY OF SOUTHERN CALIFORNIA, Los Angeles, CA

Exploratory lead · 28/100

Training-friendly

Active award

$246,244

FY 2025

Project Title

LA’s Biostatistics and Data Science Training Program (LA’s BeST)

Grant Number:

5R25HL161788-04

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2022

End Date:

7/31/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT Health disparities in our nation are acute, increasing, and known to be caused by many factors. A multi- faceted approach by multi-disciplinary teams of scientists is needed to properly tackle this chronic and growing problem. Increasing the number of biomedical research scientists is one k...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KIMBERLY D SIEGMUND

UNIVERSITY OF SOUTHERN CALIFORNIA, Los Angeles, CA

Exploratory lead · 28/100

Training-friendly

Active award

$246,244

FY 2025

Project Title

LA’s Biostatistics and Data Science Training Program (LA’s BeST)

Grant Number:

5R25HL161788-04

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2022

End Date:

7/31/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT Health disparities in our nation are acute, increasing, and known to be caused by many factors. A multi- faceted approach by multi-disciplinary teams of scientists is needed to properly tackle this chronic and growing problem. Increasing the number of biomedical research scientists is one k...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MELISSA A HARRINGTON

DELAWARE STATE UNIVERSITY, DOVER, DE

Exploratory lead · 28/100

Training-friendly

Active award

$108,000

FY 2025

Project Title

A Summer Undergraduate Research Program in Neuroscience at an HBCU

Grant Number:

5R25NS095371-10

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

12/1/2020

End Date:

11/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

A Summer Undergraduate Research Program in Neuroscience at an HBCU - This proposal is for a renewal of our R25 grant supporting a summer undergraduate research program in neuroscience. The organizing center of our undergraduate research program is the Delaware Center for Neuroscience Research, an in...

Research Terms

<2 year college><African American><Afro American><Afroamerican><Area><Baccalaureate Degree><Bachelor's Degree><Behavioral Research><Behavioral Sciences><Biomedical Research><CEGP><COBRE><Cancer Education Grant><Cancer Education Grant (R25)><Cancer Education Grant Program><Cancer Education Program (R25)><Center of Biomedical Research Excellence><Centers of Research Excellence><Communities><Counselor><Delaware><Development><Doctor of Philosophy><Educational workshop><Enrollment><Faculty><Funding><Graduate Degree><Grant><HBCUs><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Individuals from minority><Individuals of minority><Institution><Investigators><Length><Minority><Minority Groups><Minority People><Minority Population><Minority individual><NIGMS><National Institute of General Medical Sciences><Neurosciences><Neurosciences Research><P01 Mechanism><P01 Program><Participant><Pennsylvania><Ph.D.><PhD><Play><Position><Positioning Attribute><Preparation><Problem Solving><Professional counselor><Program Project Grant><Program Research Project Grants><R-Series Research Projects><R01 Mechanism><R01 Program><R25 Grant><R25E Award><Reading><Research><Research Grants><Research Personnel><Research Program Projects><Research Project Grants><Research Projects><Researchers><STEM class><STEM course><STEM discipline><STEM field><STEM major><Scholars Program><Schools><Science><Scientist><Self Efficacy><Students><Undergraduate Degree><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Universities><Workshop><college><collegiate><community college><conference><convention><design><designing><developmental><enroll><enthusiastic atmosphere><enthusiastic environment><experience><graduate school><inter-institutional><interest><junior college><literacy><meeting><meetings><member><preparations><programs><recruit><science, technology, engineering and math class><science, technology, engineering and math course><science, technology, engineering and math discipline><science, technology, engineering and math field><science, technology, engineering and math major><science, technology, engineering and mathematics class><science, technology, engineering and mathematics course><science, technology, engineering and mathematics discipline><science, technology, engineering and mathematics field><science, technology, engineering and mathematics major><scientific literacy><scientifically literate><skills><student engagement><student motivation><student participation><success><summer program><summer research><summer session><summer undergraduate training><summit><supportive atmosphere><supportive environment><symposia><symposium><technical college><technical school><two year college><under representation of groups><under represented groups><under represented people><under represented populations><undergrad><undergraduate><undergraduate research experience><undergraduate research opportunities><undergraduate research programs><undergraduate student><undergraduate summer program><undergraduate summer research><underrepresentation of groups><underrepresented people><virtual>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DAVID P. CARBONE

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 26/100

Above-average budget

Team-scale grant

$683,484

FY 2025

Project Title

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Grant Number:

3UG1CA233259-06S1

Activity Code:

UG1

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

1/2/2025

End Date:

2/28/2026

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ABSTRACT The ECOG-ACRIN Thoracic Integrated Translational Research Center (EA-ITSC) comprises a team of accomplished researchers with a proven track record of collaborative work to improve outcomes for patients with lung cancer. The EA-ITSC, funded in 2014 by the NCI (U10) at the sam...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ticiana Leal

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 26/100

Above-average budget

Team-scale grant

$683,484

FY 2025

Project Title

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Grant Number:

3UG1CA233259-06S1

Activity Code:

UG1

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

1/2/2025

End Date:

2/28/2026

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ABSTRACT The ECOG-ACRIN Thoracic Integrated Translational Research Center (EA-ITSC) comprises a team of accomplished researchers with a proven track record of collaborative work to improve outcomes for patients with lung cancer. The EA-ITSC, funded in 2014 by the NCI (U10) at the sam...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Charles M. Rudin

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 26/100

Above-average budget

Team-scale grant

$683,484

FY 2025

Project Title

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Grant Number:

3UG1CA233259-06S1

Activity Code:

UG1

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

1/2/2025

End Date:

2/28/2026

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ABSTRACT The ECOG-ACRIN Thoracic Integrated Translational Research Center (EA-ITSC) comprises a team of accomplished researchers with a proven track record of collaborative work to improve outcomes for patients with lung cancer. The EA-ITSC, funded in 2014 by the NCI (U10) at the sam...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LAURIE LUCAS

FOUR POINTS TECHNOLOGY, LLC, CHANTILLY, VA

Exploratory lead · 24/100

Large award

$7,044,534

FY 2025

Project Title

NHLBI SCIENTIFIC REVIEW AND SCIENTIFIC PORTFOLIO ANALYSIS (SR/SPA) SOLUTION AND SUPPORT SERVICES WITH ARPA-H SUPPORT (SR/SPA) SERVICES

Grant Number:

316201500034W-P00006-759202300001-1

Activity Code:

N02

Mechanism:

R and D Contracts

Agency:

NIH

Start Date:

9/19/2023

End Date:

3/18/2026

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

The National Heart Lung and Blood Institute’s (NHLBI) Information Technology and Applications Center (ITAC) guides and supports the NHLBI administrative and scientific staff in the development and effective use of IT applications and services, it collaborates with other NHLBI Divisions, Offices, and...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Birgit Schilling

BUCK INSTITUTE FOR RESEARCH ON AGING, NOVATO, CA

Exploratory lead · 24/100

Large award

$1,759,412

FY 2025

Project Title

timsTOF fleX MALDI-2 for Spatial Molecular Imaging

Grant Number:

1S10OD038264-01

Activity Code:

S10

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2025

End Date:

3/31/2026

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT This shared instrumentation proposal seeks funding for the purchase of a Bruker ‘timsTOF fleX MALDI-2 for Spatial Molecular Imaging’ including a bundled HTX M3+ sprayer. This new mass spectrometry (MS) platform will facilitate ongoing and future scientific research to spatia...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAM M BRICKMAN

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 24/100

Active award

Team-scale grant

$242,414

FY 2026

Project Title

Enhancing Alzheimer's-related research in rural South Africa with portable MRI

Grant Number:

5UG3AG090558-02

Activity Code:

UG3

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2025

End Date:

1/31/2028

Project Abstract

PROJECT SUMMARY This project will incorporate portable, low-field brain magnetic resonance imaging (MRI) into a population- representative study of Alzheimer’s disease (AD) and related dementias (ADRD) in rural South Africa, transforming the ability to assess ADRD-related brain atrophy and cerebrova...

Research Terms

<21+ years old><AD and related dementia><AD dementia><AD related dementia><ADRD><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adult><Adult Human><Affect><Africa><African><Age><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><Amyloid><Amyloid Substance><Assay><Atrophic><Atrophy><Bioassay><Biological Assay><Biological Markers><Blood><Blood Plasma><Blood Reticuloendothelial System><Brain Vascular Disorders><Brain imaging><Cerebrovascular Disease><Cerebrovascular Disorders><Clinical><Clinical Data><Cognition><Cognitive><Collaborations><Communication><Communities><Community Health><Consensus><Coupled><Data><Data Collection><Dementia><Development><Diagnostic><Dysfunction><Ensure><Epidemiology><Functional disorder><Future><General Radiology><Goals><HIV><Health><Health Care Facility><Health Facilities><Human Immunodeficiency Viruses><Incidence><Incidental Findings><Infrastructure><Interview><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Investigators><LAV-HTLV-III><LMIC><Leadership><Longitudinal Studies><Longitudinal Surveys><Lumbar Puncture><Lymphadenopathy-Associated Virus><MR Imaging><MR Tomography><MRI><MRI Scans><MRIs><MT-bound tau><Magnetic Resonance Imaging><Magnetic Resonance Imaging Scan><Measurement><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Molecular><NMR Imaging><NMR Tomography><Nerve Degeneration><Neurologic Examination><Neuron Degeneration><Neurosciences><Nuclear Magnetic Resonance Imaging><Outcome><PET><PET Scan><PET imaging><PETSCAN><PETT><Participant><Pathogenesis><Phase><Physiopathology><Plasma><Plasma Serum><Population><Positron Emission Tomography Medical Imaging><Positron Emission Tomography Scan><Positron-Emission Tomography><Prevalence><Primary Senile Degenerative Dementia><Protocol><Protocols documentation><Publications><Rad.-PET><Radiology><Radiology Specialty><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Reticuloendothelial System, Serum, Plasma><Risk Factors><Rural><Scanning><Scientific Publication><Scientist><South Africa><South African><Spinal Puncture><Survey Instrument><Surveys><System><Technology><Testing><Universities><Virus-HIV><Wit><Work><Zeugmatography><adulthood><aged><ages><bio-markers><biologic marker><biomarker><brain MR imaging><brain MRI><brain atrophy><brain magnetic resonance imaging><brain vascular disease><brain vascular dysfunction><brain visualization><care facilities><cerebral MR imaging><cerebral MRI><cerebral atrophy><cerebral magnetic resonance imaging><cerebral vascular disease><cerebral vascular dysfunction><cerebrovascular dysfunction><cognitive assessment><cognitive testing><cohort><community-based health><computerized data processing><cortical atrophy><cost><data exchange><data processing><data transfer><data transmission><dementia risk><developmental><epidemiologic><epidemiological><global health><imaging study><informant><intracranial vascular dysfunction><long-term study><longitudinal outcome studies><longitudinal research study><low and middle-income countries><microtubule bound tau><microtubule-bound tau><neural degeneration><neural imaging><neuro-imaging><neurodegeneration><neurodegenerative><neuroimaging><neurological degeneration><neurological imaging><neuronal degeneration><pathophysiology><population based><portability><positron emission tomographic (PET) imaging><positron emission tomographic imaging><positron emitting tomography><primary degenerative dementia><regional atrophy><risk factor for dementia><risk for dementia><rural South Africa><rural area><rural locality><rural location><rural place><rural region><rural setting><senile dementia of the Alzheimer type><social determinants><social factors><social health determinants><sociodeterminant><tau><tau Proteins><tau factor><training opportunity><vascular component><vascular factor><τ Proteins>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Victor Mngomezulu

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 24/100

Active award

Team-scale grant

$242,414

FY 2026

Project Title

Enhancing Alzheimer's-related research in rural South Africa with portable MRI

Grant Number:

5UG3AG090558-02

Activity Code:

UG3

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2025

End Date:

1/31/2028

Project Abstract

PROJECT SUMMARY This project will incorporate portable, low-field brain magnetic resonance imaging (MRI) into a population- representative study of Alzheimer’s disease (AD) and related dementias (ADRD) in rural South Africa, transforming the ability to assess ADRD-related brain atrophy and cerebrova...

Research Terms

<21+ years old><AD and related dementia><AD dementia><AD related dementia><ADRD><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adult><Adult Human><Affect><Africa><African><Age><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><Amyloid><Amyloid Substance><Assay><Atrophic><Atrophy><Bioassay><Biological Assay><Biological Markers><Blood><Blood Plasma><Blood Reticuloendothelial System><Brain Vascular Disorders><Brain imaging><Cerebrovascular Disease><Cerebrovascular Disorders><Clinical><Clinical Data><Cognition><Cognitive><Collaborations><Communication><Communities><Community Health><Consensus><Coupled><Data><Data Collection><Dementia><Development><Diagnostic><Dysfunction><Ensure><Epidemiology><Functional disorder><Future><General Radiology><Goals><HIV><Health><Health Care Facility><Health Facilities><Human Immunodeficiency Viruses><Incidence><Incidental Findings><Infrastructure><Interview><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Investigators><LAV-HTLV-III><LMIC><Leadership><Longitudinal Studies><Longitudinal Surveys><Lumbar Puncture><Lymphadenopathy-Associated Virus><MR Imaging><MR Tomography><MRI><MRI Scans><MRIs><MT-bound tau><Magnetic Resonance Imaging><Magnetic Resonance Imaging Scan><Measurement><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Molecular><NMR Imaging><NMR Tomography><Nerve Degeneration><Neurologic Examination><Neuron Degeneration><Neurosciences><Nuclear Magnetic Resonance Imaging><Outcome><PET><PET Scan><PET imaging><PETSCAN><PETT><Participant><Pathogenesis><Phase><Physiopathology><Plasma><Plasma Serum><Population><Positron Emission Tomography Medical Imaging><Positron Emission Tomography Scan><Positron-Emission Tomography><Prevalence><Primary Senile Degenerative Dementia><Protocol><Protocols documentation><Publications><Rad.-PET><Radiology><Radiology Specialty><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Reticuloendothelial System, Serum, Plasma><Risk Factors><Rural><Scanning><Scientific Publication><Scientist><South Africa><South African><Spinal Puncture><Survey Instrument><Surveys><System><Technology><Testing><Universities><Virus-HIV><Wit><Work><Zeugmatography><adulthood><aged><ages><bio-markers><biologic marker><biomarker><brain MR imaging><brain MRI><brain atrophy><brain magnetic resonance imaging><brain vascular disease><brain vascular dysfunction><brain visualization><care facilities><cerebral MR imaging><cerebral MRI><cerebral atrophy><cerebral magnetic resonance imaging><cerebral vascular disease><cerebral vascular dysfunction><cerebrovascular dysfunction><cognitive assessment><cognitive testing><cohort><community-based health><computerized data processing><cortical atrophy><cost><data exchange><data processing><data transfer><data transmission><dementia risk><developmental><epidemiologic><epidemiological><global health><imaging study><informant><intracranial vascular dysfunction><long-term study><longitudinal outcome studies><longitudinal research study><low and middle-income countries><microtubule bound tau><microtubule-bound tau><neural degeneration><neural imaging><neuro-imaging><neurodegeneration><neurodegenerative><neuroimaging><neurological degeneration><neurological imaging><neuronal degeneration><pathophysiology><population based><portability><positron emission tomographic (PET) imaging><positron emission tomographic imaging><positron emitting tomography><primary degenerative dementia><regional atrophy><risk factor for dementia><risk for dementia><rural South Africa><rural area><rural locality><rural location><rural place><rural region><rural setting><senile dementia of the Alzheimer type><social determinants><social factors><social health determinants><sociodeterminant><tau><tau Proteins><tau factor><training opportunity><vascular component><vascular factor><τ Proteins>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stephen Tollman

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 24/100

Active award

Team-scale grant

$242,414

FY 2026

Project Title

Enhancing Alzheimer's-related research in rural South Africa with portable MRI

Grant Number:

5UG3AG090558-02

Activity Code:

UG3

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2025

End Date:

1/31/2028

Project Abstract

PROJECT SUMMARY This project will incorporate portable, low-field brain magnetic resonance imaging (MRI) into a population- representative study of Alzheimer’s disease (AD) and related dementias (ADRD) in rural South Africa, transforming the ability to assess ADRD-related brain atrophy and cerebrova...

Research Terms

<21+ years old><AD and related dementia><AD dementia><AD related dementia><ADRD><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adult><Adult Human><Affect><Africa><African><Age><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><Amyloid><Amyloid Substance><Assay><Atrophic><Atrophy><Bioassay><Biological Assay><Biological Markers><Blood><Blood Plasma><Blood Reticuloendothelial System><Brain Vascular Disorders><Brain imaging><Cerebrovascular Disease><Cerebrovascular Disorders><Clinical><Clinical Data><Cognition><Cognitive><Collaborations><Communication><Communities><Community Health><Consensus><Coupled><Data><Data Collection><Dementia><Development><Diagnostic><Dysfunction><Ensure><Epidemiology><Functional disorder><Future><General Radiology><Goals><HIV><Health><Health Care Facility><Health Facilities><Human Immunodeficiency Viruses><Incidence><Incidental Findings><Infrastructure><Interview><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Investigators><LAV-HTLV-III><LMIC><Leadership><Longitudinal Studies><Longitudinal Surveys><Lumbar Puncture><Lymphadenopathy-Associated Virus><MR Imaging><MR Tomography><MRI><MRI Scans><MRIs><MT-bound tau><Magnetic Resonance Imaging><Magnetic Resonance Imaging Scan><Measurement><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Molecular><NMR Imaging><NMR Tomography><Nerve Degeneration><Neurologic Examination><Neuron Degeneration><Neurosciences><Nuclear Magnetic Resonance Imaging><Outcome><PET><PET Scan><PET imaging><PETSCAN><PETT><Participant><Pathogenesis><Phase><Physiopathology><Plasma><Plasma Serum><Population><Positron Emission Tomography Medical Imaging><Positron Emission Tomography Scan><Positron-Emission Tomography><Prevalence><Primary Senile Degenerative Dementia><Protocol><Protocols documentation><Publications><Rad.-PET><Radiology><Radiology Specialty><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Reticuloendothelial System, Serum, Plasma><Risk Factors><Rural><Scanning><Scientific Publication><Scientist><South Africa><South African><Spinal Puncture><Survey Instrument><Surveys><System><Technology><Testing><Universities><Virus-HIV><Wit><Work><Zeugmatography><adulthood><aged><ages><bio-markers><biologic marker><biomarker><brain MR imaging><brain MRI><brain atrophy><brain magnetic resonance imaging><brain vascular disease><brain vascular dysfunction><brain visualization><care facilities><cerebral MR imaging><cerebral MRI><cerebral atrophy><cerebral magnetic resonance imaging><cerebral vascular disease><cerebral vascular dysfunction><cerebrovascular dysfunction><cognitive assessment><cognitive testing><cohort><community-based health><computerized data processing><cortical atrophy><cost><data exchange><data processing><data transfer><data transmission><dementia risk><developmental><epidemiologic><epidemiological><global health><imaging study><informant><intracranial vascular dysfunction><long-term study><longitudinal outcome studies><longitudinal research study><low and middle-income countries><microtubule bound tau><microtubule-bound tau><neural degeneration><neural imaging><neuro-imaging><neurodegeneration><neurodegenerative><neuroimaging><neurological degeneration><neurological imaging><neuronal degeneration><pathophysiology><population based><portability><positron emission tomographic (PET) imaging><positron emission tomographic imaging><positron emitting tomography><primary degenerative dementia><regional atrophy><risk factor for dementia><risk for dementia><rural South Africa><rural area><rural locality><rural location><rural place><rural region><rural setting><senile dementia of the Alzheimer type><social determinants><social factors><social health determinants><sociodeterminant><tau><tau Proteins><tau factor><training opportunity><vascular component><vascular factor><τ Proteins>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Victor G. Davila-Roman

NATIONAL UNIVERSITY OF RWANDA, RWANDA

Exploratory lead · 18/100

Active award

Team-scale grant

$199,646

FY 2025

Project Title

SYNthetic Healthcare DAta Platform for Data SciEnce Training ("SYNAPSE")

Grant Number:

5UE5HL172181-03

Activity Code:

UE5

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/20/2023

End Date:

7/31/2026

Project Abstract

PROJECT SUMMARY/ABSTRACT This DS-I Africa UE5 application involves a partnership between University of Rwanda (UR), African Institute for Mathematical Sciences (AIMS), Washington University in St. Louis (WUSTL), and MDClone (software company that generates computationally-derived synthetic healthcar...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

RANDI E FORAKER

NATIONAL UNIVERSITY OF RWANDA, RWANDA

Exploratory lead · 18/100

Active award

Team-scale grant

$199,646

FY 2025

Project Title

SYNthetic Healthcare DAta Platform for Data SciEnce Training ("SYNAPSE")

Grant Number:

5UE5HL172181-03

Activity Code:

UE5

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/20/2023

End Date:

7/31/2026

Project Abstract

PROJECT SUMMARY/ABSTRACT This DS-I Africa UE5 application involves a partnership between University of Rwanda (UR), African Institute for Mathematical Sciences (AIMS), Washington University in St. Louis (WUSTL), and MDClone (software company that generates computationally-derived synthetic healthcar...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

David Tumusiime

NATIONAL UNIVERSITY OF RWANDA, RWANDA

Exploratory lead · 18/100

Active award

Team-scale grant

$199,646

FY 2025

Project Title

SYNthetic Healthcare DAta Platform for Data SciEnce Training ("SYNAPSE")

Grant Number:

5UE5HL172181-03

Activity Code:

UE5

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/20/2023

End Date:

7/31/2026

Project Abstract

PROJECT SUMMARY/ABSTRACT This DS-I Africa UE5 application involves a partnership between University of Rwanda (UR), African Institute for Mathematical Sciences (AIMS), Washington University in St. Louis (WUSTL), and MDClone (software company that generates computationally-derived synthetic healthcar...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Cesar Augusto Arias

METHODIST HOSPITAL RESEARCH INSTITUTE, HOUSTON, TX

Exploratory lead · 18/100

Active award

Career award

$126,566

FY 2025

Project Title

POR and Training Program on Multidrug-Resistant Organisms

Grant Number:

5K24AI121296-10

Activity Code:

K24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/25/2016

End Date:

6/30/2026

Project Abstract

ABSTRACT Antimicrobial resistance (AMR) is one of the most pressing public health priorities. AMR is thought to be re- sponsible for more than 35,000 deaths in the US with a projection of 300 million deaths worldwide by 2050. My original K24 application sought to increase my ability to conduct patie...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Clement Adebayo Adebamowo

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Exploratory lead · 10/100

Active award

$248,306

FY 2025

Project Title

Strengthening Surgical Scientists Capacity for NCD-Lifespan Research (SSSCAR) Program

Grant Number:

1D43TW013007-01

Activity Code:

D43

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2025

End Date:

5/31/2030

Project Abstract

Strengthening Surgical Scientists Capacity for NCD-Lifespan Research (SSSCAR) Program Project summary Non-communicable diseases (NCD) are now the most common causes of morbidity and mortality globally and their prevalence is rising, particularly in low- and middle-income countries (LMIC). The risin...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ouathek Ouerfelli

SLOAN-KETTERING INST CAN RESEARCH, NEW YORK, NY

Exploratory lead · 10/100

Active award

$247,416

FY 2025

Project Title

Organic Synthesis at the Service of Biology and Medicine

Grant Number:

5R50CA243895-07

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/17/2019

End Date:

8/31/2029

Project Abstract

Abstract: Dr. Ouathek Ouerfelli directs the Organic Synthesis Core Facility (OSCF) at Memorial Sloan Kettering Cancer Center (MSK) since 2004. He is committed to continue to provide chemistry services for the MSK research community and the development of new tools and therapeutic agents for cancer d...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Roman Gulati

FRED HUTCHINSON CANCER CENTER, SEATTLE, WA

Exploratory lead · 10/100

Active award

$245,182

FY 2025

Project Title

Statistical modeling to support population and translational cancer research

Grant Number:

5R50CA221836-09

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/20/2017

End Date:

8/31/2028

Project Abstract

PROJECT SUMMARY/ABSTRACT Developing effective strategies for cancer control requires rigorous analysis of empirical evidence and similarly rigorous analysis to address inevitable gaps in empirical evidence. During the previous project period, the Principal Investigator provided critical statistical ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Prashant Kumar Singh

ROSWELL PARK CANCER INSTITUTE CORP, BUFFALO, NY

Exploratory lead · 10/100

Active award

$236,003

FY 2025

Project Title

Director Genomics Shared Resource

Grant Number:

5R50CA283805-02

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2024

End Date:

8/31/2029

Project Abstract

PROJECT SUMMARY / ABSTRACT The current application seeks salary support for Prashant K. Singh, PhD who serves as the Director of the Genomics Shared Resource (GSR) at Roswell Park Comprehensive Cancer Center (Roswell Park) and Assistant Professor in the Department of Cancer Genetics and Genomics. Dr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Brian E. Eckenroth

UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, BURLINGTON, VT

Exploratory lead · 10/100

Active award

$184,769

FY 2025

Project Title

Structural Investigations Critical to Understanding DNA Damage Recognition and Repair in Cancer

Grant Number:

2R50CA233185-06A1

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/21/2018

End Date:

8/31/2030

Project Abstract

SUMMARY The human genome is under constant threat of damage through both exogenous (ultraviolet rays, chemicals from cigarette smoke) and endogenous (oxygen for normal cellular respiration) sources. Safeguarding genomic integrity from damage is fundamental to human health and prevention of disease s...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Adam L Burrack

UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MN

Exploratory lead · 10/100

Active award

$119,858

FY 2025

Project Title

Elucidating and overcoming T cell dysfunction in pancreatic cancer

Grant Number:

1R50CA293827-01A1

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/7/2025

End Date:

7/31/2030

Project Abstract

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDA) is a lethal disease notoriously resistant to therapy including immune checkpoint blockade. Meanwhile, immunotherapy targeting the PD-1:PD-L1 pathway is inducing stunning clinical outcomes in other advanced malignancies. However, the underlying m...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Linda Sangalli

MIDWESTERN UNIVERSITY, DOWNERS GROVE, IL

Exploratory lead · 10/100

Active award

$105,450

FY 2025

Project Title

Feasibility of a New Methodology for Dental Education in Temporomandibular Disorders through Virtual Patient-Based Learning

Grant Number:

1R03DE034042-01A1

Activity Code:

R03

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2025

End Date:

6/30/2027

Project Abstract

PROJECT SUMMARY/ABSTRACT Temporomandibular disorders (TMD) involve pain and dysfunction in the masticatory muscles, temporomandibular joint, and associated structures, affecting about 30% of the population. Despite its prevalence, effective TMD management faces challenges due to a limited understand...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kavita Mallya

UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE

Exploratory lead · 10/100

Active award

$97,305

FY 2025

Project Title

Novel Models and Biorepository For Early Detection And Therapeutic Intervention Of Pancreatic Cancer

Grant Number:

1R50CA305093-01

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2030

Project Abstract

Project Summary I am a Research Manager in Dr. Surinder Batra’s lab at the University of Nebraska Medical Center (UNMC). Dr. Batra’s laboratory is engaged in basic and translational research in pancreatic cancer and uses several genetically engineered mouse models (GEMMs) to study molecular mechanis...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ANNA S. GUKOVSKAYA

VA GREATER LOS ANGELES HEALTHCARE SYSTEM, LOS ANGELES, CA

Exploratory lead · 10/100

Active award

$0

FY 2026

Project Title

BLRD Research Career Scientist Award Application

Grant Number:

5IK6BX005793-05

Activity Code:

IK6

Mechanism:

Other

Agency:

VA

Start Date:

10/1/2021

End Date:

9/30/2026

Project Abstract

Pancreatitis is a potentially fatal disease of exocrine pancreas, with significant morbidity and mortality, and a heavy burden on the US healthcare system. The disease is common in Veterans patient population. Its mechanism remains obscure, and no specific or effective treatment is available. Pancre...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Wendy B Bollag

CHARLIE NORWOOD VA MEDICAL CENTER, AUGUSTA, GA

Exploratory lead · 0/100

$0

FY 2025

Project Title

BLRD Research Career Scientist Award Application

Grant Number:

5IK6BX005691-05

Activity Code:

IK6

Mechanism:

Other

Agency:

VA

Start Date:

4/1/2021

End Date:

3/31/2026

Project Abstract

Project Summary/Abstract This application requests the appointment of Dr. Wendy Bollag, a Research Physiologist at the Charlie Norwood VA Medical Center in Augusta, Georgia and a Professor of Physiology at the affiliate institution (Augusta University), to the position of Research Career Scientist....

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

NIH Grant Search by PI — Funded Principal Investigator Finder

Search NIH grants by research area to find funded PIs

Search Results

Opportunity Digest

CAROL A. DERBY

Project Title

Project Abstract

Research Terms

Panagiotis Konstantinopoulos

Project Title

Project Abstract

Research Terms

Joyce Liu

Project Title

Project Abstract

Research Terms

URSULA Anne MATULONIS

Project Title

Project Abstract

Research Terms

Dario C Altieri

Project Title

Project Abstract

Research Terms

JILL M DANIEL

Project Title

Project Abstract

Research Terms

Darrell N. Kotton

Project Title

Project Abstract

Research Terms

John Sai Keong Kauwe

Project Title

Project Abstract

Research Terms

Sterling M McPherson

Project Title

Project Abstract

Research Terms

Zahi A. Fayad

Project Title

Project Abstract

Research Terms

Joren C Madsen

Project Title

Project Abstract

Research Terms

Bruce E. Landon

Project Title

Project Abstract

Research Terms

John Michael McWilliams

Project Title

Project Abstract

Research Terms

Alexander Drilon

Project Title

Project Abstract

Research Terms

Piro Lito

Project Title

Project Abstract

Research Terms

PAUL M. LIEBERMAN

Project Title

Project Abstract

Research Terms

James A. DeCaprio

Project Title

Project Abstract

Research Terms

ELLIS L REINHERZ

Project Title

Project Abstract

Research Terms

Jennifer S Pollock

Project Title

Project Abstract

Research Terms